,Unnamed: 0,Conditions,Drug,Smiles,Phases,Study Status,Disease
6568,5636,Renal Impairment|Renal Disease|Kidney Disease,Nitazoxanide,CC(=O)OC1=CC=CC=C1C(=O)NC2=NC=C(S2)[N+](=O)[O-],PHASE1,,urinary_system_disease
6567,5631,Advanced or Metastatic Hepatocellular Cancer|Advanced or Metastatic Ovarian Cancer|Metastatic Renal Cell Cancer|Advanced or Metastatic Gastric Carcinoma,Tasquinimod,CN1C2=C(C(=CC=C2)OC)C(=C(C1=O)C(=O)N(C)C3=CC=C(C=C3)C(F)(F)F)O,PHASE2,,urinary_system_disease
6566,5585,"Sepsis|Community-acquired Pneumonia|Urinary Tract Infections|Cholecystitis, Acute|Cholangitis Acute|Intraabdominal Infections",Allocetra,,PHASE2,,urinary_system_disease
6565,5584,Healthy|Renal Impairment,Cenerimod,CCC1=C(C(=CC(=C1)C2=NOC(=N2)C3=CC(=NC(=C3)OC)C4CCCC4)C)OCC(CO)O,PHASE1,,urinary_system_disease
6564,5582,Diabetic Kidney Disease|Diabetic Nephropathy|Diabetes Mellitus|Glucagon-Like Peptide 1,Lixisenatide,CCC(C)C(C(=O)NC(CCC(=O)O)C(=O)NC(CC1=CNC2=CC=CC=C21)C(=O)NC(CC(C)C)C(=O)NC(CCCCN)C(=O)NC(CC(=O)N)C(=O)NCC(=O)NCC(=O)N3CCCC3C(=O)NC(CO)C(=O)NC(CO)C(=O)NCC(=O)NC(C)C(=O)N4CCCC4C(=O)N5CCCC5C(=O)NC(CO)C(=O)NC(CCCCN)C(=O)NC(CCCCN)C(=O)NC(CCCCN)C(=O)NC(CCCCN)C(=O)NC(CCCCN)C(=O)NC(CCCCN)C(=O)N)NC(=O)C(CC6=CC=CC=C6)NC(=O)C(CC(C)C)NC(=O)C(CCCNC(=N)N)NC(=O)C(C(C)C)NC(=O)C(C)NC(=O)C(CCC(=O)O)NC(=O)C(CCC(=O)O)NC(=O)C(CCC(=O)O)NC(=O)C(CCSC)NC(=O)C(CCC(=O)N)NC(=O)C(CCCCN)NC(=O)C(CO)NC(=O)C(CC(C)C)NC(=O)C(CC(=O)O)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C(CC7=CC=CC=C7)NC(=O)C(C(C)O)NC(=O)CNC(=O)C(CCC(=O)O)NC(=O)CNC(=O)C(CC8=CNC=N8)N,APPROVED,,urinary_system_disease
6563,5566,"Type 2 Diabetes Mellitus, CKD and Albuminuria",Saxagliptin,C1C2CC2N(C1C#N)C(=O)C(C34CC5CC(C3)CC(C5)(C4)O)N,PHASE2|PHASE3,,urinary_system_disease
6562,5557,Healthy Subjects|Renal Impairments,Levetiracetam,CCC(C(=O)N)N1CCCC1=O,APPROVED,,urinary_system_disease
6561,5554,Chronic Kidney Disease on Hemodialysis|Secondary Hyperparathyroidism,Maxacalcitol,CC(C1CCC2C1(CCCC2=CC=C3CC(CC(C3=C)O)O)C)OCCC(C)(C)O,PHASE2,,urinary_system_disease
6560,5533,Renal Insufficiency,Certoparin,CC(=O)NC1C(C(C(OC1O)COS(=O)(=O)O)OC2C(C(C(C(O2)C(=O)O)OC3C(C(C(C(O3)CO)OC4C(C(C(C(O4)C(=O)O)O)O)OS(=O)(=O)O)OS(=O)(=O)O)NS(=O)(=O)O)O)OS(=O)(=O)O)O,PHASE1|PHASE2,,urinary_system_disease
6559,5523,Advanced Kidney Cancer|Kidney Cancer|Clear Cell Renal Cell Carcinoma,Guadecitabine,C1C(C(OC1N2C=NC3=C2N=C(NC3=O)N)COP(=O)(O)OC4CC(OC4CO)N5C=NC(=NC5=O)N)O,PHASE1|PHASE2,,urinary_system_disease
6558,5516,Non-Muscle Invasive Bladder Urothelial Carcinoma|Recurrent Non-Muscle Invasive Bladder Urothelial Carcinoma,Apalutamide,CNC(=O)C1=C(C=C(C=C1)N2C(=S)N(C(=O)C23CCC3)C4=CC(=C(N=C4)C#N)C(F)(F)F)F,PHASE1,,urinary_system_disease
6557,5480,Kidney Disease,Bremelanotide,CCCCC(C(=O)NC1CC(=O)NCCCCC(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC1=O)CC2=CN=CN2)CC3=CC=CC=C3)CCCN=C(N)N)CC4=CNC5=CC=CC=C54)C(=O)O)NC(=O)C,PHASE2,,urinary_system_disease
6556,5454,Nephrotic Syndrome,Alirocumab,,PHASE2,,urinary_system_disease
6555,5445,Chronic Hepatitis C|End Stage Renal Disease,Boceprevir,CC1(C2C1C(N(C2)C(=O)C(C(C)(C)C)NC(=O)NC(C)(C)C)C(=O)NC(CC3CCC3)C(=O)C(=O)N)C,APPROVED,,urinary_system_disease
6554,5431,Schizophrenia|Renal Impairment,Paliperidone,CC1=C(C(=O)N2CCCC(C2=N1)O)CCN3CCC(CC3)C4=NOC5=C4C=CC(=C5)F,PHASE1,,urinary_system_disease
6553,5413,Kidney Calculi,Remifentanil,CCC(=O)N(C1=CC=CC=C1)C2(CCN(CC2)CCC(=O)OC)C(=O)OC,APPROVED,,urinary_system_disease
6552,5395,End Stage Renal Disease,Oseltamivir,CCC(CC)OC1C=C(CC(C1NC(=O)C)N)C(=O)OCC,PHASE1,,urinary_system_disease
6551,5355,Advanced Malignant Solid Neoplasm|Bladder Carcinoma|Breast Carcinoma|Cervical Carcinoma|Colon Carcinoma|Colorectal Carcinoma|Endometrial Carcinoma|Esophageal Carcinoma|Gastric Carcinoma|Glioma|Head and Neck Carcinoma|Kidney Carcinoma|Liver and Intrahepatic Bile Duct Carcinoma|Lung Carcinoma|Lymphoma|Malignant Uterine Neoplasm|Melanoma|Multiple Myeloma|Ovarian Carcinoma|Pancreatic Carcinoma|Prostate Carcinoma|Rectal Carcinoma|Recurrent Bladder Carcinoma|Recurrent Breast Carcinoma|Recurrent Cervical Carcinoma|Recurrent Colon Carcinoma|Recurrent Colorectal Carcinoma|Recurrent Esophageal Carcinoma|Recurrent Gastric Carcinoma|Recurrent Glioma|Recurrent Head and Neck Carcinoma|Recurrent Liver Carcinoma|Recurrent Lung Carcinoma|Recurrent Lymphoma|Recurrent Malignant Solid Neoplasm|Recurrent Melanoma|Recurrent Multiple Myeloma|Recurrent Ovarian Carcinoma|Recurrent Pancreatic Carcinoma|Recurrent Prostate Carcinoma|Recurrent Rectal Carcinoma|Recurrent Skin Carcinoma|Recurrent Thyroid Gland Carcinoma|Recurrent Uterine Corpus Cancer|Refractory Lymphoma|Refractory Malignant Solid Neoplasm|Refractory Multiple Myeloma|Skin Carcinoma|Thyroid Gland Carcinoma|Uterine Corpus Cancer,Vismodegib,CS(=O)(=O)C1=CC(=C(C=C1)C(=O)NC2=CC(=C(C=C2)Cl)C3=CC=CC=N3)Cl,PHASE2,,urinary_system_disease
6550,5351,Advanced Malignant Solid Neoplasm|Bladder Carcinoma|Breast Carcinoma|Cervical Carcinoma|Colon Carcinoma|Colorectal Carcinoma|Endometrial Carcinoma|Esophageal Carcinoma|Gastric Carcinoma|Glioma|Head and Neck Carcinoma|Kidney Carcinoma|Liver and Intrahepatic Bile Duct Carcinoma|Lung Carcinoma|Lymphoma|Malignant Uterine Neoplasm|Melanoma|Multiple Myeloma|Ovarian Carcinoma|Pancreatic Carcinoma|Prostate Carcinoma|Rectal Carcinoma|Recurrent Bladder Carcinoma|Recurrent Breast Carcinoma|Recurrent Cervical Carcinoma|Recurrent Colon Carcinoma|Recurrent Colorectal Carcinoma|Recurrent Esophageal Carcinoma|Recurrent Gastric Carcinoma|Recurrent Glioma|Recurrent Head and Neck Carcinoma|Recurrent Liver Carcinoma|Recurrent Lung Carcinoma|Recurrent Lymphoma|Recurrent Malignant Solid Neoplasm|Recurrent Melanoma|Recurrent Multiple Myeloma|Recurrent Ovarian Carcinoma|Recurrent Pancreatic Carcinoma|Recurrent Prostate Carcinoma|Recurrent Rectal Carcinoma|Recurrent Skin Carcinoma|Recurrent Thyroid Gland Carcinoma|Recurrent Uterine Corpus Cancer|Refractory Lymphoma|Refractory Malignant Solid Neoplasm|Refractory Multiple Myeloma|Skin Carcinoma|Thyroid Gland Carcinoma|Uterine Corpus Cancer,Trametinib,CC1=C2C(=C(N(C1=O)C)NC3=C(C=C(C=C3)I)F)C(=O)N(C(=O)N2C4=CC=CC(=C4)NC(=O)C)C5CC5,PHASE2,,urinary_system_disease
6549,5350,Advanced Malignant Solid Neoplasm|Bladder Carcinoma|Breast Carcinoma|Cervical Carcinoma|Colon Carcinoma|Colorectal Carcinoma|Endometrial Carcinoma|Esophageal Carcinoma|Gastric Carcinoma|Glioma|Head and Neck Carcinoma|Kidney Carcinoma|Liver and Intrahepatic Bile Duct Carcinoma|Lung Carcinoma|Lymphoma|Malignant Uterine Neoplasm|Melanoma|Multiple Myeloma|Ovarian Carcinoma|Pancreatic Carcinoma|Prostate Carcinoma|Rectal Carcinoma|Recurrent Bladder Carcinoma|Recurrent Breast Carcinoma|Recurrent Cervical Carcinoma|Recurrent Colon Carcinoma|Recurrent Colorectal Carcinoma|Recurrent Esophageal Carcinoma|Recurrent Gastric Carcinoma|Recurrent Glioma|Recurrent Head and Neck Carcinoma|Recurrent Liver Carcinoma|Recurrent Lung Carcinoma|Recurrent Lymphoma|Recurrent Malignant Solid Neoplasm|Recurrent Melanoma|Recurrent Multiple Myeloma|Recurrent Ovarian Carcinoma|Recurrent Pancreatic Carcinoma|Recurrent Prostate Carcinoma|Recurrent Rectal Carcinoma|Recurrent Skin Carcinoma|Recurrent Thyroid Gland Carcinoma|Recurrent Uterine Corpus Cancer|Refractory Lymphoma|Refractory Malignant Solid Neoplasm|Refractory Multiple Myeloma|Skin Carcinoma|Thyroid Gland Carcinoma|Uterine Corpus Cancer,Taselisib,CC1=NN(C(=N1)C2=CN3CCOC4=C(C3=N2)C=CC(=C4)C5=CN(N=C5)C(C)(C)C(=O)N)C(C)C,PHASE2,,urinary_system_disease
6548,5344,Advanced Malignant Solid Neoplasm|Bladder Carcinoma|Breast Carcinoma|Cervical Carcinoma|Colon Carcinoma|Colorectal Carcinoma|Endometrial Carcinoma|Esophageal Carcinoma|Gastric Carcinoma|Glioma|Head and Neck Carcinoma|Kidney Carcinoma|Liver and Intrahepatic Bile Duct Carcinoma|Lung Carcinoma|Lymphoma|Malignant Uterine Neoplasm|Melanoma|Multiple Myeloma|Ovarian Carcinoma|Pancreatic Carcinoma|Prostate Carcinoma|Rectal Carcinoma|Recurrent Bladder Carcinoma|Recurrent Breast Carcinoma|Recurrent Cervical Carcinoma|Recurrent Colon Carcinoma|Recurrent Colorectal Carcinoma|Recurrent Esophageal Carcinoma|Recurrent Gastric Carcinoma|Recurrent Glioma|Recurrent Head and Neck Carcinoma|Recurrent Liver Carcinoma|Recurrent Lung Carcinoma|Recurrent Lymphoma|Recurrent Malignant Solid Neoplasm|Recurrent Melanoma|Recurrent Multiple Myeloma|Recurrent Ovarian Carcinoma|Recurrent Pancreatic Carcinoma|Recurrent Prostate Carcinoma|Recurrent Rectal Carcinoma|Recurrent Skin Carcinoma|Recurrent Thyroid Gland Carcinoma|Recurrent Uterine Corpus Cancer|Refractory Lymphoma|Refractory Malignant Solid Neoplasm|Refractory Multiple Myeloma|Skin Carcinoma|Thyroid Gland Carcinoma|Uterine Corpus Cancer,Osimertinib,CN1C=C(C2=CC=CC=C21)C3=NC(=NC=C3)NC4=C(C=C(C(=C4)NC(=O)C=C)N(C)CCN(C)C)OC,PHASE2,,urinary_system_disease
6547,5338,Advanced Malignant Solid Neoplasm|Bladder Carcinoma|Breast Carcinoma|Cervical Carcinoma|Colon Carcinoma|Colorectal Carcinoma|Endometrial Carcinoma|Esophageal Carcinoma|Gastric Carcinoma|Glioma|Head and Neck Carcinoma|Kidney Carcinoma|Liver and Intrahepatic Bile Duct Carcinoma|Lung Carcinoma|Lymphoma|Malignant Uterine Neoplasm|Melanoma|Multiple Myeloma|Ovarian Carcinoma|Pancreatic Carcinoma|Prostate Carcinoma|Rectal Carcinoma|Recurrent Bladder Carcinoma|Recurrent Breast Carcinoma|Recurrent Cervical Carcinoma|Recurrent Colon Carcinoma|Recurrent Colorectal Carcinoma|Recurrent Esophageal Carcinoma|Recurrent Gastric Carcinoma|Recurrent Glioma|Recurrent Head and Neck Carcinoma|Recurrent Liver Carcinoma|Recurrent Lung Carcinoma|Recurrent Lymphoma|Recurrent Malignant Solid Neoplasm|Recurrent Melanoma|Recurrent Multiple Myeloma|Recurrent Ovarian Carcinoma|Recurrent Pancreatic Carcinoma|Recurrent Prostate Carcinoma|Recurrent Rectal Carcinoma|Recurrent Skin Carcinoma|Recurrent Thyroid Gland Carcinoma|Recurrent Uterine Corpus Cancer|Refractory Lymphoma|Refractory Malignant Solid Neoplasm|Refractory Multiple Myeloma|Skin Carcinoma|Thyroid Gland Carcinoma|Uterine Corpus Cancer,Ipatasertib,CC1CC(C2=C1C(=NC=N2)N3CCN(CC3)C(=O)C(CNC(C)C)C4=CC=C(C=C4)Cl)O,PHASE2,,urinary_system_disease
6546,5335,Advanced Malignant Solid Neoplasm|Bladder Carcinoma|Breast Carcinoma|Cervical Carcinoma|Colon Carcinoma|Colorectal Carcinoma|Endometrial Carcinoma|Esophageal Carcinoma|Gastric Carcinoma|Glioma|Head and Neck Carcinoma|Kidney Carcinoma|Liver and Intrahepatic Bile Duct Carcinoma|Lung Carcinoma|Lymphoma|Malignant Uterine Neoplasm|Melanoma|Multiple Myeloma|Ovarian Carcinoma|Pancreatic Carcinoma|Prostate Carcinoma|Rectal Carcinoma|Recurrent Bladder Carcinoma|Recurrent Breast Carcinoma|Recurrent Cervical Carcinoma|Recurrent Colon Carcinoma|Recurrent Colorectal Carcinoma|Recurrent Esophageal Carcinoma|Recurrent Gastric Carcinoma|Recurrent Glioma|Recurrent Head and Neck Carcinoma|Recurrent Liver Carcinoma|Recurrent Lung Carcinoma|Recurrent Lymphoma|Recurrent Malignant Solid Neoplasm|Recurrent Melanoma|Recurrent Multiple Myeloma|Recurrent Ovarian Carcinoma|Recurrent Pancreatic Carcinoma|Recurrent Prostate Carcinoma|Recurrent Rectal Carcinoma|Recurrent Skin Carcinoma|Recurrent Thyroid Gland Carcinoma|Recurrent Uterine Corpus Cancer|Refractory Lymphoma|Refractory Malignant Solid Neoplasm|Refractory Multiple Myeloma|Skin Carcinoma|Thyroid Gland Carcinoma|Uterine Corpus Cancer,Defactinib,CNC(=O)C1=CC=C(C=C1)NC2=NC=C(C(=N2)NCC3=NC=CN=C3N(C)S(=O)(=O)C)C(F)(F)F,PHASE2,,urinary_system_disease
6545,5326,Advanced Malignant Solid Neoplasm|Bladder Carcinoma|Breast Carcinoma|Cervical Carcinoma|Colon Carcinoma|Colorectal Carcinoma|Endometrial Carcinoma|Esophageal Carcinoma|Gastric Carcinoma|Glioma|Head and Neck Carcinoma|Kidney Carcinoma|Liver and Intrahepatic Bile Duct Carcinoma|Lung Carcinoma|Lymphoma|Malignant Uterine Neoplasm|Melanoma|Multiple Myeloma|Ovarian Carcinoma|Pancreatic Carcinoma|Prostate Carcinoma|Rectal Carcinoma|Recurrent Bladder Carcinoma|Recurrent Breast Carcinoma|Recurrent Cervical Carcinoma|Recurrent Colon Carcinoma|Recurrent Colorectal Carcinoma|Recurrent Esophageal Carcinoma|Recurrent Gastric Carcinoma|Recurrent Glioma|Recurrent Head and Neck Carcinoma|Recurrent Liver Carcinoma|Recurrent Lung Carcinoma|Recurrent Lymphoma|Recurrent Malignant Solid Neoplasm|Recurrent Melanoma|Recurrent Multiple Myeloma|Recurrent Ovarian Carcinoma|Recurrent Pancreatic Carcinoma|Recurrent Prostate Carcinoma|Recurrent Rectal Carcinoma|Recurrent Skin Carcinoma|Recurrent Thyroid Gland Carcinoma|Recurrent Uterine Corpus Cancer|Refractory Lymphoma|Refractory Malignant Solid Neoplasm|Refractory Multiple Myeloma|Skin Carcinoma|Thyroid Gland Carcinoma|Uterine Corpus Cancer,Capivasertib,C1CN(CCC1(C(=O)NC(CCO)C2=CC=C(C=C2)Cl)N)C3=NC=NC4=C3C=CN4,PHASE2,,urinary_system_disease
6544,5325,Advanced Malignant Solid Neoplasm|Bladder Carcinoma|Breast Carcinoma|Cervical Carcinoma|Colon Carcinoma|Colorectal Carcinoma|Endometrial Carcinoma|Esophageal Carcinoma|Gastric Carcinoma|Glioma|Head and Neck Carcinoma|Kidney Carcinoma|Liver and Intrahepatic Bile Duct Carcinoma|Lung Carcinoma|Lymphoma|Malignant Uterine Neoplasm|Melanoma|Multiple Myeloma|Ovarian Carcinoma|Pancreatic Carcinoma|Prostate Carcinoma|Rectal Carcinoma|Recurrent Bladder Carcinoma|Recurrent Breast Carcinoma|Recurrent Cervical Carcinoma|Recurrent Colon Carcinoma|Recurrent Colorectal Carcinoma|Recurrent Esophageal Carcinoma|Recurrent Gastric Carcinoma|Recurrent Glioma|Recurrent Head and Neck Carcinoma|Recurrent Liver Carcinoma|Recurrent Lung Carcinoma|Recurrent Lymphoma|Recurrent Malignant Solid Neoplasm|Recurrent Melanoma|Recurrent Multiple Myeloma|Recurrent Ovarian Carcinoma|Recurrent Pancreatic Carcinoma|Recurrent Prostate Carcinoma|Recurrent Rectal Carcinoma|Recurrent Skin Carcinoma|Recurrent Thyroid Gland Carcinoma|Recurrent Uterine Corpus Cancer|Refractory Lymphoma|Refractory Malignant Solid Neoplasm|Refractory Multiple Myeloma|Skin Carcinoma|Thyroid Gland Carcinoma|Uterine Corpus Cancer,Binimetinib,CN1C=NC2=C1C=C(C(=C2F)NC3=C(C=C(C=C3)Br)F)C(=O)NOCCO,PHASE2,,urinary_system_disease
6543,5303,Bladder Cancer,Amrubicin,CC(=O)C1(CC(C2=C(C1)C(=C3C(=C2O)C(=O)C4=CC=CC=C4C3=O)O)OC5CC(C(CO5)O)O)N,PHASE2,,urinary_system_disease
6542,5302,Renal Dysfunction|Acute Renal Failure|Mortality,Ularitide,CCC(C)C1C(=O)NCC(=O)NC(C(=O)NC(C(=O)NC(C(=O)NCC(=O)NC(C(=O)NCC(=O)NC(CSSCC(C(=O)NC(C(=O)NCC(=O)NCC(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N1)CCCNC(=N)N)CC(=O)O)CCSC)CCCNC(=N)N)CC2=CC=CC=C2)NC(=O)C(CO)NC(=O)C(CO)NC(=O)C(CCCNC(=N)N)NC(=O)C(CCCNC(=N)N)NC(=O)C(CC(C)C)NC(=O)C(CO)NC(=O)C(CCCNC(=N)N)NC(=O)C3CCCN3C(=O)C(C)NC(=O)C(C(C)O)N)C(=O)NC(CC(=O)N)C(=O)NC(CO)C(=O)NC(CC4=CC=CC=C4)C(=O)NC(CCCNC(=N)N)C(=O)NC(CC5=CC=C(C=C5)O)C(=O)O)CC(C)C)CO)CCC(=O)N)C,PHASE2,,urinary_system_disease
6541,5297,Chronic Kidney Disease,Arotinolol,CC(C)(C)NCC(CSC1=NC(=CS1)C2=CC=C(S2)C(=O)N)O,APPROVED,,urinary_system_disease
6540,5284,Renal Impairment,Betrixaban,CN(C)C(=N)C1=CC=C(C=C1)C(=O)NC2=C(C=C(C=C2)OC)C(=O)NC3=NC=C(C=C3)Cl,PHASE1,,urinary_system_disease
6539,5283,Advanced Renal Cell Carcinoma,Dalantercept,,PHASE2,,urinary_system_disease
6538,5264,Renal Insufficiency,Dalfampridine,C1=CN=CC=C1N,PHASE1,,urinary_system_disease
6537,5245,Renal Impairment,Glasdegib,CN1CCC(CC1C2=NC3=CC=CC=C3N2)NC(=O)NC4=CC=C(C=C4)C#N,PHASE1,,urinary_system_disease
6536,5219,Pruritus|Uremia|Chronic Kidney Diseases,Loratadine,CCOC(=O)N1CCC(=C2C3=C(CCC4=C2N=CC=C4)C=C(C=C3)Cl)CC1,APPROVED,,urinary_system_disease
6535,5218,Lower Urinary Tract Symptoms Associated With Benign Prostatic Hyperplasia,Naftopidil,COC1=CC=CC=C1N2CCN(CC2)CC(COC3=CC=CC4=CC=CC=C43)O,APPROVED,,urinary_system_disease
6534,5208,Renal Impairment,Glepaglutide,CCC(C)C(C(=O)NC(C(C)O)C(=O)NC(CC(=O)O)C(=O)NC(CCCCN)C(=O)NC(CCCCN)C(=O)NC(CCCCN)C(=O)NC(CCCCN)C(=O)NC(CCCCN)C(=O)NC(CCCCN)C(=O)N)NC(=O)C(CCCCN)NC(=O)C(C(C)O)NC(=O)C(C)NC(=O)C(C(C)CC)NC(=O)C(CC(C)C)NC(=O)C(CC1=CNC2=CC=CC=C21)NC(=O)C(C)NC(=O)C(C(C)CC)NC(=O)C(CC3=CC=CC=C3)NC(=O)C(CC(=O)O)NC(=O)C(CCCN=C(N)N)NC(=O)C(C)NC(=O)C(C)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CC(=O)O)NC(=O)C(CC(C)C)NC(=O)C(C(C)CC)NC(=O)C(C(C)O)NC(=O)C(C)NC(=O)C(CC(C)C)NC(=O)C(CCC(=O)O)NC(=O)C(CO)NC(=O)C(CO)NC(=O)C(CC4=CC=CC=C4)NC(=O)C(C(C)O)NC(=O)CNC(=O)C(CCC(=O)O)NC(=O)CNC(=O)C(CC5=CNC=N5)N,PHASE1,,urinary_system_disease
6533,5172,Renal Impairment,Teriflunomide,CC(=C(C#N)C(=O)NC1=CC=C(C=C1)C(F)(F)F)O,PHASE1,,urinary_system_disease
6532,5159,Somatostatin Analogs|Polycystic Liver Disease|Autosomal Dominant Polycystic Kidney Disease|Autosomal Dominant Polycystic Liver Disease,Pasireotide,C1C(CN2C1C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C2=O)CC3=CC=CC=C3)CC4=CC=C(C=C4)OCC5=CC=CC=C5)CCCCN)CC6=CNC7=CC=CC=C76)C8=CC=CC=C8)OC(=O)NCCN,PHASE2,,urinary_system_disease
6531,5158,Hypertension,Lercanidipine,CC1=C(C(C(=C(N1)C)C(=O)OC(C)(C)CN(C)CCC(C2=CC=CC=C2)C3=CC=CC=C3)C4=CC(=CC=C4)[N+](=O)[O-])C(=O)OC,APPROVED,,urinary_system_disease
6530,5131,Acute Kidney Injury,Deferoxamine,CC(=O)N(CCCCCNC(=O)CCC(=O)N(CCCCCNC(=O)CCC(=O)N(CCCCCN)O)O)O,PHASE2,,urinary_system_disease
6529,5100,Chronic Kidney Disease,Flucloxacillin,CC1=C(C(=NO1)C2=C(C=CC=C2Cl)F)C(=O)NC3C4N(C3=O)C(C(S4)(C)C)C(=O)O,PHASE1,,urinary_system_disease
6528,5099,Chronic Kidney Disease,Floxacillin,CC1=C(C(=NO1)C2=C(C=CC=C2Cl)F)C(=O)NC3C4N(C3=O)C(C(S4)(C)C)C(=O)O,PHASE1,,urinary_system_disease
6527,5082,Complicated Skin and Skin Structure Infections|S. Aureus Bacteremia|Renal Impairment,Penicillin,CC1(C(N2C(S1)C(C2=O)NC(=O)CC3=CC=CC=C3)C(=O)O)C,APPROVED,,urinary_system_disease
6526,5081,Complicated Skin and Skin Structure Infections|S. Aureus Bacteremia|Renal Impairment,Phenoxymethylpenicillin,CC1(C(N2C(S1)C(C2=O)NC(=O)COC3=CC=CC=C3)C(=O)O)C,APPROVED,,urinary_system_disease
6525,5080,Complicated Skin and Skin Structure Infections|S. Aureus Bacteremia|Renal Impairment,Daptomycin,CCCCCCCCCC(=O)NC(CC1=CNC2=CC=CC=C21)C(=O)NC(CC(=O)N)C(=O)NC(CC(=O)O)C(=O)NC3C(OC(=O)C(NC(=O)C(NC(=O)C(NC(=O)CNC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)CNC3=O)CCCN)CC(=O)O)C)CC(=O)O)CO)C(C)CC(=O)O)CC(=O)C4=CC=CC=C4N)C,APPROVED,,urinary_system_disease
6524,5060,Renal Impairment,Hydrocodone,CN1CCC23C4C1CC5=C2C(=C(C=C5)OC)OC3C(=O)CC4,PHASE1,,urinary_system_disease
6523,5057,Venous Thromboembolism|Renal Impairment,Enoxaparin,CC(=O)NC1C(C(C(OC1O)COS(=O)(=O)O)OC2C(C(C(C(O2)C(=O)O)OC3C(C(C(C(O3)CO)OC4C(C(C(C(O4)C(=O)O)O)O)OS(=O)(=O)O)OS(=O)(=O)O)NS(=O)(=O)O)O)OS(=O)(=O)O)O,APPROVED,,urinary_system_disease
6522,5045,Hyperuricemia,Rasburicase,,PHASE2,,urinary_system_disease
6521,5038,Recurrent Renal Cell Carcinoma|Stage III Renal Cell Cancer|Stage IV Renal Cell Cancer|Type 1 Papillary Renal Cell Carcinoma|Type 2 Papillary Renal Cell Carcinoma,Tivantinib,C1CC2=C3C(=CC=C2)C(=CN3C1)C4C(C(=O)NC4=O)C5=CNC6=CC=CC=C65,PHASE2,,urinary_system_disease
6520,5031,Renal Impaired|Gilteritinib|Normal Renal Function|Pharmacokinetics of ASP2215,Gilteritinib,CCC1=C(N=C(C(=N1)C(=O)N)NC2=CC(=C(C=C2)N3CCC(CC3)N4CCN(CC4)C)OC)NC5CCOCC5,PHASE1,,urinary_system_disease
6519,5019,"Carcinoma, Renal Cell",Gefitinib,COC1=C(C=C2C(=C1)N=CN=C2NC3=CC(=C(C=C3)F)Cl)OCCCN4CCOCC4,PHASE1|PHASE2,,urinary_system_disease
6518,5001,Renal Impairment,Asciminib,C1CN(CC1O)C2=C(C=C(C=N2)C(=O)NC3=CC=C(C=C3)OC(F)(F)Cl)C4=CC=NN4,PHASE1,,urinary_system_disease
6517,4992,Long QT Syndrome,Eleclazine,C1COC2=C(C=C(C=C2)C3=CC=C(C=C3)OC(F)(F)F)C(=O)N1CC4=NC=CC=N4,PHASE1,,urinary_system_disease
6516,4968,Nocturia,Fedovapagon,CC1=C(C=CC(=C1)C(=O)N2CCCCC3=CC=CC=C32)CNC(=O)N4CCCC4C(=O)N(C)C,PHASE2|PHASE3,,urinary_system_disease
6515,4966,HIV Infections,Darunavir,CC(C)CN(CC(C(CC1=CC=CC=C1)NC(=O)OC2COC3C2CCO3)O)S(=O)(=O)C4=CC=C(C=C4)N,PHASE2,,urinary_system_disease
6514,4965,HIV Infections,Atazanavir,CC(C)(C)C(C(=O)NC(CC1=CC=CC=C1)C(CN(CC2=CC=C(C=C2)C3=CC=CC=N3)NC(=O)C(C(C)(C)C)NC(=O)OC)O)NC(=O)OC,PHASE2,,urinary_system_disease
6513,4963,HIV Infections,Lopinavir,CC1=C(C(=CC=C1)C)OCC(=O)NC(CC2=CC=CC=C2)C(CC(CC3=CC=CC=C3)NC(=O)C(C(C)C)N4CCCNC4=O)O,PHASE2,,urinary_system_disease
6512,4962,HIV Infections,Emtricitabine,C1C(OC(S1)CO)N2C=C(C(=NC2=O)N)F,PHASE2,,urinary_system_disease
6511,4958,HIV Infections,Raltegravir,CC1=NN=C(O1)C(=O)NC(C)(C)C2=NC(=C(C(=O)N2C)O)C(=O)NCC3=CC=C(C=C3)F,PHASE2,,urinary_system_disease
6510,4932,Renal Impairment,Evobrutinib,C=CC(=O)N1CCC(CC1)CNC2=NC=NC(=C2C3=CC=C(C=C3)OC4=CC=CC=C4)N,PHASE1,,urinary_system_disease
6509,4926,Renal Insufficiency,Odalasvir,CC(C)C(C(=O)N1C2CCCCC2CC1C3=NC4=C(N3)C=C(C=C4)C5=C6CCC7=CC(=C(CCC(=C5)C=C6)C=C7)C8=CC9=C(C=C8)N=C(N9)C1CC2CCCCC2N1C(=O)C(C(C)C)NC(=O)OC)NC(=O)OC,PHASE1,,urinary_system_disease
6508,4922,Chronic Kidney Diseases,Quetiapine,C1CN(CCN1CCOCCO)C2=NC3=CC=CC=C3SC4=CC=CC=C42,PHASE1,,urinary_system_disease
6507,4900,Muscle Invasive Bladder Cancer,Vistusertib,CC1COCCN1C2=NC(=NC3=C2C=CC(=N3)C4=CC(=CC=C4)C(=O)NC)N5CCOCC5C,PHASE1,,urinary_system_disease
6506,4880,Bladder Transitional Cell Carcinoma|Bladder Cancer|Fibroblast Growth Factor Receptor,Infigratinib,CCN1CCN(CC1)C2=CC=C(C=C2)NC3=CC(=NC=N3)N(C)C(=O)NC4=C(C(=CC(=C4Cl)OC)OC)Cl,PHASE1,,urinary_system_disease
6505,4876,Nocturia|Daytime Sleepiness,Modafinil,C1=CC=C(C=C1)C(C2=CC=CC=C2)S(=O)CC(=O)N,PHASE2|PHASE3,,urinary_system_disease
6504,4875,Nocturia|Daytime Sleepiness,Armodafinil,C1=CC=C(C=C1)C(C2=CC=CC=C2)S(=O)CC(=O)N,PHASE2|PHASE3,,urinary_system_disease
6503,4864,"Carcinoma, Transitional Cell|Bladder Cancer|Bladder Neoplasm",Pralatrexate,C#CCC(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)NC(CCC(=O)O)C(=O)O,PHASE2,,urinary_system_disease
6502,4830,Renal Cell Carcinoma|Melanoma|Lung Cancer,Infliximab,,PHASE2,,urinary_system_disease
6501,4825,Urinary Incontinence,Sildenafil,CCCC1=NN(C2=C1N=C(NC2=O)C3=C(C=CC(=C3)S(=O)(=O)N4CCN(CC4)C)OCC)C,PHASE1,,urinary_system_disease
6500,4822,Cognitive Disorders|Delirium|Acute Kidney Injury,Ketamine,CNC1(CCCCC1=O)C2=CC=CC=C2Cl,PHASE2,,urinary_system_disease
6499,4799,Diabetic Nephropathy,Pyridoxamine,CC1=NC=C(C(=C1O)CN)CO,PHASE2,,urinary_system_disease
6498,4790,Muscle-invasive Bladder Cancer,Epacadostat,C1=CC(=C(C=C1N=C(C2=NON=C2NCCNS(=O)(=O)N)NO)Br)F,PHASE2,,urinary_system_disease
6497,4779,Renal Impairment,Tasimelteon,CCC(=O)NCC1CC1C2=C3CCOC3=CC=C2,PHASE1,,urinary_system_disease
6496,4778,Urinary Tract Infections,Amoxicillin,CC1(C(N2C(S1)C(C2=O)NC(=O)C(C3=CC=C(C=C3)O)N)C(=O)O)C,APPROVED,,urinary_system_disease
6495,4775,"Kidney Failure, Chronic|Arthralgia",Lumiracoxib,CC1=CC(=C(C=C1)NC2=C(C=CC=C2Cl)F)CC(=O)O,PHASE2,,urinary_system_disease
6494,4747,Clinical Pharmacology,Riociguat,CN(C1=C(N=C(N=C1N)C2=NN(C3=C2C=CC=N3)CC4=CC=CC=C4F)N)C(=O)OC,PHASE1,,urinary_system_disease
6493,4742,Renal Insufficiency,Epetraborole,B1(C2=C(C=CC=C2OCCCO)C(O1)CN)O,PHASE1,,urinary_system_disease
6492,4702,Bladder Cancer|Urothelial Carcinoma|Metastatic Urothelial Carcinoma|Renal Pelvis Carcinoma|Ureter Carcinoma|Urinary Bladder Carcinoma|Urethra Carcinoma|Muscle Invasive Bladder Cancer,Rucaparib,CNCC1=CC=C(C=C1)C2=C3CCNC(=O)C4=C3C(=CC(=C4)F)N2,PHASE2,,urinary_system_disease
6491,4697,Bladder Cancer|NMIBC|Non-Muscle Invasive Bladder Cancer|Urothelial Carcinoma Recurrent,Pemigatinib,CCN1C2=C3C=C(NC3=NC=C2CN(C1=O)C4=C(C(=CC(=C4F)OC)OC)F)CN5CCOCC5,PHASE2,,urinary_system_disease
6490,4688,Contrast-induced Nephropathy,Carvedilol,COC1=CC=CC=C1OCCNCC(COC2=CC=CC3=C2C4=CC=CC=C4N3)O,PHASE2,,urinary_system_disease
6489,4679,Renal Insufficiency,Lanabecestat,CC#CC1=CC(=CN=C1)C2=CC3=C(CC4(C35N=C(C(=N5)N)C)CCC(CC4)OC)C=C2,PHASE1,,urinary_system_disease
6488,4659,Renal Cell Cancer|Metastatic Castration Resistant Prostate Cancer,Ciforadenant,CC1=CC=C(O1)C2=C3C(=NC(=N2)N)N(N=N3)CC4=NC(=CC=C4)COC5CCOC5,PHASE1,,urinary_system_disease
6487,4650,Lupus Nephritis,Iptacopan,CCOC1CCN(C(C1)C2=CC=C(C=C2)C(=O)O)CC3=C(C=C(C4=C3C=CN4)C)OC,PHASE2,,urinary_system_disease
6486,4638,Heart Failure With Preserved Ejection Fraction|Chronic Kidney Diseases,Sacubitril,CCOC(=O)C(C)CC(CC1=CC=C(C=C1)C2=CC=CC=C2)NC(=O)CCC(=O)O,PHASE1|PHASE2,,urinary_system_disease
6485,4635,Clear Cell Renal Cell Carcinoma|Locally Advanced Pancreatic Cancer|Locally Advanced Malignant Solid Neoplasm|Metastatic Malignant Solid Neoplasm|Metastatic Renal Cell Carcinoma|Metastatic Urothelial Carcinoma|Metastatic Pancreatic Cancer|Stage III Pancreatic Cancer|Stage III Renal Cell Cancer|Stage IV Pancreatic Cancer|Stage IV Renal Cell Cancer|Endometrial Cancer|Metastatic Castration-resistant Prostate Cancer,Ceralasertib,CC1COCCN1C2=NC(=NC(=C2)C3(CC3)S(=N)(=O)C)C4=C5C=CNC5=NC=C4,PHASE2,,urinary_system_disease
6484,4614,Bladder Cancer,Lirilumab,,PHASE1,,urinary_system_disease
6483,4549,Locally Advanced or Metastatic Urothelial Cell Carcinoma|Urinary Bladder Disease|Urological Diseases,Vofatamab,,PHASE1|PHASE2,,urinary_system_disease
6482,4531,Acute Kidney Injury,Nafamostat,C1=CC(=CC=C1C(=O)OC2=CC3=C(C=C2)C=C(C=C3)C(=N)N)N=C(N)N,APPROVED,,urinary_system_disease
6481,4530,Chronic Kidney Disease,Quercetin,C1=CC(=C(C=C1C2=C(C(=O)C3=C(C=C(C=C3O2)O)O)O)O)O,PHASE2,,urinary_system_disease
6480,4529,Chronic Kidney Disease,Dasatinib,CC1=C(C(=CC=C1)Cl)NC(=O)C2=CN=C(S2)NC3=CC(=NC(=N3)C)N4CCN(CC4)CCO,PHASE2,,urinary_system_disease
6479,4525,Latent Tuberculosis|Kidney Failure,Rifapentine,CC1C=CC=C(C(=O)NC2=C(C(=C3C(=C2O)C(=C(C4=C3C(=O)C(O4)(OC=CC(C(C(C(C(C(C1O)C)O)C)OC(=O)C)C)OC)C)C)O)O)C=NN5CCN(CC5)C6CCCC6)C,APPROVED,,urinary_system_disease
6478,4524,Latent Tuberculosis|Kidney Failure,Isoniazid,C1=CN=CC=C1C(=O)NN,APPROVED,,urinary_system_disease
6477,4517,Urothelial Carcinoma|Bladder Cancer|Myelosuppression Adult|Chemotherapy-induced Neutropenia|Metastatic Bladder Cancer,Trilaciclib,CN1CCN(CC1)C2=CN=C(C=C2)NC3=NC=C4C=C5C(=O)NCC6(N5C4=N3)CCCCC6,PHASE2,,urinary_system_disease
6476,4510,0.5-14 Year Old Children With Nephroblastoma,Pirarubicin,CC1C(C(CC(O1)OC2CC(CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)(C(=O)CO)O)N)OC6CCCCO6,APPROVED,,urinary_system_disease
6475,4506,0.5-14 Year Old Children With Nephroblastoma,Oxytetracycline,CC1(C2C(C3C(C(=O)C(=C(C3(C(=O)C2=C(C4=C1C=CC=C4O)O)O)O)C(=O)N)N(C)C)O)O,APPROVED,,urinary_system_disease
6474,4500,Impaired Renal Function,Aldafermin,,PHASE1,,urinary_system_disease
6473,4485,Renal Impairment|Healthy Volunteers,Mobocertinib,CC(C)OC(=O)C1=CN=C(N=C1C2=CN(C3=CC=CC=C32)C)NC4=C(C=C(C(=C4)NC(=O)C=C)N(C)CCN(C)C)OC,PHASE1,,urinary_system_disease
6472,4484,Chronic Kidney Disease|Hypertension,Nitrendipine,CCOC(=O)C1=C(NC(=C(C1C2=CC(=CC=C2)[N+](=O)[O-])C(=O)OC)C)C,APPROVED,,urinary_system_disease
6471,4483,Chronic Kidney Disease|Hypertension,Rilmenidine,C1CC1C(C2CC2)NC3=NCCO3,APPROVED,,urinary_system_disease
6470,4482,Hypertension,Daglutril,CCOC(=O)C(CCC1=CC=CC=C1)CC2(CCCC2)C(=O)NC3CCC4=CC=CC=C4N(C3=O)CC(=O)O,PHASE2,,urinary_system_disease
6469,4478,Renal Insufficiency,Aztreonam,CC1C(C(=O)N1S(=O)(=O)O)NC(=O)C(=NOC(C)(C)C(=O)O)C2=CSC(=N2)N,PHASE1,,urinary_system_disease
6468,4477,Renal Impairment,Telotristat,CC1=NN(C=C1)C2=C(C=CC(=C2)Cl)C(C(F)(F)F)OC3=NC(=NC(=C3)C4=CC=C(C=C4)CC(C(=O)O)N)N,PHASE1,,urinary_system_disease
6467,4476,Renal Impairment|Renal Insufficiency|Kidney Diseases|Pharmacokinetics,Elafibranor,CC1=CC(=CC(=C1OC(C)(C)C(=O)O)C)C=CC(=O)C2=CC=C(C=C2)SC,PHASE1,,urinary_system_disease
6466,4456,Bladder Cancer,Rogaratinib,CC1=CC2=C(C(=C1)OC)SC(=C2)C3=C4C(=NC=NN4C(=C3COC)CN5CCNC(=O)C5)N,PHASE2,,urinary_system_disease
6465,4455,Recurrent Ependymoma|Recurrent Ewing Sarcoma|Recurrent Hepatoblastoma|Recurrent Langerhans Cell Histiocytosis|Recurrent Malignant Germ Cell Tumor|Recurrent Malignant Glioma|Recurrent Malignant Solid Neoplasm|Recurrent Medulloblastoma|Recurrent Neuroblastoma|Recurrent Non-Hodgkin Lymphoma|Recurrent Osteosarcoma|Recurrent Peripheral Primitive Neuroectodermal Tumor|Recurrent Rhabdoid Tumor|Recurrent Rhabdomyosarcoma|Recurrent Soft Tissue Sarcoma|Recurrent WHO Grade 2 Glioma|Refractory Ependymoma|Refractory Ewing Sarcoma|Refractory Hepatoblastoma|Refractory Langerhans Cell Histiocytosis|Refractory Malignant Germ Cell Tumor|Refractory Malignant Glioma|Refractory Malignant Solid Neoplasm|Refractory Medulloblastoma|Refractory Neuroblastoma|Refractory Non-Hodgkin Lymphoma|Refractory Osteosarcoma|Refractory Peripheral Primitive Neuroectodermal Tumor|Refractory Rhabdoid Tumor|Refractory Rhabdomyosarcoma|Refractory Soft Tissue Sarcoma|Refractory WHO Grade 2 Glioma|Wilms Tumor,Ivosidenib,C1CC(=O)N(C1C(=O)N(C2=CC(=CN=C2)F)C(C3=CC=CC=C3Cl)C(=O)NC4CC(C4)(F)F)C5=NC=CC(=C5)C#N,PHASE2,,urinary_system_disease
6464,4442,Healthy|Renal Impairment,Quinine,COC1=CC2=C(C=CN=C2C=C1)C(C3CC4CCN3CC4C=C)O,PHASE1,,urinary_system_disease
6463,4438,Urinary Bladder Neoplasm|Neoplasm Metastasis,Bempegaldesleukin,,PHASE2,,urinary_system_disease
6462,4437,Parkinson Disease,Preladenant,COCCOC1=CC=C(C=C1)N2CCN(CC2)CCN3C4=C(C=N3)C5=NC(=NN5C(=N4)N)C6=CC=CO6,PHASE1,,urinary_system_disease
6461,4425,Multiple Myeloma|Renal Impairment,Dextromethorphan,CN1CCC23CCCCC2C1CC4=C3C=C(C=C4)OC,PHASE1,,urinary_system_disease
6460,4423,Diabetic Nephropathy,Bindarit,CC(C)(C(=O)O)OCC1=NN(C2=CC=CC=C21)CC3=CC=CC=C3,PHASE2,,urinary_system_disease
6459,4398,Chemotherapy-induced Nausea and Vomiting,Fosaprepitant,CC(C1=CC(=CC(=C1)C(F)(F)F)C(F)(F)F)OC2C(N(CCO2)CC3=NN(C(=O)N3)P(=O)(O)O)C4=CC=C(C=C4)F,PHASE2,,urinary_system_disease
6458,4397,Cohort 1 : Metastatic Non Small Cell Lung Cancer|Cohort 2 : Metastatic Bladder Cancer|Cohort 3 : Metastatic Renal Cell Carcinoma|Cohort 4 : Metastatic Head and Neck Cancer,Tiragolumab,,PHASE1,,urinary_system_disease
6457,4386,Urothelial Bladder Cancer|Gastric Adenocarcinoma|Gastro-oesophageal Adenocarcinoma|Head and Neck Cancer|Biliary Tract Cancer|Platinum-sensitive Urothelial Bladder Cancer|Clear Cell Renal Cell Carcinoma|Pancreatic Ductal Adenocarcinoma,Dostarlimab,,PHASE2,,urinary_system_disease
6456,4384,Focal Glomerulosclerosis,Adalimumab,,PHASE1,,urinary_system_disease
6455,4382,Focal Glomerulosclerosis,Rosiglitazone,CN(CCOC1=CC=C(C=C1)CC2C(=O)NC(=O)S2)C3=CC=CC=N3,PHASE1,,urinary_system_disease
6454,4381,Renal Cell Carcinoma,Decitabine,C1C(C(OC1N2C=NC(=NC2=O)N)CO)O,PHASE2,,urinary_system_disease
6453,4353,Schistosomiasis Haematobia,Artefenomel,C1CC2(CCC1C3=CC=C(C=C3)OCCN4CCOCC4)OC5(C6CC7CC(C6)CC5C7)OO2,PHASE2,,urinary_system_disease
6452,4352,Schistosomiasis Haematobia,Lumefantrine,CCCCN(CCCC)CC(C1=CC(=CC2=C1C3=C(C2=CC4=CC=C(C=C4)Cl)C=C(C=C3)Cl)Cl)O,PHASE2,,urinary_system_disease
6451,4351,Schistosomiasis Haematobia,Artemether,CC1CCC2C(C(OC3C24C1CCC(O3)(OO4)C)OC)C,PHASE2,,urinary_system_disease
6450,4350,Schistosomiasis Haematobia,Pyronaridine,COC1=NC2=C(C3=C(C=C(C=C3)Cl)N=C2C=C1)NC4=CC(=C(C(=C4)CN5CCCC5)O)CN6CCCC6,PHASE2,,urinary_system_disease
6449,4349,Schistosomiasis Haematobia,Artesunate,CC1CCC2C(C(OC3C24C1CCC(O3)(OO4)C)OC(=O)CCC(=O)O)C,PHASE2,,urinary_system_disease
6448,4348,Relapsed/Refractory Solid Tumors/Hematological Malignancies,Belinostat,C1=CC=C(C=C1)NS(=O)(=O)C2=CC=CC(=C2)C=CC(=O)NO,PHASE1,,urinary_system_disease
6447,4334,Complicated Urinary Tract Infection|Infection|Pediatric Infectious Disease,Benzylpenicillin,CC1(C(N2C(S1)C(C2=O)NC(=O)CC3=CC=CC=C3)C(=O)O)C,APPROVED,,urinary_system_disease
6446,4333,Complicated Urinary Tract Infection|Infection|Pediatric Infectious Disease,Penicillin G,CC1(C(N2C(S1)C(C2=O)NC(=O)CC3=CC=CC=C3)C(=O)O)C,APPROVED,,urinary_system_disease
6445,4320,Sickle Cell Disease|Sickle Cell Nephropathy,Voxelotor,CC(C)N1C(=CC=N1)C2=C(C=CC=N2)COC3=CC=CC(=C3C=O)O,PHASE1|PHASE2,,urinary_system_disease
6444,4319,Chronic Kidney Disease,Runcaciguat,CC(C(C1=CC=C(C=C1)Cl)C(=O)NC2=C(C=CC(=C2)C(CC(=O)O)C3CC3)Cl)C(F)(F)F,PHASE1,,urinary_system_disease
6443,4316,Cystinuria,Tiopronin,CC(C(=O)NCC(=O)O)S,APPROVED,,urinary_system_disease
6442,4298,Hypertension|Renal Insufficiency,Indapamide,CC1CC2=CC=CC=C2N1NC(=O)C3=CC(=C(C=C3)Cl)S(=O)(=O)N,APPROVED,,urinary_system_disease
6441,4288,Kidney Disease|Glomerulonephritis,Mezagitamab,,PHASE1,,urinary_system_disease
6440,4284,Urinary Tract Infections,Pivmecillinam,CC1(C(N2C(S1)C(C2=O)N=CN3CCCCCC3)C(=O)OCOC(=O)C(C)(C)C)C,APPROVED,,urinary_system_disease
6439,4266,IGA Nephropathy,Budesonide,CCCC1OC2CC3C4CCC5=CC(=O)C=CC5(C4C(CC3(C2(O1)C(=O)CO)C)O)C,PHASE2,,urinary_system_disease
6438,4239,End Stage Renal Disease,Escitalopram,CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F,PHASE2,,urinary_system_disease
6437,4230,Type 2 Diabetes Mellitus,Ipragliflozin,C1=CC=C2C(=C1)C=C(S2)CC3=C(C=CC(=C3)C4C(C(C(C(O4)CO)O)O)O)F,APPROVED,,urinary_system_disease
6436,4220,Bladder Cancer Stage IV,Tucidinostat,C1=CC(=CN=C1)C=CC(=O)NCC2=CC=C(C=C2)C(=O)NC3=C(C=C(C=C3)F)N,PHASE2,,urinary_system_disease
6435,4186,Infectious Disease,Omeprazole,CC1=CN=C(C(=C1OC)C)CS(=O)C2=NC3=C(N2)C=C(C=C3)OC,PHASE1,,urinary_system_disease
6434,4175,"Transplant; Failure, Kidney",Alefacept,,PHASE1,,urinary_system_disease
6433,4165,Gout|Chronic Kidney Disease (CKD),Lesinurad,C1CC1C2=CC=C(C3=CC=CC=C23)N4C(=NN=C4Br)SCC(=O)O,APPROVED,,urinary_system_disease
6432,4156,"Kidney Failure, Acute",Ambrisentan,CC1=CC(=NC(=N1)OC(C(=O)O)C(C2=CC=CC=C2)(C3=CC=CC=C3)OC)C,PHASE2,,urinary_system_disease
6431,4152,"Interstitial Fibrosis|Kidney Transplant; Complications|Kidney Transplant Rejection|Kidney Transplant Failure and Rejection|Kidney Transplant Failure|Kidney Failure, Chronic|Graft Rejection",Fingolimod,CCCCCCCCC1=CC=C(C=C1)CCC(CO)(CO)N,PHASE2,,urinary_system_disease
6430,4146,Overactive Bladder Associated With HTLV-1,Propantheline,CC(C)[N+](C)(CCOC(=O)C1C2=CC=CC=C2OC3=CC=CC=C13)C(C)C,PHASE1,,urinary_system_disease
6429,4121,Benign Prostatic Hyperplasia,Doxazosin,COC1=C(C=C2C(=C1)C(=NC(=N2)N3CCN(CC3)C(=O)C4COC5=CC=CC=C5O4)N)OC,PHASE2,,urinary_system_disease
6428,4117,Solid Tumor|Bladder Cancer|Non-muscle-invasive Bladder Cancer,Lerapolturev,,PHASE1|PHASE2,,urinary_system_disease
6427,4102,Renal Impairment,Elinogrel,CNC1=C(C=C2C(=C1)NC(=O)N(C2=O)C3=CC=C(C=C3)NC(=O)NS(=O)(=O)C4=CC=C(S4)Cl)F,PHASE1,,urinary_system_disease
6426,4101,Locally Advanced Bladder Urothelial Carcinoma|Metastatic Transitional Cell Carcinoma|Metastatic Urothelial Carcinoma|Recurrent Bladder Carcinoma|Stage III Bladder Urothelial Carcinoma AJCC v6 and v7|Stage IV Bladder Urothelial Carcinoma AJCC v7,Sapanisertib,CC(C)N1C2=NC=NC(=C2C(=N1)C3=CC4=C(C=C3)OC(=N4)N)N,PHASE2,,urinary_system_disease
6425,4098,Vomiting,Casopitant,CC1=C(C=CC(=C1)F)C2CC(CCN2C(=O)N(C)C(C)C3=CC(=CC(=C3)C(F)(F)F)C(F)(F)F)N4CCN(CC4)C(=O)C,PHASE1,,urinary_system_disease
6424,4087,Lupus Membranous Nephropathy,Filgotinib,C1CC1C(=O)NC2=NN3C(=N2)C=CC=C3C4=CC=C(C=C4)CN5CCS(=O)(=O)CC5,PHASE2,,urinary_system_disease
6423,4082,Diabetic Nephropathy,Sarpogrelate,CN(C)CC(COC1=CC=CC=C1CCC2=CC(=CC=C2)OC)OC(=O)CCC(=O)O,APPROVED,,urinary_system_disease
6422,4049,Gout|Hyperuricemia|Arthritis|Joint Disease|Renal Insufficiency,Ulodesine,C1C(C(CN1CC2=CNC3=C2N=CNC3=O)O)CO,PHASE2,,urinary_system_disease
6421,4038,Secondary Hypogonadism,Enclomiphene,CCN(CC)CCOC1=CC=C(C=C1)C(=C(C2=CC=CC=C2)Cl)C3=CC=CC=C3,PHASE1,,urinary_system_disease
6420,4036,Locally Advanced Papillary Renal Cell Carcinoma|Metastatic Papillary Renal Cell Carcinoma|Stage III Renal Cell Cancer AJCC v7|Stage IV Renal Cell Cancer AJCC v7|Type 1 Papillary Renal Cell Carcinoma|Type 2 Papillary Renal Cell Carcinoma|Unresectable Renal Cell Carcinoma,Savolitinib,CC(C1=CN2C=CN=C2C=C1)N3C4=NC(=CN=C4N=N3)C5=CN(N=C5)C,PHASE2,,urinary_system_disease
6419,4028,Kidney Injury|Proteinuria|Hypertension,Isosorbide,C1C(C2C(O1)C(CO2)O)O,PHASE2,,urinary_system_disease
6418,4022,"Bladder Cancer|Brain and Central Nervous System Tumors|Carcinoma of Unknown Primary|Extragonadal Germ Cell Tumor|Head and Neck Cancer|Kidney Cancer|Lung Cancer|Ovarian Cancer|Sarcoma|Testicular Germ Cell Tumor|Unspecified Adult Solid Tumor, Protocol Specific",Amifostine,C(CN)CNCCSP(=O)(O)O,PHASE2,,urinary_system_disease
6417,4003,Immunoglobulin A (IgA) Nephropathy,Felzartamab,,PHASE2,,urinary_system_disease
6416,3994,Fanconi Anemia,Oxandrolone,CC12CCC3C(C1CCC2(C)O)CCC4C3(COC(=O)C4)C,PHASE1,,urinary_system_disease
6415,3973,Type 2 Diabetes Mellitus|Hypertension,Fluvastatin,CC(C)N1C2=CC=CC=C2C(=C1C=CC(CC(CC(=O)O)O)O)C3=CC=C(C=C3)F,APPROVED,,urinary_system_disease
6414,3945,Diabetic Nephropathies,Levocetirizine,C1CN(CCN1CCOCC(=O)O)C(C2=CC=CC=C2)C3=CC=C(C=C3)Cl,PHASE2,,urinary_system_disease
6413,3923,"Renal Insufficiency, Chronic|Coronary Angiography|Angioplasty, Transluminal, Percutaneous Coronary",Iloprost,CC#CCC(C)C(C=CC1C(CC2C1CC(=CCCCC(=O)O)C2)O)O,PHASE2|PHASE3,,urinary_system_disease
6412,3915,Urinary Tract Infections|Pyelonephritis,Relebactam,C1CC(N2CC1N(C2=O)OS(=O)(=O)O)C(=O)NC3CCNCC3,PHASE2,,urinary_system_disease
6411,3891,"Renal Dialysis|Renal Failure, Chronic",Tobramycin,C1C(C(C(C(C1N)OC2C(C(C(C(O2)CO)O)N)O)O)OC3C(CC(C(O3)CN)O)N)N,PHASE1,,urinary_system_disease
6410,3851,Overactive Bladder|Detrusor Overactivity,Vardenafil,CCCC1=NC(=C2N1N=C(NC2=O)C3=C(C=CC(=C3)S(=O)(=O)N4CCN(CC4)CC)OCC)C,PHASE2,,urinary_system_disease
6409,3833,Amyotrophic Lateral Sclerosis|Renal Insufficiency,Pramipexole,CCCNC1CCC2=C(C1)SC(=N2)N,PHASE1,,urinary_system_disease
6408,3832,Amyotrophic Lateral Sclerosis|Renal Insufficiency,Dexpramipexole,CCCNC1CCC2=C(C1)SC(=N2)N,PHASE1,,urinary_system_disease
6407,3818,Autosomal Dominant Polycystic Kidney Disease,Lixivaptan,CC1=C(C=C(C=C1)F)C(=O)NC2=CC(=C(C=C2)C(=O)N3CC4=CC=CN4CC5=CC=CC=C53)Cl,PHASE2,,urinary_system_disease
6406,3811,Diabetic Nephropathies,Moxonidine,CC1=NC(=C(C(=N1)Cl)NC2=NCCN2)OC,APPROVED,,urinary_system_disease
6405,3796,"Paroxysmal Hemoglobinuria, Nocturnal",Crovalimab,,PHASE1|PHASE2,,urinary_system_disease
6404,3794,Acute Decompensated Heart Failure,Dopamine,C1=CC(=C(C=C1CCN)O)O,APPROVED,,urinary_system_disease
6403,3785,Metastatic Castration-resistant Prostate Cancer (mCRPC)|Clear Cell Renal Cell Carcinoma (ccRCC),Sarilumab,,PHASE1|PHASE2,,urinary_system_disease
6402,3783,"COVID-19|Renal Insufficiency, Chronic",Nirmatrelvir,CC1(C2C1C(N(C2)C(=O)C(C(C)(C)C)NC(=O)C(F)(F)F)C(=O)NC(CC3CCNC3=O)C#N)C,APPROVED,,urinary_system_disease
6401,3778,Urinary Tract Infections,Cefotaxime,CC(=O)OCC1=C(N2C(C(C2=O)NC(=O)C(=NOC)C3=CSC(=N3)N)SC1)C(=O)O,APPROVED,,urinary_system_disease
6400,3765,"Glomerulosclerosis, Focal Segmental",Losmapimod,CC1=C(C=C(C=C1F)C(=O)NC2CC2)C3=NC=C(C=C3)C(=O)NCC(C)(C)C,PHASE2,,urinary_system_disease
6399,3756,Renal Impairment|Healthy,Rivipansel,CC1C(C(C(C(O1)OC2C(CC(CC2OC3C(C(C(C(O3)CO)O)OC(CC4CCCCC4)C(=O)O)OC(=O)C5=CC=CC=C5)C(=O)NCCNC(=O)COCCOCC(=O)NC6=C7C(=CC(=C6)S(=O)(=O)O)C=C(C=C7S(=O)(=O)O)S(=O)(=O)O)NC(=O)C8=CC(=O)NC(=O)N8)O)O)O,PHASE1,,urinary_system_disease
6398,3755,Cardiorenal Syndrome,Dobutamine,CC(CCC1=CC=C(C=C1)O)NCCC2=CC(=C(C=C2)O)O,PHASE2,,urinary_system_disease
6397,3751,Ischemia-Reperfusion Injury|Kidney Diseases,Reparixin,CC(C)CC1=CC=C(C=C1)C(C)C(=O)NS(=O)(=O)C,PHASE2,,urinary_system_disease
6396,3732,End-stage Renal Disease|Cardiovascular Disease,Ranolazine,CC1=C(C(=CC=C1)C)NC(=O)CN2CCN(CC2)CC(COC3=CC=CC=C3OC)O,APPROVED,,urinary_system_disease
6395,3722,Hepatitis C,Asunaprevir,CC(C)(C)C(C(=O)N1CC(CC1C(=O)NC2(CC2C=C)C(=O)NS(=O)(=O)C3CC3)OC4=NC=C(C5=C4C=C(C=C5)Cl)OC)NC(=O)OC(C)(C)C,APPROVED,,urinary_system_disease
6394,3703,Complicated Urinary Tract Infection,Cilastatin,CC1(CC1C(=O)NC(=CCCCCSCC(C(=O)O)N)C(=O)O)C,PHASE2,,urinary_system_disease
6393,3691,Recurrent Solid Tumor|Recurrent Ewing Sarcoma|Recurrent Hepatoblastoma|Recurrent Malignant Germ Cell Tumor|Recurrent Malignant Solid Neoplasm|Recurrent Neuroblastoma|Recurrent Osteosarcoma|Recurrent Peripheral Primitive Neuroectodermal Tumor|Recurrent Rhabdoid Tumor|Recurrent Rhabdomyosarcoma|Recurrent Soft Tissue Sarcoma|Recurrent Wilms Tumor|Refractory Ewing Sarcoma|Refractory Hepatoblastoma|Refractory Malignant Germ Cell Tumor|Refractory Malignant Solid Neoplasm|Refractory Neuroblastoma|Refractory Osteosarcoma|Refractory Peripheral Primitive Neuroectodermal Tumor|Refractory Rhabdoid Tumor|Refractory Rhabdomyosarcoma|Refractory Soft Tissue Sarcoma,Talazoparib,CN1C(=NC=N1)C2C(NC3=CC(=CC4=C3C2=NNC4=O)F)C5=CC=C(C=C5)F,PHASE1|PHASE2,,urinary_system_disease
6392,3676,Lupus Nephritis,Atacicept,,PHASE1,,urinary_system_disease
6391,3665,Myelofibrosis,Pacritinib,C1CCN(C1)CCOC2=C3COCC=CCOCC4=CC(=CC=C4)C5=NC(=NC=C5)NC(=C3)C=C2,PHASE1,,urinary_system_disease
6390,3636,Cannabis|Chronic Kidney Diseases|Dialysis,Dronabinol,CCCCCC1=CC(=C2C3C=C(CCC3C(OC2=C1)(C)C)C)O,PHASE1,,urinary_system_disease
6389,3619,Advanced Bladder Carcinoma|Advanced Lung Non-Small Cell Carcinoma|Advanced Malignant Solid Neoplasm|Advanced Melanoma|Advanced Merkel Cell Carcinoma|Advanced Renal Cell Carcinoma|Clinical Stage III Cutaneous Melanoma AJCC v8|Clinical Stage III Merkel Cell Carcinoma AJCC v8|Clinical Stage IV Cutaneous Melanoma AJCC v8|Clinical Stage IV Merkel Cell Carcinoma AJCC v8|Pathologic Stage III Cutaneous Melanoma AJCC v8|Pathologic Stage III Merkel Cell Carcinoma AJCC v8|Pathologic Stage IIIA Cutaneous Melanoma AJCC v8|Pathologic Stage IIIA Merkel Cell Carcinoma AJCC v8|Pathologic Stage IIIB Cutaneous Melanoma AJCC v8|Pathologic Stage IIIB Merkel Cell Carcinoma AJCC v8|Pathologic Stage IIIC Cutaneous Melanoma AJCC v8|Pathologic Stage IIID Cutaneous Melanoma AJCC v8|Pathologic Stage IV Cutaneous Melanoma AJCC v8|Pathologic Stage IV Merkel Cell Carcinoma AJCC v8|Stage III Bladder Cancer AJCC v8|Stage III Lung Cancer AJCC v8|Stage III Renal Cell Cancer AJCC v8|Stage IIIA Bladder Cancer AJCC v8|Stage IIIA Lung Cancer AJCC v8|Stage IIIB Bladder Cancer AJCC v8|Stage IIIB Lung Cancer AJCC v8|Stage IIIC Lung Cancer AJCC v8|Stage IV Bladder Cancer AJCC v8|Stage IV Lung Cancer AJCC v8|Stage IV Renal Cell Cancer AJCC v8|Stage IVA Bladder Cancer AJCC v8|Stage IVA Lung Cancer AJCC v8|Stage IVB Bladder Cancer AJCC v8|Stage IVB Lung Cancer AJCC v8,Plinabulin,CC(C)(C)C1=C(N=CN1)C=C2C(=O)NC(=CC3=CC=CC=C3)C(=O)N2,PHASE1|PHASE2,,urinary_system_disease
6388,3591,"Cystitis, Interstitial",Tanezumab,,PHASE2,,urinary_system_disease
6387,3569,Renal Impairment|Healthy,Sotagliflozin,CCOC1=CC=C(C=C1)CC2=C(C=CC(=C2)C3C(C(C(C(O3)SC)O)O)O)Cl,PHASE1,,urinary_system_disease
6386,3561,Cough|Endometriosis|Overactive Bladder,Moxifloxacin,COC1=C2C(=CC(=C1N3CC4CCCNC4C3)F)C(=O)C(=CN2C5CC5)C(=O)O,PHASE1,,urinary_system_disease
6385,3552,"Cirrhosis, Liver|End Stage Liver DIsease|Acute Kidney Injury|Liver Transplant; Complications",Norepinephrine,C1=CC(=C(C=C1C(CN)O)O)O,APPROVED,,urinary_system_disease
6384,3548,Hemodialysis-Induced Symptom|Mitochondrial Diseases,Icatibant,C1CCC2C(C1)CC(N2C(=O)C3CC4=CC=CC=C4CN3C(=O)C(CO)NC(=O)C(CC5=CC=CS5)NC(=O)CNC(=O)C6CC(CN6C(=O)C7CCCN7C(=O)C(CCCN=C(N)N)NC(=O)C(CCCN=C(N)N)N)O)C(=O)NC(CCCN=C(N)N)C(=O)O,PHASE2,,urinary_system_disease
6383,3538,Clear Cell Renal Cell Carcinoma|Metastatic Kidney Carcinoma|Stage III Renal Cell Cancer AJCC v7|Stage IV Renal Cell Cancer AJCC v7,Fludeoxyglucose,C(C(C(C(C(C=O)F)O)O)O)O,PHASE1|PHASE2,,urinary_system_disease
6382,3533,Metastatic Renal Cell Cancer|Stage IV Renal Cell Cancer,Ibrutinib,C=CC(=O)N1CCCC(C1)N2C3=NC=NC(=C3C(=N2)C4=CC=C(C=C4)OC5=CC=CC=C5)N,PHASE1|PHASE2,,urinary_system_disease
6381,3531,End Stage Renal Disease,Etanercept,,PHASE2,,urinary_system_disease
6380,3528,"Kidney Failure, Chronic|Renal Disease, End-Stage",Argatroban,CC1CCN(C(C1)C(=O)O)C(=O)C(CCCN=C(N)N)NS(=O)(=O)C2=CC=CC3=C2NCC(C3)C,APPROVED,,urinary_system_disease
6379,3526,Nephrotic Syndrome|Thromboembolic Disease,Dalteparin,CC(=O)NC1C(C(C(OC1O)COS(=O)(=O)O)OC2C(C(C(C(O2)C(=O)O)OC3C(C(C(C(O3)CO)OC4C(C(C(C(O4)C(=O)O)O)O)OS(=O)(=O)O)OS(=O)(=O)O)NS(=O)(=O)O)O)OS(=O)(=O)O)O,PHASE1|PHASE2,,urinary_system_disease
6378,3506,Renal Impairment|Heart Failure,Torsemide,CC1=CC(=CC=C1)NC2=C(C=NC=C2)S(=O)(=O)NC(=O)NC(C)C,PHASE1,,urinary_system_disease
6377,3505,Renal Impairment|Heart Failure,Torasemide,CC1=CC(=CC=C1)NC2=C(C=NC=C2)S(=O)(=O)NC(=O)NC(C)C,PHASE1,,urinary_system_disease
6376,3499,Congenital Heart Defects,Milrinone,CC1=C(C=C(C(=O)N1)C#N)C2=CC=NC=C2,PHASE2,,urinary_system_disease
6375,3483,Chronic Renal Insufficiency|Type 2 Diabetes Mellitus,Omarigliptin,CS(=O)(=O)N1C=C2CN(CC2=N1)C3CC(C(OC3)C4=C(C=CC(=C4)F)F)N,PHASE1,,urinary_system_disease
6374,3466,"Carcinoma, Renal Cell",Girentuximab,,PHASE1,,urinary_system_disease
6373,3465,Urinary Bladder Neoplasms,Catumaxomab,,PHASE1,,urinary_system_disease
6372,3449,Lupus Nephritis,Zanubrutinib,C=CC(=O)N1CCC(CC1)C2CCNC3=C(C(=NN23)C4=CC=C(C=C4)OC5=CC=CC=C5)C(=O)N,PHASE2,,urinary_system_disease
6371,3443,Clinical Stage III Cutaneous Melanoma AJCC v8|Clinical Stage IV Cutaneous Melanoma AJCC v8|Locally Advanced Bladder Carcinoma|Locally Advanced Bladder Urothelial Carcinoma|Locally Advanced Lung Non-Small Cell Carcinoma|Locally Advanced Renal Pelvis Carcinoma|Locally Advanced Renal Pelvis Urothelial Carcinoma|Locally Advanced Ureter Urothelial Carcinoma|Locally Advanced Urethral Urothelial Carcinoma|Malignant Solid Neoplasm|Metastatic Bladder Carcinoma|Metastatic Bladder Urothelial Carcinoma|Metastatic Lung Non-Small Cell Carcinoma|Metastatic Melanoma|Metastatic Renal Pelvis Urothelial Carcinoma|Metastatic Ureter Urothelial Carcinoma|Metastatic Urethral Carcinoma|Metastatic Urethral Urothelial Carcinoma|Pathologic Stage III Cutaneous Melanoma AJCC v8|Pathologic Stage IIIA Cutaneous Melanoma AJCC v8|Pathologic Stage IIIB Cutaneous Melanoma AJCC v8|Pathologic Stage IIIC Cutaneous Melanoma AJCC v8|Pathologic Stage IIID Cutaneous Melanoma AJCC v8|Pathologic Stage IV Cutaneous Melanoma AJCC v8|Stage III Bladder Cancer AJCC v8|Stage III Lung Cancer AJCC v8|Stage III Renal Pelvis Cancer AJCC v8|Stage III Ureter Cancer AJCC v8|Stage III Urethral Cancer AJCC v8|Stage IIIA Bladder Cancer AJCC v8|Stage IIIA Lung Cancer AJCC v8|Stage IIIB Bladder Cancer AJCC v8|Stage IIIB Lung Cancer AJCC v8|Stage IIIC Lung Cancer AJCC v8|Stage IV Bladder Cancer AJCC v8|Stage IV Lung Cancer AJCC v6|Stage IV Renal Pelvis Cancer AJCC v8|Stage IV Ureter Cancer AJCC v8|Stage IV Urethral Cancer AJCC v8|Stage IVA Lung Cancer AJCC v8|Stage IVB Lung Cancer AJCC v8|Unresectable Melanoma,Tocilizumab,,PHASE2,,urinary_system_disease
6370,3432,Renal Impairment|End-stage Renal Disease,Daclatasvir,CC(C)C(C(=O)N1CCCC1C2=NC=C(N2)C3=CC=C(C=C3)C4=CC=C(C=C4)C5=CN=C(N5)C6CCCN6C(=O)C(C(C)C)NC(=O)OC)NC(=O)OC,PHASE2,,urinary_system_disease
6369,3431,Renal Impairment|End-stage Renal Disease,Simeprevir,CC1=C(C=CC2=C1N=C(C=C2OC3CC4C(C3)C(=O)N(CCCCC=CC5CC5(NC4=O)C(=O)NS(=O)(=O)C6CC6)C)C7=NC(=CS7)C(C)C)OC,PHASE2,,urinary_system_disease
6368,3430,"Kidney Stone|Pain, Postoperative|Addiction|Opioid Use",Pregabalin,CC(C)CC(CC(=O)O)CN,PHASE2|PHASE3,,urinary_system_disease
6367,3411,Advanced Malignant Solid Neoplasm|Clinical Stage III Cutaneous Melanoma AJCC v8|Clinical Stage IV Cutaneous Melanoma AJCC v8|Fallopian Tube Carcinoma|Metastatic Lung Non-Small Cell Carcinoma|Metastatic Malignant Solid Neoplasm|Metastatic Melanoma|Metastatic Renal Cell Carcinoma|Ovarian Carcinoma|Pathologic Stage III Cutaneous Melanoma AJCC v8|Pathologic Stage IIIA Cutaneous Melanoma AJCC v8|Pathologic Stage IIIB Cutaneous Melanoma AJCC v8|Pathologic Stage IIIC Cutaneous Melanoma AJCC v8|Pathologic Stage IIID Cutaneous Melanoma AJCC v8|Pathologic Stage IV Cutaneous Melanoma AJCC v8|Primary Peritoneal Carcinoma|Stage III Lung Cancer AJCC v8|Stage III Renal Cell Cancer AJCC v8|Stage IIIA Lung Cancer AJCC v8|Stage IIIB Lung Cancer AJCC v8|Stage IIIC Lung Cancer AJCC v8|Stage IV Lung Cancer AJCC v8|Stage IV Renal Cell Cancer AJCC v8|Stage IVA Lung Cancer AJCC v8|Stage IVB Lung Cancer AJCC v8|Triple-Negative Breast Carcinoma|Unresectable Lung Non-Small Cell Carcinoma|Unresectable Melanoma|Unresectable Renal Cell Carcinoma,Selinexor,C1=CN=C(C=N1)NNC(=O)C=CN2C=NC(=N2)C3=CC(=CC(=C3)C(F)(F)F)C(F)(F)F,PHASE1,,urinary_system_disease
6366,3395,End Stage Renal Disease,Mupirocin,CC(C1C(O1)CC2COC(C(C2O)O)CC(=CC(=O)OCCCCCCCCC(=O)O)C)C(C)O,APPROVED,,urinary_system_disease
6365,3393,Metastatic Renal Cell Carcinoma,Enzastaurin,CN1C=C(C2=CC=CC=C21)C3=C(C(=O)NC3=O)C4=CN(C5=CC=CC=C54)C6CCN(CC6)CC7=CC=CC=N7,PHASE2,,urinary_system_disease
6364,3373,"Leukemia, Acute Lymphocytic (ALL)|Leukemia, Myeloid, Acute(AML)|Leukemia, Myeloid, Chronic(CML)|Juvenile Myelomonocytic Leukemia (JMML)|Hemoglobinuria, Paroxysmal Nocturnal (PNH)|Hodgkin Lymphoma|Lymphoma, Non-Hodgkin (NHL)|Myelodysplastic Syndrome (MDS)",Muromonab,,PHASE2,,urinary_system_disease
6363,3362,Breast Cancer|Breast Neoplasms|Colon Cancer|Colonic Cancer|Colon Neoplasms|Lung Cancer|Melanoma|Kidney Cancer,Dacarbazine,CN(C)N=NC1=C(NC=N1)C(=O)N,PHASE1,,urinary_system_disease
6362,3340,Renal Impairment|Renal Disease,Venetoclax,CC1(CCC(=C(C1)C2=CC=C(C=C2)Cl)CN3CCN(CC3)C4=CC(=C(C=C4)C(=O)NS(=O)(=O)C5=CC(=C(C=C5)NCC6CCOCC6)[N+](=O)[O-])OC7=CN=C8C(=C7)C=CN8)C,PHASE1,,urinary_system_disease
6361,3328,Kidney Cancer|Renal Cancer|Renal Neoplasm,Hydromorphone,CN1CCC23C4C1CC5=C2C(=C(C=C5)O)OC3C(=O)CC4,PHASE2,,urinary_system_disease
6360,3321,Patients With Severe Chronic Kidney Disease Being Evaluated With Nuclear Stress Testing of the Heart Using the Stress Agent Regadenoson,Aminophylline,CN1C2=C(C(=O)N(C1=O)C)NC=N2.CN1C2=C(C(=O)N(C1=O)C)NC=N2.C(CN)N,APPROVED,,urinary_system_disease
6359,3311,Kidney Failure|Kidney Transplant; Complications|Chimera,Siplizumab,,PHASE1|PHASE2,,urinary_system_disease
6358,3301,Acute Pyelonephritis,Omadacycline,CC(C)(C)CNCC1=CC(=C2CC3CC4C(C(=O)C(=C(C4(C(=O)C3=C(C2=C1O)O)O)O)C(=O)N)N(C)C)N(C)C,PHASE2,,urinary_system_disease
6357,3268,Bladder Carcinoma|Refractory Bladder Carcinoma|Urinary Tract Infection,Clindamycin,CCCC1CC(N(C1)C)C(=O)NC(C2C(C(C(C(O2)SC)O)O)O)C(C)Cl,APPROVED,,urinary_system_disease
6356,3252,Growth Hormone Disorder|Adult Growth Hormone Deficiency|Growth Hormone Deficiency in Children,Somapacitan,C(CCCCCCCC1=NNN=N1)CCCCCCCC(=O)NS(=O)(=O)CCCC(=O)NCCOCCOCC(=O)NC(CCC(=O)NC(CCC(=O)NCCOCCOCC(=O)NC(CCCCNC(=O)CSCC(C(=O)O)N)C(=O)N)C(=O)O)C(=O)O,PHASE1,,urinary_system_disease
6355,3245,Renal Function,Ulipristal,CC(=O)C1(CCC2C1(CC(C3=C4CCC(=O)C=C4CCC23)C5=CC=C(C=C5)N(C)C)C)O,PHASE1,,urinary_system_disease
6354,3241,Chronic Kidney Disease|Proteinuria|Blood Pressure,Sitaxentan,CC1=CC2=C(C=C1CC(=O)C3=C(C=CS3)S(=O)(=O)NC4=C(C(=NO4)C)Cl)OCO2,PHASE2,,urinary_system_disease
6353,3236,"Renal Insufficiency, Chronic",Bumetanide,CCCCNC1=C(C(=CC(=C1)C(=O)O)S(=O)(=O)N)OC2=CC=CC=C2,PHASE2,,urinary_system_disease
6352,3234,Glioma|Hematopoietic and Lymphoid Cell Neoplasm|Lymphoma|Metastatic Malignant Solid Neoplasm|Neuroendocrine Neoplasm|Recurrent Adult Soft Tissue Sarcoma|Recurrent Bladder Carcinoma|Recurrent Breast Carcinoma|Recurrent Chronic Lymphocytic Leukemia|Recurrent Colorectal Carcinoma|Recurrent Head and Neck Carcinoma|Recurrent Lung Carcinoma|Recurrent Malignant Solid Neoplasm|Recurrent Melanoma|Recurrent Pancreatic Carcinoma|Recurrent Primary Cutaneous T-Cell Non-Hodgkin Lymphoma|Recurrent Prostate Carcinoma|Recurrent Renal Cell Carcinoma|Recurrent Thyroid Gland Carcinoma|Refractory Chronic Lymphocytic Leukemia|Refractory Mature T-Cell and NK-Cell Non-Hodgkin Lymphoma|Refractory Primary Cutaneous T-Cell Non-Hodgkin Lymphoma|Stage III Breast Cancer AJCC v7|Stage III Colorectal Cancer AJCC v7|Stage III Cutaneous Melanoma AJCC v7|Stage III Lung Cancer AJCC v7|Stage III Pancreatic Cancer AJCC v6 and v7|Stage III Prostate Cancer AJCC v7|Stage III Renal Cell Cancer AJCC v7|Stage III Soft Tissue Sarcoma AJCC v7|Stage IIIA Breast Cancer AJCC v7|Stage IIIA Colorectal Cancer AJCC v7|Stage IIIA Cutaneous Melanoma AJCC v7|Stage IIIB Breast Cancer AJCC v7|Stage IIIB Colorectal Cancer AJCC v7|Stage IIIB Cutaneous Melanoma AJCC v7|Stage IIIC Breast Cancer AJCC v7|Stage IIIC Colorectal Cancer AJCC v7|Stage IIIC Cutaneous Melanoma AJCC v7|Stage IV Breast Cancer AJCC v6 and v7|Stage IV Colorectal Cancer AJCC v7|Stage IV Cutaneous Melanoma AJCC v6 and v7|Stage IV Lung Cancer AJCC v7|Stage IV Pancreatic Cancer AJCC v6 and v7|Stage IV Prostate Cancer AJCC v7|Stage IV Renal Cell Cancer AJCC v7|Stage IV Soft Tissue Sarcoma AJCC v7|Stage IVA Colorectal Cancer AJCC v7|Stage IVB Colorectal Cancer AJCC v7|Unresectable Solid Neoplasm,Romidepsin,CC=C1C(=O)NC(C(=O)OC2CC(=O)NC(C(=O)NC(CSSCCC=C2)C(=O)N1)C(C)C)C(C)C,PHASE1,,urinary_system_disease
6351,3227,"Cancer|Pancreatic Cancer|Sarcoma|Renal Cancer|Refractory Cancer|Refractory Neoplasm|Refractory Non-Hodgkin Lymphoma|Pancreatic Adenocarcinoma|Resistant Cancer|Neoplasm Metastasis|Neoplasm of Bone|Neoplasm, Breast|Neoplasm of Lung|Neoplasms,Colorectal|Neoplasms Pancreatic|Malignant Glioma|Malignancies|Malignancies Multiple|Bone Metastases|Bone Neoplasm|Bone Cancer|Pancreas Cancer|Pancreatic Neoplasms|Breast Neoplasms|Acute T Cell Leukemia Lymphoma",Lomustine,C1CCC(CC1)NC(=O)N(CCCl)N=O,PHASE2,,urinary_system_disease
6350,3220,Solid Tumors|Non-small Cell Lung Cancer|Renal Cell Carcinoma|Hepatocellular Carcinoma,Envafolimab,,PHASE1|PHASE2,,urinary_system_disease
6349,3217,"Pain, Chronic|Urge Incontinence|Overactive Bladder Syndrome|Quality of Life",Valacyclovir,CC(C)C(C(=O)OCCOCN1C=NC2=C1N=C(NC2=O)N)N,PHASE1,,urinary_system_disease
6348,3216,"Pain, Chronic|Urge Incontinence|Overactive Bladder Syndrome|Quality of Life",Valaciclovir,CC(C)C(C(=O)OCCOCN1C=NC2=C1N=C(NC2=O)N)N,PHASE1,,urinary_system_disease
6347,3212,Renal Impairment,Otamixaban,CC(C(CC1=CC(=CC=C1)C(=N)N)C(=O)OC)NC(=O)C2=CC=C(C=C2)C3=CC=[N+](C=C3)[O-],PHASE1,,urinary_system_disease
6346,3203,Gram-Positive Bacterial Infections|Nephrotoxicity|Sepsis,Vancomycin,CC1C(C(CC(O1)OC2C(C(C(OC2OC3=C4C=C5C=C3OC6=C(C=C(C=C6)C(C(C(=O)NC(C(=O)NC5C(=O)NC7C8=CC(=C(C=C8)O)C9=C(C=C(C=C9O)O)C(NC(=O)C(C(C1=CC(=C(O4)C=C1)Cl)O)NC7=O)C(=O)O)CC(=O)N)NC(=O)C(CC(C)C)NC)O)Cl)CO)O)O)(C)N)O,APPROVED,,urinary_system_disease
6345,3180,Depression,Fluoxetine,CNCCC(C1=CC=CC=C1)OC2=CC=C(C=C2)C(F)(F)F,APPROVED,,urinary_system_disease
6344,3177,Solid Tumor|Colorectal Cancer|Cholangiocarcinoma|Bladder Cancer|Ovarian Cancer|Gastric Cancer|Palpable Subcutaneous Malignant Lesions|Renal Cell Carcinoma|Melanoma|Epithelial Ovarian Cancer|Primary Peritoneal Cancer|Fallopian Tube Cancer,Imiquimod,CC(C)CN1C=NC2=C1C3=CC=CC=C3N=C2N,PHASE1,,urinary_system_disease
6343,3151,Renal Insufficiency,Iberdomide,C1CC(=O)NC(=O)C1N2CC3=C(C2=O)C=CC=C3OCC4=CC=C(C=C4)CN5CCOCC5,PHASE1,,urinary_system_disease
6342,3147,Renal Impairment,Deflazacort,CC1=NC2(C(O1)CC3C2(CC(C4C3CCC5=CC(=O)C=CC45C)O)C)C(=O)COC(=O)C,PHASE1,,urinary_system_disease
6341,3145,Chronic Hepatitis D Infection,Bulevirtide,,PHASE1,,urinary_system_disease
6340,3137,Adynamic Bone Disease|Chronic Kidney Diseases|Cardiac Disease|Chronic Kidney Disease-Mineral and Bone Disorder,Teriparatide,CCC(C)C(C(=O)NC(CCC(=O)N)C(=O)NC(CC(C)C)C(=O)NC(CCSC)C(=O)NC(CC1=CNC=N1)C(=O)NC(CC(=O)N)C(=O)NC(CC(C)C)C(=O)NCC(=O)NC(CCCCN)C(=O)NC(CC2=CNC=N2)C(=O)NC(CC(C)C)C(=O)NC(CC(=O)N)C(=O)NC(CO)C(=O)NC(CCSC)C(=O)NC(CCC(=O)O)C(=O)NC(CCCNC(=N)N)C(=O)NC(C(C)C)C(=O)NC(CCC(=O)O)C(=O)NC(CC3=CNC4=CC=CC=C43)C(=O)NC(CC(C)C)C(=O)NC(CCCNC(=N)N)C(=O)NC(CCCCN)C(=O)NC(CCCCN)C(=O)NC(CC(C)C)C(=O)NC(CCC(=O)N)C(=O)NC(CC(=O)O)C(=O)NC(C(C)C)C(=O)NC(CC5=CNC=N5)C(=O)NC(CC(=O)N)C(=O)NC(CC6=CC=CC=C6)C(=O)O)NC(=O)C(CCC(=O)O)NC(=O)C(CO)NC(=O)C(C(C)C)NC(=O)C(CO)N,APPROVED,,urinary_system_disease
6339,3131,Restless Legs Syndrome|End Stage Renal Disease,Ropinirole,CCCN(CCC)CCC1=C2CC(=O)NC2=CC=C1,PHASE2,,urinary_system_disease
6338,3121,Urinary Stone,Cannabidiol,CCCCCC1=CC(=C(C(=C1)O)C2C=C(CCC2C(=C)C)C)O,PHASE2|PHASE3,,urinary_system_disease
6337,3085,Chronic Kidney Disease|End Stage Renal Disease,Metolazone,CC1NC2=CC(=C(C=C2C(=O)N1C3=CC=CC=C3C)S(=O)(=O)N)Cl,PHASE2,,urinary_system_disease
6336,3084,Renal Impairment,Phentermine,CC(C)(CC1=CC=CC=C1)N,PHASE1,,urinary_system_disease
6335,3082,Lupus Nephritis,Guselkumab,,PHASE2,,urinary_system_disease
6334,3066,Advanced Solid Tumors|Head and Neck Cancer|Pancreatic Cancer|Ovarian Cancer|Renal Cell Carcinoma|Malignant Glioma|Non-small Cell Lung Cancer,Cabiralizumab,,PHASE1,,urinary_system_disease
6333,3023,Diabetic Kidney Disease,Tilmanocept,,PHASE1,,urinary_system_disease
6332,3013,Enuresis,Indomethacin,CC1=C(C2=C(N1C(=O)C3=CC=C(C=C3)Cl)C=CC(=C2)OC)CC(=O)O,APPROVED,,urinary_system_disease
6331,3008,"Kidney Failure, Chronic",Alisporivir,CCC1C(=O)N(C(C(=O)N(C(C(=O)NC(C(=O)N(C(C(=O)NC(C(=O)NC(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N1)C(C(C)CC=CC)O)C)C(C)C)C)CC(C)C)C)CC(C)C)C)C)C)CC(C)C)C)C(C)C)C(C)C)CC)C)C,PHASE1,,urinary_system_disease
6330,3006,Lupus Nephritis,Anifrolumab,,PHASE2,,urinary_system_disease
6329,2996,Wilms' Tumor|Sarcoma|Adenaocortical Carcinoma|Refractory Cancer|Coldrhood Cancer,Tariquidar,COC1=C(C=C2CN(CCC2=C1)CCC3=CC=C(C=C3)NC(=O)C4=CC(=C(C=C4NC(=O)C5=CC6=CC=CC=C6N=C5)OC)OC)OC,PHASE1,,urinary_system_disease
6328,2992,Hiv|HIV Infections|HIV Lipodystrophy|Osteoporosis|Renal Insufficiency|Weight Gain|Obesity,Lamivudine,C1C(OC(S1)CO)N2C=CC(=NC2=O)N,APPROVED,,urinary_system_disease
6327,2990,Lupus Nephritis,Tamibarotene,CC1(CCC(C2=C1C=CC(=C2)NC(=O)C3=CC=C(C=C3)C(=O)O)(C)C)C,PHASE2,,urinary_system_disease
6326,2987,End-stage Kidney Disease,Methylcellulose,,PHASE2,,urinary_system_disease
6325,2946,Respiratory Tract Infections|Urinary Tract Infections,Sulbactam,CC1(C(N2C(S1(=O)=O)CC2=O)C(=O)O)C,PHASE2,,urinary_system_disease
6324,2945,Respiratory Tract Infections|Urinary Tract Infections,Cefoperazone,CCN1CCN(C(=O)C1=O)C(=O)NC(C2=CC=C(C=C2)O)C(=O)NC3C4N(C3=O)C(=C(CS4)CSC5=NN=NN5C)C(=O)O,PHASE2,,urinary_system_disease
6323,2932,Urinary Tract Infections,Temocillin,CC1(C(N2C(S1)C(C2=O)(NC(=O)C(C3=CSC=C3)C(=O)O)OC)C(=O)O)C,APPROVED,,urinary_system_disease
6322,2931,"Beta-thalassemia|Myelodysplastic Syndromes|Fanconi Syndrome|Anemia, Diamond-Blackfan|Anemia, Aplastic",Deferasirox,C1=CC=C(C(=C1)C2=NN(C(=N2)C3=CC=CC=C3O)C4=CC=C(C=C4)C(=O)O)O,PHASE2,,urinary_system_disease
6321,2927,Kidney Disease,Eprosartan,CCCCC1=NC=C(N1CC2=CC=C(C=C2)C(=O)O)C=C(CC3=CC=CS3)C(=O)O,PHASE1,,urinary_system_disease
6320,2914,Hepatoblastoma|Previously Treated Childhood Rhabdomyosarcoma|Recurrent Childhood Acute Lymphoblastic Leukemia|Recurrent Childhood Acute Myeloid Leukemia|Recurrent Childhood Kidney Neoplasm|Recurrent Childhood Malignant Germ Cell Tumor|Recurrent Childhood Rhabdomyosarcoma|Recurrent Childhood Soft Tissue Sarcoma|Recurrent Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor|Recurrent Neuroblastoma|Recurrent Osteosarcoma,Alisertib,COC1=C(C(=CC=C1)F)C2=NCC3=CN=C(N=C3C4=C2C=C(C=C4)Cl)NC5=CC(=C(C=C5)C(=O)O)OC,PHASE2,,urinary_system_disease
6319,2909,Solid Tumor|Haematological Malignancy|Colorectal Neoplasms|Urinary Bladder Neoplasm|Gallbladder Neoplasms|Salivary Gland Neoplasm|Lung Neoplasm|Pancreatic Neoplasm|Ovarian Neoplasms|Prostatic Neoplasm|Skin Neoplasm,Pertuzumab,,PHASE2|PHASE3,,urinary_system_disease
6318,2897,Neuromuscular Blockade|Renal Impairment,Cisatracurium,C[N+]1(CCC2=CC(=C(C=C2C1CC3=CC(=C(C=C3)OC)OC)OC)OC)CCC(=O)OCCCCCOC(=O)CC[N+]4(CCC5=CC(=C(C=C5C4CC6=CC(=C(C=C6)OC)OC)OC)OC)C,PHASE2,,urinary_system_disease
6317,2894,Head and Neck Neoplasms|Lung Neoplasms|Urinary Bladder Neoplasms|Breast Neoplasms,Tetrahydrouridine,C1CN(C(=O)NC1O)C2C(C(C(O2)CO)O)O,PHASE2,,urinary_system_disease
6316,2818,HIV,Dolutegravir,CC1CCOC2N1C(=O)C3=C(C(=O)C(=CN3C2)C(=O)NCC4=C(C=C(C=C4)F)F)O,APPROVED,,urinary_system_disease
6315,2817,Urinary Stress Incontinence,Duloxetine,CNCCC(C1=CC=CS1)OC2=CC=CC3=CC=CC=C32,PHASE2,,urinary_system_disease
6314,2787,Acute Cystitis (Excl in Pregnancy),Amdinocillin,CC1(C(N2C(S1)C(C2=O)N=CN3CCCCCC3)C(=O)O)C,APPROVED,,urinary_system_disease
6313,2781,Chronic Kidney Diseases|Major Depressive Disorder,Bupropion,CC(C(=O)C1=CC(=CC=C1)Cl)NC(C)(C)C,PHASE2,,urinary_system_disease
6312,2779,"Neoplasms|Neoplasms, Glandular and Epithelial|Neoplasms by Histologic Type|Bronchial Neoplasms|Lung Neoplasms|Respiratory Tract Neoplasms|Thoracic Neoplasms|Digestive System Neoplasms|Endocrine Gland Neoplasms|Carcinoma, Non-Small-Cell Lung|Lung Diseases|Breast Diseases|Renal Neoplasm|Solid Tumors",Entinostat,C1=CC=C(C(=C1)N)NC(=O)C2=CC=C(C=C2)CNC(=O)OCC3=CN=CC=C3,PHASE1,,urinary_system_disease
6311,2775,Lupus Nephritis,Iguratimod,CS(=O)(=O)NC1=C(C=C2C(=C1)OC=C(C2=O)NC=O)OC3=CC=CC=C3,PHASE2,,urinary_system_disease
6310,2762,Renal Insufficiency,Setmelanotide,CC1C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(CSSCC(C(=O)N1)NC(=O)C(CCCN=C(N)N)NC(=O)C)C(=O)N)CC2=CNC3=CC=CC=C32)CCCN=C(N)N)CC4=CC=CC=C4)CC5=CN=CN5,PHASE1,,urinary_system_disease
6309,2741,"Diabetes Mellitus, Type 2|Albuminuria",Canagliflozin,CC1=C(C=C(C=C1)C2C(C(C(C(O2)CO)O)O)O)CC3=CC=C(S3)C4=CC=C(C=C4)F,APPROVED,,urinary_system_disease
6308,2739,Atrial Fibrillation and Flutter|Stroke|Major Bleed|End-stage Renal Disease,Warfarin,CC(=O)CC(C1=CC=CC=C1)C2=C(C3=CC=CC=C3OC2=O)O,APPROVED,,urinary_system_disease
6307,2733,Renal Insufficiency,Abiraterone,CC12CCC(CC1=CCC3C2CCC4(C3CC=C4C5=CN=CC=C5)C)O,PHASE1,,urinary_system_disease
6306,2731,Renal Disease|End Stage Renal Disease,Droxidopa,C1=CC(=C(C=C1C(C(C(=O)O)N)O)O)O,PHASE1,,urinary_system_disease
6305,2727,Prostate Cancer|Erectile Dysfunction|Lower Urinary Tract Symptoms,Bicalutamide,CC(CS(=O)(=O)C1=CC=C(C=C1)F)(C(=O)NC2=CC(=C(C=C2)C#N)C(F)(F)F)O,PHASE2,,urinary_system_disease
6304,2721,Breast Cancer|Ovarian Cancer|Non Small Cell Lung Cancer|Colorectal Cancer|Pancreatic Cancer|Renal Cell Carcinoma|Nasopharyngeal Cancer|Head and Neck Squamous Cell Carcinoma|Gastric Cancer,Rimiducid,CCC(C1=CC(=C(C(=C1)OC)OC)OC)C(=O)N2CCCCC2C(=O)OC(CCC3=CC(=C(C=C3)OC)OC)C4=CC(=CC=C4)OCC(=O)NCCNC(=O)COC5=CC=CC(=C5)C(CCC6=CC(=C(C=C6)OC)OC)OC(=O)C7CCCCN7C(=O)C(CC)C8=CC(=C(C(=C8)OC)OC)OC,PHASE1,,urinary_system_disease
6303,2718,Malignant Neoplasms of Urinary Tract|Bladder Cancer,Glycopyrrolate,C[N+]1(CCC(C1)OC(=O)C(C2CCCC2)(C3=CC=CC=C3)O)C.[Br-],APPROVED,,urinary_system_disease
6302,2717,Malignant Neoplasms of Urinary Tract|Bladder Cancer,Neostigmine,CN(C)C(=O)OC1=CC=CC(=C1)[N+](C)(C)C,APPROVED,,urinary_system_disease
6301,2705,Renal Insufficiency,Tirofiban,CCCCS(=O)(=O)NC(CC1=CC=C(C=C1)OCCCCC2CCNCC2)C(=O)O,PHASE1,,urinary_system_disease
6300,2697,Childhood Renal Cell Carcinoma|Clear Cell Renal Cell Carcinoma|Clear Cell Sarcoma of the Kidney|Papillary Renal Cell Carcinoma|Rhabdoid Tumor of the Kidney|Stage I Renal Cell Cancer|Stage I Renal Wilms Tumor|Stage II Renal Cell Cancer|Stage II Renal Wilms Tumor|Stage III Renal Cell Cancer|Stage III Renal Wilms Tumor|Stage IV Renal Cell Cancer|Stage IV Renal Wilms Tumor,Dactinomycin,CC1C(C(=O)NC(C(=O)N2CCCC2C(=O)N(CC(=O)N(C(C(=O)O1)C(C)C)C)C)C(C)C)NC(=O)C3=C4C(=C(C=C3)C)OC5=C(C(=O)C(=C(C5=N4)C(=O)NC6C(OC(=O)C(N(C(=O)CN(C(=O)C7CCCN7C(=O)C(NC6=O)C(C)C)C)C)C(C)C)C)N)C,PHASE2,,urinary_system_disease
6299,2687,Renal Cell Carcinoma|Hereditary Leiomyomatosis|Renal Cell Cancer,Vandetanib,CN1CCC(CC1)COC2=C(C=C3C(=C2)N=CN=C3NC4=C(C=C(C=C4)Br)F)OC,PHASE1|PHASE2,,urinary_system_disease
6298,2686,Renal Impairment,Brensocatib,CN1C2=C(C=CC(=C2)C3=CC=C(C=C3)CC(C#N)NC(=O)C4CNCCCO4)OC1=O,PHASE1,,urinary_system_disease
6297,2681,End Stage Renal Disease|Peritoneal Dialysis,Chlorhexidine,C1=CC(=CC=C1NC(=NC(=NCCCCCCN=C(N)N=C(N)NC2=CC=C(C=C2)Cl)N)N)Cl,APPROVED,,urinary_system_disease
6296,2678,End Stage Renal Disease,Plazomicin,CC1(COC(C(C1NC)O)OC2C(CC(C(C2O)OC3C(CC=C(O3)CNCCO)N)N)NC(=O)C(CCN)O)O,PHASE1,,urinary_system_disease
6295,2671,Diabetic Nephropathy,Topiroxostat,C1=CN=CC=C1C2=NC(=NN2)C3=CC(=NC=C3)C#N,PHASE2,,urinary_system_disease
6294,2656,Uremic Pruritus,Nalfurafine,CN(C1CCC2(C3CC4=C5C2(C1OC5=C(C=C4)O)CCN3CC6CC6)O)C(=O)C=CC7=COC=C7,PHASE2,,urinary_system_disease
6293,2625,Metastatic Non-small Cell Lung Cancer|Locally Advanced Urothelial Cancer|Metastatic Urothelial Cancer|Unresectable Melanoma|Metastatic Melanoma|Locally Advanced Renal Cell Carcinoma|Metastatic Clear-Cell Renal Cell Carcinoma,Retifanlimab,,PHASE2,,urinary_system_disease
6292,2621,Non Clear Cell Renal Carcinoma,Sintilimab,,PHASE2,,urinary_system_disease
6291,2588,Healthy,Megestrol,CC1=CC2C(CCC3(C2CCC3(C(=O)C)O)C)C4(C1=CC(=O)CC4)C,PHASE1,,urinary_system_disease
6290,2546,Proteinuria|Idiopathic Membranous Nephropathy,Corticotropin,CC(C)CC(C(=O)NC(CCC(=O)O)C(=O)NC(CC1=CC=CC=C1)C(=O)O)NC(=O)C2CCCN2C(=O)C(CC3=CC=CC=C3)NC(=O)C(C)NC(=O)C(CCC(=O)O)NC(=O)C(C)NC(=O)C(CO)NC(=O)C(CCC(=O)O)NC(=O)C(CC(=O)O)NC(=O)C(CCC(=O)O)NC(=O)C(C)NC(=O)CNC(=O)C(CC(=O)N)NC(=O)C4CCCN4C(=O)C(CC5=CC=C(C=C5)O)NC(=O)C(C(C)C)NC(=O)C(CCCCN)NC(=O)C(C(C)C)NC(=O)C6CCCN6C(=O)C(CCCNC(=N)N)NC(=O)C(CCCNC(=N)N)NC(=O)C(CCCCN)NC(=O)C(CCCCN)NC(=O)CNC(=O)C(C(C)C)NC(=O)C7CCCN7C(=O)C(CCCCN)NC(=O)CNC(=O)C(CC8=CNC9=CC=CC=C98)NC(=O)C(CCCNC(=N)N)NC(=O)C(CC1=CC=CC=C1)NC(=O)C(CC1=CN=CN1)NC(=O)C(CCC(=O)O)NC(=O)C(CCSC)NC(=O)C(CO)NC(=O)C(CC1=CC=C(C=C1)O)NC(=O)C(CO)N,APPROVED,,urinary_system_disease
6289,2544,Clinical Stage IV Cutaneous Melanoma AJCC v8|Metastatic Colorectal Carcinoma|Metastatic Malignant Solid Neoplasm|Metastatic Melanoma|Metastatic Ovarian Carcinoma|Metastatic Renal Cell Carcinoma|Platinum-Resistant Ovarian Carcinoma|Recurrent Melanoma|Recurrent Renal Cell Carcinoma|Refractory Melanoma|Refractory Renal Cell Carcinoma|Sarcoma|Stage IV Colorectal Cancer AJCC v8|Stage IV Ovarian Cancer AJCC v8|Stage IV Renal Cell Cancer AJCC v8,Aflibercept,,PHASE1,,urinary_system_disease
6288,2536,Acute Renal Failure|Infection,Anidulafungin,CCCCCOC1=CC=C(C=C1)C2=CC=C(C=C2)C3=CC=C(C=C3)C(=O)NC4CC(C(NC(=O)C5C(C(CN5C(=O)C(NC(=O)C(NC(=O)C6CC(CN6C(=O)C(NC4=O)C(C)O)O)C(C(C7=CC=C(C=C7)O)O)O)C(C)O)C)O)O)O,PHASE2,,urinary_system_disease
6287,2521,Stage III Cutaneous Melanoma|Stage IV Cutaneous Melanoma|Locally Advanced Melanoma|Locally Advanced Solid Neoplasm|Metastatic Head and Neck Squamous Cell Carcinoma|Metastatic Malignant Solid Neoplasm|Metastatic Melanoma|Metastatic Urothelial Carcinoma|Non-Small Cell Lung Carcinoma|Stage IB Lung Cancer AJCC v7|Stage III Cutaneous Squamous Cell Carcinoma of the Head and Neck AJCC v8|Stage III Lung Cancer AJCC v8|Stage III Ureter Cancer AJCC v8|Stage IIIA Lung Cancer AJCC v8|Stage IIIB Lung Cancer AJCC v8|Stage IIIC Lung Cancer AJCC v8|Stage IV Cutaneous Squamous Cell Carcinoma of the Head and Neck AJCC v8|Stage IV Lung Cancer AJCC v8|Stage IV Ureter Cancer AJCC v8|Stage IVA Lung Cancer AJCC v8|Stage IVB Lung Cancer AJCC v8,Abexinostat,CN(C)CC1=C(OC2=CC=CC=C21)C(=O)NCCOC3=CC=C(C=C3)C(=O)NO,PHASE1,,urinary_system_disease
6286,2516,Kidney Transplantation|Kidney Disease,Nystatin,CC1C=CC=CCCC=CC=CC=CC=CC(CC2C(C(CC(O2)(CC(C(CCC(CC(CC(CC(=O)OC(C(C1O)C)C)O)O)O)O)O)O)O)C(=O)O)OC3C(C(C(C(O3)C)O)N)O,PHASE1|PHASE2,,urinary_system_disease
6285,2515,Kidney Transplantation|Kidney Disease,Clotrimazole,C1=CC=C(C=C1)C(C2=CC=CC=C2)(C3=CC=CC=C3Cl)N4C=CN=C4,PHASE1|PHASE2,,urinary_system_disease
6284,2514,Kidney Transplantation|Kidney Disease,Pentamidine,C1=CC(=CC=C1C(=N)N)OCCCCCOC2=CC=C(C=C2)C(=N)N,PHASE1|PHASE2,,urinary_system_disease
6283,2513,Kidney Transplantation|Kidney Disease,Acyclovir,C1=NC2=C(N1COCCO)N=C(NC2=O)N,PHASE1|PHASE2,,urinary_system_disease
6282,2504,Renal Impairment,Inclisiran,CC(=O)NC1C(C(C(OC1OCCCCC(=O)NCCCNC(=O)CCOCC(COCCC(=O)NCCCNC(=O)CCCCOC2C(C(C(C(O2)CO)O)O)NC(=O)C)(COCCC(=O)NCCCNC(=O)CCCCOC3C(C(C(C(O3)CO)O)O)NC(=O)C)NC(=O)CCCCCCCCCCC(=O)N4CC(CC4COP(=O)(O)O)O)CO)O)O,PHASE1,,urinary_system_disease
6281,2501,Metastatic Melanoma|Metastatic Renal Cancer,Zanolimumab,,PHASE2,,urinary_system_disease
6280,2498,"Urinary Incontinence, Stress|Fecal Incontinence",Imipramine,CN(C)CCCN1C2=CC=CC=C2CCC3=CC=CC=C31,PHASE1,,urinary_system_disease
6279,2476,Proteinuria,Triamterene,C1=CC=C(C=C1)C2=NC3=C(N=C(N=C3N=C2N)N)N,APPROVED,,urinary_system_disease
6278,2469,"Renal Disease, End Stage",Amisulpride,CCN1CCCC1CNC(=O)C2=CC(=C(C=C2OC)N)S(=O)(=O)CC,PHASE1,,urinary_system_disease
6277,2462,Albuminuria,Montelukast,CC(C)(C1=CC=CC=C1CCC(C2=CC=CC(=C2)C=CC3=NC4=C(C=CC(=C4)Cl)C=C3)SCC5(CC5)CC(=O)O)O,APPROVED,,urinary_system_disease
6276,2459,Chronic Kidney Disease|Proteinuria,Rosuvastatin,CC(C)C1=NC(=NC(=C1C=CC(CC(CC(=O)O)O)O)C2=CC=C(C=C2)F)N(C)S(=O)(=O)C,APPROVED,,urinary_system_disease
6275,2441,T2DM (Type 2 Diabetes Mellitus)|Metformin|SGLT2-Inhibitors,Tofogliflozin,CCC1=CC=C(C=C1)CC2=CC3=C(COC34C(C(C(C(O4)CO)O)O)O)C=C2,PHASE2,,urinary_system_disease
6274,2426,Heart Failure|Renal Insufficiency,Simendan,CC1CC(=O)NN=C1C2=CC=C(C=C2)NN=C(C#N)C#N,APPROVED,,urinary_system_disease
6273,2425,Heart Failure|Renal Insufficiency,Levosimendan,CC1CC(=O)NN=C1C2=CC=C(C=C2)NN=C(C#N)C#N,APPROVED,,urinary_system_disease
6272,2411,Renal Cell Carcinoma,Brivanib,CC1=CC2=C(N1)C=CC(=C2F)OC3=NC=NN4C3=C(C(=C4)OCC(C)O)C,PHASE2,,urinary_system_disease
6271,2406,Chronic Kidney Disease|Proteinuria,Nifedipine,CC1=C(C(C(=C(N1)C)C(=O)OC)C2=CC=CC=C2[N+](=O)[O-])C(=O)OC,PHASE1,,urinary_system_disease
6270,2401,Chronic Kidney Disease|Cardiovascular Disease,Rilonacept,,PHASE2,,urinary_system_disease
6269,2388,Renal Impairment,Teduglutide,CCC(C)C(C(=O)NC(C(C)O)C(=O)NC(CC(=O)O)C(=O)O)NC(=O)C(CCCCN)NC(=O)C(C(C)O)NC(=O)C(CCC(=O)N)NC(=O)C(C(C)CC)NC(=O)C(CC(C)C)NC(=O)C(CC1=CNC2=CC=CC=C21)NC(=O)C(CC(=O)N)NC(=O)C(C(C)CC)NC(=O)C(CC3=CC=CC=C3)NC(=O)C(CC(=O)O)NC(=O)C(CCCNC(=N)N)NC(=O)C(C)NC(=O)C(C)NC(=O)C(CC(C)C)NC(=O)C(CC(=O)N)NC(=O)C(CC(=O)O)NC(=O)C(CC(C)C)NC(=O)C(C(C)CC)NC(=O)C(C(C)O)NC(=O)C(CC(=O)N)NC(=O)C(CCSC)NC(=O)C(CCC(=O)O)NC(=O)C(CC(=O)O)NC(=O)C(CO)NC(=O)C(CC4=CC=CC=C4)NC(=O)C(CO)NC(=O)CNC(=O)C(CC(=O)O)NC(=O)CNC(=O)C(CC5=CN=CN5)N,PHASE1,,urinary_system_disease
6268,2382,Enuresis|Obstructive Sleep Apnea|Sleep Disordered Breathing,Mometasone,CC1CC2C3CCC4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)CCl)O)C)O)Cl)C,APPROVED,,urinary_system_disease
6267,2363,Stress Urinary Incontinence,Epinephrine,CNCC(C1=CC(=C(C=C1)O)O)O,APPROVED,,urinary_system_disease
6266,2341,Urinary Tract Infections,Norfloxacin,CCN1C=C(C(=O)C2=CC(=C(C=C21)N3CCNCC3)F)C(=O)O,APPROVED,,urinary_system_disease
6265,2337,Wolfram Syndrome,Tirzepatide,CCC(C)C(C(=O)NC(C)C(=O)NC(CCC(=O)N)C(=O)NC(CCCCNC(=O)COCCOCCNC(=O)COCCOCCNC(=O)CCC(C(=O)O)NC(=O)CCCCCCCCCCCCCCCCCCC(=O)O)C(=O)NC(C)C(=O)NC(CC1=CC=CC=C1)C(=O)NC(C(C)C)C(=O)NC(CCC(=O)N)C(=O)NC(CC2=CNC3=CC=CC=C32)C(=O)NC(CC(C)C)C(=O)NC(C(C)CC)C(=O)NC(C)C(=O)NCC(=O)NCC(=O)N4CCCC4C(=O)NC(CO)C(=O)NC(CO)C(=O)NCC(=O)NC(C)C(=O)N5CCCC5C(=O)N6CCCC6C(=O)N7CCCC7C(=O)NC(CO)C(=O)N)NC(=O)C(CCCCN)NC(=O)C(CC(=O)O)NC(=O)C(CC(C)C)NC(=O)C(C)(C)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(CC8=CC=C(C=C8)O)NC(=O)C(CC(=O)O)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C(CC9=CC=CC=C9)NC(=O)C(C(C)O)NC(=O)CNC(=O)C(CCC(=O)O)NC(=O)C(C)(C)NC(=O)C(CC1=CC=C(C=C1)O)N,PHASE2,,urinary_system_disease
6264,2334,Nephrolithiasis,Fexofenadine,CC(C)(C1=CC=C(C=C1)C(CCCN2CCC(CC2)C(C3=CC=CC=C3)(C4=CC=CC=C4)O)O)C(=O)O,PHASE2,,urinary_system_disease
6263,2333,Overactive Bladder,Propiverine,CCCOC(C1=CC=CC=C1)(C2=CC=CC=C2)C(=O)OC3CCN(CC3)C,APPROVED,,urinary_system_disease
6262,2327,Kidney Cancer|Leukemia|Lymphoma|Neurotoxicity|Peripheral Neuropathy|Sarcoma,Glutamine,C(CC(=O)N)C(C(=O)O)N,PHASE2,,urinary_system_disease
6261,2322,"Carcinoma, Renal Cell|Kidney Diseases|Kidney Neoplasms|Urogenital Neoplasms|Urologic Diseases|Urologic Neoplasms|Neoplasms by Histologic Type|Neoplasms|Clear-cell Metastatic Renal Cell Carcinoma|Melanoma|Triple Negative Breast Cancer|Bladder Cancer|Head and Neck Cancer|Non-small Cell Lung Cancer",Varlilumab,,PHASE1,,urinary_system_disease
6260,2320,Accidental Falls|Chronic Renal Insufficiency|Aged,Alfacalcidol,CC(C)CCCC(C)C1CCC2C1(CCCC2=CC=C3CC(CC(C3=C)O)O)C,APPROVED,,urinary_system_disease
6259,2300,"Cirrhosis, Liver|Upper Gastrointestinal Bleeding",Somatostatin,CC(C1C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(CSSCC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N1)CCCCN)CC2=CNC3=CC=CC=C32)CC4=CC=CC=C4)CC5=CC=CC=C5)CC(=O)N)CCCCN)NC(=O)CNC(=O)C(C)N)C(=O)O)CO)C(C)O)CC6=CC=CC=C6)O,APPROVED,,urinary_system_disease
6258,2293,"Chronic Kidney Disease, Stage 5|Secondary Hyperparathyroidism",Doxercalciferol,CC(C)C(C)C=CC(C)C1CCC2C1(CCCC2=CC=C3CC(CC(C3=C)O)O)C,APPROVED,,urinary_system_disease
6257,2288,Bladder Pain Syndrome|Interstitial Cystitis,Naltrexone,C1CC1CN2CCC34C5C(=O)CCC3(C2CC6=C4C(=C(C=C6)O)O5)O,PHASE2,,urinary_system_disease
6256,2286,"Anti-Infective Agents, Urinary|Escherichia Coli Infections|Klebsiella Infections|Kidney Transplantation|Urinary Tract Infections",Sitafloxacin,C1CC12CN(CC2N)C3=C(C=C4C(=C3Cl)N(C=C(C4=O)C(=O)O)C5CC5F)F,PHASE2|PHASE3,,urinary_system_disease
6255,2282,Bladder Urothelial Carcinoma|Stage I Bladder Cancer AJCC v6 and v7|Stage II Bladder Cancer AJCC v6 and v7|Stage III Bladder Cancer AJCC v6 and v7,Trastuzumab,,PHASE1|PHASE2,,urinary_system_disease
6254,2252,Neoplasms|Solid Tumors|Bone Cancer|Kidney Tumor|Neuroblastoma,Robatumumab,,PHASE1,,urinary_system_disease
6253,2251,Neoplasms|Solid Tumors|Bone Cancer|Kidney Tumor|Neuroblastoma,Irinotecan,CCC1=C2CN3C(=CC4=C(C3=O)COC(=O)C4(CC)O)C2=NC5=C1C=C(C=C5)OC(=O)N6CCC(CC6)N7CCCCC7,PHASE1,,urinary_system_disease
6252,2250,Neoplasms|Solid Tumors|Bone Cancer|Kidney Tumor|Neuroblastoma,Ifosfamide,C1CN(P(=O)(OC1)NCCCl)CCCl,PHASE1,,urinary_system_disease
6251,2247,End Stage Renal Disease on Hemodialysis,Difelikefalin,CC(C)CC(C(=O)NC(CCCCN)C(=O)N1CCC(CC1)(C(=O)O)N)NC(=O)C(CC2=CC=CC=C2)NC(=O)C(CC3=CC=CC=C3)N,PHASE1,,urinary_system_disease
6250,2239,Renal Impairment,Lemborexant,CC1=NC(=NC=C1OCC2(CC2C(=O)NC3=NC=C(C=C3)F)C4=CC(=CC=C4)F)C,PHASE1,,urinary_system_disease
6249,2232,Cardiorenal Syndrome,Chlortalidone,C1=CC=C2C(=C1)C(=O)NC2(C3=CC(=C(C=C3)Cl)S(=O)(=O)N)O,PHASE2,,urinary_system_disease
6248,2225,"Gastrointestinal Tumors, Urinary System Tumors, Neuroendocrine Tumors",Anlotinib,CC1=CC2=C(N1)C=CC(=C2F)OC3=C4C=C(C(=CC4=NC=C3)OCC5(CC5)N)OC,PHASE2,,urinary_system_disease
6247,2207,Diabetic Nephropathy,Nidufexor,CN1C2=C(COC3=C2C=C(C=C3)Cl)C(=N1)C(=O)N(CC4=CC=CC=C4)CC5=CC=C(C=C5)C(=O)O,PHASE2,,urinary_system_disease
6246,2205,"Diabetes Mellitus, Type 2|Renal Disease|Diabetes Mellitus|Metabolic Disease|Endocrine System Diseases",Evogliptin,CC(C)(C)OCC1C(=O)NCCN1C(=O)CC(CC2=CC(=C(C=C2F)F)F)N,APPROVED,,urinary_system_disease
6245,2203,Renal Insufficiency,Tiotropium,C[N+]1(C2CC(CC1C3C2O3)OC(=O)C(C4=CC=CS4)(C5=CC=CS5)O)C,PHASE1,,urinary_system_disease
6244,2202,Renal Impairment,Methylnaltrexone,C[N+]1(CCC23C4C(=O)CCC2(C1CC5=C3C(=C(C=C5)O)O4)O)CC6CC6,PHASE1,,urinary_system_disease
6243,2201,Renal Insufficiency|Tenofovir,Tenofovir,CC(CN1C=NC2=C(N=CN=C21)N)OCP(=O)(O)O,APPROVED,,urinary_system_disease
6242,2191,Urinary Incontinence,Litoxetine,C1CNCCC1OCC2=CC3=CC=CC=C3C=C2,PHASE1|PHASE2,,urinary_system_disease
6241,2178,Renal Impairment|Diabetes,Vildagliptin,C1CC(N(C1)C(=O)CNC23CC4CC(C2)CC(C4)(C3)O)C#N,PHASE1|PHASE2,,urinary_system_disease
6240,2170,Lupus Nephritis|Immunoglobulin A Nephropathy,Ravulizumab,,PHASE2,,urinary_system_disease
6239,2165,"Carcinoma, Renal Cell",Quavonlimab,,PHASE1|PHASE2,,urinary_system_disease
6238,2160,"Carcinoma, Renal Cell",Favezelimab,,PHASE1|PHASE2,,urinary_system_disease
6237,2158,Urinary Tract Infections|Elderly Infection,Amikacin,C1C(C(C(C(C1NC(=O)C(CCN)O)OC2C(C(C(C(O2)CO)O)N)O)O)OC3C(C(C(C(O3)CN)O)O)O)N,APPROVED,,urinary_system_disease
6236,2157,BK Virus Infection|Nephropathy|Kidney Transplantation,Brincidofovir,CCCCCCCCCCCCCCCCOCCCOP(=O)(COC(CN1C=CC(=NC1=O)N)CO)O,PHASE2,,urinary_system_disease
6235,2156,Small Cell Neuroendocrine Carcinoma of Bladder|Bladder Cancer|Urothelial Carcinoma Bladder,Etoposide,CC1OCC2C(O1)C(C(C(O2)OC3C4COC(=O)C4C(C5=CC6=C(C=C35)OCO6)C7=CC(=C(C(=C7)OC)O)OC)O)O,PHASE2,,urinary_system_disease
6234,2148,End-stage Renal Disease|HCV Coinfection,Ritonavir,CC(C)C1=NC(=CS1)CN(C)C(=O)NC(C(C)C)C(=O)NC(CC2=CC=CC=C2)CC(C(CC3=CC=CC=C3)NC(=O)OCC4=CN=CS4)O,APPROVED,,urinary_system_disease
6233,2147,End-stage Renal Disease|HCV Coinfection,Paritaprevir,CC1=CN=C(C=N1)C(=O)NC2CCCCCC=CC3CC3(NC(=O)C4CC(CN4C2=O)OC5=NC6=CC=CC=C6C7=CC=CC=C75)C(=O)NS(=O)(=O)C8CC8,APPROVED,,urinary_system_disease
6232,2146,End-stage Renal Disease|HCV Coinfection,Ombitasvir,CC(C)C(C(=O)N1CCCC1C(=O)NC2=CC=C(C=C2)C3CCC(N3C4=CC=C(C=C4)C(C)(C)C)C5=CC=C(C=C5)NC(=O)C6CCCN6C(=O)C(C(C)C)NC(=O)OC)NC(=O)OC,APPROVED,,urinary_system_disease
6231,2113,Advanced Cancer|Advanced Malignancies|Bladder Cancer|Cervical Cancer|Esophageal Cancer|Gastric Cancer|Gastroesophageal-junction Cancer (GEJ)|Head and Neck Squamous Cell Carcinoma (HNSCC)|Non-Small Cell Lung Cancer (NSCLC)|Ovarian Cancer|Renal Cell Carcinoma (RCC)|Triple Negative Breast Cancer (TNBC),Pemetrexed,C1=CC(=CC=C1CCC2=CNC3=C2C(=O)NC(=N3)N)C(=O)NC(CCC(=O)O)C(=O)O,PHASE1,,urinary_system_disease
6230,2097,Gastric Cancer|Esophageal Cancer|Lung Cancer|Renal Cancer|Oral Cancer,Mogamulizumab,,PHASE1,,urinary_system_disease
6229,2092,Prostatic Hyperplasia,Lemuteporfin,CC1=C(C2=CC3=NC(=CC4=C(C(=C(N4)C=C5C6(C(C(=CC=C6C(=N5)C=C1N2)C(=O)OC)C(=O)OC)C)C)CCC(=O)OCCO)C(=C3C)CCC(=O)OCCO)C=C,PHASE2,,urinary_system_disease
6228,2078,Catheter; Infection (Indwelling Catheter)|Catheter Infection|Catheter-Related Infections|Catheter Bacteraemia|Urinary Tract Infections,Povidone,C=CN1CCCC1=O,APPROVED,,urinary_system_disease
6227,2072,Urothelial Carcinoma|Bladder Cancer|Renal Pelvis Cancer|Ureter Cancer|Urethra Cancer,Vinflunine,CCC12C=CCN3C1C4(CC3)C(C(C2OC(=O)C)(C(=O)OC)O)N(C5=CC(=C(C=C45)C6(CC7CC(CN(C7)CC8=C6NC9=CC=CC=C89)C(C)(F)F)C(=O)OC)OC)C,PHASE2,,urinary_system_disease
6226,2061,Henoch-Schönlein Purpura Nephritis,Dipyridamole,C1CCN(CC1)C2=NC(=NC3=C2N=C(N=C3N4CCCCC4)N(CCO)CCO)N(CCO)CCO,PHASE1|PHASE2,,urinary_system_disease
6225,2056,Nephrotic Syndrome in Children,Levamisole,C1CSC2=NC(CN21)C3=CC=CC=C3,APPROVED,,urinary_system_disease
6224,2037,Bladder Cancer,Vinblastine,CCC1(CC2CC(C3=C(CCN(C2)C1)C4=CC=CC=C4N3)(C5=C(C=C6C(=C5)C78CCN9C7C(C=CC9)(C(C(C8N6C)(C(=O)OC)O)OC(=O)C)CC)OC)C(=O)OC)O,PHASE2,,urinary_system_disease
6223,2034,"Carcinoma, Renal Cell",Regorafenib,CNC(=O)C1=NC=CC(=C1)OC2=CC(=C(C=C2)NC(=O)NC3=CC(=C(C=C3)Cl)C(F)(F)F)F,PHASE2,,urinary_system_disease
6222,1978,Recurrent Renal Cell Carcinoma|Stage IV Renal Cell Cancer,Suramin,CC1=C(C=C(C=C1)C(=O)NC2=C3C(=CC(=CC3=C(C=C2)S(=O)(=O)O)S(=O)(=O)O)S(=O)(=O)O)NC(=O)C4=CC(=CC=C4)NC(=O)NC5=CC=CC(=C5)C(=O)NC6=C(C=CC(=C6)C(=O)NC7=C8C(=CC(=CC8=C(C=C7)S(=O)(=O)O)S(=O)(=O)O)S(=O)(=O)O)C,PHASE1|PHASE2,,urinary_system_disease
6221,1973,Chronic Kidney Disease Associated Moderate to Severe Pruritus,Nemolizumab,,PHASE2|PHASE3,,urinary_system_disease
6220,1972,First-line Treatment of Non-clear Renal Cell Carcinoma,Fruquintinib,CC1=C(C2=C(O1)C=C(C=C2)OC3=NC=NC4=CC(=C(C=C43)OC)OC)C(=O)NC,PHASE2,,urinary_system_disease
6219,1963,Fanconi Anemia|Myelodysplastic Syndrome (MDS)|Acute Myelogenous Leukemia (AML),Busulfan,CS(=O)(=O)OCCCCOS(=O)(=O)C,PHASE2,,urinary_system_disease
6218,1961,Renal Impairment,Besifovir,C1CC1(CN2C=NC3=CN=C(N=C32)N)OCP(=O)(O)O,PHASE1,,urinary_system_disease
6217,1957,Clear Cell Renal Cell Carcinoma,Imatinib,CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5,PHASE1|PHASE2,,urinary_system_disease
6216,1947,Acute Interstitial Nephritis,Omalizumab,,PHASE2,,urinary_system_disease
6215,1946,Renal Impairment,Molnupiravir,CC(C)C(=O)OCC1C(C(C(O1)N2C=CC(=NC2=O)NO)O)O,PHASE1,,urinary_system_disease
6214,1945,HIV Infections|Kidney Diseases,Maraviroc,CC1=NN=C(N1C2CC3CCC(C2)N3CCC(C4=CC=CC=C4)NC(=O)C5CCC(CC5)(F)F)C(C)C,PHASE2,,urinary_system_disease
6213,1937,Analgesia|Urolithiasis,Meperidine,CCOC(=O)C1(CCN(CC1)C)C2=CC=CC=C2,APPROVED,,urinary_system_disease
6212,1935,Urothelial Carcinoma|Bladder Cancer,Urelumab,,PHASE2,,urinary_system_disease
6211,1926,Coronary Artery Disease|End Stage Renal Disease,Nicorandil,C1=CC(=CN=C1)C(=O)NCCO[N+](=O)[O-],APPROVED,,urinary_system_disease
6210,1893,Healthy,Licarbazepine,C1C(C2=CC=CC=C2N(C3=CC=CC=C31)C(=O)N)O,PHASE1,,urinary_system_disease
6209,1876,Metastatic Ureter Carcinoma|Metastatic Urethral Carcinoma|Stage III Bladder Urothelial Carcinoma AJCC v6 and v7|Stage III Ureter Cancer AJCC v7|Stage III Urethral Cancer AJCC v7|Stage IV Bladder Urothelial Carcinoma AJCC v7|Stage IV Ureter Cancer AJCC v7|Stage IV Urethral Cancer AJCC v7|Ureter Urothelial Carcinoma|Urethral Urothelial Carcinoma,Eribulin,CC1CC2CCC3C(=C)CC(O3)CCC45CC6C(O4)C7C(O6)C(O5)C8C(O7)CCC(O8)CC(=O)CC9C(CC(C1=C)O2)OC(C9OC)CC(CN)O,PHASE2,,urinary_system_disease
6208,1872,Acute Kidney Injury|Renal Replacement Therapy|Anticoagulants,Tinzaparin,CC(=O)NC1C(C(C(OC1O)COS(=O)(=O)O)OC2C(C(C(C(O2)C(=O)O)OC3C(C(C(C(O3)CO)OC4C(C(C(C(O4)C(=O)O)O)O)OS(=O)(=O)O)OS(=O)(=O)O)NS(=O)(=O)O)O)OS(=O)(=O)O)O,APPROVED,,urinary_system_disease
6207,1864,AKI - Acute Kidney Injury,Trimetazidine,COC1=C(C(=C(C=C1)CN2CCNCC2)OC)OC,APPROVED,,urinary_system_disease
6206,1841,IgA Nephropathy,Blisibimod,,PHASE2|PHASE3,,urinary_system_disease
6205,1840,Benign Prostatic Hyperplasia|Lower Urinary Tract Symptoms,Alfuzosin,CN(CCCNC(=O)C1CCCO1)C2=NC3=CC(=C(C=C3C(=N2)N)OC)OC,APPROVED,,urinary_system_disease
6204,1837,Urinary Bladder Neoplasms,Cetrelimab,,PHASE2,,urinary_system_disease
6203,1819,"Renal Failure, Chronic|End-Stage Renal Disease",Serelaxin,CCC(C)C1C(=O)NC(CSSCC(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C2CSSCC(C(=O)NC(CSSCC(C(=O)NCC(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N1)C)C(C)CC)CCC(=O)N)C)CCCNC(=N)N)C(C)C)CC(C)C)CCC(=O)O)CCCNC(=N)N)NC(=O)C(CC(C)C)NC(=O)C(CCCCN)NC(=O)C(C(C)CC)NC(=O)C(C(C)C)NC(=O)C(CCC(=O)O)NC(=O)C(CCC(=O)O)NC(=O)C(CCSC)NC(=O)C(CC3=CNC4=CC=CC=C43)NC(=O)C(CO)NC(=O)C(CC(=O)O)N)C(=O)NC(C(=O)NC(C(=O)NCC(=O)N2)C(C)C)CC5=CN=CN5)NC(=O)C(CCCCN)NC(=O)C(CC(=O)N)NC(=O)C(C)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CO)NC(=O)C(CC6=CC=C(C=C6)O)NC(=O)C(CC(C)C)NC(=O)C7CCC(=O)N7)C(C)O)CCCCN)CCCNC(=N)N)CO)CC(C)C)C)CCCNC(=N)N)CC8=CC=CC=C8)C(=O)O)C(=O)NCC(=O)NC(CCSC)C(=O)NC(CO)C(=O)NC(C(C)O)C(=O)NC(CC9=CNC1=CC=CC=C19)C(=O)NC(CO)C(=O)O,PHASE1,,urinary_system_disease
6202,1808,Renal Impairment|Healthy,Esketamine,CNC1(CCCCC1=O)C2=CC=CC=C2Cl,PHASE1,,urinary_system_disease
6201,1802,Advanced/Metastasis Renal Cell Carcinoma,Lipotecan,CCC1(C2=C(COC1=O)C(=O)N3CC4=CC5=C(C=CC(=C5CN(C)C)O)N=C4C3=C2)OC(=O)C(C)ON=C6C7=C(C(=CC(=C7)[N+](=O)[O-])[N+](=O)[O-])C8=C6C=C(C=C8[N+](=O)[O-])[N+](=O)[O-],PHASE2,,urinary_system_disease
6200,1790,Multiple Myeloma,Denosumab,,PHASE2,,urinary_system_disease
6199,1787,Clear-Cell Renal Cell Carcinoma,Sitravatinib,COCCNCC1=CN=C(C=C1)C2=CC3=NC=CC(=C3S2)OC4=C(C=C(C=C4)NC(=O)C5(CC5)C(=O)NC6=CC=C(C=C6)F)F,PHASE1,,urinary_system_disease
6198,1779,Urothelial Carcinoma of the Urinary Bladder,Cabazitaxel,CC1=C2C(C(=O)C3(C(CC4C(C3C(C(C2(C)C)(CC1OC(=O)C(C(C5=CC=CC=C5)NC(=O)OC(C)(C)C)O)O)OC(=O)C6=CC=CC=C6)(CO4)OC(=O)C)OC)C)OC,PHASE1|PHASE2,,urinary_system_disease
6197,1777,Lupus Nephritis,Voclosporin,CCC1C(=O)N(CC(=O)N(C(C(=O)NC(C(=O)N(C(C(=O)NC(C(=O)NC(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N1)C(C(C)CC=CC=C)O)C)C(C)C)C)CC(C)C)C)CC(C)C)C)C)C)CC(C)C)C)C(C)C)CC(C)C)C)C,PHASE2,,urinary_system_disease
6196,1756,Renal Impairment|Healthy Participants,Linzagolix,COC1=C(C(=C(C=C1)F)F)COC2=C(C=C(C(=C2)N3C(=O)C4=C(SC=C4NC3=O)C(=O)O)F)OC,PHASE1,,urinary_system_disease
6195,1754,Bladder Cancer,Simvastatin,CCC(C)(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC3CC(CC(=O)O3)O)C,PHASE2,,urinary_system_disease
6194,1750,Urinary Bladder Neoplasms|Ureteral Neoplasms|Urethral Neoplasms,Crizotinib,CC(C1=C(C=CC(=C1Cl)F)Cl)OC2=C(N=CC(=C2)C3=CN(N=C3)C4CCNCC4)N,PHASE2,,urinary_system_disease
6193,1749,"Diabetes Mellitus, Type 1|Diabetic Nephropathy",Alagebrium,CC1=C(SC=[N+]1CC(=O)C2=CC=CC=C2)C,PHASE2,,urinary_system_disease
6192,1737,Diabetic Nephropathy,Benfotiamine,CC1=NC=C(C(=N1)N)CN(C=O)C(=C(CCOP(=O)(O)O)SC(=O)C2=CC=CC=C2)C,APPROVED,,urinary_system_disease
6191,1708,Renal Cell Carcinoma,Cediranib,CC1=CC2=C(N1)C=CC(=C2F)OC3=NC=NC4=CC(=C(C=C43)OC)OCCCN5CCCC5,PHASE2,,urinary_system_disease
6190,1700,Brain and Central Nervous System Tumors|Kidney Cancer|Liver Cancer|Retinoblastoma|Sarcoma,Mesna,C(CS(=O)(=O)[O-])S.[Na+],PHASE1,,urinary_system_disease
6189,1693,Critical Illness|Acute Kidney Injury|End-stage Renal Disease|Renal Replacement Therapy|Proton Pump Inhibitor,Pantoprazole,COC1=C(C(=NC=C1)CS(=O)C2=NC3=C(N2)C=C(C=C3)OC(F)F)OC,APPROVED,,urinary_system_disease
6188,1692,Chronic Kidney Disease,Rifampicin,CC1C=CC=C(C(=O)NC2=C(C(=C3C(=C2O)C(=C(C4=C3C(=O)C(O4)(OC=CC(C(C(C(C(C(C1O)C)O)C)OC(=O)C)C)OC)C)C)O)O)C=NN5CCN(CC5)C)C,PHASE1,,urinary_system_disease
6187,1691,Chronic Kidney Disease,Rifampin,CC1C=CC=C(C(=O)NC2=C(C(=C3C(=C2O)C(=C(C4=C3C(=O)C(O4)(OC=CC(C(C(C(C(C(C1O)C)O)C)OC(=O)C)C)OC)C)C)O)O)C=NN5CCN(CC5)C)C,PHASE1,,urinary_system_disease
6186,1664,Pyelonephritis Acute,Ceftriaxone,CN1C(=NC(=O)C(=O)N1)SCC2=C(N3C(C(C3=O)NC(=O)C(=NOC)C4=CSC(=N4)N)SC2)C(=O)O,APPROVED,,urinary_system_disease
6185,1654,Endstage Renal Disease,Nadroparin,CC(=O)NC1C(C(C(OC1O)COS(=O)(=O)O)OC2C(C(C(C(O2)C(=O)O)OC3C(C(C(C(O3)CO)OC4C(C(C(C(O4)C(=O)O)O)O)OS(=O)(=O)O)OS(=O)(=O)O)NS(=O)(=O)O)O)OS(=O)(=O)O)O,APPROVED,,urinary_system_disease
6184,1646,BRAF Gene Mutation|Hepatic Complication|Renal Failure|Solid Neoplasm,Dabrafenib,CC(C)(C)C1=NC(=C(S1)C2=NC(=NC=C2)N)C3=C(C(=CC=C3)NS(=O)(=O)C4=C(C=CC=C4F)F)F,PHASE1,,urinary_system_disease
6183,1635,Ovarian Cancer|Renal Cancer|Non-small Cell Lung Cancer|Small Cell Lung Cancer|Solid Tumors|Multiple Myeloma|Lymphoma,Carfilzomib,CC(C)CC(C(=O)C1(CO1)C)NC(=O)C(CC2=CC=CC=C2)NC(=O)C(CC(C)C)NC(=O)C(CCC3=CC=CC=C3)NC(=O)CN4CCOCC4,PHASE1|PHASE2,,urinary_system_disease
6182,1632,Acute Renal Colic|Ureteric Stone,Parecoxib,CCC(=O)NS(=O)(=O)C1=CC=C(C=C1)C2=C(ON=C2C3=CC=CC=C3)C,APPROVED,,urinary_system_disease
6181,1629,Atherosclerosis,Darapladib,CCN(CC)CCN(CC1=CC=C(C=C1)C2=CC=C(C=C2)C(F)(F)F)C(=O)CN3C4=C(CCC4)C(=O)N=C3SCC5=CC=C(C=C5)F,PHASE1,,urinary_system_disease
6180,1624,"Polycystic Kidney, Autosomal Dominant",Venglustat,CC(C)(C1=CSC(=N1)C2=CC=C(C=C2)F)NC(=O)OC3CN4CCC3CC4,PHASE2|PHASE3,,urinary_system_disease
6179,1622,Motor Weakness in Two or Four Limbs|Damage in the Anterior Spinal Artery (ASA)|Temperature and Superficial Sensation|Urinary Retention or Bowel Disorder,Alteplase,,PHASE2,,urinary_system_disease
6178,1598,Neuroblastoma|Rhabdomyosarcoma|Osteosarcoma|Ewing Sarcoma|Wilms Tumor|Desmoplastic Small Round Cell Tumor,Enoblituzumab,,PHASE1,,urinary_system_disease
6177,1595,"Glomerulonephritis, IGA|Renal Insufficiency, Chronic",Leflunomide,CC1=C(C=NO1)C(=O)NC2=CC=C(C=C2)C(F)(F)F,APPROVED,,urinary_system_disease
6176,1594,Nephrotic Syndrome|Hyperlipidemia,Pravastatin,CCC(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC(CC(CC(=O)O)O)O)O,PHASE1,,urinary_system_disease
6175,1591,Renal Cell Cancer|Metastatic Renal Cell Cancer,Famitinib,CCN(CC)CCN1CCC2=C(C1=O)C(=C(N2)C=C3C4=C(C=CC(=C4)F)NC3=O)C,PHASE2,,urinary_system_disease
6174,1583,Kidney Stone|Unexplained Haematuria|Benignant Tumour Mass in the Upper Urinary Tract,Isoprenaline,CC(C)NCC(C1=CC(=C(C=C1)O)O)O,PHASE2|PHASE3,,urinary_system_disease
6173,1582,Kidney Stone|Unexplained Haematuria|Benignant Tumour Mass in the Upper Urinary Tract,Isoproterenol,CC(C)NCC(C1=CC(=C(C=C1)O)O)O,PHASE2|PHASE3,,urinary_system_disease
6172,1565,Advanced Cancer|Metastatic Cancer|Biliary Tract Carcinoma|Cholangiocarcinoma|Gall Bladder Carcinoma|Solid Tumor|Non-Hodgkin's Lymphoma,Merestinib,CC1=CC=C(C(=O)N1C2=CC=C(C=C2)F)C(=O)NC3=CC(=C(C=C3)OC4=C(C=C5C(=C4)C=NN5C)C6=CNN=C6)F,PHASE1,,urinary_system_disease
6171,1564,Renal Disease,Imlifidase,,PHASE1|PHASE2,,urinary_system_disease
6170,1562,"Renal Insufficiency, Chronic|Proteinuria",Lisinopril,C1CC(N(C1)C(=O)C(CCCCN)NC(CCC2=CC=CC=C2)C(=O)O)C(=O)O,APPROVED,,urinary_system_disease
6169,1561,Kidney Dysfunction,Nemonoxacin,CC1CC(CN(C1)C2=C(C3=C(C=C2)C(=O)C(=CN3C4CC4)C(=O)O)OC)N,PHASE1,,urinary_system_disease
6168,1556,Insomnia,Suvorexant,CC1CCN(CCN1C(=O)C2=C(C=CC(=C2)C)N3N=CC=N3)C4=NC5=C(O4)C=CC(=C5)Cl,PHASE1,,urinary_system_disease
6167,1549,Urinary Schistosomiasis,Mefloquine,C1CCNC(C1)C(C2=CC(=NC3=C2C=CC=C3C(F)(F)F)C(F)(F)F)O,PHASE2,,urinary_system_disease
6166,1544,Multiple Myeloma|Chronic Kidney Disease,Bendamustine,CN1C2=C(C=C(C=C2)N(CCCl)CCCl)N=C1CCCC(=O)O,PHASE2,,urinary_system_disease
6165,1543,Multiple Myeloma|Chronic Kidney Disease,Thalidomide,C1CC(=O)NC(=O)C1N2C(=O)C3=CC=CC=C3C2=O,PHASE2,,urinary_system_disease
6164,1540,Kidney Failure|Renal Failure,Erythropoietin,CCCCC1=NC(=C(N1CC2=CC=C(C=C2)C3=CC=CC=C3C4=NN=N[N-]4)CO)Cl.[K+],PHASE2,,urinary_system_disease
6163,1534,Membranous Nephropathy|Nephrotic Syndrome,Belimumab,,PHASE2,,urinary_system_disease
6162,1531,Vestibulodynia|Temporomandibular Disorder|Fibromyalgia Syndrome|Irritable Bowel Syndrome|Migraines|Tension Headache|Endometriosis|Interstitial Cystitis|Back Pain|Chronic Fatigue Syndrome,Nortriptyline,CNCCC=C1C2=CC=CC=C2CCC3=CC=CC=C31,PHASE2,,urinary_system_disease
6161,1508,Colorectal Carcinoma|Endometrial Carcinoma|Melanoma|Neuroblastoma|Ovarian Carcinoma|Pancreatic Ductal Adenocarcinoma|Recurrent Desmoid Fibromatosis|Recurrent Ewing Sarcoma|Recurrent Hepatoblastoma|Recurrent Hepatocellular Carcinoma|Recurrent Malignant Solid Neoplasm|Recurrent Non-Hodgkin Lymphoma|Recurrent Osteosarcoma|Refractory Desmoid Fibromatosis|Refractory Ewing Sarcoma|Refractory Hepatoblastoma|Refractory Hepatocellular Carcinoma|Refractory Malignant Solid Neoplasm|Refractory Non-Hodgkin Lymphoma|Refractory Osteosarcoma|Solid Pseudopapillary Neoplasm of the Pancreas|Wilms Tumor,Tegavivint,CC1CC(CN(C1)S(=O)(=O)C2=CC3=C(C=C2)C(=C4C=CC(=CC4=C3N=O)S(=O)(=O)N5CC(CC(C5)C)C)NO)C,PHASE1|PHASE2,,urinary_system_disease
6160,1507,Muscle Invasive Bladder Cancer,Oleclumab,,PHASE1,,urinary_system_disease
6159,1482,"Kidney Failure, Chronic",Folate,C1=CC(=CC=C1C(=O)NC(CCC(=O)O)C(=O)O)NCC2=CN=C3C(=N2)C(=O)NC(=N3)N,PHASE2,,urinary_system_disease
6158,1481,"Kidney Failure, Chronic",Tetrahydrobiopterin,CC(C(C1CNC2=C(N1)C(=O)NC(=N2)N)O)O,PHASE2,,urinary_system_disease
6157,1480,"Kidney Failure, Chronic",Sapropterin,CC(C(C1CNC2=C(N1)C(=O)NC(=N2)N)O)O,PHASE2,,urinary_system_disease
6156,1470,Lupus Nephritis,Nipocalimab,,PHASE2,,urinary_system_disease
6155,1467,Postural Tachycardia Syndrome|Orthostatic Intolerance,Carbidopa,CC(CC1=CC(=C(C=C1)O)O)(C(=O)O)NN,PHASE2|PHASE3,,urinary_system_disease
6154,1455,Urinary Tract Infection|Acute Pyelonephritis|Hospital Acquired Pneumonia|Ventilator-associated Pneumonia|Bacteremia|Intra-abdominal Infection,Avibactam,C1CC(N2CC1N(C2=O)OS(=O)(=O)O)C(=O)N,APPROVED,,urinary_system_disease
6153,1454,Urinary Tract Infection|Acute Pyelonephritis|Hospital Acquired Pneumonia|Ventilator-associated Pneumonia|Bacteremia|Intra-abdominal Infection,Ceftazidime,CC(C)(C(=O)O)ON=C(C1=CSC(=N1)N)C(=O)NC2C3N(C2=O)C(=C(CS3)C[N+]4=CC=CC=C4)C(=O)[O-],APPROVED,,urinary_system_disease
6152,1449,Urolithiasis,Paracetamol,CC(=O)NC1=CC=C(C=C1)O,APPROVED,,urinary_system_disease
6151,1448,Urolithiasis,Morphine,CN1CCC23C4C1CC5=C2C(=C(C=C5)O)OC3C(C=C4)O,APPROVED,,urinary_system_disease
6150,1447,Nephrogenic Fibrosing Dermopathy,Meglumine,CNCC(C(C(C(CO)O)O)O)O,APPROVED,,urinary_system_disease
6149,1446,Nephrogenic Fibrosing Dermopathy,Gadodiamide,CNC(=O)CN(CCN(CCN(CC(=O)NC)CC(=O)[O-])CC(=O)[O-])CC(=O)[O-].[Gd+3],APPROVED,,urinary_system_disease
6148,1445,"Leukemia|Lymphoma|Hodgkin's Disease|Hematologic Neoplasms|Multiple Myeloma|Carcinoma, Renal Cell",Alemtuzumab,,PHASE2,,urinary_system_disease
6147,1444,"Leukemia|Lymphoma|Hodgkin's Disease|Hematologic Neoplasms|Multiple Myeloma|Carcinoma, Renal Cell",Pentostatin,C1C(C(OC1N2C=NC3=C2NC=NCC3O)CO)O,PHASE2,,urinary_system_disease
6146,1442,Chronic Kidney Disease,Pitavastatin,C1CC1C2=NC3=CC=CC=C3C(=C2C=CC(CC(CC(=O)O)O)O)C4=CC=C(C=C4)F,APPROVED,,urinary_system_disease
6145,1438,Renal Cell Carcinoma,Fluzoparib,C1CN2C(=NC(=N2)C(F)(F)F)CN1C(=O)C3=C(C=CC(=C3)CC4=NNC(=O)C5=CC=CC=C54)F,PHASE2,,urinary_system_disease
6144,1429,"Kidney Failure, Chronic|Cardiovascular Diseases",Candesartan,CCOC1=NC2=CC=CC(=C2N1CC3=CC=C(C=C3)C4=CC=CC=C4C5=NNN=N5)C(=O)O,APPROVED,,urinary_system_disease
6143,1410,Heart Failure|Renal Insufficiency,Cenderitide,CCC(C)C(C(=O)NCC(=O)NC(CO)C(=O)NC(CCSC)C(=O)NC(CO)C(=O)NCC(=O)NC(CC(C)C)C(=O)NCC(=O)NC(CS)C(=O)N1CCCC1C(=O)NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CCCN=C(N)N)C(=O)NC(CC(=O)O)C(=O)N2CCCC2C(=O)NC(CCCN=C(N)N)C(=O)N3CCCC3C(=O)NC(CC(=O)O)C(=O)NC(C)C(=O)N4CCCC4C(=O)NC(CO)C(=O)NC(C(C)O)C(=O)NC(CO)C(=O)NC(C)C(=O)O)NC(=O)C(CCCN=C(N)N)NC(=O)C(CC(=O)O)NC(=O)C(CC(C)C)NC(=O)C(CCCCN)NC(=O)C(CC(C)C)NC(=O)CNC(=O)C(CC5=CC=CC=C5)NC(=O)C(CS)NC(=O)CNC(=O)C(CCCCN)NC(=O)C(CO)NC(=O)C(CC(C)C)NC(=O)CN,PHASE1|PHASE2,,urinary_system_disease
6142,1404,Healthy Volunteer|Renal Impairment,Probenecid,CCCN(CCC)S(=O)(=O)C1=CC=C(C=C1)C(=O)O,PHASE1,,urinary_system_disease
6141,1401,Non Muscle Invasive Bladder Cancer,Celecoxib,CC1=CC=C(C=C1)C2=CC(=NN2C3=CC=C(C=C3)S(=O)(=O)N)C(F)(F)F,PHASE2,,urinary_system_disease
6140,1399,HIV-infected Participants With ESRD Undergoing Routine Hemodialysis,Doravirine,CN1C(=NNC1=O)CN2C=CC(=C(C2=O)OC3=CC(=CC(=C3)C#N)Cl)C(F)(F)F,APPROVED,,urinary_system_disease
6139,1395,"Kidney Failure, Chronic",Pimodivir,C1CC2CCC1C(C2NC3=NC(=NC=C3F)C4=CNC5=C4C=C(C=N5)F)C(=O)O,PHASE1,,urinary_system_disease
6138,1391,"Kidney Failure, Chronic|Disorders Associated With Peritoneal Dialysis",Isoxaflutole,CS(=O)(=O)C1=C(C=CC(=C1)C(F)(F)F)C(=O)C2=C(ON=C2)C3CC3,APPROVED,,urinary_system_disease
6137,1390,Urinary Tract Infections,Imipenem,CC(C1C2CC(=C(N2C1=O)C(=O)O)SCCN=CN)O,PHASE2,,urinary_system_disease
6136,1389,Urinary Tract Infections,Cefiderocol,CC(C)(C(=O)O)ON=C(C1=CSC(=N1)N)C(=O)NC2C3N(C2=O)C(=C(CS3)C[N+]4(CCCC4)CCNC(=O)C5=C(C(=C(C=C5)O)O)Cl)C(=O)[O-],PHASE2,,urinary_system_disease
6135,1386,"Renal Insufficiency, Chronic|Angioplasty, Transluminal, Percutaneous Coronary|Coronary Arteriosclerosis",Iomeprol,CN(C1=C(C(=C(C(=C1I)C(=O)NCC(CO)O)I)C(=O)NCC(CO)O)I)C(=O)CO,APPROVED,,urinary_system_disease
6134,1374,Primary Hyperoxaluria,Stiripentol,CC(C)(C)C(C=CC1=CC2=C(C=C1)OCO2)O,PHASE2,,urinary_system_disease
6133,1368,Hepatorenal Syndrome,Ifetroban,CCCCCNC(=O)C1=COC(=N1)C2C3CCC(C2CC4=CC=CC=C4CCC(=O)O)O3,PHASE2,,urinary_system_disease
6132,1361,Diabetic Kidney Disease,Selonsertib,CC1=CC(=C(C=C1N2C=C(N=C2)C3CC3)C(=O)NC4=CC=CC(=N4)C5=NN=CN5C(C)C)F,PHASE2,,urinary_system_disease
6131,1360,Urinary Tract Infections,Gentamicin,CC(C1CCC(C(O1)OC2C(CC(C(C2O)OC3C(C(C(CO3)(C)O)NC)O)N)N)N)NC,APPROVED,,urinary_system_disease
6130,1357,End Stage Renal Disease,Apixaban,COC1=CC=C(C=C1)N2C3=C(CCN(C3=O)C4=CC=C(C=C4)N5CCCCC5=O)C(=N2)C(=O)N,PHASE1,,urinary_system_disease
6129,1344,Chronic Kidney Disease,Amiloride,C1(=C(N=C(C(=N1)Cl)N)N)C(=O)N=C(N)N,APPROVED,,urinary_system_disease
6128,1343,"Carcinoma, Renal Cell",Topotecan,CCC1(C2=C(COC1=O)C(=O)N3CC4=CC5=C(C=CC(=C5CN(C)C)O)N=C4C3=C2)O,PHASE1,,urinary_system_disease
6127,1317,Diabetic Nephropathy Type 2,Sulodexide,CNC1=C2C(=NC=N1)N(C=N2)C3C(C(C(O3)CO)O)OC,APPROVED,,urinary_system_disease
6126,1314,Diabetic Nephropathy Type 2,Linagliptin,CC#CCN1C2=C(N=C1N3CCCC(C3)N)N(C(=O)N(C2=O)CC4=NC5=CC=CC=C5C(=N4)C)C,APPROVED,,urinary_system_disease
6125,1310,Urothelial Carcinoma Bladder|Androgen Receptor Positive,Degarelix,CC(C)CC(C(=O)NC(CCCCNC(C)C)C(=O)N1CCCC1C(=O)NC(C)C(=O)N)NC(=O)C(CC2=CC=C(C=C2)NC(=O)N)NC(=O)C(CC3=CC=C(C=C3)NC(=O)C4CC(=O)NC(=O)N4)NC(=O)C(CO)NC(=O)C(CC5=CN=CC=C5)NC(=O)C(CC6=CC=C(C=C6)Cl)NC(=O)C(CC7=CC8=CC=CC=C8C=C7)NC(=O)C,PHASE1,,urinary_system_disease
6124,1306,Renal Impairment,Nalmefene,C=C1CCC2(C3CC4=C5C2(C1OC5=C(C=C4)O)CCN3CC6CC6)O,PHASE1,,urinary_system_disease
6123,1305,Kidney Failure,Voriconazole,CC(C1=NC=NC=C1F)C(CN2C=NC=N2)(C3=C(C=C(C=C3)F)F)O,PHASE1|PHASE2,,urinary_system_disease
6122,1296,Cholecystitis|Endometriosis|Bowel Obstruction|Fibroids|Prostate Cancer|Chronic Kidney Disease|Uterine Prolapse,Rocuronium,CC(=O)OC1C(CC2C1(CCC3C2CCC4C3(CC(C(C4)O)N5CCOCC5)C)C)[N+]6(CCCC6)CC=C,APPROVED,,urinary_system_disease
6121,1292,HIV Infections|Kidney Disease,Zidovudine,CC1=CN(C(=O)NC1=O)C2CC(C(O2)CO)N=[N+]=[N-],PHASE1,,urinary_system_disease
6120,1288,Paroxysmal Nocturnal Hemoglobinuria (PNH),Danicopan,CC1=NC=C(C=N1)C2=CC3=C(C=C2)N(N=C3C(=O)C)CC(=O)N4CC(CC4C(=O)NC5=NC(=CC=C5)Br)F,PHASE2,,urinary_system_disease
6119,1287,Primary Hyperoxaluria Type 1 (PH1),Lumasiran,,PHASE1|PHASE2,,urinary_system_disease
6118,1286,Renal Impairment,Buparlisib,C1COCCN1C2=NC(=NC(=C2)C3=CN=C(C=C3C(F)(F)F)N)N4CCOCC4,PHASE1,,urinary_system_disease
6117,1277,Fanconi Anemia,Eltrombopag,CC1=C(C=C(C=C1)N2C(=O)C(=C(N2)C)N=NC3=CC=CC(=C3O)C4=CC(=CC=C4)C(=O)O)C,PHASE2,,urinary_system_disease
6116,1266,Focal Segmental Glomerulosclerosis|Minimal Change Disease|Immunoglobulin A Nephropathy|IgA Vasculitis|Alport Syndrome,Sparsentan,CCCCC1=NC2(CCCC2)C(=O)N1CC3=CC(=C(C=C3)C4=CC=CC=C4S(=O)(=O)NC5=NOC(=C5C)C)COCC,PHASE2,,urinary_system_disease
6115,1265,Hypertension|Hemodialysis,Digoxin,CC1C(C(CC(O1)OC2C(OC(CC2O)OC3C(OC(CC3O)OC4CCC5(C(C4)CCC6C5CC(C7(C6(CCC7C8=CC(=O)OC8)O)C)O)C)C)C)O)O,APPROVED,,urinary_system_disease
6114,1264,Renal Impairment,Olorofim,CC1=CC(=C(N1C)C(=O)C(=O)NC2=CC=C(C=C2)N3CCN(CC3)C4=NC=C(C=N4)F)C5=CC=CC=C5,PHASE1,,urinary_system_disease
6113,1241,End Stage Renal Disease|Chronic Pain|Opioid Dependence,Buprenorphine,CC(C)(C)C(C)(C1CC23CCC1(C4C25CCN(C3CC6=C5C(=C(C=C6)O)O4)CC7CC7)OC)O,PHASE2,,urinary_system_disease
6112,1239,Nephrotic Syndrome,Ofatumumab,,PHASE2,,urinary_system_disease
6111,1236,Type 2 Diabetes Mellitus,Perindopril,CCCC(C(=O)OCC)NC(C)C(=O)N1C2CCCCC2CC1C(=O)O,APPROVED,,urinary_system_disease
6110,1230,Diabetes,Acarbose,CC1C(C(C(C(O1)OC2C(OC(C(C2O)O)OC3C(OC(C(C3O)O)O)CO)CO)O)O)NC4C=C(C(C(C4O)O)O)CO,APPROVED,,urinary_system_disease
6109,1225,Benign Prostatic Hypertrophy,Ozarelix,CCCCC(C(=O)NC(CCCN=C(N)N)C(=O)N1CCCC1C(=O)NC(C)C(=O)N)NC(=O)C(CCCCNC(=O)N)NC(=O)C(CC2=CC=C(C=C2)O)N(C)C(=O)C(CO)NC(=O)C(CC3=CN=CC=C3)NC(=O)C(CC4=CC=C(C=C4)Cl)NC(=O)C(CC5=CC6=CC=CC=C6C=C5)NC(=O)C,PHASE2,,urinary_system_disease
6108,1219,Renal Impairment|Type 2 Diabetes Mellitus,Ertugliflozin,CCOC1=CC=C(C=C1)CC2=C(C=CC(=C2)C34C(C(C(C(O3)(CO4)CO)O)O)O)Cl,PHASE1,,urinary_system_disease
6107,1218,"Carcinoma, Renal Cell",Lactoferrin,CCC(C)C(C(=NC(C(C)O)C(=NC(CS)C(=NC(C(C)C)C(=NC(CCCNC(=N)N)C(=NC(CCCNC(=N)N)C(=NC(C)C(=NC(CC1=CC=CC=C1)C(=O)O)O)O)O)O)O)O)O)N=C(C(CO)N=C(C2CCCN2C(=O)C(C)N=C(CN=C(C(CC(C)C)N=C(C(CCCCN)N=C(C(CCCCN)N=C(C(CCSC)N=C(C(CCCNC(=N)N)N=C(C(CC3=CNC4=CC=CC=C43)N=C(C(CCC(=N)O)N=C(C(CC5=CNC6=CC=CC=C65)N=C(C(CCCNC(=N)N)N=C(C(CCCNC(=N)N)N=C(C(CS)N=C(C(CCCCN)N=C(C(CC7=CC=CC=C7)N)O)O)O)O)O)O)O)O)O)O)O)O)O)O)O)O,PHASE2,,urinary_system_disease
6106,1215,Primary Polydipsia,Dulaglutide,,PHASE2,,urinary_system_disease
6105,1214,Urinary Tract Infections|Pyelonephritis Acute|Intraabdominal Infections,Sulopenem,CC(C1C2N(C1=O)C(=C(S2)SC3CCS(=O)C3)C(=O)O)O,PHASE1,,urinary_system_disease
6104,1213,Renal Cell Cancer|Cancer,Nelfinavir,CC1=C(C=CC=C1O)C(=O)NC(CSC2=CC=CC=C2)C(CN3CC4CCCCC4CC3C(=O)NC(C)(C)C)O,PHASE1,,urinary_system_disease
6103,1211,Urologic Neoplasms,Afatinib,CN(C)CC=CC(=O)NC1=C(C=C2C(=C1)C(=NC=N2)NC3=CC(=C(C=C3)F)Cl)OC4CCOC4,PHASE2,,urinary_system_disease
6102,1210,Overactive Bladder,Solabegron,C1=CC(=CC(=C1)C(=O)O)C2=CC(=CC=C2)NCCNCC(C3=CC(=CC=C3)Cl)O,PHASE2,,urinary_system_disease
6101,1206,Contrast Induced Nephropathy,Iopamidol,CC(C(=O)NC1=C(C(=C(C(=C1I)C(=O)NC(CO)CO)I)C(=O)NC(CO)CO)I)O,APPROVED,,urinary_system_disease
6100,1203,Renal Cell Carcinoma|Metastases,Volociximab,,PHASE2,,urinary_system_disease
6099,1198,Diabetic Nephropathies,Fenofibrate,CC(C)OC(=O)C(C)(C)OC1=CC=C(C=C1)C(=O)C2=CC=C(C=C2)Cl,PHASE2,,urinary_system_disease
6098,1193,Nephrolithiasis|Urolithiasis|Idiopathic Hypercalciuria|Vitamin D Deficiency|Disorder of Vitamin D,Ergocalciferol,CC(C)C(C)C=CC(C)C1CCC2C1(CCCC2=CC=C3CC(CCC3=C)O)C,APPROVED,,urinary_system_disease
6097,1192,Bladder Cancer|Muscle-invasive Bladder Cancer,Pegfilgrastim,CC(C(C(=O)O)N)OC1C(C(C(C(O1)COC2(CC(C(C(O2)C(C(CO)O)O)NC(=O)CNC(=O)OCCOC)O)C(=O)O)O)O)NC(=O)C,PHASE2,,urinary_system_disease
6096,1185,Lupus Erythematosus|Lupus Nephritis,Itolizumab,,PHASE1,,urinary_system_disease
6095,1184,"Kidney, Polycystic, Autosomal Dominant",Imidapril,CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N2C(CN(C2=O)C)C(=O)O,PHASE2,,urinary_system_disease
6094,1183,"Kidney, Polycystic, Autosomal Dominant",Cilnidipine,CC1=C(C(C(=C(N1)C)C(=O)OCC=CC2=CC=CC=C2)C3=CC(=CC=C3)[N+](=O)[O-])C(=O)OCCOC,PHASE2,,urinary_system_disease
6093,1182,Bladder Cancer,Cetuximab,,PHASE2,,urinary_system_disease
6092,1177,Urinary Tract Infections,Hydrocortisone,CC12CCC(=O)C=C1CCC3C2C(CC4(C3CCC4(C(=O)CO)O)C)O,APPROVED,,urinary_system_disease
6091,1174,Carcinoma of Urinary Tract|Urethral Carcinoma|Carcinoma of Ureter|Carcinoma of Renal Pelvis,Icrucumab,,PHASE2,,urinary_system_disease
6090,1170,Rare Diseases|X-linked Hypophosphatemia,Burosumab,,APPROVED,,urinary_system_disease
6089,1156,Vascular Calcification|Arteriosclerosis,Alendronate,C(CC(O)(P(=O)(O)O)P(=O)(O)O)CN,APPROVED,,urinary_system_disease
6088,1147,Renal Impairment,Cefepime,C[N+]1(CCCC1)CC2=C(N3C(C(C3=O)NC(=O)C(=NOC)C4=CSC(=N4)N)SC2)C(=O)[O-],PHASE1,,urinary_system_disease
6087,1137,End-stage Renal Disease|Prevention of Thromboembolic Events|Hemodialysis|Hemodiafiltration,Osocimab,,PHASE2,,urinary_system_disease
6086,1132,Renal Impairment,Ioversol,C(CO)N(C1=C(C(=C(C(=C1I)C(=O)NCC(CO)O)I)C(=O)NCC(CO)O)I)C(=O)CO,APPROVED,,urinary_system_disease
6085,1118,"Hepatitis C|Renal Insufficiency, Chronic|Disorder of Transplanted Kidney",Elbasvir,CC(C)C(C(=O)N1CCCC1C2=NC=C(N2)C3=CC4=C(C=C3)N5C(OC6=C(C5=C4)C=CC(=C6)C7=CN=C(N7)C8CCCN8C(=O)C(C(C)C)NC(=O)OC)C9=CC=CC=C9)NC(=O)OC,APPROVED,,urinary_system_disease
6084,1117,"Hepatitis C|Renal Insufficiency, Chronic|Disorder of Transplanted Kidney",Grazoprevir,CC(C)(C)C1C(=O)N2CC(CC2C(=O)NC3(CC3C=C)C(=O)NS(=O)(=O)C4CC4)OC5=NC6=C(C=CC(=C6)OC)N=C5CCCCCC7CC7OC(=O)N1,APPROVED,,urinary_system_disease
6083,1114,Cystinuria,Bucillamine,CC(C)(C(=O)NC(CS)C(=O)O)S,PHASE2,,urinary_system_disease
6082,1112,Renal Insufficiency|Heart Failure,Tonapofylline,CCCN1C2=C(C(=O)N(C1=O)CCC)NC(=N2)C34CCC(CC3)(CC4)CCC(=O)O,PHASE2,,urinary_system_disease
6081,1106,"Collapsing Glomerulopathy|Glomerulosclerosis, Focal Segmental",Isotretinoin,CC1=C(C(CCC1)(C)C)C=CC(=CC=CC(=CC(=O)O)C)C,PHASE2,,urinary_system_disease
6080,1101,"Anemia|Kidney Failure, Chronic",Sotatercept,,PHASE2,,urinary_system_disease
6079,1100,Bladder Cancer,Mitomycin C,CC1=C(C(=O)C2=C(C1=O)N3CC4C(C3(C2COC(=O)N)OC)N4)N,PHASE2,,urinary_system_disease
6078,1087,"Renal Disease, End-Stage|Renal Insufficiency, Chronic|Renal Insufficiency, Acute",Bosutinib,CN1CCN(CC1)CCCOC2=C(C=C3C(=C2)N=CC(=C3NC4=CC(=C(C=C4Cl)Cl)OC)C#N)OC,PHASE1,,urinary_system_disease
6077,1081,Interstitial Cystitis/Painful Bladder Syndrome|Myofascial Pelvic Pain,Metoprolol,CC(C)NCC(COC1=CC=C(C=C1)CCOC)O,APPROVED,,urinary_system_disease
6076,1066,Insomnia Disorder|Nocturia,Daridorexant,CC1=C(C=CC2=C1N=C(N2)C3(CCCN3C(=O)C4=C(C=CC(=C4)OC)N5N=CC=N5)C)Cl,APPROVED,,urinary_system_disease
6075,1065,Advanced Malignant Solid Neoplasm|Ann Arbor Stage III Non-Hodgkin Lymphoma|Ann Arbor Stage IV Non-Hodgkin Lymphoma|Histiocytic Sarcoma|Juvenile Xanthogranuloma|Langerhans Cell Histiocytosis|Malignant Glioma|Recurrent Childhood Rhabdomyosarcoma|Recurrent Ependymoma|Recurrent Ewing Sarcoma|Recurrent Glioma|Recurrent Hepatoblastoma|Recurrent Langerhans Cell Histiocytosis|Recurrent Malignant Germ Cell Tumor|Recurrent Malignant Solid Neoplasm|Recurrent Medulloblastoma|Recurrent Neuroblastoma|Recurrent Non-Hodgkin Lymphoma|Recurrent Osteosarcoma|Recurrent Peripheral Primitive Neuroectodermal Tumor|Recurrent Primary Central Nervous System Neoplasm|Recurrent Rhabdoid Tumor|Recurrent Soft Tissue Sarcoma|Refractory Ewing Sarcoma|Refractory Glioma|Refractory Hepatoblastoma|Refractory Langerhans Cell Histiocytosis|Refractory Malignant Germ Cell Tumor|Refractory Malignant Solid Neoplasm|Refractory Medulloblastoma|Refractory Neuroblastoma|Refractory Non-Hodgkin Lymphoma|Refractory Osteosarcoma|Refractory Peripheral Primitive Neuroectodermal Tumor|Refractory Primary Central Nervous System Neoplasm|Refractory Rhabdoid Tumor|Refractory Rhabdomyosarcoma|Rhabdoid Tumor|Stage III Osteosarcoma AJCC v7|Stage III Soft Tissue Sarcoma AJCC v7|Stage IV Osteosarcoma AJCC v7|Stage IV Soft Tissue Sarcoma AJCC v7|Stage IVA Osteosarcoma AJCC v7|Stage IVB Osteosarcoma AJCC v7|Wilms Tumor,Vemurafenib,CCCS(=O)(=O)NC1=C(C(=C(C=C1)F)C(=O)C2=CNC3=C2C=C(C=N3)C4=CC=C(C=C4)Cl)F,PHASE2,,urinary_system_disease
6074,1064,Advanced Malignant Solid Neoplasm|Ann Arbor Stage III Non-Hodgkin Lymphoma|Ann Arbor Stage IV Non-Hodgkin Lymphoma|Histiocytic Sarcoma|Juvenile Xanthogranuloma|Langerhans Cell Histiocytosis|Malignant Glioma|Recurrent Childhood Rhabdomyosarcoma|Recurrent Ependymoma|Recurrent Ewing Sarcoma|Recurrent Glioma|Recurrent Hepatoblastoma|Recurrent Langerhans Cell Histiocytosis|Recurrent Malignant Germ Cell Tumor|Recurrent Malignant Solid Neoplasm|Recurrent Medulloblastoma|Recurrent Neuroblastoma|Recurrent Non-Hodgkin Lymphoma|Recurrent Osteosarcoma|Recurrent Peripheral Primitive Neuroectodermal Tumor|Recurrent Primary Central Nervous System Neoplasm|Recurrent Rhabdoid Tumor|Recurrent Soft Tissue Sarcoma|Refractory Ewing Sarcoma|Refractory Glioma|Refractory Hepatoblastoma|Refractory Langerhans Cell Histiocytosis|Refractory Malignant Germ Cell Tumor|Refractory Malignant Solid Neoplasm|Refractory Medulloblastoma|Refractory Neuroblastoma|Refractory Non-Hodgkin Lymphoma|Refractory Osteosarcoma|Refractory Peripheral Primitive Neuroectodermal Tumor|Refractory Primary Central Nervous System Neoplasm|Refractory Rhabdoid Tumor|Refractory Rhabdomyosarcoma|Rhabdoid Tumor|Stage III Osteosarcoma AJCC v7|Stage III Soft Tissue Sarcoma AJCC v7|Stage IV Osteosarcoma AJCC v7|Stage IV Soft Tissue Sarcoma AJCC v7|Stage IVA Osteosarcoma AJCC v7|Stage IVB Osteosarcoma AJCC v7|Wilms Tumor,Ulixertinib,CC(C)NC1=NC=C(C(=C1)C2=CNC(=C2)C(=O)NC(CO)C3=CC(=CC=C3)Cl)Cl,PHASE2,,urinary_system_disease
6073,1063,Advanced Malignant Solid Neoplasm|Ann Arbor Stage III Non-Hodgkin Lymphoma|Ann Arbor Stage IV Non-Hodgkin Lymphoma|Histiocytic Sarcoma|Juvenile Xanthogranuloma|Langerhans Cell Histiocytosis|Malignant Glioma|Recurrent Childhood Rhabdomyosarcoma|Recurrent Ependymoma|Recurrent Ewing Sarcoma|Recurrent Glioma|Recurrent Hepatoblastoma|Recurrent Langerhans Cell Histiocytosis|Recurrent Malignant Germ Cell Tumor|Recurrent Malignant Solid Neoplasm|Recurrent Medulloblastoma|Recurrent Neuroblastoma|Recurrent Non-Hodgkin Lymphoma|Recurrent Osteosarcoma|Recurrent Peripheral Primitive Neuroectodermal Tumor|Recurrent Primary Central Nervous System Neoplasm|Recurrent Rhabdoid Tumor|Recurrent Soft Tissue Sarcoma|Refractory Ewing Sarcoma|Refractory Glioma|Refractory Hepatoblastoma|Refractory Langerhans Cell Histiocytosis|Refractory Malignant Germ Cell Tumor|Refractory Malignant Solid Neoplasm|Refractory Medulloblastoma|Refractory Neuroblastoma|Refractory Non-Hodgkin Lymphoma|Refractory Osteosarcoma|Refractory Peripheral Primitive Neuroectodermal Tumor|Refractory Primary Central Nervous System Neoplasm|Refractory Rhabdoid Tumor|Refractory Rhabdomyosarcoma|Rhabdoid Tumor|Stage III Osteosarcoma AJCC v7|Stage III Soft Tissue Sarcoma AJCC v7|Stage IV Osteosarcoma AJCC v7|Stage IV Soft Tissue Sarcoma AJCC v7|Stage IVA Osteosarcoma AJCC v7|Stage IVB Osteosarcoma AJCC v7|Wilms Tumor,Tipifarnib,CN1C=NC=C1C(C2=CC=C(C=C2)Cl)(C3=CC4=C(C=C3)N(C(=O)C=C4C5=CC(=CC=C5)Cl)C)N,PHASE2,,urinary_system_disease
6072,1061,Advanced Malignant Solid Neoplasm|Ann Arbor Stage III Non-Hodgkin Lymphoma|Ann Arbor Stage IV Non-Hodgkin Lymphoma|Histiocytic Sarcoma|Juvenile Xanthogranuloma|Langerhans Cell Histiocytosis|Malignant Glioma|Recurrent Childhood Rhabdomyosarcoma|Recurrent Ependymoma|Recurrent Ewing Sarcoma|Recurrent Glioma|Recurrent Hepatoblastoma|Recurrent Langerhans Cell Histiocytosis|Recurrent Malignant Germ Cell Tumor|Recurrent Malignant Solid Neoplasm|Recurrent Medulloblastoma|Recurrent Neuroblastoma|Recurrent Non-Hodgkin Lymphoma|Recurrent Osteosarcoma|Recurrent Peripheral Primitive Neuroectodermal Tumor|Recurrent Primary Central Nervous System Neoplasm|Recurrent Rhabdoid Tumor|Recurrent Soft Tissue Sarcoma|Refractory Ewing Sarcoma|Refractory Glioma|Refractory Hepatoblastoma|Refractory Langerhans Cell Histiocytosis|Refractory Malignant Germ Cell Tumor|Refractory Malignant Solid Neoplasm|Refractory Medulloblastoma|Refractory Neuroblastoma|Refractory Non-Hodgkin Lymphoma|Refractory Osteosarcoma|Refractory Peripheral Primitive Neuroectodermal Tumor|Refractory Primary Central Nervous System Neoplasm|Refractory Rhabdoid Tumor|Refractory Rhabdomyosarcoma|Rhabdoid Tumor|Stage III Osteosarcoma AJCC v7|Stage III Soft Tissue Sarcoma AJCC v7|Stage IV Osteosarcoma AJCC v7|Stage IV Soft Tissue Sarcoma AJCC v7|Stage IVA Osteosarcoma AJCC v7|Stage IVB Osteosarcoma AJCC v7|Wilms Tumor,Selumetinib,CN1C=NC2=C1C=C(C(=C2F)NC3=C(C=C(C=C3)Br)Cl)C(=O)NOCCO,PHASE2,,urinary_system_disease
6071,1052,Advanced Malignant Solid Neoplasm|Ann Arbor Stage III Non-Hodgkin Lymphoma|Ann Arbor Stage IV Non-Hodgkin Lymphoma|Histiocytic Sarcoma|Juvenile Xanthogranuloma|Langerhans Cell Histiocytosis|Malignant Glioma|Recurrent Childhood Rhabdomyosarcoma|Recurrent Ependymoma|Recurrent Ewing Sarcoma|Recurrent Glioma|Recurrent Hepatoblastoma|Recurrent Langerhans Cell Histiocytosis|Recurrent Malignant Germ Cell Tumor|Recurrent Malignant Solid Neoplasm|Recurrent Medulloblastoma|Recurrent Neuroblastoma|Recurrent Non-Hodgkin Lymphoma|Recurrent Osteosarcoma|Recurrent Peripheral Primitive Neuroectodermal Tumor|Recurrent Primary Central Nervous System Neoplasm|Recurrent Rhabdoid Tumor|Recurrent Soft Tissue Sarcoma|Refractory Ewing Sarcoma|Refractory Glioma|Refractory Hepatoblastoma|Refractory Langerhans Cell Histiocytosis|Refractory Malignant Germ Cell Tumor|Refractory Malignant Solid Neoplasm|Refractory Medulloblastoma|Refractory Neuroblastoma|Refractory Non-Hodgkin Lymphoma|Refractory Osteosarcoma|Refractory Peripheral Primitive Neuroectodermal Tumor|Refractory Primary Central Nervous System Neoplasm|Refractory Rhabdoid Tumor|Refractory Rhabdomyosarcoma|Rhabdoid Tumor|Stage III Osteosarcoma AJCC v7|Stage III Soft Tissue Sarcoma AJCC v7|Stage IV Osteosarcoma AJCC v7|Stage IV Soft Tissue Sarcoma AJCC v7|Stage IVA Osteosarcoma AJCC v7|Stage IVB Osteosarcoma AJCC v7|Wilms Tumor,Erdafitinib,CC(C)NCCN(C1=CC2=NC(=CN=C2C=C1)C3=CN(N=C3)C)C4=CC(=CC(=C4)OC)OC,PHASE2,,urinary_system_disease
6070,1033,Nephrolithiasis|Nephrocalcinosis|Hypercalciuria,Fluconazole,C1=CC(=C(C=C1F)F)C(CN2C=NC=N2)(CN3C=NC=N3)O,PHASE2,,urinary_system_disease
6069,1032,Malignant Solid Tumour|Renal Cell Carcinoma|Non Small Cell Lung Carcinoma,Vorinostat,C1=CC=C(C=C1)NC(=O)CCCCCCC(=O)NO,PHASE1,,urinary_system_disease
6068,1017,Renal Insufficiency|Chronic Hypertension,Chlorthalidone,C1=CC=C2C(=C1)C(=O)NC2(C3=CC(=C(C=C3)Cl)S(=O)(=O)N)O,PHASE2,,urinary_system_disease
6067,1010,Chronic Kidney Disease|Type 2 Diabetes Mellitus,Finerenone,CCOC1=NC=C(C2=C1C(C(=C(N2)C)C(=O)N)C3=C(C=C(C=C3)C#N)OC)C,PHASE2,,urinary_system_disease
6066,1009,Contrast Induced Nephropathy,Acetazolamide,CC(=O)NC1=NN=C(S1)S(=O)(=O)N,PHASE2,,urinary_system_disease
6065,1000,Renal Calculus,Tramadol,CN(C)CC1CCCCC1(C2=CC(=CC=C2)OC)O,APPROVED,,urinary_system_disease
6064,993,"Polycystic Kidney, Autosomal Dominant",Tesevatinib,CN1CC2CC(CC2C1)COC3=C(C=C4C(=C3)N=CN=C4NC5=C(C(=C(C=C5)Cl)Cl)F)OC,PHASE1|PHASE2,,urinary_system_disease
6063,986,"Myelodysplastic Syndromes|Leukemia, Myelomonocytic, Chronic|Leukemia, Myeloid, Acute|Renal Insufficiency|Liver Disease|Neoplasms",Pevonedistat,C1CC2=CC=CC=C2C1NC3=C4C=CN(C4=NC=N3)C5CC(C(C5)O)COS(=O)(=O)N,PHASE1,,urinary_system_disease
6062,985,"Myelodysplastic Syndromes|Leukemia, Myelomonocytic, Chronic|Leukemia, Myeloid, Acute|Renal Insufficiency|Liver Disease|Neoplasms",Azacitidine,C1=NC(=NC(=O)N1C2C(C(C(O2)CO)O)O)N,PHASE1,,urinary_system_disease
6061,982,Chronic Renal Disease,Beraprost,CC#CCC(C)C(C=CC1C(CC2C1C3=CC=CC(=C3O2)CCCC(=O)O)O)O,APPROVED,,urinary_system_disease
6060,975,Diabetic Nephropathy,Captopril,CC(CS)C(=O)N1CCCC1C(=O)O,PHASE2|PHASE3,,urinary_system_disease
6059,972,Kidney Failure,Terlipressin,C1CC(N(C1)C(=O)C2CSSCC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N2)CC(=O)N)CCC(=O)N)CC3=CC=CC=C3)CC4=CC=C(C=C4)O)NC(=O)CNC(=O)CNC(=O)CN)C(=O)NC(CCCCN)C(=O)NCC(=O)N,PHASE2,,urinary_system_disease
6058,964,HCV Infection,Voxilaprevir,CCC1C2CN(C1C(=O)NC3(CC3C(F)F)C(=O)NS(=O)(=O)C4(CC4)C)C(=O)C(NC(=O)OC5CC5CCCCC(C6=NC7=C(C=C(C=C7)OC)N=C6O2)(F)F)C(C)(C)C,PHASE1,,urinary_system_disease
6057,962,Wolfram Syndrome,Valproate,CCCC(CCC)C(=O)O,PHASE2,,urinary_system_disease
6056,951,Anemia,Peginesatide,,PHASE2,,urinary_system_disease
6055,944,"Short Stature, Idiopathic|Infant, Small for Gestational Age|Growth Hormone Deficiency|Chronic Renal Failure|Turner Syndrome",Somatotropin,,APPROVED,,urinary_system_disease
6054,943,Chronic Hemodialysis (ESRD),Hydralazine,C1=CC=C2C(=C1)C=NN=C2NN,APPROVED,,urinary_system_disease
6053,937,End-Stage Renal Disease|Stage 5 Chronic Kidney Disease,Telavancin,CCCCCCCCCCNCCNC1(CC(OC(C1O)C)OC2C(C(C(OC2OC3=C4C=C5C=C3OC6=C(C=C(C=C6)C(C(C(=O)NC(C(=O)NC5C(=O)NC7C8=CC(=C(C=C8)O)C9=C(C(=C(C=C9C(NC(=O)C(C(C1=CC(=C(O4)C=C1)Cl)O)NC7=O)C(=O)O)O)CNCP(=O)(O)O)O)CC(=O)N)NC(=O)C(CC(C)C)NC)O)Cl)CO)O)O)C,APPROVED,,urinary_system_disease
6052,909,Renal Insufficiency|Hepatic Insufficiency,Nevirapine,CC1=C2C(=NC=C1)N(C3=C(C=CC=N3)C(=O)N2)C4CC4,PHASE1,,urinary_system_disease
6051,899,Hypertension,Telmisartan,CCCC1=NC2=C(N1CC3=CC=C(C=C3)C4=CC=CC=C4C(=O)O)C=C(C=C2C)C5=NC6=CC=CC=C6N5C,APPROVED,,urinary_system_disease
6050,894,Chronic Kidney Diseases,Zibotentan,CC1=CN=C(C(=N1)OC)NS(=O)(=O)C2=C(N=CC=C2)C3=CC=C(C=C3)C4=NN=CO4,PHASE2,,urinary_system_disease
6049,890,Platelet Aggregation|Adenosine|Coronary Artery Disease|Kidney Dysfunction|Antiplatelet Therapy,Ticagrelor,CCCSC1=NC(=C2C(=N1)N(N=N2)C3CC(C(C3O)O)OCCO)NC4CC4C5=CC(=C(C=C5)F)F,PHASE2,,urinary_system_disease
6048,889,Platelet Aggregation|Adenosine|Coronary Artery Disease|Kidney Dysfunction|Antiplatelet Therapy,Clopidogrel,COC(=O)C(C1=CC=CC=C1Cl)N2CCC3=C(C2)C=CS3,PHASE2,,urinary_system_disease
6047,888,Subjects With Impaired Renal Function and Healthy Subjects,Rivoceranib,C1CCC(C1)(C#N)C2=CC=C(C=C2)NC(=O)C3=C(N=CC=C3)NCC4=CC=NC=C4,PHASE1,,urinary_system_disease
6046,864,Lupus Nephritis,Obinutuzumab,,PHASE2,,urinary_system_disease
6045,862,Anemia of Chronic Kidney Disease,Cholecalciferol,CC(C)CCCC(C)C1CCC2C1(CCCC2=CC=C3CC(CCC3=C)O)C,PHASE2,,urinary_system_disease
6044,856,Type 2 Diabetes Mellitus|Chronic Kidney Diseases,Semaglutide,CCC(C)C(C(=O)NC(C)C(=O)NC(CC1=CNC2=CC=CC=C21)C(=O)NC(CC(C)C)C(=O)NC(C(C)C)C(=O)NC(CCCNC(=N)N)C(=O)NCC(=O)NC(CCCNC(=N)N)C(=O)NCC(=O)O)NC(=O)C(CC3=CC=CC=C3)NC(=O)C(CCC(=O)O)NC(=O)C(CCCCNC(=O)COCCOCCNC(=O)COCCOCCNC(=O)CCC(C(=O)O)NC(=O)CCCCCCCCCCCCCCCCC(=O)O)NC(=O)C(C)NC(=O)C(C)NC(=O)C(CCC(=O)N)NC(=O)CNC(=O)C(CCC(=O)O)NC(=O)C(CC(C)C)NC(=O)C(CC4=CC=C(C=C4)O)NC(=O)C(CO)NC(=O)C(CO)NC(=O)C(C(C)C)NC(=O)C(CC(=O)O)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C(CC5=CC=CC=C5)NC(=O)C(C(C)O)NC(=O)CNC(=O)C(CCC(=O)O)NC(=O)C(C)(C)NC(=O)C(CC6=CN=CN6)N,PHASE2,,urinary_system_disease
6043,853,Type 2 Diabetes Mellitus|Chronic Kidney Diseases,Cotadutide,CCCCCCCCCCCCCCCC(=O)NC(CCC(=O)NCCCCC(C(=O)NC(CO)C(=O)NC(CCC(=O)O)C(=O)NC(CC1=CC=C(C=C1)O)C(=O)NC(CC(C)C)C(=O)NC(CC(=O)O)C(=O)NC(CO)C(=O)NC(CCC(=O)O)C(=O)NC(CCCNC(=N)N)C(=O)NC(C)C(=O)NC(CCCNC(=N)N)C(=O)NC(CC(=O)O)C(=O)NC(CC2=CC=CC=C2)C(=O)NC(C(C)C)C(=O)NC(C)C(=O)NC(CC3=CNC4=CC=CC=C43)C(=O)NC(CC(C)C)C(=O)NC(CCC(=O)O)C(=O)NC(C)C(=O)NCC(=O)NCC(=O)O)NC(=O)C(CC(=O)O)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C(CC5=CC=CC=C5)NC(=O)C(C(C)O)NC(=O)CNC(=O)C(CCC(=O)N)NC(=O)C(CO)NC(=O)C(CC6=CNC=N6)N)C(=O)O,PHASE2,,urinary_system_disease
6042,851,Renal Cancer|GIST,Perifosine,CCCCCCCCCCCCCCCCCCOP(=O)([O-])OC1CC[N+](CC1)(C)C,PHASE1,,urinary_system_disease
6041,849,Kidney Cancer,Temsirolimus,CC1CCC2CC(C(=CC=CC=CC(CC(C(=O)C(C(C(=CC(C(=O)CC(OC(=O)C3CCCCN3C(=O)C(=O)C1(O2)O)C(C)CC4CCC(C(C4)OC)OC(=O)C(C)(CO)CO)C)C)O)OC)C)C)C)OC,PHASE2,,urinary_system_disease
6040,847,"Kidney Failure|Hepatitis C|Kidney Disease, Chronic",Pibrentasvir,CC(C(C(=O)N1CCCC1C2=NC3=C(N2)C=C(C(=C3)F)C4CCC(N4C5=CC(=C(C(=C5)F)N6CCC(CC6)C7=CC=C(C=C7)F)F)C8=CC9=C(C=C8F)N=C(N9)C1CCCN1C(=O)C(C(C)OC)NC(=O)OC)NC(=O)OC)OC,APPROVED,,urinary_system_disease
6039,846,"Kidney Failure|Hepatitis C|Kidney Disease, Chronic",Glecaprevir,CC1(CC1)S(=O)(=O)NC(=O)C2(CC2C(F)F)NC(=O)C3CC4CN3C(=O)C(NC(=O)OC5CCCC5OCC=CC(C6=NC7=CC=CC=C7N=C6O4)(F)F)C(C)(C)C,APPROVED,,urinary_system_disease
6038,843,Cardiorenal Syndrome,Nesiritide,CCC(C)C1C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NCC(=O)NC(C(=O)NCC(=O)NC(CSSCC(C(=O)NC(C(=O)NCC(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N1)CCCNC(=N)N)CC(=O)O)CCSC)CCCCN)CCCNC(=N)N)CC2=CC=CC=C2)NC(=O)CNC(=O)C(CO)NC(=O)CNC(=O)C(CCC(=O)N)NC(=O)C(C(C)C)NC(=O)C(CCSC)NC(=O)C(CCCCN)NC(=O)C3CCCN3C(=O)C(CO)N)C(=O)NC(CCCCN)C(=O)NC(C(C)C)C(=O)NC(CC(C)C)C(=O)NC(CCCNC(=N)N)C(=O)NC(CCCNC(=N)N)C(=O)NC(CC4=CN=CN4)C(=O)O)CC(C)C)CO)CO)CO)CO,PHASE1|PHASE2,,urinary_system_disease
6037,839,Urinary Tract Infection,Levofloxacin,CC1COC2=C3N1C=C(C(=O)C3=CC(=C2N4CCN(CC4)C)F)C(=O)O,APPROVED,,urinary_system_disease
6036,836,Renal Impairment,Saroglitazar,CCOC(CC1=CC=C(C=C1)OCCN2C(=CC=C2C3=CC=C(C=C3)SC)C)C(=O)O,PHASE1,,urinary_system_disease
6035,835,Diabetic Nephropathies,Exenatide,CCC(C)C(C(=O)NC(CCC(=O)O)C(=O)NC(CC1=CNC2=CC=CC=C21)C(=O)NC(CC(C)C)C(=O)NC(CCCCN)C(=O)NC(CC(=O)N)C(=O)NCC(=O)NCC(=O)N3CCCC3C(=O)NC(CO)C(=O)NC(CO)C(=O)NCC(=O)NC(C)C(=O)N4CCCC4C(=O)N5CCCC5C(=O)N6CCCC6C(=O)NC(CO)C(=O)N)NC(=O)C(CC7=CC=CC=C7)NC(=O)C(CC(C)C)NC(=O)C(CCCNC(=N)N)NC(=O)C(C(C)C)NC(=O)C(C)NC(=O)C(CCC(=O)O)NC(=O)C(CCC(=O)O)NC(=O)C(CCC(=O)O)NC(=O)C(CCSC)NC(=O)C(CCC(=O)N)NC(=O)C(CCCCN)NC(=O)C(CO)NC(=O)C(CC(C)C)NC(=O)C(CC(=O)O)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C(CC8=CC=CC=C8)NC(=O)C(C(C)O)NC(=O)CNC(=O)C(CCC(=O)O)NC(=O)CNC(=O)C(CC9=CNC=N9)N,APPROVED,,urinary_system_disease
6034,833,Microalbuminuria|Macroalbuminuric Diabetic Nephropathy|Diabetes|Proteinuria|Albuminuria,Aliskiren,CC(C)C(CC1=CC(=C(C=C1)OC)OCCCOC)CC(C(CC(C(C)C)C(=O)NCC(C)(C)C(=O)N)O)N,APPROVED,,urinary_system_disease
6033,832,Renal Cell Carcinoma,Quinacrine,CCN(CC)CCCC(C)NC1=C2C=C(C=CC2=NC3=C1C=CC(=C3)Cl)OC,PHASE2,,urinary_system_disease
6032,831,Paroxysmal Nocturnal Hemoglobinuria (PNH),Zilucoplan,CCCCCCCCCCCCCCCC(=O)NC(CCC(=O)NCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCC(=O)NCCCCC(C(=O)O)NC(=O)C(C1CCCCC1)NC(=O)C2CCCN2C(=O)C(CC3=CC=C(C=C3)O)NC(=O)C(CCC(=O)O)NC(=O)C(CC4=CNC5=C4C=CC=N5)NC(=O)C(CC6=CC=C(C=C6)O)NC(=O)C(C(C)(C)C)NC(=O)C(CC(=O)O)N(C)C(=O)C7CC(=O)NCCCCC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N7)CC8=CC=CC=C8)CCCNC(=N)N)CCC(=O)O)C(C)C)NC(=O)C)C(=O)O,PHASE2,,urinary_system_disease
6031,830,Kidney Diseases|Coronary Artery Disease,Regadenoson,CNC(=O)C1=CN(N=C1)C2=NC(=C3C(=N2)N(C=N3)C4C(C(C(O4)CO)O)O)N,APPROVED,,urinary_system_disease
6030,828,"Hepatorenal Syndrome|Cirrhosis|Kidney Failure, Acute",Octreotide,CC(C1C(=O)NC(CSSCC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N1)CCCCN)CC2=CNC3=CC=CC=C32)CC4=CC=CC=C4)NC(=O)C(CC5=CC=CC=C5)N)C(=O)NC(CO)C(C)O)O,PHASE2,,urinary_system_disease
6029,827,"Hepatorenal Syndrome|Cirrhosis|Kidney Failure, Acute",Midodrine,COC1=CC(=C(C=C1)OC)C(CNC(=O)CN)O,PHASE2,,urinary_system_disease
6028,819,Neurogenic Bladder,Methantheline,CC[N+](C)(CC)CCOC(=O)C1C2=CC=CC=C2OC3=CC=CC=C13,PHASE1,,urinary_system_disease
6027,815,Wilms Tumor,Tricyclazole,CC1=C2C(=CC=C1)SC3=NN=CN23,PHASE2,,urinary_system_disease
6026,812,Diabetic Nephropathy,Cilostazol,C1CCC(CC1)N2C(=NN=N2)CCCCOC3=CC4=C(C=C3)NC(=O)CC4,APPROVED,,urinary_system_disease
6025,810,Diabetic Nephropathy,Probucol,CC(C)(C)C1=CC(=CC(=C1O)C(C)(C)C)SC(C)(C)SC2=CC(=C(C(=C2)C(C)(C)C)O)C(C)(C)C,APPROVED,,urinary_system_disease
6024,805,Albuminuria,Irbesartan,CCCCC1=NC2(CCCC2)C(=O)N1CC3=CC=C(C=C3)C4=CC=CC=C4C5=NNN=N5,APPROVED,,urinary_system_disease
6023,799,Urinary Tract Infection|Asymptomatic Bacteriuria|Allograft Rejection|Microbiologic Resistance|Hospitalization,Tromethamine,C(C(CO)(CO)N)O,APPROVED,,urinary_system_disease
6022,798,Urinary Tract Infection|Asymptomatic Bacteriuria|Allograft Rejection|Microbiologic Resistance|Hospitalization,Fosfomycin,CC1C(O1)P(=O)(O)O,APPROVED,,urinary_system_disease
6021,791,"Renal Insufficiency, Chronic|Hepatic Insufficiency|Healthy",Diclofenac,C1=CC=C(C(=C1)CC(=O)O)NC2=C(C=CC=C2Cl)Cl,PHASE1,,urinary_system_disease
6020,790,"Renal Insufficiency, Chronic|Hepatic Insufficiency|Healthy",Itraconazole,CCC(C)N1C(=O)N(C=N1)C2=CC=C(C=C2)N3CCN(CC3)C4=CC=C(C=C4)OCC5COC(O5)(CN6C=NC=N6)C7=C(C=C(C=C7)Cl)Cl,PHASE1,,urinary_system_disease
6019,785,Bladder Urothelial Carcinoma|Stage III Bladder Cancer AJCC v8,Mitomycin,CC1=C(C(=O)C2=C(C1=O)N3CC4C(C3(C2COC(=O)N)OC)N4)N,PHASE2,,urinary_system_disease
6018,777,Chronic Kidney Disease,Hydrochlorothiazide,C1NC2=CC(=C(C=C2S(=O)(=O)N1)S(=O)(=O)N)Cl,APPROVED,,urinary_system_disease
6017,776,Chronic Kidney Disease,Benidipine,CC1=C(C(C(=C(N1)C)C(=O)OC2CCCN(C2)CC3=CC=CC=C3)C4=CC(=CC=C4)[N+](=O)[O-])C(=O)OC,APPROVED,,urinary_system_disease
6016,775,Chronic Kidney Disease,Fosinopril,CCC(=O)OC(C(C)C)OP(=O)(CCCCC1=CC=CC=C1)CC(=O)N2CC(CC2C(=O)O)C3CCCCC3,APPROVED,,urinary_system_disease
6015,773,Gout|Moderate Renal Impairment,Lansoprazole,CC1=C(C=CN=C1CS(=O)C2=NC3=CC=CC=C3N2)OCC(F)(F)F,PHASE2,,urinary_system_disease
6014,772,Gout|Moderate Renal Impairment,Naproxen,CC(C1=CC2=C(C=C1)C=C(C=C2)OC)C(=O)O,PHASE2,,urinary_system_disease
6013,768,Gout|Moderate Renal Impairment,Febuxostat,CC1=C(SC(=N1)C2=CC(=C(C=C2)OCC(C)C)C#N)C(=O)O,PHASE2,,urinary_system_disease
6012,764,Atrial Fibrillation,Dabigatran,CN1C2=C(C=C(C=C2)C(=O)N(CCC(=O)O)C3=CC=CC=N3)N=C1CNC4=CC=C(C=C4)C(=N)N,APPROVED,,urinary_system_disease
6011,762,Bladder Cancer,Camrelizumab,,PHASE2,,urinary_system_disease
6010,753,Congestive Heart Failure|Renal Impairment,Pecavaptan,CC(C1=NC(=NN1C2=CC(=CC=C2)Cl)CN3C(=O)N(C(=N3)C4=CC=C(C=C4)Cl)CC(C(F)(F)F)O)O,PHASE1,,urinary_system_disease
6009,742,Renal Cancer|Non Small Cell Lung Cancer (NSCLC)|Soft Tissue Sarcoma,Panobinostat,CC1=C(C2=CC=CC=C2N1)CCNCC3=CC=C(C=C3)C=CC(=O)NO,PHASE1,,urinary_system_disease
6008,740,Renal Transplantation|Uremia,Bortezomib,B(C(CC(C)C)NC(=O)C(CC1=CC=CC=C1)NC(=O)C2=NC=CN=C2)(O)O,PHASE1|PHASE2,,urinary_system_disease
6007,736,Biliary Carcinoma|Gall Bladder Carcinoma|Cholangiocarcinoma|Gastrointestinal Tumor,Copanlisib,COC1=C(C=CC2=C3NCCN3C(=NC(=O)C4=CN=C(N=C4)N)N=C21)OCCCN5CCOCC5,PHASE2,,urinary_system_disease
6006,722,Chronic Kidney Disease Requiring Chronic Dialysis|Hyperphosphatemia,Tenapanor,CN1CC(C2=C(C1)C(=CC(=C2)Cl)Cl)C3=CC(=CC=C3)S(=O)(=O)NCCOCCOCCNC(=O)NCCCCNC(=O)NCCOCCOCCNS(=O)(=O)C4=CC=CC(=C4)C5CN(CC6=C5C=C(C=C6Cl)Cl)C,APPROVED,,urinary_system_disease
6005,714,Renal Insufficiency|Kidney Diseases|Urologic Diseases,Udenafil,CCCC1=NN(C2=C1N=C(NC2=O)C3=C(C=CC(=C3)S(=O)(=O)NCCC4CCCN4C)OCCC)C,PHASE1,,urinary_system_disease
6004,712,"Transplant; Failure, Kidney",Desflurane,C(C(F)(F)F)(OC(F)F)F,PHASE2,,urinary_system_disease
6003,708,End Stage Renal Disease,Empagliflozin,C1COCC1OC2=CC=C(C=C2)CC3=C(C=CC(=C3)C4C(C(C(C(O4)CO)O)O)O)Cl,PHASE2,,urinary_system_disease
6002,702,HIV,Bictegravir,C1CC2CC1N3C(O2)CN4C=C(C(=O)C(=C4C3=O)O)C(=O)NCC5=C(C=C(C=C5F)F)F,PHASE1,,urinary_system_disease
6001,699,Renal Cell Carcinoma|Metastatic Castration-resistant Prostate Cancer|Urothelial Carcinoma|Solid Tumor|Hepatocellular Carcinoma|Non-small Cell Lung Cancer|Colorectal Cancer|Head and Neck Squamous Cell Carcinoma,Relatlimab,,PHASE1,,urinary_system_disease
6000,686,Urinary Tract Infections|Acute Pyelonephritis,Finafloxacin,C1CC1N2C=C(C(=O)C3=CC(=C(C(=C32)C#N)N4CC5C(C4)OCCN5)F)C(=O)O,PHASE2,,urinary_system_disease
5999,682,Soft Tissue Sarcoma|Lymphoma|Leukemia|Wilms' Tumor|Osteosarcoma,Vincristine,CCC1(CC2CC(C3=C(CCN(C2)C1)C4=CC=CC=C4N3)(C5=C(C=C6C(=C5)C78CCN9C7C(C=CC9)(C(C(C8N6C=O)(C(=O)OC)O)OC(=O)C)CC)OC)C(=O)OC)O,PHASE2,,urinary_system_disease
5998,681,"Alport Syndrome, X-Linked",Benazepril,CCOC(=O)C(CCC1=CC=CC=C1)NC2CCC3=CC=CC=C3N(C2=O)CC(=O)O,PHASE2,,urinary_system_disease
5997,671,Polycystic Liver Disease|Autosomal Dominant Polycystic Kidney,Leuprorelin,CCNC(=O)C1CCCN1C(=O)C(CCCN=C(N)N)NC(=O)C(CC(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC2=CC=C(C=C2)O)NC(=O)C(CO)NC(=O)C(CC3=CNC4=CC=CC=C43)NC(=O)C(CC5=CN=CN5)NC(=O)C6CCC(=O)N6,PHASE2,,urinary_system_disease
5996,670,Polycystic Liver Disease|Autosomal Dominant Polycystic Kidney,Leuprolide,CCNC(=O)C1CCCN1C(=O)C(CCCN=C(N)N)NC(=O)C(CC(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC2=CC=C(C=C2)O)NC(=O)C(CO)NC(=O)C(CC3=CNC4=CC=CC=C43)NC(=O)C(CC5=CN=CN5)NC(=O)C6CCC(=O)N6,PHASE2,,urinary_system_disease
5995,667,"Solid Tumor|Breast Tumor|Colon Tumor, Malignant|Lung Tumor|Urologic Cancer|Pancreatic Cancer|Melanoma|Metastatic Cancer|Locally Advanced Solid Tumor|Esophageal Cancer|Endometrial Cancer|Head and Neck Cancer",Niraparib,C1CC(CNC1)C2=CC=C(C=C2)N3C=C4C=CC=C(C4=N3)C(=O)N,PHASE2,,urinary_system_disease
5994,665,Renal Cell Carcinoma|Colorectal Adenocarcinoma|Non-squamous Non-small Cell Lung Cancer|Platinum-refractory Ovarian Carcinoma|Cervical Carcinoma,Nintedanib,CN1CCN(CC1)CC(=O)N(C)C2=CC=C(C=C2)N=C(C3=CC=CC=C3)C4=C(NC5=C4C=CC(=C5)C(=O)OC)O,PHASE1,,urinary_system_disease
5993,664,Paroxysmal Nocturnal Hemoglobinuria,Cemdisiran,CC(=O)NC1C(C(C(OC1OCCCCC(=O)NCCCNC(=O)CCOCC(COCCC(=O)NCCCNC(=O)CCCCOC2C(C(C(C(O2)CO)O)O)NC(=O)C)(COCCC(=O)NCCCNC(=O)CCCCOC3C(C(C(C(O3)CO)O)O)NC(=O)C)NC(=O)CCCCCCCCCCC(=O)N4CC(CC4COP(=O)(O)O)O)CO)O)O,PHASE2,,urinary_system_disease
5992,663,Paroxysmal Nocturnal Hemoglobinuria,Pozelimab,,PHASE2,,urinary_system_disease
5991,662,"Carcinoma, Renal Cell",Tivozanib,CC1=CC(=NO1)NC(=O)NC2=C(C=C(C=C2)OC3=C4C=C(C(=CC4=NC=C3)OC)OC)Cl,PHASE2,,urinary_system_disease
5990,661,Chronic Kidney Disease|Peritoneal Dialysis,Icodextrin,C1=CC(=C(C(=C1)Cl)C=NN=C(N)N)Cl,APPROVED,,urinary_system_disease
5989,655,Colorectal Cancer|Gastroesophageal Cancer|Renal Cell Carcinoma,Gevokizumab,,PHASE1,,urinary_system_disease
5988,652,Chronic Kidney Diseases,Pioglitazone,CCC1=CN=C(C=C1)CCOC2=CC=C(C=C2)CC3C(=O)NC(=O)S3,APPROVED,,urinary_system_disease
5987,649,IGA Glomerulonephritis,Ramipril,CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N2C3CCCC3CC2C(=O)O,APPROVED,,urinary_system_disease
5986,647,Chronic Kidney Disease,Minocycline,CN(C)C1C2CC3CC4=C(C=CC(=C4C(=C3C(=O)C2(C(=C(C1=O)C(=O)N)O)O)O)O)N(C)C,APPROVED,,urinary_system_disease
5985,645,Renal Cell Cancer,Melphalan,C1=CC(=CC=C1CC(C(=O)O)N)N(CCCl)CCCl,PHASE2,,urinary_system_disease
5984,643,Liver Cirrhosis|Renal Failure,Lactulose,C(C1C(C(C(C(O1)OC2C(OC(C2O)(CO)O)CO)O)O)O)O,APPROVED,,urinary_system_disease
5983,642,Liver Cirrhosis|Renal Failure,Rifaximin,CC1C=CC=C(C(=O)NC2=C(C3=C(C4=C(C(=C3O)C)OC(C4=O)(OC=CC(C(C(C(C(C(C1O)C)O)C)OC(=O)C)C)OC)C)C5=C2N6C=CC(=CC6=N5)C)O)C,APPROVED,,urinary_system_disease
5982,640,Advanced Malignant Solid Neoplasm|Recurrent Ependymoma|Recurrent Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor|Recurrent Glioma|Recurrent Hepatoblastoma|Recurrent Kidney Wilms Tumor|Recurrent Langerhans Cell Histiocytosis|Recurrent Malignant Germ Cell Tumor|Recurrent Malignant Glioma|Recurrent Malignant Solid Neoplasm|Recurrent Medulloblastoma|Recurrent Neuroblastoma|Recurrent Non-Hodgkin Lymphoma|Recurrent Osteosarcoma|Recurrent Rhabdoid Tumor|Recurrent Rhabdomyosarcoma|Recurrent Soft Tissue Sarcoma|Refractory Ependymoma|Refractory Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor|Refractory Glioma|Refractory Hepatoblastoma|Refractory Langerhans Cell Histiocytosis|Refractory Malignant Germ Cell Tumor|Refractory Malignant Glioma|Refractory Malignant Solid Neoplasm|Refractory Medulloblastoma|Refractory Neuroblastoma|Refractory Non-Hodgkin Lymphoma|Refractory Osteosarcoma|Refractory Primary Central Nervous System Neoplasm|Refractory Rhabdoid Tumor|Refractory Rhabdomyosarcoma|Refractory Soft Tissue Sarcoma,Larotrectinib,C1CC(N(C1)C2=NC3=C(C=NN3C=C2)NC(=O)N4CCC(C4)O)C5=C(C=CC(=C5)F)F,PHASE2,,urinary_system_disease
5981,639,Contrast-induced Acute Kidney Injury,Alprostadil,CCCCCC(C=CC1C(CC(=O)C1CCCCCCC(=O)O)O)O,PHASE2,,urinary_system_disease
5980,637,Overactive Bladder,Imidafenacin,CC1=NC=CN1CCC(C2=CC=CC=C2)(C3=CC=CC=C3)C(=O)N,APPROVED,,urinary_system_disease
5979,636,"Anemia|Renal Insufficiency, Chronic",Molidustat,C1COCCN1C2=NC=NC(=C2)N3C(=O)C(=CN3)N4C=CN=N4,PHASE2,,urinary_system_disease
5978,632,Kidney Transplant Recipients|BK Virus,Mizoribine,C1=NC(=C(N1C2C(C(C(O2)CO)O)O)O)C(=O)N,APPROVED,,urinary_system_disease
5977,630,Uncomplicated Urinary Tract Infection|Antibiotic Resistant Infection,Cefuroxime,CON=C(C1=CC=CO1)C(=O)NC2C3N(C2=O)C(=C(CS3)COC(=O)N)C(=O)O,APPROVED,,urinary_system_disease
5976,629,Uncomplicated Urinary Tract Infection|Antibiotic Resistant Infection,Cefixime,C=CC1=C(N2C(C(C2=O)NC(=O)C(=NOCC(=O)O)C3=CSC(=N3)N)SC1)C(=O)O,APPROVED,,urinary_system_disease
5975,623,"Transplant;Failure,Kidney|Pain, Postoperative",Ropivacaine,CCCN1CCCCC1C(=O)NC2=C(C=CC=C2C)C,APPROVED,,urinary_system_disease
5974,619,Chronic Kidney Disease,Allopurinol,C1=NNC2=C1C(=O)NC=N2,PHASE2,,urinary_system_disease
5973,618,Chronic Kidney Disease,Verinurad,CC(C)(C(=O)O)SC1=C(C=NC=C1)C2=CC=C(C3=CC=CC=C32)C#N,PHASE2,,urinary_system_disease
5972,617,"Diabetes Mellitus, Type 2|Diabetic Nephropathies",Gliclazide,CC1=CC=C(C=C1)S(=O)(=O)NC(=O)NN2CC3CCCC3C2,APPROVED,,urinary_system_disease
5971,615,Sickle Cell Disease,Hydroxyurea,C(=O)(N)NO,PHASE2,,urinary_system_disease
5970,614,Sickle Cell Disease,Hydroxycarbamide,C(=O)(N)NO,PHASE2,,urinary_system_disease
5969,613,Overactive Bladder|Constipation|Lower Urinary Tract Symptoms,Baclofen,C1=CC(=CC=C1C(CC(=O)O)CN)Cl,APPROVED,,urinary_system_disease
5968,606,End-Stage Renal Disease|Hepatitis C,Sofosbuvir,CC(C)OC(=O)C(C)NP(=O)(OCC1C(C(C(O1)N2C=CC(=O)NC2=O)(C)F)O)OC3=CC=CC=C3,APPROVED,,urinary_system_disease
5967,605,End-Stage Renal Disease|Hepatitis C,Ribavirin,C1=NC(=NN1C2C(C(C(O2)CO)O)O)C(=O)N,APPROVED,,urinary_system_disease
5966,597,Melanoma|Prostate Cancer|Ovarian Cancer|Renal Cell Carcinoma|Colorectal Carcinoma|Pancreatic Carcinoma|Non-small Cell Lung Carcinoma|Solid Tumors|Breast Cancer,Leucovorin,C1C(N(C2=C(N1)N=C(NC2=O)N)C=O)CNC3=CC=C(C=C3)C(=O)NC(CCC(=O)O)C(=O)O,PHASE1,,urinary_system_disease
5965,591,Melanoma|Prostate Cancer|Ovarian Cancer|Renal Cell Carcinoma|Colorectal Carcinoma|Pancreatic Carcinoma|Non-small Cell Lung Carcinoma|Solid Tumors|Breast Cancer,Pegilodecakin,,PHASE1,,urinary_system_disease
5964,581,Renal Impairment,Lorlatinib,CC1C2=C(C=CC(=C2)F)C(=O)N(CC3=NN(C(=C3C4=CC(=C(N=C4)N)O1)C#N)C)C,PHASE1,,urinary_system_disease
5963,580,Post-Op Complication,Fentanyl,CCC(=O)N(C1CCN(CC1)CCC2=CC=CC=C2)C3=CC=CC=C3,APPROVED,,urinary_system_disease
5962,579,Post-Op Complication,Bupivacaine,CCCCN1CCCCC1C(=O)NC2=C(C=CC=C2C)C,APPROVED,,urinary_system_disease
5961,574,Advanced Malignant Solid Neoplasm|Malignant Solid Neoplasm|Recurrent Ependymoma|Recurrent Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor|Recurrent Hepatoblastoma|Recurrent Langerhans Cell Histiocytosis|Recurrent Malignant Germ Cell Tumor|Recurrent Malignant Glioma|Recurrent Malignant Solid Neoplasm|Recurrent Medulloblastoma|Recurrent Neuroblastoma|Recurrent Non-Hodgkin Lymphoma|Recurrent Osteosarcoma|Recurrent Primary Central Nervous System Neoplasm|Recurrent Rhabdoid Tumor|Recurrent Rhabdomyosarcoma|Recurrent Soft Tissue Sarcoma|Refractory Ependymoma|Refractory Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor|Refractory Hepatoblastoma|Refractory Langerhans Cell Histiocytosis|Refractory Malignant Germ Cell Tumor|Refractory Malignant Glioma|Refractory Malignant Solid Neoplasm|Refractory Medulloblastoma|Refractory Neuroblastoma|Refractory Non-Hodgkin Lymphoma|Refractory Osteosarcoma|Refractory Primary Central Nervous System Neoplasm|Refractory Rhabdoid Tumor|Refractory Rhabdomyosarcoma|Refractory Soft Tissue Sarcoma|Wilms Tumor,Ensartinib,CC1CN(CC(N1)C)C(=O)C2=CC=C(C=C2)NC(=O)C3=NN=C(C(=C3)OC(C)C4=C(C=CC(=C4Cl)F)Cl)N,PHASE2,,urinary_system_disease
5960,566,Renal Cell Carcinoma,Cemiplimab,,PHASE1|PHASE2,,urinary_system_disease
5959,559,Advanced Metastatic Clear Cell Renal Cell Carcinoma (CCRCC),Selenomethionine,C[Se]CCC(C(=O)O)N,PHASE1|PHASE2,,urinary_system_disease
5958,556,"Urinary Tract Infections|Enterobacteriaceae Infections|Infection Due to ESBL Bacteria|Carbapenem|Escherichia Coli Infection|Klebsiella Pneumoniae Infection|Clinical Trial|Drug Resistance, Bacterial",Piperacillin,CCN1CCN(C(=O)C1=O)C(=O)NC(C2=CC=CC=C2)C(=O)NC3C4N(C3=O)C(C(S4)(C)C)C(=O)O,APPROVED,,urinary_system_disease
5957,549,"Multiple Myeloma|Renal Impairment|Neoplasms, Plasma Cell|Neoplasms by Histologic Type|Neoplasms|Paraproteinemias|Blood Protein Disorders|Hematologic Diseases",Diphenhydramine,CN(C)CCOC(C1=CC=CC=C1)C2=CC=CC=C2,PHASE2,,urinary_system_disease
5956,548,"Multiple Myeloma|Renal Impairment|Neoplasms, Plasma Cell|Neoplasms by Histologic Type|Neoplasms|Paraproteinemias|Blood Protein Disorders|Hematologic Diseases",Ranitidine,CNC(=C[N+](=O)[O-])NCCSCC1=CC=C(O1)CN(C)C,PHASE2,,urinary_system_disease
5955,547,"Multiple Myeloma|Renal Impairment|Neoplasms, Plasma Cell|Neoplasms by Histologic Type|Neoplasms|Paraproteinemias|Blood Protein Disorders|Hematologic Diseases",Acetaminophen,CC(=O)NC1=CC=C(C=C1)O,PHASE2,,urinary_system_disease
5954,545,"Multiple Myeloma|Renal Impairment|Neoplasms, Plasma Cell|Neoplasms by Histologic Type|Neoplasms|Paraproteinemias|Blood Protein Disorders|Hematologic Diseases",Pomalidomide,C1CC(=O)NC(=O)C1N2C(=O)C3=C(C2=O)C(=CC=C3)N,PHASE2,,urinary_system_disease
5953,544,"Multiple Myeloma|Renal Impairment|Neoplasms, Plasma Cell|Neoplasms by Histologic Type|Neoplasms|Paraproteinemias|Blood Protein Disorders|Hematologic Diseases",Isatuximab,,PHASE2,,urinary_system_disease
5952,538,Muscle-Invasive Bladder Carcinoma|Programmed Cell Death Protein 1 Inhibitor|Radiotherapy,Toripalimab,,PHASE2,,urinary_system_disease
5951,526,Benign Prostate Hyperplasia,Finasteride,CC12CCC3C(C1CCC2C(=O)NC(C)(C)C)CCC4C3(C=CC(=O)N4)C,APPROVED,,urinary_system_disease
5950,516,Chronic Kidney Diseases|Hemodialysis Complication|Hyperphosphatemia,Cholestyramine,CCC(C)C.CCC(CC(C)C1=CC=CC=C1)C2=CC=C(C=C2)C[N+](C)(C)C.N.[Cl-],APPROVED,,urinary_system_disease
5949,514,End-Stage Renal Disease,Anakinra,,PHASE2,,urinary_system_disease
5948,510,Bone Marrow Failure Syndrome|Congenital Amegakaryocytic Thrombocytopenia|Congenital Pure Red Cell Aplasia|Hereditary Sideroblastic Anemia|Myeloid Neoplasms With Germline GATA2 Mutation|Paroxysmal Nocturnal Hemoglobinuria|Shwachman-Diamond Syndrome,Methotrexate,CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)NC(CCC(=O)O)C(=O)O,PHASE2,,urinary_system_disease
5947,507,Bone Marrow Failure Syndrome|Congenital Amegakaryocytic Thrombocytopenia|Congenital Pure Red Cell Aplasia|Hereditary Sideroblastic Anemia|Myeloid Neoplasms With Germline GATA2 Mutation|Paroxysmal Nocturnal Hemoglobinuria|Shwachman-Diamond Syndrome,Treosulfan,CS(=O)(=O)OCC(C(COS(=O)(=O)C)O)O,PHASE2,,urinary_system_disease
5946,502,Lupus Nephritis,Prednisolone,CC12CC(C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C)O,PHASE2,,urinary_system_disease
5945,500,Lupus Nephritis,Laquinimod,CCN(C1=CC=CC=C1)C(=O)C2=C(C3=C(C=CC=C3Cl)N(C2=O)C)O,PHASE2,,urinary_system_disease
5944,496,Chronic Kidney Diseases|Anemia of Chronic Kidney Disease,Desidustat,C1CC1CON2C3=CC=CC=C3C(=C(C2=O)C(=O)NCC(=O)O)O,APPROVED,,urinary_system_disease
5943,495,Advanced Malignant Solid Neoplasm|Stage III Cutaneous Melanoma AJCC v7|Stage III Prostate Cancer AJCC v7|Stage III Renal Cell Cancer AJCC v7|Stage IIIA Cutaneous Melanoma AJCC v7|Stage IIIB Cutaneous Melanoma AJCC v7|Stage IIIC Cutaneous Melanoma AJCC v7|Stage IV Cutaneous Melanoma AJCC v6 and v7|Stage IV Prostate Cancer AJCC v7|Stage IV Renal Cell Cancer AJCC v7,Hydroxychloroquine,CCN(CCCC(C)NC1=C2C=CC(=CC2=NC=C1)Cl)CCO,PHASE1,,urinary_system_disease
5942,490,Osteoporosis,Romosozumab,,PHASE1,,urinary_system_disease
5941,486,"Kidney Failure, Chronic|Renal Insufficiency",Belatacept,,PHASE1,,urinary_system_disease
5940,485,"Kidney Failure, Chronic|Renal Insufficiency",Abatacept,,PHASE1,,urinary_system_disease
5939,467,Bladder Cancer,Tamoxifen,CCC(=C(C1=CC=CC=C1)C2=CC=C(C=C2)OCCN(C)C)C3=CC=CC=C3,PHASE2,,urinary_system_disease
5938,466,"Hepatitis B, Chronic|Chronic Kidney Diseases",Telbivudine,CC1=CN(C(=O)NC1=O)C2CC(C(O2)CO)O,APPROVED,,urinary_system_disease
5937,463,Renal Failure|Anesthesia,Sevoflurane,C(OC(C(F)(F)F)C(F)(F)F)F,PHASE1,,urinary_system_disease
5936,462,Hyperkalemia|Resistant Hypertension,Spironolactone,CC(=O)SC1CC2=CC(=O)CCC2(C3C1C4CCC5(C4(CC3)C)CCC(=O)O5)C,PHASE2,,urinary_system_disease
5935,460,Postoperative Ileus|Bladder Cancer,Prucalopride,COCCCN1CCC(CC1)NC(=O)C2=CC(=C(C3=C2OCC3)N)Cl,PHASE2,,urinary_system_disease
5934,457,C3G|IC-MPGN|Renal Transplant|Complement 3 Glomerulopathy|Complement 3 Glomerulopathy (C3G)|Dense Deposit Disease (DDD)|Membranoproliferative Glomerulonephritis|Membranoproliferative Glomerulonephritis (MPGN)|Immune Complex Membranoproliferative Glomerulonephritis (IC-MPGN)|C3 Glomerulopathy|C3 Glomerulonephritis|Complement 3 Glomerulonephritis,Pegcetacoplan,,PHASE2,,urinary_system_disease
5933,456,Non-muscle-invasive Bladder Cancer,Tislelizumab,,APPROVED,,urinary_system_disease
5932,455,Uric Acid Nephropathy,Losartan,CCCCC1=NC(=C(N1CC2=CC=C(C=C2)C3=CC=CC=C3C4=NNN=N4)CO)Cl,APPROVED,,urinary_system_disease
5931,454,"Polycystic Liver Disease|Hepatomegaly|Liver Diseases|Polycystic Kidney, Autosomal Dominant",Lanreotide,CC(C)C1C(=O)NC(CSSCC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N1)CCCCN)CC2=CNC3=CC=CC=C32)CC4=CC=C(C=C4)O)NC(=O)C(CC5=CC6=CC=CC=C6C=C5)N)C(=O)NC(C(C)O)C(=O)N,PHASE2|PHASE3,,urinary_system_disease
5930,452,Chronic Kidney Disease,Sevelamer,C=CCN.C1C(O1)CCl,APPROVED,,urinary_system_disease
5929,450,Cytomegalovirus Retinitis|Acute Renal Failure,Cidofovir,C1=CN(C(=O)N=C1N)CC(CO)OCP(=O)(O)O,APPROVED,,urinary_system_disease
5928,446,Acute Kidney Injury|Melatonin|Polymyxin B Adverse Reaction,Melatonin,CC(=O)NCCC1=CNC2=C1C=C(C=C2)OC,PHASE2,,urinary_system_disease
5927,444,Metastatic Cancer|Metastatic Melanoma|Renal Cancer,Aldesleukin,,PHASE1|PHASE2,,urinary_system_disease
5926,442,Acute Kidney Injury,Phenylephrine,CNCC(C1=CC(=CC=C1)O)O,APPROVED,,urinary_system_disease
5925,441,Acute Kidney Injury,Vasopressin,,APPROVED,,urinary_system_disease
5924,438,Advanced Malignant Solid Neoplasm|Ann Arbor Stage III Childhood Non-Hodgkin Lymphoma|Ann Arbor Stage IV Childhood Non-Hodgkin Lymphoma|Low Grade Glioma|Malignant Glioma|Recurrent Childhood Central Nervous System Neoplasm|Recurrent Childhood Ependymoma|Recurrent Childhood Malignant Germ Cell Tumor|Recurrent Childhood Non-Hodgkin Lymphoma|Recurrent Childhood Rhabdomyosarcoma|Recurrent Childhood Soft Tissue Sarcoma|Recurrent Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor|Recurrent Glioma|Recurrent Hepatoblastoma|Recurrent Langerhans Cell Histiocytosis|Recurrent Malignant Solid Neoplasm|Recurrent Medulloblastoma|Recurrent Neuroblastoma|Recurrent Osteosarcoma|Refractory Childhood Malignant Germ Cell Tumor|Refractory Ependymoma|Refractory Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor|Refractory Glioma|Refractory Hepatoblastoma|Refractory Langerhans Cell Histiocytosis|Refractory Malignant Glioma|Refractory Malignant Solid Neoplasm|Refractory Medulloblastoma|Refractory Neuroblastoma|Refractory Non-Hodgkin Lymphoma|Refractory Osteosarcoma|Refractory Primary Central Nervous System Neoplasm|Refractory Rhabdomyosarcoma|Refractory Soft Tissue Sarcoma|Rhabdoid Tumor|Wilms Tumor,Olaparib,C1CC1C(=O)N2CCN(CC2)C(=O)C3=C(C=CC(=C3)CC4=NNC(=O)C5=CC=CC=C54)F,PHASE2,,urinary_system_disease
5923,434,Anemia|Dialysis-dependent Chronic Kidney Disease,Vadadustat,C1=CC(=CC(=C1)Cl)C2=CC(=C(N=C2)C(=O)NCC(=O)O)O,PHASE2,,urinary_system_disease
5922,420,Type 2 Diabetes|Microalbuminuria,Sitagliptin,C1CN2C(=NN=C2C(F)(F)F)CN1C(=O)CC(CC3=CC(=C(C=C3F)F)F)N,APPROVED,,urinary_system_disease
5921,414,Chronic Kidney Disease Stage 3|Chronic Kidney Disease Stage 4,Sulforaphane,CS(=O)CCCCN=C=S,PHASE2,,urinary_system_disease
5920,413,Uterine Cervical Neoplasms|Endometrial Neoplasms|Squamous Cell Carcinoma of Head and Neck|Gallbladder Neoplasms|Cholangiocarcinoma|Esophageal Neoplasms|Triple Negative Breast Neoplasms|Hepatocellular Carcinoma|Urinary Bladder Neoplasms|Ovarian Neoplasms|Stomach Neoplasms,Oxaliplatin,C1CCC(C(C1)[NH-])[NH-].C(=O)(C(=O)O)O.[Pt+2],PHASE2,,urinary_system_disease
5919,405,Uterine Cervical Neoplasms|Endometrial Neoplasms|Squamous Cell Carcinoma of Head and Neck|Gallbladder Neoplasms|Cholangiocarcinoma|Esophageal Neoplasms|Triple Negative Breast Neoplasms|Hepatocellular Carcinoma|Urinary Bladder Neoplasms|Ovarian Neoplasms|Stomach Neoplasms,Fluorouracil,C1=C(C(=O)NC(=O)N1)F,PHASE2,,urinary_system_disease
5918,402,Uterine Cervical Neoplasms|Endometrial Neoplasms|Squamous Cell Carcinoma of Head and Neck|Gallbladder Neoplasms|Cholangiocarcinoma|Esophageal Neoplasms|Triple Negative Breast Neoplasms|Hepatocellular Carcinoma|Urinary Bladder Neoplasms|Ovarian Neoplasms|Stomach Neoplasms,Vibostolimab,,PHASE2,,urinary_system_disease
5917,398,Urinary Tract Infections,Cefoxitin,COC1(C2N(C1=O)C(=C(CS2)COC(=O)N)C(=O)O)NC(=O)CC3=CC=CS3,APPROVED,,urinary_system_disease
5916,397,Benzodiazepines|Bladder Cancer|Delirium|Surgery|Cancer Recurrence,Propofol,CC(C)C1=C(C(=CC=C1)C(C)C)O,APPROVED,,urinary_system_disease
5915,396,Benzodiazepines|Bladder Cancer|Delirium|Surgery|Cancer Recurrence,Remimazolam,CC1=CN=C2N1C3=C(C=C(C=C3)Br)C(=NC2CCC(=O)OC)C4=CC=CC=N4,APPROVED,,urinary_system_disease
5914,395,Inflammation|End-stage Renal Disease|Hemodialysis,Pentoxifylline,CC(=O)CCCCN1C(=O)C2=C(N=CN2C)N(C1=O)C,APPROVED,,urinary_system_disease
5913,394,Antibiotic Toxicity,Polymyxin B,,PHASE1,,urinary_system_disease
5912,391,Advanced Renal Cell Carcinoma,Balstilimab,,PHASE2,,urinary_system_disease
5911,390,Advanced Renal Cell Carcinoma,Botensilimab,,PHASE2,,urinary_system_disease
5910,383,Fanconi Anemia,Plerixafor,C1CNCCNCCCN(CCNC1)CC2=CC=C(C=C2)CN3CCCNCCNCCCNCC3,PHASE1|PHASE2,,urinary_system_disease
5909,382,Fanconi Anemia,Filgrastim,,PHASE1|PHASE2,,urinary_system_disease
5908,377,Contrast-Induced Acute Kidney Injury,Deferiprone,CC1=C(C(=O)C=CN1C)O,PHASE2,,urinary_system_disease
5907,376,Infections Joint Prosthetic|Overweight or Obesity|MSSA Colonization|MRSA|Chronic Kidney Diseases|Diabetes|Autoimmune Diseases|Inflammatory Disease|Tobacco Use,Cefadroxil,CC1=C(N2C(C(C2=O)NC(=O)C(C3=CC=C(C=C3)O)N)SC1)C(=O)O,APPROVED,,urinary_system_disease
5906,373,"Anemia|Renal Insufficiency, Chronic|Renal Anemia",Daprodustat,C1CCC(CC1)N2C(=O)C(C(=O)N(C2=O)C3CCCCC3)C(=O)NCC(=O)O,APPROVED,,urinary_system_disease
5905,372,Hypercholesterolemia|CKD Stage 5|Chronic Kidney Disease Requiring Chronic Dialysis,Ezetimibe,C1=CC(=CC=C1C2C(C(=O)N2C3=CC=C(C=C3)F)CCC(C4=CC=C(C=C4)F)O)O,APPROVED,,urinary_system_disease
5904,371,Hypercholesterolemia|CKD Stage 5|Chronic Kidney Disease Requiring Chronic Dialysis,Evolocumab,,APPROVED,,urinary_system_disease
5903,361,Atypical Hemolytic Uremic Syndrome (aHUS),Eculizumab,,PHASE2,,urinary_system_disease
5902,360,Bladder Neoplasms,Apaziquone,CN1C(=C(C2=C1C(=O)C=C(C2=O)N3CC3)CO)C=CCO,PHASE2,,urinary_system_disease
5901,352,Breast Cancer|Ovarian Cancer|Colorectal Cancer|Cervical Cancer|Renal Cell Carcinoma,Tremelimumab,,PHASE1,,urinary_system_disease
5900,350,Heart Transplantation|Renal Failure,Sirolimus,CC1CCC2CC(C(=CC=CC=CC(CC(C(=O)C(C(C(=CC(C(=O)CC(OC(=O)C3CCCCN3C(=O)C(=O)C1(O2)O)C(C)CC4CCC(C(C4)OC)O)C)C)O)OC)C)C)C)OC,APPROVED,,urinary_system_disease
5899,349,Heart Transplantation|Renal Failure,Cyclosporine,CCC1C(=O)N(CC(=O)N(C(C(=O)NC(C(=O)N(C(C(=O)NC(C(=O)NC(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N1)C(C(C)CC=CC)O)C)C(C)C)C)CC(C)C)C)CC(C)C)C)C)C)CC(C)C)C)C(C)C)CC(C)C)C)C,APPROVED,,urinary_system_disease
5898,345,Advanced/Metastatic Clear Cell Renal Cell Carcinoma,Fludarabine,C1=NC2=C(N=C(N=C2N1C3C(C(C(O3)CO)O)O)F)N,PHASE1,,urinary_system_disease
5897,344,Primary Monosymptomatic Nocturnal Enuresis,Desmopressin,C1CC(N(C1)C(=O)C2CSSCCC(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N2)CC(=O)N)CCC(=O)N)CC3=CC=CC=C3)CC4=CC=C(C=C4)O)C(=O)NC(CCCN=C(N)N)C(=O)NCC(=O)N,APPROVED,,urinary_system_disease
5896,343,Staphylococcal Skin Infections|Streptococcal Infections,Ceftobiprole,C1CNCC1N2CCC(=CC3=C(N4C(C(C4=O)NC(=O)C(=NO)C5=NSC(=N5)N)SC3)C(=O)O)C2=O,PHASE1,,urinary_system_disease
5895,341,Benign Prostatic Hyperplasia,Dutasteride,CC12CCC3C(C1CCC2C(=O)NC4=C(C=CC(=C4)C(F)(F)F)C(F)(F)F)CCC5C3(C=CC(=O)N5)C,APPROVED,,urinary_system_disease
5894,340,Fibrosis|Renal Impairment,Gadobutrol,C1CN(CCN(CCN(CCN1CC(=O)[O-])CC(=O)[O-])C(CO)C(CO)O)CC(=O)[O-].[Gd+3],APPROVED,,urinary_system_disease
5893,338,Postoperative Urinary Retention,Sugammadex,C(CSCC1C2C(C(C(O1)OC3C(OC(C(C3O)O)OC4C(OC(C(C4O)O)OC5C(OC(C(C5O)O)OC6C(OC(C(C6O)O)OC7C(OC(C(C7O)O)OC8C(OC(C(C8O)O)OC9C(OC(O2)C(C9O)O)CSCCC(=O)O)CSCCC(=O)O)CSCCC(=O)O)CSCCC(=O)O)CSCCC(=O)O)CSCCC(=O)O)CSCCC(=O)O)O)O)C(=O)O,PHASE1|PHASE2,,urinary_system_disease
5892,336,Hematuria|Urinary Bladder Neoplasms,Aspirin,CC(=O)OC1=CC=CC=C1C(=O)O,APPROVED,,urinary_system_disease
5891,334,Diabetes Mellitus|Diabetic Nephropathy,Pirfenidone,CC1=CN(C(=O)C=C1)C2=CC=CC=C2,PHASE1|PHASE2,,urinary_system_disease
5890,332,Kidney Diseases|Kidney Transplantation|Kidney Transplant|Renal Transplantation|Renal Transplant,Valganciclovir,CC(C)C(C(=O)OCC(CO)OCN1C=NC2=C1N=C(NC2=O)N)N,PHASE1|PHASE2,,urinary_system_disease
5889,331,Kidney Diseases|Kidney Transplantation|Kidney Transplant|Renal Transplantation|Renal Transplant,Ganciclovir,C1=NC2=C(N1COC(CO)CO)N=C(NC2=O)N,PHASE1|PHASE2,,urinary_system_disease
5888,327,Kidney Diseases|Kidney Transplantation|Kidney Transplant|Renal Transplantation|Renal Transplant,Daclizumab,,PHASE1|PHASE2,,urinary_system_disease
5887,325,Venous Thromboembolism,Fondaparinux,COC1C(C(C(C(O1)COS(=O)(=O)O)OC2C(C(C(C(O2)C(=O)O)OC3C(C(C(C(O3)COS(=O)(=O)O)OC4C(C(C(C(O4)C(=O)O)OC5C(C(C(C(O5)COS(=O)(=O)O)O)O)NS(=O)(=O)O)O)O)OS(=O)(=O)O)NS(=O)(=O)O)O)OS(=O)(=O)O)O)NS(=O)(=O)O,APPROVED,,urinary_system_disease
5886,323,"Diabetic Kidney Disease|Hyperuricemia|Diabetes|Diabetes Mellitus, Type 2|Type2 Diabetes|Type 2 Diabetes Mellitus|Diabetic Nephropathies|Diabetes Complications",Pegloticase,,PHASE2,,urinary_system_disease
5885,322,Complicated Urinary Tract Infection Including Acute Pyelonephritis,Ertapenem,CC1C2C(C(=O)N2C(=C1SC3CC(NC3)C(=O)NC4=CC=CC(=C4)C(=O)O)C(=O)O)C(C)O,PHASE2|PHASE3,,urinary_system_disease
5884,316,Prostate Cancer|Bladder Cancer|Kidney Cancer,Ferumoxytol,O[Fe]=O.O[Fe]=O.[Fe],PHASE2,,urinary_system_disease
5883,314,Advanced Cancer|Clear Cell Renal Cell Carcinoma,Cabozantinib,COC1=CC2=C(C=CN=C2C=C1OC)OC3=CC=C(C=C3)NC(=O)C4(CC4)C(=O)NC5=CC=C(C=C5)F,PHASE2,,urinary_system_disease
5882,306,"Bladder Cancer|Carcinoma, Transitional Cell|Renal Pelvis Cancer|Ureter Cancer|Urethra Cancer",Enzalutamide,CC1(C(=O)N(C(=S)N1C2=CC(=C(C=C2)C(=O)NC)F)C3=CC(=C(C=C3)C#N)C(F)(F)F)C,PHASE1,,urinary_system_disease
5881,305,Advanced Cancer|Gastric Adenocarcinoma|Gastroesophageal Junction Adenocarcinoma|Hepatocellular Cancer|Renal Cell Carcinoma|Non-Small Cell Lung Cancer,Ramucirumab,,PHASE1|PHASE2,,urinary_system_disease
5880,304,Advanced Cancer|Gastric Adenocarcinoma|Gastroesophageal Junction Adenocarcinoma|Hepatocellular Cancer|Renal Cell Carcinoma|Non-Small Cell Lung Cancer,Emibetuzumab,,PHASE1|PHASE2,,urinary_system_disease
5879,301,IGA Nephropathy,Valsartan,CCCCC(=O)N(CC1=CC=C(C=C1)C2=CC=CC=C2C3=NNN=N3)C(C(C)C)C(=O)O,APPROVED,,urinary_system_disease
5878,300,IGA Nephropathy,Enalapril,CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N2CCCC2C(=O)O,APPROVED,,urinary_system_disease
5877,299,Bladder Cancer,Durvalumab,,PHASE2,,urinary_system_disease
5876,291,Radiocontrast Nephropathy,Acetylcysteine,CC(=O)NC(CS)C(=O)O,PHASE2,,urinary_system_disease
5875,289,Spinal Cord Injury|Neurogenic Detrusor Overactivity,Trospium,C1CC[N+]2(C1)C3CCC2CC(C3)OC(=O)C(C4=CC=CC=C4)(C5=CC=CC=C5)O,APPROVED,,urinary_system_disease
5874,287,Urinary Tract Infections,Doripenem,CC1C2C(C(=O)N2C(=C1SC3CC(NC3)CNS(=O)(=O)N)C(=O)O)C(C)O,PHASE2,,urinary_system_disease
5873,284,"Kidney Failure, Chronic|End-Stage Renal Disease|Transplant Glomerulopathy|Transplant;Failure,Kidney|Kidney Transplant Failure and Rejection|Antibody-mediated Rejection|Kidney Transplant; Complications",Clazakizumab,,PHASE1|PHASE2,,urinary_system_disease
5872,277,Stage I Bladder Cancer|Stage II Bladder Cancer|Stage III Bladder Cancer,Catechin,C1C(C(OC2=CC(=CC(=C21)O)O)C3=CC(=C(C=C3)O)O)O,PHASE2,,urinary_system_disease
5871,276,Stage I Bladder Cancer|Stage II Bladder Cancer|Stage III Bladder Cancer,Cianidanol,C1C(C(OC2=CC(=CC(=C21)O)O)C3=CC(=C(C=C3)O)O)O,PHASE2,,urinary_system_disease
5870,275,Proteinuria,Calcitriol,CC(CCCC(C)(C)O)C1CCC2C1(CCCC2=CC=C3CC(CC(C3=C)O)O)C,APPROVED,,urinary_system_disease
5869,271,Renal Insufficiency|Kidney Diseases|Urologic Diseases,Mirodenafil,CCCC1=CN(C2=C1N=C(NC2=O)C3=C(C=CC(=C3)S(=O)(=O)N4CCN(CC4)CCO)OCCC)CC,PHASE1,,urinary_system_disease
5868,269,Menopausal Syndromes,Tibolone,CC1CC2=C(CCC(=O)C2)C3C1C4CCC(C4(CC3)C)(C#C)O,APPROVED,,urinary_system_disease
5867,265,Non Small-cell Lung Cancer|Renal-cell Cancer|Gastrointestinal Stroma Tumor,Midazolam,CC1=NC=C2N1C3=C(C=C(C=C3)Cl)C(=NC2)C4=CC=CC=C4F,APPROVED,,urinary_system_disease
5866,264,Non Small-cell Lung Cancer|Renal-cell Cancer|Gastrointestinal Stroma Tumor,Erlotinib,COCCOC1=C(C=C2C(=C1)C(=NC=N2)NC3=CC=CC(=C3)C#C)OCCOC,APPROVED,,urinary_system_disease
5865,260,Postoperative Pain|Renal Insufficiency|Myocardial Infarction,Ibuprofen,CC(C)CC1=CC=C(C=C1)C(C)C(=O)O,APPROVED,,urinary_system_disease
5864,259,Chronic Kidney Diseases,Colchicine,CC(=O)NC1CCC2=CC(=C(C(=C2C3=CC=C(C(=O)C=C13)OC)OC)OC)OC,PHASE2,,urinary_system_disease
5863,258,SGLT2 INHIBITORS|Lupus Nephritis|BMD,Dapagliflozin,CCOC1=CC=C(C=C1)CC2=C(C=CC(=C2)C3C(C(C(C(O3)CO)O)O)O)Cl,APPROVED,,urinary_system_disease
5862,257,Chronic Kidney Disease|End Stage Renal Disease|Anemia,Roxadustat,CC1=C2C=C(C=CC2=C(C(=N1)C(=O)NCC(=O)O)O)OC3=CC=CC=C3,PHASE2,,urinary_system_disease
5861,255,Renal Cell Carcinoma Metastatic,Abemaciclib,CCN1CCN(CC1)CC2=CN=C(C=C2)NC3=NC=C(C(=N3)C4=CC5=C(C(=C4)F)N=C(N5C(C)C)C)F,PHASE1,,urinary_system_disease
5860,251,"Kidney Failures, Acute",Furosemide,C1=COC(=C1)CNC2=CC(=C(C=C2C(=O)O)S(=O)(=O)N)Cl,APPROVED,,urinary_system_disease
5859,250,"Kidney Failures, Acute",Fenoldopam,C1CNCC(C2=CC(=C(C(=C21)Cl)O)O)C3=CC=C(C=C3)O,APPROVED,,urinary_system_disease
5858,249,Clear Cell Papillary Renal Neoplasm|Collecting Duct Carcinoma|Hereditary Leiomyomatosis and Renal Cell Carcinoma|Hereditary Papillary Renal Cell Carcinoma|Metastatic Renal Cell Carcinoma|Metastatic Unclassified Renal Cell Carcinoma|Papillary Renal Cell Carcinoma|Stage III Renal Cell Cancer American Joint Committee on Cancer (AJCC) v8|Stage IV Renal Cell Cancer AJCC v8|Tubulocystic Renal Cell Carcinoma|Unresectable Renal Cell Carcinoma,Temozolomide,CN1C(=O)N2C=NC(=C2N=N1)C(=O)N,PHASE2,,urinary_system_disease
5857,248,Clear Cell Papillary Renal Neoplasm|Collecting Duct Carcinoma|Hereditary Leiomyomatosis and Renal Cell Carcinoma|Hereditary Papillary Renal Cell Carcinoma|Metastatic Renal Cell Carcinoma|Metastatic Unclassified Renal Cell Carcinoma|Papillary Renal Cell Carcinoma|Stage III Renal Cell Cancer American Joint Committee on Cancer (AJCC) v8|Stage IV Renal Cell Cancer AJCC v8|Tubulocystic Renal Cell Carcinoma|Unresectable Renal Cell Carcinoma,Pamiparib,CC12CCCN1CC3=NNC(=O)C4=C5C3=C2NC5=CC(=C4)F,PHASE2,,urinary_system_disease
5856,243,Renal Impairment,Surufatinib,CC1=CC2=C(N1)C=CC(=C2)OC3=NC(=NC=C3)NC4=CC=CC(=C4)CS(=O)(=O)NCCN(C)C,PHASE1,,urinary_system_disease
5855,242,Stress Urinary Incontinence|Fecal Incontinence,Reboxetine,CCOC1=CC=CC=C1OC(C2CNCCO2)C3=CC=CC=C3,PHASE1,,urinary_system_disease
5854,241,Stress Urinary Incontinence|Fecal Incontinence,Citalopram,CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F,PHASE1,,urinary_system_disease
5853,236,Urethritis,Doxycycline,CC1C2C(C3C(C(=O)C(=C(C3(C(=O)C2=C(C4=C1C=CC=C4O)O)O)O)C(=O)N)N(C)C)O,PHASE2,,urinary_system_disease
5852,233,Urethritis,Tinidazole,CCS(=O)(=O)CCN1C(=NC=C1[N+](=O)[O-])C,PHASE2,,urinary_system_disease
5851,228,Chronic Kidney Disease|Type 2 Diabetes|Diabetic Nephropathy,Bardoxolone,CC1(CCC2(CCC3(C(C2C1)C(=O)C=C4C3(CCC5C4(C=C(C(=O)C5(C)C)C#N)C)C)C)C(=O)O)C,PHASE2,,urinary_system_disease
5850,225,Advanced Malignant Solid Neoplasm|Ann Arbor Stage III Hodgkin Lymphoma|Ann Arbor Stage III Non-Hodgkin Lymphoma|Ann Arbor Stage IV Hodgkin Lymphoma|Ann Arbor Stage IV Non-Hodgkin Lymphoma|Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor|Low Grade Glioma|Recurrent Ependymoma|Recurrent Ewing Sarcoma|Recurrent Glioma|Recurrent Hepatoblastoma|Recurrent Hodgkin Lymphoma|Recurrent Langerhans Cell Histiocytosis|Recurrent Malignant Germ Cell Tumor|Recurrent Malignant Glioma|Recurrent Malignant Solid Neoplasm|Recurrent Medulloblastoma|Recurrent Neuroblastoma|Recurrent Non-Hodgkin Lymphoma|Recurrent Osteosarcoma|Recurrent Peripheral Primitive Neuroectodermal Tumor|Recurrent Primary Central Nervous System Neoplasm|Recurrent Rhabdoid Tumor|Recurrent Rhabdomyosarcoma|Recurrent Soft Tissue Sarcoma|Refractory Hodgkin Lymphoma|Refractory Langerhans Cell Histiocytosis|Refractory Malignant Germ Cell Tumor|Refractory Malignant Glioma|Refractory Malignant Solid Neoplasm|Refractory Medulloblastoma|Refractory Neuroblastoma|Refractory Non-Hodgkin Lymphoma|Refractory Osteosarcoma|Refractory Peripheral Primitive Neuroectodermal Tumor|Refractory Rhabdoid Tumor|Refractory Soft Tissue Sarcoma|Rhabdoid Tumor|Stage III Soft Tissue Sarcoma AJCC v7|Stage IV Soft Tissue Sarcoma AJCC v7|Wilms Tumor,Tazemetostat,CCN(C1CCOCC1)C2=CC(=CC(=C2C)C(=O)NCC3=C(C=C(NC3=O)C)C)C4=CC=C(C=C4)CN5CCOCC5,PHASE2,,urinary_system_disease
5849,224,Kidney Diseases|Kidney Transplant,Sargramostim,,PHASE2,,urinary_system_disease
5848,223,Benign Prostatic Hyperplasia|Lower Urinary Tract Symptoms,Talaporfin,CCC1=C(C2=CC3=C(C(=C(N3)C=C4C(C(C(=N4)C(=C5C(=C(C(=N5)C=C1N2)C)C(=O)O)CC(=O)NC(CC(=O)O)C(=O)O)CCC(=O)O)C)C)C=C)C,PHASE1,,urinary_system_disease
5847,222,Hematopoietic and Lymphoid System Neoplasm|Recurrent Ependymoma|Recurrent Ewing Sarcoma|Recurrent Hepatoblastoma|Recurrent Histiocytic and Dendritic Cell Neoplasm|Recurrent Langerhans Cell Histiocytosis|Recurrent Lymphoma|Recurrent Malignant Germ Cell Tumor|Recurrent Malignant Glioma|Recurrent Malignant Solid Neoplasm|Recurrent Medulloblastoma|Recurrent Neuroblastoma|Recurrent Non-Hodgkin Lymphoma|Recurrent Osteosarcoma|Recurrent Peripheral Primitive Neuroectodermal Tumor|Recurrent Rhabdoid Tumor|Recurrent Rhabdomyosarcoma|Recurrent Soft Tissue Sarcoma|Recurrent WHO Grade 2 Glioma|Refractory Ependymoma|Refractory Ewing Sarcoma|Refractory Hepatoblastoma|Refractory Histiocytic and Dendritic Cell Neoplasm|Refractory Langerhans Cell Histiocytosis|Refractory Lymphoma|Refractory Malignant Germ Cell Tumor|Refractory Malignant Glioma|Refractory Malignant Solid Neoplasm|Refractory Medulloblastoma|Refractory Neuroblastoma|Refractory Non-Hodgkin Lymphoma|Refractory Osteosarcoma|Refractory Peripheral Primitive Neuroectodermal Tumor|Refractory Rhabdoid Tumor|Refractory Rhabdomyosarcoma|Refractory Soft Tissue Sarcoma|Refractory WHO Grade 2 Glioma|Wilms Tumor,Selpercatinib,CC(C)(COC1=CN2C(=C(C=N2)C#N)C(=C1)C3=CN=C(C=C3)N4CC5CC(C4)N5CC6=CN=C(C=C6)OC)O,PHASE2,,urinary_system_disease
5846,219,"Low Birthweight|Preterm Birth|Maternal; Malnutrition, Affecting Fetus|Sexually Transmitted Diseases|Urinary Tract Infections|Pregnancy and Infectious Disease",Azithromycin,CCC1C(C(C(N(CC(CC(C(C(C(C(C(=O)O1)C)OC2CC(C(C(O2)C)O)(C)OC)C)OC3C(C(CC(O3)C)N(C)C)O)(C)O)C)C)C)O)(C)O,APPROVED,,urinary_system_disease
5845,216,Healthy|Renal Impairment,Lacosamide,CC(=O)NC(COC)C(=O)NCC1=CC=CC=C1,PHASE1,,urinary_system_disease
5844,215,Diabetic Kidney Disease,Liraglutide,CCCCCCCCCCCCCCCC(=O)NC(CCC(=O)NCCCCC(C(=O)NC(CCC(=O)O)C(=O)NC(CC1=CC=CC=C1)C(=O)NC(C(C)CC)C(=O)NC(C)C(=O)NC(CC2=CNC3=CC=CC=C32)C(=O)NC(CC(C)C)C(=O)NC(C(C)C)C(=O)NC(CCCNC(=N)N)C(=O)NCC(=O)NC(CCCNC(=N)N)C(=O)NCC(=O)O)NC(=O)C(C)NC(=O)C(C)NC(=O)C(CCC(=O)N)NC(=O)CNC(=O)C(CCC(=O)O)NC(=O)C(CC(C)C)NC(=O)C(CC4=CC=C(C=C4)O)NC(=O)C(CO)NC(=O)C(CO)NC(=O)C(C(C)C)NC(=O)C(CC(=O)O)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C(CC5=CC=CC=C5)NC(=O)C(C(C)O)NC(=O)CNC(=O)C(CCC(=O)O)NC(=O)C(C)NC(=O)C(CC6=CN=CN6)N)C(=O)O,APPROVED,,urinary_system_disease
5843,213,Renal Cell Carcinoma|Metastatic Disease,Sorafenib,CNC(=O)C1=NC=CC(=C1)OC2=CC=C(C=C2)NC(=O)NC3=CC(=C(C=C3)Cl)C(F)(F)F,PHASE2,,urinary_system_disease
5842,211,"Neoplasm, Ureter|Neoplasm, Bladder",Epirubicin,CC1C(C(CC(O1)OC2CC(CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)(C(=O)CO)O)N)O,PHASE2,,urinary_system_disease
5841,208,Fecal Incontinence|Accidental Bowel Leakage|Anal Incontinence|Diarrhea|Urge Incontinence,Eluxadoline,CC1=CC(=CC(=C1CC(C(=O)N(CC2=CC(=C(C=C2)OC)C(=O)O)C(C)C3=NC=C(N3)C4=CC=CC=C4)N)C)C(=O)N,PHASE2,,urinary_system_disease
5840,207,Benign Prostatic Hyperplasia|Urinary Tract Infections,Ciprofloxacin,C1CC1N2C=C(C(=O)C3=CC(=C(C=C32)N4CCNCC4)F)C(=O)O,APPROVED,,urinary_system_disease
5839,205,Benign Prostatic Hyperplasia|Urinary Tract Infections,Sulfamethoxazole,CC1=CC(=NO1)NS(=O)(=O)C2=CC=C(C=C2)N,APPROVED,,urinary_system_disease
5838,201,Urinary Bladder Neoplasms,Paclitaxel,CC1=C2C(C(=O)C3(C(CC4C(C3C(C(C2(C)C)(CC1OC(=O)C(C(C5=CC=CC=C5)NC(=O)C6=CC=CC=C6)O)O)OC(=O)C7=CC=CC=C7)(CO4)OC(=O)C)O)C)OC(=O)C,PHASE2,,urinary_system_disease
5837,197,Renal Impairment,Tavapadon,CC1=C(C=CC(=C1)OC2=C(C=CC=N2)C(F)(F)F)C3=C(C(=O)NC(=O)N3C)C,PHASE1,,urinary_system_disease
5836,194,Ureteral Stone,Silodosin,CC(CC1=CC2=C(C(=C1)C(=O)N)N(CC2)CCCO)NCCOC3=CC=CC=C3OCC(F)(F)F,APPROVED,,urinary_system_disease
5835,193,"Kidney Failure, Chronic",Iodixanol,CC(=O)N(CC(CN(C1=C(C(=C(C(=C1I)C(=O)NCC(CO)O)I)C(=O)NCC(CO)O)I)C(=O)C)O)C2=C(C(=C(C(=C2I)C(=O)NCC(CO)O)I)C(=O)NCC(CO)O)I,APPROVED,,urinary_system_disease
5834,192,"Kidney Failure, Chronic",Iopromide,CN(CC(CO)O)C(=O)C1=C(C(=C(C(=C1I)C(=O)NCC(CO)O)I)NC(=O)COC)I,APPROVED,,urinary_system_disease
5833,191,Lupus Nephritis,Daratumumab,,PHASE2,,urinary_system_disease
5832,188,Muscle-invasive Transitional Cell Carcinoma of the Bladder,Pelareorep,,PHASE1,,urinary_system_disease
5831,185,IgA Nephropathy|Immunoglobulin A Nephropathy,Atrasentan,CCCCN(CCCC)C(=O)CN1CC(C(C1C2=CC=C(C=C2)OC)C(=O)O)C3=CC4=C(C=C3)OCO4,PHASE2,,urinary_system_disease
5830,184,Inflammatory Disease,Lanraplenib,C1CN(CCN1C2COC2)C3=CC=C(C=C3)NC4=NC(=CN5C4=NC=C5)C6=CN=CC(=N6)N,PHASE1,,urinary_system_disease
5829,183,Chronic Kidney Diseases,Baricitinib,CCS(=O)(=O)N1CC(C1)(CC#N)N2C=C(C=N2)C3=C4C=CNC4=NC=N3,PHASE2,,urinary_system_disease
5828,182,"Hypertension, Renal",Amlodipine,CCOC(=O)C1=C(NC(=C(C1C2=CC=CC=C2Cl)C(=O)OC)C)COCCN,APPROVED,,urinary_system_disease
5827,181,"Hypertension, Renal",Bisoprolol,CC(C)NCC(COC1=CC=C(C=C1)COCCOC(C)C)O,APPROVED,,urinary_system_disease
5826,180,Renal Impairment,Lorcaserin,CC1CNCCC2=C1C=C(C=C2)Cl,PHASE1,,urinary_system_disease
5825,178,"Carcinoma, Renal Cell",Lapatinib,CS(=O)(=O)CCNCC1=CC=C(O1)C2=CC3=C(C=C2)N=CN=C3NC4=CC(=C(C=C4)OCC5=CC(=CC=C5)F)Cl,PHASE1,,urinary_system_disease
5824,173,"Urinary Tract Infections, Recurrent",Cephalexin,CC1=C(N2C(C(C2=O)NC(=O)C(C3=CC=CC=C3)N)SC1)C(=O)O,APPROVED,,urinary_system_disease
5823,172,"Urinary Tract Infections, Recurrent",Trimethoprim,COC1=CC(=CC(=C1OC)OC)CC2=CN=C(N=C2N)N,APPROVED,,urinary_system_disease
5822,171,"Urinary Tract Infections, Recurrent",Nitrofurantoin,C1C(=O)NC(=O)N1N=CC2=CC=C(O2)[N+](=O)[O-],APPROVED,,urinary_system_disease
5821,170,Multiple Sclerosis|Overactive Detrusor,Darifenacin,C1CN(CC1C(C2=CC=CC=C2)(C3=CC=CC=C3)C(=O)N)CCC4=CC5=C(C=C4)OCC5,PHASE2,,urinary_system_disease
5820,169,Advanced Renal Cell Carcinoma,Trebananib,,PHASE2,,urinary_system_disease
5819,166,Migraine,Lasmiditan,CN1CCC(CC1)C(=O)C2=NC(=CC=C2)NC(=O)C3=C(C=C(C=C3F)F)F,PHASE1,,urinary_system_disease
5818,164,Bladder Cancer,Pembrolizumab,,PHASE2,,urinary_system_disease
5817,163,Autosomal Dominant Polycystic Kidney Disease,Tolvaptan,CC1=CC=CC=C1C(=O)NC2=CC(=C(C=C2)C(=O)N3CCCC(C4=C3C=CC(=C4)Cl)O)C,PHASE2,,urinary_system_disease
5816,160,Chronic Kidney Disease,Eplerenone,CC12CCC(=O)C=C1CC(C3C24C(O4)CC5(C3CCC56CCC(=O)O6)C)C(=O)OC,PHASE2,,urinary_system_disease
5815,158,"Clinical Trial, Phase I",Fulacimstat,CN1C2=C(C=C(C=C2)N3C=C(C(=O)N(C3=O)C4CCC5=C4C=CC=C5C(F)(F)F)C(=O)O)OC1=O,PHASE1,,urinary_system_disease
5814,154,Lupus Nephritis,Daxdilimab,,PHASE2,,urinary_system_disease
5813,152,Bladder Cancer,Dexamethasone,CC1CC2C3CCC4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)CO)O)C)O)F)C,PHASE2,,urinary_system_disease
5812,151,Bladder Cancer,Docetaxel,CC1=C2C(C(=O)C3(C(CC4C(C3C(C(C2(C)C)(CC1OC(=O)C(C(C5=CC=CC=C5)NC(=O)OC(C)(C)C)O)O)OC(=O)C6=CC=CC=C6)(CO4)OC(=O)C)O)C)O,PHASE2,,urinary_system_disease
5811,149,Renal Disease,Ceftaroline,CCON=C(C1=NSC(=N1)NP(=O)(O)O)C(=O)NC2C3N(C2=O)C(=C(CS3)SC4=NC(=CS4)C5=CC=[N+](C=C5)C)C(=O)[O-],PHASE1,,urinary_system_disease
5810,148,Hyperkalemia|End Stage Renal Disease,Patiromer,,APPROVED,,urinary_system_disease
5809,141,"Urge Incontinence|Urinary Incontinence, Urge",Mirabegron,C1=CC=C(C=C1)C(CNCCC2=CC=C(C=C2)NC(=O)CC3=CSC(=N3)N)O,APPROVED,,urinary_system_disease
5808,136,Bladder Cancer,Propranolol,CC(C)NCC(COC1=CC=CC2=CC=CC=C21)O,PHASE2,,urinary_system_disease
5807,130,Kidney Transplantation|Primary Focal Segmental Glomerulosclerosis (FSGS),Prednisone,CC12CC(=O)C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C,PHASE2,,urinary_system_disease
5806,129,Kidney Transplantation|Primary Focal Segmental Glomerulosclerosis (FSGS),Methylprednisone,CC1CC2C3CCC4=CC(=O)C=CC4(C3C(=O)CC2(C1(C(=O)CO)O)C)C,PHASE2,,urinary_system_disease
5805,128,Kidney Transplantation|Primary Focal Segmental Glomerulosclerosis (FSGS),Tacrolimus,CC1CC(C2C(CC(C(O2)(C(=O)C(=O)N3CCCCC3C(=O)OC(C(C(CC(=O)C(C=C(C1)C)CC=C)O)C)C(=CC4CCC(C(C4)OC)O)C)O)C)OC)OC,PHASE2,,urinary_system_disease
5804,127,Kidney Transplantation|Primary Focal Segmental Glomerulosclerosis (FSGS),Mycophenolate,CC1=C2COC(=O)C2=C(C(=C1OC)CC=C(C)CCC(=O)O)O,PHASE2,,urinary_system_disease
5803,126,Kidney Transplantation|Primary Focal Segmental Glomerulosclerosis (FSGS),Basiliximab,,PHASE2,,urinary_system_disease
5802,125,Kidney Transplantation|Primary Focal Segmental Glomerulosclerosis (FSGS),Bleselumab,,PHASE2,,urinary_system_disease
5801,124,Thrombotic Thrombocytopenic Purpura|Hemolytic Uremic Syndrome,Rituximab,,PHASE2,,urinary_system_disease
5800,123,Renal Cell Carcinoma,Sunitinib,CCN(CC)CCNC(=O)C1=C(NC(=C1C)C=C2C3=C(C=CC(=C3)F)NC2=O)C,PHASE2,,urinary_system_disease
5799,122,Renal Cell Carcinoma,Bevacizumab,,PHASE2,,urinary_system_disease
5798,121,Renal Cell Carcinoma,Atezolizumab,,PHASE2,,urinary_system_disease
5797,115,Overactive Bladder Syndrome|Urge Incontinence|Urinary Incontinence|Detrusor Hyperreflexia|Detrusor Instability,Phenazopyridine,C1=CC=C(C=C1)N=NC2=C(N=C(C=C2)N)N,APPROVED,,urinary_system_disease
5796,111,Pelvic Pain|Interstitial Cystitis|Bladder Diseases,Lidocaine,CCN(CC)CC(=O)NC1=C(C=CC=C1C)C,PHASE2,,urinary_system_disease
5795,110,Urinary Bladder Cancer,Panitumumab,,PHASE2,,urinary_system_disease
5794,109,Advanced Clear Cell Renal Cell Carcinoma,Avelumab,,PHASE2,,urinary_system_disease
5793,108,Advanced Clear Cell Renal Cell Carcinoma,Palbociclib,CC1=C(C(=O)N(C2=NC(=NC=C12)NC3=NC=C(C=C3)N4CCNCC4)C5CCCC5)C(=O)C,PHASE2,,urinary_system_disease
5792,104,Urinary Tract Infections,Methylthioninium,CN(C)C1=CC2=C(C=C1)N=C3C=CC(=[N+](C)C)C=C3S2,APPROVED,,urinary_system_disease
5791,103,Urinary Tract Infections,Methenamine,C1N2CN3CN1CN(C2)C3,APPROVED,,urinary_system_disease
5790,102,Metastatic Clear Cell Renal Cancer,Everolimus,CC1CCC2CC(C(=CC=CC=CC(CC(C(=O)C(C(C(=CC(C(=O)CC(OC(=O)C3CCCCN3C(=O)C(=O)C1(O2)O)C(C)CC4CCC(C(C4)OC)OCCO)C)C)O)OC)C)C)C)OC,PHASE1,,urinary_system_disease
5789,101,Metastatic Clear Cell Renal Cancer,Dovitinib,CN1CCN(CC1)C2=CC3=C(C=C2)N=C(N3)C4=C(C5=C(C=CC=C5F)NC4=O)N,PHASE1,,urinary_system_disease
5788,100,Lupus Nephritis,Methylprednisolone,CC1CC2C3CCC(C3(CC(C2C4(C1=CC(=O)C=C4)C)O)C)(C(=O)CO)O,APPROVED,,urinary_system_disease
5787,99,Lupus Nephritis,Azathioprine,CN1C=NC(=C1SC2=NC=NC3=C2NC=N3)[N+](=O)[O-],APPROVED,,urinary_system_disease
5786,98,Lupus Nephritis,Cyclophosphamide,C1CNP(=O)(OC1)N(CCCl)CCCl,APPROVED,,urinary_system_disease
5785,96,"Infections, Bacterial",Gepotidacin,C1CC2=CC(=NC=C2OC1)CNC3CCN(CC3)CC4CN5C(=O)C=CC6=C5N4C(=O)C=N6,PHASE1,,urinary_system_disease
5784,95,Cancer|Cisplatin Adverse Reaction,Cisplatin,N.N.Cl[Pt]Cl,PHASE2|PHASE3,,urinary_system_disease
5783,94,Cancer|Cisplatin Adverse Reaction,Gemigliptin,C1CC(CN(C1=O)CC(CC(=O)N2CCC3=C(C2)N=C(N=C3C(F)(F)F)C(F)(F)F)N)(F)F,PHASE2|PHASE3,,urinary_system_disease
5782,93,Overactive Bladder,Oxybutynin,CCN(CC)CC#CCOC(=O)C(C1CCCCC1)(C2=CC=CC=C2)O,APPROVED,,urinary_system_disease
5781,92,Overactive Bladder,Solifenacin,C1CN2CCC1C(C2)OC(=O)N3CCC4=CC=CC=C4C3C5=CC=CC=C5,APPROVED,,urinary_system_disease
5780,88,Lower Urinary Tract Symptoms|Voiding Disorders|Pain|Quality of Life,Tadalafil,CN1CC(=O)N2C(C1=O)CC3=C(C2C4=CC5=C(C=C4)OCO5)NC6=CC=CC=C36,APPROVED,,urinary_system_disease
5779,87,Secondary Hyperparathyroidism,Cinacalcet,CC(C1=CC=CC2=CC=CC=C21)NCCCC3=CC(=CC=C3)C(F)(F)F,PHASE2|PHASE3,,urinary_system_disease
5778,86,Breast Cancer|Lung Cancer|Colon Cancer|Pancreatic Cancer|Head and Neck Cancer|Kidney Cancer|Sarcoma|Hepatocellular Cancer,Ixabepilone,CC1CCCC2(C(O2)CC(NC(=O)CC(C(C(=O)C(C1O)C)(C)C)O)C(=CC3=CSC(=N3)C)C)C,PHASE1,,urinary_system_disease
5777,85,Breast Cancer|Lung Cancer|Colon Cancer|Pancreatic Cancer|Head and Neck Cancer|Kidney Cancer|Sarcoma|Hepatocellular Cancer,Pazopanib,CC1=C(C=C(C=C1)NC2=NC=CC(=N2)N(C)C3=CC4=NN(C(=C4C=C3)C)C)S(=O)(=O)N,PHASE1,,urinary_system_disease
5776,83,Healthy|Renal Insufficiency,Erythromycin,CCC1C(C(C(C(=O)C(CC(C(C(C(C(C(=O)O1)C)OC2CC(C(C(O2)C)O)(C)OC)C)OC3C(C(CC(O3)C)N(C)C)O)(C)O)C)C)O)(C)O,PHASE1,,urinary_system_disease
5775,81,Healthy|Renal Insufficiency,Rivaroxaban,C1COCC(=O)N1C2=CC=C(C=C2)N3CC(OC3=O)CNC(=O)C4=CC=C(S4)Cl,PHASE1,,urinary_system_disease
5774,77,Chronic Kidney Disease,Isoquercetin,C1=CC(=C(C=C1C2=C(C(=O)C3=C(C=C(C=C3O2)O)O)OC4C(C(C(C(O4)CO)O)O)O)O)O,PHASE2,,urinary_system_disease
5773,74,Renal Cell Carcinoma,Axitinib,CNC(=O)C1=CC=CC=C1SC2=CC3=C(C=C2)C(=NN3)C=CC4=CC=CC=N4,PHASE1,,urinary_system_disease
5772,73,Cerebral Infarction,Kallidinogenase,,PHASE2,,urinary_system_disease
5771,68,Urothelial Carcinoma|Bladder Cancer,Ipilimumab,,PHASE2,,urinary_system_disease
5770,66,Kidney Cancer,Perflutren,C(C(F)(F)F)(C(F)(F)F)(F)F,PHASE2,,urinary_system_disease
5769,64,"Kidney Failure, Chronic|Disorder of Vitamin D",Calcifediol,CC(CCCC(C)(C)O)C1CCC2C1(CCCC2=CC=C3CC(CCC3=C)O)C,APPROVED,,urinary_system_disease
5768,57,Neurogenic Detrusor Overactivity,Fesoterodine,CC(C)C(=O)OC1=C(C=C(C=C1)CO)C(CCN(C(C)C)C(C)C)C2=CC=CC=C2,PHASE1,,urinary_system_disease
5767,56,Complicated Urinary Tract Infection|Pyelonephritis,Meropenem,CC1C2C(C(=O)N2C(=C1SC3CC(NC3)C(=O)N(C)C)C(=O)O)C(C)O,PHASE2,,urinary_system_disease
5766,55,Complicated Urinary Tract Infection|Pyelonephritis,Tazobactam,CC1(C(N2C(S1(=O)=O)CC2=O)C(=O)O)CN3C=CN=N3,PHASE2,,urinary_system_disease
5765,54,Complicated Urinary Tract Infection|Pyelonephritis,Ceftolozane,CC(C)(C(=O)O)ON=C(C1=NSC(=N1)N)C(=O)NC2C3N(C2=O)C(=C(CS3)C[N+]4=CC(=C(N4C)N)NC(=O)NCCN)C(=O)[O-],PHASE2,,urinary_system_disease
5764,53,Acute Kidney Injury,Dexmedetomidine,CC1=C(C(=CC=C1)C(C)C2=CN=CN2)C,PHASE2|PHASE3,,urinary_system_disease
5763,51,Metastatic Kidney Medullary Carcinoma|Metastatic Renal Cell Carcinoma|SMARCB1 Negative|Stage III Renal Cell Cancer AJCC v8|Stage IV Renal Cell Cancer AJCC v8,Ixazomib,B(C(CC(C)C)NC(=O)CNC(=O)C1=C(C=CC(=C1)Cl)Cl)(O)O,PHASE2,,urinary_system_disease
5762,47,Metastatic Kidney Medullary Carcinoma|Metastatic Renal Cell Carcinoma|SMARCB1 Negative|Stage III Renal Cell Cancer AJCC v8|Stage IV Renal Cell Cancer AJCC v8,Doxorubicin,CC1C(C(CC(O1)OC2CC(CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)(C(=O)CO)O)N)O,PHASE2,,urinary_system_disease
5761,46,Urinary Retention Postoperative,Tamsulosin,CCOC1=CC=CC=C1OCCNC(C)CC2=CC(=C(C=C2)OC)S(=O)(=O)N,PHASE2,,urinary_system_disease
5760,44,IGA Nephropathy,Fostamatinib,CC1(C(=O)N(C2=C(O1)C=CC(=N2)NC3=NC(=NC=C3F)NC4=CC(=C(C(=C4)OC)OC)OC)COP(=O)(O)O)C,PHASE2,,urinary_system_disease
5759,41,Renal Impairment,Gabapentin,C1CCC(CC1)(CC(=O)O)CN,APPROVED,,urinary_system_disease
5758,38,Advanced Cancer|Malignant Neoplasm of Breast|Malignant Neoplasms of Bone and Articular Cartilage|Malignant Neoplasms of Digestive Organs|Malignant Neoplasms of Eye Brain and Other Parts of Central Nervous System|Malignant Neoplasms of Female Genital Organs|Malignant Neoplasms of Ill-defined Secondary and Unspecified Sites|Malignant Neoplasms of Independent (Primary) Multiple Sites|Malignant Neoplasms of Lip Oral Cavity and Pharynx|Malignant Neoplasms of Male Genital Organs|Malignant Neoplasms of Mesothelial and Soft Tissue|Malignant Neoplasms of Respiratory and Intrathoracic Organs|Malignant Neoplasms of Thyroid and Other Endocrine Glands|Malignant Neoplasms of Urinary Tract,Capecitabine,CCCCCOC(=O)NC1=NC(=O)N(C=C1F)C2C(C(C(O2)C)O)O,PHASE1,,urinary_system_disease
5757,37,Advanced Cancer|Malignant Neoplasm of Breast|Malignant Neoplasms of Bone and Articular Cartilage|Malignant Neoplasms of Digestive Organs|Malignant Neoplasms of Eye Brain and Other Parts of Central Nervous System|Malignant Neoplasms of Female Genital Organs|Malignant Neoplasms of Ill-defined Secondary and Unspecified Sites|Malignant Neoplasms of Independent (Primary) Multiple Sites|Malignant Neoplasms of Lip Oral Cavity and Pharynx|Malignant Neoplasms of Male Genital Organs|Malignant Neoplasms of Mesothelial and Soft Tissue|Malignant Neoplasms of Respiratory and Intrathoracic Organs|Malignant Neoplasms of Thyroid and Other Endocrine Glands|Malignant Neoplasms of Urinary Tract,Lenvatinib,COC1=CC2=NC=CC(=C2C=C1C(=O)N)OC3=CC(=C(C=C3)NC(=O)NC4CC4)Cl,PHASE1,,urinary_system_disease
5756,30,Chronic Kidney Disease,Atorvastatin,CC(C)C1=C(C(=C(N1CCC(CC(CC(=O)O)O)O)C2=CC=C(C=C2)F)C3=CC=CC=C3)C(=O)NC4=CC=CC=C4,APPROVED,,urinary_system_disease
5755,29,Neurogenic Bladder|Catheter-Related Infections,Octenidine,CCCCCCCCN=C1C=CN(C=C1)CCCCCCCCCCN2C=CC(=NCCCCCCCC)C=C2,PHASE2|PHASE3,,urinary_system_disease
5754,28,Secondary Hyperparathyroidism in Patients With ESRD on Hemodialysis,Etelcalcetide,CC(C(=O)NC(CCCN=C(N)N)C(=O)N)NC(=O)C(CCCN=C(N)N)NC(=O)C(CCCN=C(N)N)NC(=O)C(CCCN=C(N)N)NC(=O)C(C)NC(=O)C(CSSCC(C(=O)O)N)NC(=O)C,PHASE1,,urinary_system_disease
5753,27,"Urinary Bladder, Overactive",Tolterodine,CC1=CC(=C(C=C1)O)C(CCN(C(C)C)C(C)C)C2=CC=CC=C2,PHASE2,,urinary_system_disease
5752,26,"Urinary Bladder, Overactive",Vibegron,C1CC(NC1CC2=CC=C(C=C2)NC(=O)C3CCC4=NC=CC(=O)N34)C(C5=CC=CC=C5)O,PHASE2,,urinary_system_disease
5751,25,End-Stage Renal Disease,Carnitine,C[N+](C)(C)CC(CC(=O)[O-])O,PHASE2,,urinary_system_disease
5750,24,End-Stage Renal Disease,Levocarnitine,C[N+](C)(C)CC(CC(=O)[O-])O,PHASE2,,urinary_system_disease
5749,23,Bladder Pain Syndrome,Gefapixant,CC(C)C1=CC(=C(C=C1OC2=CN=C(N=C2N)N)S(=O)(=O)N)OC,PHASE2,,urinary_system_disease
5748,22,Chronic Kidney Disease,Paricalcitol,CC(C=CC(C)C(C)(C)O)C1CCC2C1(CCCC2=CC=C3CC(CC(C3)O)O)C,APPROVED,,urinary_system_disease
5747,17,Type 1 Diabetes|Diabetic Kidney Disease|Cardiovascular Diseases|Endothelial Dysfunction|Insulin Sensitivity,Iohexol,CC(=O)N(CC(CO)O)C1=C(C(=C(C(=C1I)C(=O)NCC(CO)O)I)C(=O)NCC(CO)O)I,PHASE1,,urinary_system_disease
5746,16,Type 1 Diabetes|Diabetic Kidney Disease|Cardiovascular Diseases|Endothelial Dysfunction|Insulin Sensitivity,Metformin,CN(C)C(=N)N=C(N)N,PHASE1,,urinary_system_disease
5745,13,"Urethral Neoplasms|Neoplasms, Urethral|Cancer of the Urethra|Urethral Cancer",Lenalidomide,C1CC(=O)NC(=O)C1N2CC3=C(C2=O)C=CC=C3N,PHASE1,,urinary_system_disease
5744,12,"Urethral Neoplasms|Neoplasms, Urethral|Cancer of the Urethra|Urethral Cancer",Carboplatin,C1CC(C1)(C(=O)O)C(=O)O.[NH2-].[NH2-].[Pt+2],PHASE1,,urinary_system_disease
5743,11,"Urethral Neoplasms|Neoplasms, Urethral|Cancer of the Urethra|Urethral Cancer",Gemcitabine,C1=CN(C(=O)N=C1N)C2C(C(C(O2)CO)O)(F)F,PHASE1,,urinary_system_disease
5742,8,Low Risk Prostate Cancer,Padeliporfin,CCC1C(C2=CC3=NC(=C(C3=C(C)[O-])C)C=C4C(C(C(=N4)C(=C5C(=C(C(=N5)C=C1N2)C)C(=NCCS(=O)(=O)O)[O-])CC(=O)OC)CCC(=O)O)C)C.[Pd+2],APPROVED,,urinary_system_disease
5741,5,Nephrolithiasis,Ketorolac,C1CN2C(=CC=C2C(=O)C3=CC=CC=C3)C1C(=O)O,APPROVED,,urinary_system_disease
5740,4,Nephrolithiasis,Oxycodone,CN1CCC23C4C(=O)CCC2(C1CC5=C3C(=C(C=C5)OC)O4)O,APPROVED,,urinary_system_disease
5739,3,"Urinary Bladder Cancer|Bladder Tumors|Transitional Cell Carcinoma of the Bladder|Malignant Melanoma|Melanoma|Skin Cancer|Carcinoma, Non-Small-Cell Lung|Lung Cancer",Ciclosporin,CCC1C(=O)N(CC(=O)N(C(C(=O)NC(C(=O)N(C(C(=O)NC(C(=O)NC(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N1)C(C(C)CC=CC)O)C)C(C)C)C)CC(C)C)C)CC(C)C)C)C)C)CC(C)C)C)C(C)C)CC(C)C)C)C,PHASE1,,urinary_system_disease
5738,2,"Urinary Bladder Cancer|Bladder Tumors|Transitional Cell Carcinoma of the Bladder|Malignant Melanoma|Melanoma|Skin Cancer|Carcinoma, Non-Small-Cell Lung|Lung Cancer",Chloroquine,CCN(CC)CCCC(C)NC1=C2C=CC(=CC2=NC=C1)Cl,PHASE1,,urinary_system_disease
5737,1,"Urinary Bladder Cancer|Bladder Tumors|Transitional Cell Carcinoma of the Bladder|Malignant Melanoma|Melanoma|Skin Cancer|Carcinoma, Non-Small-Cell Lung|Lung Cancer",Nivolumab,,PHASE1,,urinary_system_disease
5736,0,"Advanced Solid Tumors|Solid Tumor|Solid Carcinoma|Solid Tumor, Adult|ccRCC|RCC, Clear Cell Adenocarcinoma|RCC|Kidney Cancer|Clear Cell Renal Cell Carcinoma|Renal Cell Carcinoma, Metastatic|Renal Cell Carcinoma Recurrent|Renal Cell Carcinoma, Clear Cell Adenocarcinoma|Glioblastoma|Glioblastoma, Adult|GBM|Glioblastoma Multiforme",Belzutifan,CS(=O)(=O)C1=C2C(C(C(C2=C(C=C1)OC3=CC(=CC(=C3)C#N)F)F)F)O,PHASE1,,urinary_system_disease
5730,455,Systemic Sclerosis,Fibrinolysin,,PHASE2,,skin_and_connective_tissue_disease
5728,451,Systemic Lupus Erythematosus,Epratuzumab,,PHASE1,,skin_and_connective_tissue_disease
5727,447,Carney Complex|Chondrosarcoma|Gastrointestinal Stromal Tumor|Paraganglioma,Linsitinib,CC1(CC(C1)C2=NC(=C3N2C=CN=C3N)C4=CC5=C(C=C4)C=CC(=N5)C6=CC=CC=C6)O,PHASE2,,skin_and_connective_tissue_disease
5726,442,Diffuse Cutaneous Systemic Sclerosis,Teprotumumab,,PHASE1,,skin_and_connective_tissue_disease
5722,417,"Lipomatosis, Multiple Symmetrical",Metreleptin,,PHASE1,,skin_and_connective_tissue_disease
5716,397,Localized Scleroderma,Dupilumab,,PHASE2,,skin_and_connective_tissue_disease
5711,359,Idiopathic Pulmonary Fibrosis|Systemic Sclerosis With Lung Involvement,Vixarelimab,,PHASE2,,skin_and_connective_tissue_disease
5710,358,"Lupus Erythematosus, Discoid|Lupus Erythematosus, Subacute Cutaneous",Deucravacitinib,CNC(=O)C1=NN=C(C=C1NC2=CC=CC(=C2OC)C3=NN(C=N3)C)NC(=O)C4CC4,PHASE2,,skin_and_connective_tissue_disease
5709,356,Rheumatoid Arthritis|Psoriatic Arthritis|Ankylosing Spondylitis|Hypertension,Certolizumab,,APPROVED,,skin_and_connective_tissue_disease
5706,349,Interstitial Lung Disease|Scleroderma|Pulmonary Hypertension,Macitentan,CCCNS(=O)(=O)NC1=C(C(=NC=N1)OCCOC2=NC=C(C=N2)Br)C3=CC=C(C=C3)Br,PHASE2|PHASE3,,skin_and_connective_tissue_disease
5703,323,MSI-H Colorectal Cancer|Melanoma|Anal Carcinoma|Mesothelioma|Triple Negative Breast Cancer|Lung Adenocarcinoma|Cholangiocarcinoma|Cervical Carcinoma|Kidney Clear Cell Carcinoma|Stomach Adenocarcinoma|Esophageal Adenocarcinoma|Uterine Adenocarcinoma|Head and Neck Squamous Cell Carcinoma|Sarcoma|Lung Squamous Cell Carcinoma|Urothelial Carcinoma|Thyroid Carcinoma|Hepatocellular Carcinoma|Uveal Melanoma|HER2-positive Breast Cancer|Pancreatic Adenocarcinoma|Squamous Esophageal Carcinoma|Epithelial Ovarian Cancer|Uterine Carcinosarcoma|Small Cell Lung Cancer|Hormone Receptor Positive / HER2-negative Breast Cancer|Lung Adenocarcinoma EGFR-mutated/ ALK Traslocation|Colorectal Adenocarcinoma|Prostate Adenocarcinoma|Carcinoma of Unknown Primary|Other Histology,Spartalizumab,,PHASE2,,skin_and_connective_tissue_disease
5701,317,Raynaud's Phenomenon Secondary to Systemic Sclerosis,Selexipag,CC(C)N(CCCCOCC(=O)NS(=O)(=O)C)C1=CN=C(C(=N1)C2=CC=CC=C2)C3=CC=CC=C3,PHASE2,,skin_and_connective_tissue_disease
5699,311,"Breast Cancer|Ovarian Epithelial Cancer Recurrent|Sarcoma|Non-small Cell Lung Cancer|Carcinoma, Transitional Cell|Prostate Cancer|Prostatic Neoplasms",Mifepristone,CC#CC1(CCC2C1(CC(C3=C4CCC(=O)C=C4CCC23)C5=CC=C(C=C5)N(C)C)C)O,PHASE1,,skin_and_connective_tissue_disease
5698,309,Epidermolysis Bullosa Dystrophica|Squamous Cell Carcinoma,Rigosertib,COC1=C(C=C(C=C1)CS(=O)(=O)C=CC2=C(C=C(C=C2OC)OC)OC)NCC(=O)O,PHASE1|PHASE2,,skin_and_connective_tissue_disease
5693,288,Advanced Solid Tumors|HR+ Breast Cancer|CCNE1 Amplification|HER2-negative Breast Cancer|Ovarian Cancer|Endometrial Cancer|Gastric Cancer|Esophageal Adenocarcinoma|Carcinosarcoma,Ribociclib,CN(C)C(=O)C1=CC2=CN=C(N=C2N1C3CCCC3)NC4=NC=C(C=C4)N5CCNCC5,PHASE1|PHASE2,,skin_and_connective_tissue_disease
5691,283,Systemic Sclerosis,Itacitinib,C1CN(CCC1N2CC(C2)(CC#N)N3C=C(C=N3)C4=C5C=CNC5=NC=N4)C(=O)C6=C(C(=NC=C6)C(F)(F)F)F,PHASE2,,skin_and_connective_tissue_disease
5690,280,Diffuse Cutaneous Systemic Sclerosis,Belumosudil,CC(C)NC(=O)COC1=CC=CC(=C1)C2=NC3=CC=CC=C3C(=N2)NC4=CC5=C(C=C4)NN=C5,PHASE2,,skin_and_connective_tissue_disease
5686,272,"Breast Neoplasm|Head and Neck Neoplasm|Skin Neoplasm|Respiratory Tract Neoplasm|Urogenital Neoplasm|Digestive System Neoplasm|Pancreatic Neoplasm|Connective and Soft Tissue Neoplasm|Lymphoma, Non-Hodgkin",Tenatumomab,,PHASE1,,skin_and_connective_tissue_disease
5684,268,Systemic Sclerosis-associated Interstitial Lung Disease,Abituzumab,,PHASE2,,skin_and_connective_tissue_disease
5680,250,"Skin Infections, Bacterial",Retapamulin,CC1CCC23CCC(=O)C2C1(C(CC(C(C3C)O)(C)C=C)OC(=O)CSC4CC5CCC(C4)N5C)C,PHASE1,,skin_and_connective_tissue_disease
5677,241,Skin and Connective Tissue Diseases,Betamethasone,CC1CC2C3CCC4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)CO)O)C)O)F)C,PHASE1,,skin_and_connective_tissue_disease
5676,237,Breast Neoplasms|Breast Cancer|Breast Tumors|Angiosarcoma|TNBC - Triple-Negative Breast Cancer|HER2-positive Breast Cancer|HER2-negative Breast Cancer|Hormone Receptor Positive Tumor|Hormone Receptor Negative Tumor|Early-stage Breast Cancer|Locally Advanced Breast Cancer,Lasofoxifene,C1CCN(C1)CCOC2=CC=C(C=C2)C3C(CCC4=C3C=CC(=C4)O)C5=CC=CC=C5,PHASE2,,skin_and_connective_tissue_disease
5675,236,Breast Neoplasms|Breast Cancer|Breast Tumors|Angiosarcoma|TNBC - Triple-Negative Breast Cancer|HER2-positive Breast Cancer|HER2-negative Breast Cancer|Hormone Receptor Positive Tumor|Hormone Receptor Negative Tumor|Early-stage Breast Cancer|Locally Advanced Breast Cancer,Zanidatamab,,PHASE2,,skin_and_connective_tissue_disease
5668,222,Breast Neoplasms|Breast Cancer|Breast Tumors|Angiosarcoma|TNBC - Triple-Negative Breast Cancer|HER2-positive Breast Cancer|HER2-negative Breast Cancer|Hormone Receptor Positive Tumor|Hormone Receptor Negative Tumor|Early-stage Breast Cancer|Locally Advanced Breast Cancer,Tucatinib,CC1=C(C=CC(=C1)NC2=NC=NC3=C2C=C(C=C3)NC4=NC(CO4)(C)C)OC5=CC6=NC=NN6C=C5,PHASE2,,skin_and_connective_tissue_disease
5666,216,Breast Neoplasms|Breast Cancer|Breast Tumors|Angiosarcoma|TNBC - Triple-Negative Breast Cancer|HER2-positive Breast Cancer|HER2-negative Breast Cancer|Hormone Receptor Positive Tumor|Hormone Receptor Negative Tumor|Early-stage Breast Cancer|Locally Advanced Breast Cancer,Patritumab,,PHASE2,,skin_and_connective_tissue_disease
5663,212,Breast Neoplasms|Breast Cancer|Breast Tumors|Angiosarcoma|TNBC - Triple-Negative Breast Cancer|HER2-positive Breast Cancer|HER2-negative Breast Cancer|Hormone Receptor Positive Tumor|Hormone Receptor Negative Tumor|Early-stage Breast Cancer|Locally Advanced Breast Cancer,Neratinib,CCOC1=C(C=C2C(=C1)N=CC(=C2NC3=CC(=C(C=C3)OCC4=CC=CC=N4)Cl)C#N)NC(=O)C=CCN(C)C,PHASE2,,skin_and_connective_tissue_disease
5662,211,Breast Neoplasms|Breast Cancer|Breast Tumors|Angiosarcoma|TNBC - Triple-Negative Breast Cancer|HER2-positive Breast Cancer|HER2-negative Breast Cancer|Hormone Receptor Positive Tumor|Hormone Receptor Negative Tumor|Early-stage Breast Cancer|Locally Advanced Breast Cancer,Ganetespib,CC(C)C1=C(C=C(C(=C1)C2=NNC(=O)N2C3=CC4=C(C=C3)N(C=C4)C)O)O,PHASE2,,skin_and_connective_tissue_disease
5659,204,Breast Neoplasms|Breast Cancer|Breast Tumors|Angiosarcoma|TNBC - Triple-Negative Breast Cancer|HER2-positive Breast Cancer|HER2-negative Breast Cancer|Hormone Receptor Positive Tumor|Hormone Receptor Negative Tumor|Early-stage Breast Cancer|Locally Advanced Breast Cancer,Ganitumab,,PHASE2,,skin_and_connective_tissue_disease
5655,193,Systemic Sclerosis,Nilotinib,CC1=C(C=C(C=C1)C(=O)NC2=CC(=CC(=C2)C(F)(F)F)N3C=C(N=C3)C)NC4=NC=CC(=N4)C5=CN=CC=C5,PHASE2,,skin_and_connective_tissue_disease
5654,192,Community Acquired Pneumonia|Staphylococcal Skin Infections,Friulimicin B,CC1C(C(=O)N2CCCCC2C(=O)NC(C(=O)NC(C(=O)NCC(=O)NC(C(=O)NCC(=O)NC(C(=O)NC(C(=O)N3CCCC3C(=O)N1)C(C)C)C(C)N)CC(=O)O)CC(=O)O)C(C)C(=O)O)NC(=O)C(CC(=O)N)NC(=O)CC=CCCCCCCCC(C)C,PHASE1,,skin_and_connective_tissue_disease
5648,165,Infectious Skin Diseases|Bacterial Skin Diseases|Staphylococcal Skin Infections|Streptococcal Infections|Abscess,Linezolid,CC(=O)NCC1CN(C(=O)O1)C2=CC(=C(C=C2)N3CCOCC3)F,PHASE2,,skin_and_connective_tissue_disease
5647,163,Infectious Skin Diseases|Bacterial Skin Diseases|Staphylococcal Skin Infections|Streptococcal Infections|Abscess,Radezolid,CC(=O)NCC1CN(C(=O)O1)C2=CC(=C(C=C2)C3=CC=C(C=C3)CNCC4=NNN=C4)F,PHASE2,,skin_and_connective_tissue_disease
5646,159,Rheumatoid Arthritis|Psoriatic Arthritis|Spondylarthritis,Ixekizumab,,APPROVED,,skin_and_connective_tissue_disease
5644,157,Rheumatoid Arthritis|Psoriatic Arthritis|Spondylarthritis,Canakinumab,,APPROVED,,skin_and_connective_tissue_disease
5643,155,Rheumatoid Arthritis|Psoriatic Arthritis|Spondylarthritis,Secukinumab,,APPROVED,,skin_and_connective_tissue_disease
5642,153,Rheumatoid Arthritis|Psoriatic Arthritis|Spondylarthritis,Upadacitinib,CCC1CN(CC1C2=CN=C3N2C4=C(NC=C4)N=C3)C(=O)NCC(F)(F)F,APPROVED,,skin_and_connective_tissue_disease
5640,143,Skin Infection,Dalbavancin,CC(C)CCCCCCCCC(=O)NC1C(C(C(OC1OC2=C3C=C4C=C2OC5=C(C=C(C=C5)C(C6C(=O)NC(C7=C(C(=CC(=C7)O)OC8C(C(C(C(O8)CO)O)O)O)C9=C(C=CC(=C9)C(C(=O)N6)NC(=O)C4NC(=O)C1C2=C(C(=CC(=C2)OC2=C(C=CC(=C2)C(C(=O)NC(CC2=CC=C(O3)C=C2)C(=O)N1)NC)O)O)Cl)O)C(=O)NCCCN(C)C)O)Cl)C(=O)O)O)O,APPROVED,,skin_and_connective_tissue_disease
5638,138,Discoid Lupus Erythematosus,Delgocitinib,CC1CN(C12CCN(C2)C3=NC=NC4=C3C=CN4)C(=O)CC#N,PHASE2,,skin_and_connective_tissue_disease
5629,116,Epidermolysis Bullosa (EB)|Epidermolysis Bullosa Simplex|Dystrophic Epidermolysis Bullosa|Junctional Epidermolysis Bullosa,Diacerein,CC(=O)OC1=CC=CC2=C1C(=O)C3=C(C2=O)C=C(C=C3OC(=O)C)C(=O)O,PHASE1,,skin_and_connective_tissue_disease
5628,114,Immune Thrombocytopenia|Autoantibodies|Evan Syndrome|Connective Tissue Diseases,Avatrombopag,C1CCC(CC1)N2CCN(CC2)C3=C(N=C(S3)NC(=O)C4=CC(=C(N=C4)N5CCC(CC5)C(=O)O)Cl)C6=CC(=CS6)Cl,APPROVED,,skin_and_connective_tissue_disease
5623,91,Cellulitis|Wound Infection|Abscess,Penicillin V,CC1(C(N2C(S1)C(C2=O)NC(=O)COC3=CC=CC=C3)C(=O)O)C,APPROVED,,skin_and_connective_tissue_disease
5620,87,Small-cell Lung Cancer|Soft Tissue Sarcoma|Triple-negative Breast Cancer|Ovarian Cancer|Endometrial Cancer,Tinostamustine,CN1C2=C(C=C(C=C2)N(CCCl)CCCl)N=C1CCCCCCC(=O)NO,PHASE1|PHASE2,,skin_and_connective_tissue_disease
5618,85,"Lupus Erythematosus, Cutaneous",Alitretinoin,CC1=C(C(CCC1)(C)C)C=CC(=CC=CC(=CC(=O)O)C)C,PHASE2,,skin_and_connective_tissue_disease
5615,77,Anatomic Stage IV Breast Cancer AJCC v8|Clinical Stage IV Gastroesophageal Junction Adenocarcinoma AJCC v8|Clinical Stage IVA Gastroesophageal Junction Adenocarcinoma AJCC v8|Clinical Stage IVB Gastroesophageal Junction Adenocarcinoma AJCC v8|Locally Advanced Malignant Solid Neoplasm|Locally Advanced Melanoma|Locally Advanced Primary Malignant Central Nervous System Neoplasm|Locally Advanced Sarcoma|Metastatic Malignant Solid Neoplasm|Metastatic Melanoma|Metastatic Primary Malignant Central Nervous System Neoplasm|Metastatic Sarcoma|Pathologic Stage IV Gastroesophageal Junction Adenocarcinoma AJCC v8|Pathologic Stage IVA Gastroesophageal Junction Adenocarcinoma AJCC v8|Pathologic Stage IVB Gastroesophageal Junction Adenocarcinoma AJCC v8|Postneoadjuvant Therapy Stage IV Gastroesophageal Junction Adenocarcinoma AJCC v8|Postneoadjuvant Therapy Stage IVA Gastroesophageal Junction Adenocarcinoma AJCC v8|Postneoadjuvant Therapy Stage IVB Gastroesophageal Junction Adenocarcinoma AJCC v8|Prognostic Stage IIIC Breast Cancer AJCC v8|Prognostic Stage IV Breast Cancer AJCC v8|Stage IIIC Colorectal Cancer AJCC v8|Stage IIIC Lung Cancer AJCC v8|Stage IV Colorectal Cancer AJCC v8|Stage IV Lung Cancer AJCC v8|Stage IVA Colorectal Cancer AJCC v8|Stage IVA Lung Cancer AJCC v8|Stage IVB Colorectal Cancer AJCC v8|Stage IVB Lung Cancer AJCC v8|Stage IVC Colorectal Cancer AJCC v8,Avapritinib,CC(C1=CC=C(C=C1)F)(C2=CN=C(N=C2)N3CCN(CC3)C4=NC=NN5C4=CC(=C5)C6=CN(N=C6)C)N,PHASE2,,skin_and_connective_tissue_disease
5597,50,Liposarcoma|CRC|Prostate Cancer|Breast Neoplasms|Adenocarcinoma of Lung|Solid Tumors,Fulvestrant,CC12CCC3C(C1CCC2O)C(CC4=C3C=CC(=C4)O)CCCCCCCCCS(=O)CCCC(C(F)(F)F)(F)F,PHASE1|PHASE2,,skin_and_connective_tissue_disease
5596,49,Liposarcoma|CRC|Prostate Cancer|Breast Neoplasms|Adenocarcinoma of Lung|Solid Tumors,Letrozole,C1=CC(=CC=C1C#N)C(C2=CC=C(C=C2)C#N)N3C=NC=N3,PHASE1|PHASE2,,skin_and_connective_tissue_disease
5594,47,"Pulmonary Fibrosis|Scleroderma, Systemic",Bosentan,CC(C)(C)C1=CC=C(C=C1)S(=O)(=O)NC2=C(C(=NC(=N2)C3=NC=CC=N3)OCCO)OC4=CC=CC=C4OC,PHASE2|PHASE3,,skin_and_connective_tissue_disease
5587,39,Scleroderma,Calcipotriene,CC(C=CC(C1CC1)O)C2CCC3C2(CCCC3=CC=C4CC(CC(C4=C)O)O)C,PHASE1,,skin_and_connective_tissue_disease
5586,38,Scleroderma,Calcipotriol,CC(C=CC(C1CC1)O)C2CCC3C2(CCCC3=CC=C4CC(CC(C4=C)O)O)C,PHASE1,,skin_and_connective_tissue_disease
5585,37,Scleroderma,Clobetasol,CC1CC2C3CCC4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)CCl)O)C)O)F)C,PHASE1,,skin_and_connective_tissue_disease
5583,35,Digital Ulcer of Scleroderma,Diltiazem,CC(=O)OC1C(SC2=CC=CC=C2N(C1=O)CCN(C)C)C3=CC=C(C=C3)OC,PHASE2,,skin_and_connective_tissue_disease
5580,26,"Juvenile Psoriatic Arthritis|Psoriasis|Arthritis, Juvenile",Ustekinumab,,PHASE1,,skin_and_connective_tissue_disease
5573,13,"Arthritis, Rheumatoid",Cantharidin,CC12C3CCC(C1(C(=O)OC2=O)C)O3,PHASE1,,skin_and_connective_tissue_disease
5571,11,Skin Infection|Bacterial Infection,Brilacidin,C1CNCC1OC2=C(C=C(C=C2NC(=O)C3=CC(=NC=N3)C(=O)NC4=CC(=CC(=C4OC5CCNC5)NC(=O)CCCCN=C(N)N)C(F)(F)F)C(F)(F)F)NC(=O)CCCCN=C(N)N,PHASE2,,skin_and_connective_tissue_disease
5566,5,Polymyalgia Rheumatica|Effect of Drug|Safety Issues,Tofacitinib,CC1CCN(CC1N(C)C2=NC=NC3=C2C=CN3)C(=O)CC#N,PHASE2,,skin_and_connective_tissue_disease
5560,13356,Multiple Myeloma,Teclistamab,,PHASE2,,nervous_system_disease
5559,13323,Agitation,Asenapine,CN1CC2C(C1)C3=C(C=CC(=C3)Cl)OC4=CC=CC=C24,APPROVED,,nervous_system_disease
5558,13264,Cerebral Palsy|Excessive Crying|Pain,Trihexyphenidyl,C1CCC(CC1)C(CCN2CCCCC2)(C3=CC=CC=C3)O,APPROVED,,nervous_system_disease
5557,13085,Relapsing Multiple Sclerosis,Fenebrutinib,CC1CN(CCN1C2=CN=C(C=C2)NC3=CC(=CN(C3=O)C)C4=C(C(=NC=C4)N5CCN6C7=C(CC(C7)(C)C)C=C6C5=O)CO)C8COC8,PHASE2,,nervous_system_disease
5556,12933,DIPG,Omburtamab,,PHASE1,,nervous_system_disease
5554,12902,"Stroke, Acute|Stroke, Ischemic",Glenzocimab,,PHASE2|PHASE3,,nervous_system_disease
5552,12847,Nausea|Vomiting|Vertigo,Dimenhydrinate,CN1C2=C(C(=O)N(C1=O)C)NC(=N2)Cl.CN(C)CCOC(C1=CC=CC=C1)C2=CC=CC=C2,APPROVED,,nervous_system_disease
5551,12845,Mitochondrial Diseases,Bezafibrate,CC(C)(C(=O)O)OC1=CC=C(C=C1)CCNC(=O)C2=CC=C(C=C2)Cl,PHASE2,,nervous_system_disease
5549,12752,"Hepatic Encephalopathy|Cirrhosis, Liver",Rifamycin,CC1C=CC=C(C(=O)NC2=CC(=C3C(=C2O)C(=C(C4=C3C(=O)C(O4)(OC=CC(C(C(C(C(C(C1O)C)O)C)OC(=O)C)C)OC)C)C)O)O)C,PHASE2,,nervous_system_disease
5548,12664,Parkinson Disease,Gemfibrozil,CC1=CC(=C(C=C1)C)OCCCC(C)(C)C(=O)O,PHASE2,,nervous_system_disease
5546,12601,Hydromorphone|Analgesia|ICU,Butorphanol,C1CCC2(C3CC4=C(C2(C1)CCN3CC5CCC5)C=C(C=C4)O)O,APPROVED,,nervous_system_disease
5545,12582,Primary Insomnia|Chronic Insomnia,Chamomile,C1=CC(=CC=C1C2=CC(=O)C3=C(C=C(C=C3O2)O)O)O,PHASE2,,nervous_system_disease
5544,12543,Duchenne Muscular Dystrophy,Pamrevlumab,,PHASE2,,nervous_system_disease
5543,12524,Normal Tension Glaucoma|Ocular Hypertension,Travoprost,CC(C)OC(=O)CCCC=CCC1C(CC(C1C=CC(COC2=CC=CC(=C2)C(F)(F)F)O)O)O,APPROVED,,nervous_system_disease
5542,12496,"Ischemic Stroke, Acute",Sarecycline,CN(C)C1C2CC3CC4=C(C=CC(=C4C(=C3C(=O)C2(C(=C(C1=O)C(=O)N)O)O)O)O)CN(C)OC,PHASE2,,nervous_system_disease
5541,12488,Neuropathic Pain,Priralfinamide,CC(C(=O)N)NCC1=CC=C(C=C1)OCC2=CC=CC=C2F,PHASE2,,nervous_system_disease
5540,12480,"Diffuse Intrinsic Pontine Glioma|Diffuse Midline Glioma, H3 K27M-Mutant",Zalifrelimab,,PHASE1,,nervous_system_disease
5537,12459,Parkinson's Disease|Dyskinesia,Eltoprazine,C1CN(CCN1)C2=C3C(=CC=C2)OCCO3,PHASE2,,nervous_system_disease
5536,12439,Parkinson Disease,Repaglinide,CCOC1=C(C=CC(=C1)CC(=O)NC(CC(C)C)C2=CC=CC=C2N3CCCCC3)C(=O)O,PHASE1,,nervous_system_disease
5535,12332,Acute Gout Flare|Gout Attack|Gout Flare|Gouty Arthritis|Gout|Arthritis|Joint Pain,Dapansutrile,CS(=O)(=O)CCC#N,PHASE2|PHASE3,,nervous_system_disease
5534,12313,Alzheimer's Disease,Tilavonemab,,PHASE2,,nervous_system_disease
5533,12306,"Gaucher Disease, Type 1|Type 1 Gaucher Disease|Gaucher Disease",Afegostat,C1C(C(C(CN1)O)O)CO,PHASE2,,nervous_system_disease
5532,12298,Amyotrophic Lateral Sclerosis,Nitrofurazone,C1=C(OC(=C1)[N+](=O)[O-])C=NNC(=O)N,PHASE2,,nervous_system_disease
5531,12297,Amyotrophic Lateral Sclerosis,Nitrofural,C1=C(OC(=C1)[N+](=O)[O-])C=NNC(=O)N,PHASE2,,nervous_system_disease
5530,12291,Systemic Lupus Erythematosus,Sifalimumab,,PHASE2,,nervous_system_disease
5529,12285,Cerebral Venous Sinus Thrombosis|Batroxobin,Batroxobin,,APPROVED,,nervous_system_disease
5527,12208,Tinnitus,Vestipitant,CC1=C(C=CC(=C1)F)C2CNCCN2C(=O)N(C)C(C)C3=CC(=CC(=C3)C(F)(F)F)C(F)(F)F,PHASE2,,nervous_system_disease
5524,12138,Corneal Abrasion,Tetracaine,CCCCNC1=CC=C(C=C1)C(=O)OCCN(C)C,PHASE2|PHASE3,,nervous_system_disease
5523,12097,Secondary Progressive Multiple Sclerosis,Baminercept,,PHASE1|PHASE2,,nervous_system_disease
5522,12082,Asthma|Chronic Obstructive Pulmonary Disease|Obstructive Sleep Apnea,Fluticasone,CC1CC2C3CC(C4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)SCF)O)C)O)F)C)F,APPROVED,,nervous_system_disease
5520,12005,"Stroke, Ischemic",Olmesartan,CCCC1=NC(=C(N1CC2=CC=C(C=C2)C3=CC=CC=C3C4=NNN=N4)C(=O)O)C(C)(C)O,PHASE2,,nervous_system_disease
5515,11790,Alzheimer Disease (AD),Zagotenemab,,PHASE2,,nervous_system_disease
5514,11785,Stroke,Protein C,,PHASE2,,nervous_system_disease
5513,11762,Postthoracotomy Pain|Postthoracoscopy Neuropathic Pain,Terbutaline,CC(C)(C)NCC(C1=CC(=CC(=C1)O)O)O,PHASE2,,nervous_system_disease
5511,11722,Movement Disorders|Parkinson Disease,Eliprodil,C1CN(CCC1CC2=CC=C(C=C2)F)CC(C3=CC=C(C=C3)Cl)O,PHASE2,,nervous_system_disease
5510,11703,Depression|Psychosis|Anhedonia,Raclopride,CCN1CCCC1CNC(=O)C2=C(C(=CC(=C2OC)Cl)Cl)O,APPROVED,,nervous_system_disease
5509,11606,Insulin Resistance|Healthy|Obesity,Phentolamine,CC1=CC=C(C=C1)N(CC2=NCCN2)C3=CC(=CC=C3)O,PHASE1,,nervous_system_disease
5506,11503,Parkinson's Disease,Tozadenant,CC1(CCN(CC1)C(=O)NC2=NC3=C(C=CC(=C3S2)N4CCOCC4)OC)O,PHASE2,,nervous_system_disease
5505,11428,Meningioma,Alpelisib,CC1=C(SC(=N1)NC(=O)N2CCCC2C(=O)N)C3=CC(=NC=C3)C(C)(C)C(F)(F)F,PHASE1,,nervous_system_disease
5504,11385,Multiple Sclerosis,Temelimab,,PHASE2,,nervous_system_disease
5503,11382,Parkinson Disease,Radotinib,CC1=C(C=C(C=C1)C(=O)NC2=CC(=CC(=C2)C(F)(F)F)N3C=C(N=C3)C)NC4=NC=CC(=N4)C5=NC=CN=C5,PHASE2,,nervous_system_disease
5502,11363,Spinobulbar Muscular Atrophy|Kennedy's Disease,Goserelin,CC(C)CC(C(=O)NC(CCCN=C(N)N)C(=O)N1CCCC1C(=O)NNC(=O)N)NC(=O)C(COC(C)(C)C)NC(=O)C(CC2=CC=C(C=C2)O)NC(=O)C(CO)NC(=O)C(CC3=CNC4=CC=CC=C43)NC(=O)C(CC5=CN=CN5)NC(=O)C6CCC(=O)N6,APPROVED,,nervous_system_disease
5501,11356,Delayed Onset Muscle Soreness,Loxoprofen,CC(C1=CC=C(C=C1)CC2CCCC2=O)C(=O)O,PHASE2,,nervous_system_disease
5500,11351,Alzheimer's Disease,Rilapladib,COCCN1CCC(CC1)N(CC2=CC=C(C=C2)C3=CC=C(C=C3)C(F)(F)F)C(=O)CN4C5=CC=CC=C5C(=O)C=C4SCC6=C(C(=CC=C6)F)F,PHASE1,,nervous_system_disease
5497,11173,Cushing Disease,Seliciclib,CCC(CO)NC1=NC(=C2C(=N1)N(C=N2)C(C)C)NCC3=CC=CC=C3,PHASE2,,nervous_system_disease
5496,11130,Obsessive-Compulsive Disorder,Clomipramine,CN(C)CCCN1C2=CC=CC=C2CCC3=C1C=C(C=C3)Cl,PHASE2,,nervous_system_disease
5495,11096,Fibromyalgia|Chronic Fatigue Syndrome|Multiple Sclerosis|Healthy,Oxyquinoline,C1=CC2=C(C(=C1)O)N=CC=C2,PHASE1,,nervous_system_disease
5493,11041,Coronary Artery Disease|Carotid Artery Diseases|Atherosclerosis,Colesevelam,CCCCCCCCCCNCC=C.C[N+](C)(C)CCCCCCNCC=C.C=CCN.C1C(O1)CCl.Cl.[Cl-],APPROVED,,nervous_system_disease
5492,11016,Hematopoietic and Lymphoid Cell Neoplasm|Malignant Solid Neoplasm|Metastatic Malignant Neoplasm in the Brain,Ropidoxuridine,C1C(C(OC1N2C=C(C=NC2=O)I)CO)O,PHASE1,,nervous_system_disease
5491,10995,Parkinson Disease|Excessive Daytime Somnolence,Valiloxybate,CC(C)C(C(=O)OCCCC(=O)O)N,PHASE2,,nervous_system_disease
5490,10974,Acute Migraine,Zavegepant,CC1=CC(=CC2=C1NN=C2)CC(C(=O)N3CCN(CC3)C4CCN(CC4)C)NC(=O)N5CCC(CC5)C6=CC7=CC=CC=C7NC6=O,PHASE2|PHASE3,,nervous_system_disease
5488,10855,Parkinson Disease,Lisuride,CCN(CC)C(=O)NC1CN(C2CC3=CNC4=CC=CC(=C34)C2=C1)C,PHASE2,,nervous_system_disease
5487,10832,MItochondrial Myopathies,Omaveloxolone,CC1(CCC2(CCC3(C(C2C1)C(=O)C=C4C3(CCC5C4(C=C(C(=O)C5(C)C)C#N)C)C)C)NC(=O)C(C)(F)F)C,PHASE2,,nervous_system_disease
5486,10785,Parkinson Disease Psychosis,Iloperidone,CC(=O)C1=CC(=C(C=C1)OCCCN2CCC(CC2)C3=NOC4=C3C=CC(=C4)F)OC,PHASE2,,nervous_system_disease
5485,10708,Temporomandibular Joint Disorders|Temporomandibular Joint Dysfunction Syndrome|Temporomandibular Joint Pain,Nimesulide,CS(=O)(=O)NC1=C(C=C(C=C1)[N+](=O)[O-])OC2=CC=CC=C2,PHASE2,,nervous_system_disease
5484,10692,Idiopathic Hypersomnia,Pentetrazol,C1CCC2=NN=NN2CC1,PHASE2,,nervous_system_disease
5483,10677,Familial Dysautonomia,Kinetin,C1=COC(=C1)CNC2=NC=NC3=C2NC=N3,PHASE1,,nervous_system_disease
5482,10665,Alzheimer's Disease,Verubecestat,CC1(CS(=O)(=O)N(C(=N1)N)C)C2=C(C=CC(=C2)NC(=O)C3=NC=C(C=C3)F)F,PHASE2|PHASE3,,nervous_system_disease
5481,10628,ALS (Amyotrophic Lateral Sclerosis),Lunasine,CC(C)C1CC2=C(C3=C(C(=CC=C3)OC)[N+](=C2O1)C)OC,PHASE2,,nervous_system_disease
5477,10451,Hearing Loss,Ofloxacin,CC1COC2=C3N1C=C(C(=O)C3=CC(=C2N4CCN(CC4)C)F)C(=O)O,PHASE1,,nervous_system_disease
5476,10415,Post-dural Puncture Headache,Cosyntropin,CC(C)C(C(=O)NCC(=O)NC(CCCCN)C(=O)NC(CCCCN)C(=O)NC(CCCNC(=N)N)C(=O)NC(CCCNC(=N)N)C(=O)N1CCCC1C(=O)NC(C(C)C)C(=O)NC(CCCCN)C(=O)NC(C(C)C)C(=O)NC(CC2=CC=C(C=C2)O)C(=O)N3CCCC3C(=O)O)NC(=O)C4CCCN4C(=O)C(CCCCN)NC(=O)CNC(=O)C(CC5=CNC6=CC=CC=C65)NC(=O)C(CCCNC(=N)N)NC(=O)C(CC7=CC=CC=C7)NC(=O)C(CC8=CNC=N8)NC(=O)C(CCC(=O)O)NC(=O)C(CCSC)NC(=O)C(CO)NC(=O)C(CC9=CC=C(C=C9)O)NC(=O)C(CO)N,PHASE2,,nervous_system_disease
5475,10414,Post-dural Puncture Headache,Tetracosactide,CC(C)C(C(=O)NCC(=O)NC(CCCCN)C(=O)NC(CCCCN)C(=O)NC(CCCNC(=N)N)C(=O)NC(CCCNC(=N)N)C(=O)N1CCCC1C(=O)NC(C(C)C)C(=O)NC(CCCCN)C(=O)NC(C(C)C)C(=O)NC(CC2=CC=C(C=C2)O)C(=O)N3CCCC3C(=O)O)NC(=O)C4CCCN4C(=O)C(CCCCN)NC(=O)CNC(=O)C(CC5=CNC6=CC=CC=C65)NC(=O)C(CCCNC(=N)N)NC(=O)C(CC7=CC=CC=C7)NC(=O)C(CC8=CNC=N8)NC(=O)C(CCC(=O)O)NC(=O)C(CCSC)NC(=O)C(CO)NC(=O)C(CC9=CC=C(C=C9)O)NC(=O)C(CO)N,PHASE2,,nervous_system_disease
5474,10405,Fabry Disease,Lucerastat,CCCCN1CC(C(C(C1CO)O)O)O,PHASE1,,nervous_system_disease
5473,10395,Ischemic Stroke|Post-stroke Cognitive Impairment,Cromolyn,C1=CC2=C(C(=C1)OCC(COC3=CC=CC4=C3C(=O)C=C(O4)C(=O)O)O)C(=O)C=C(O2)C(=O)O,PHASE2,,nervous_system_disease
5472,10364,Osteogenesis Imperfecta,Risedronate,C1=CC(=CN=C1)CC(O)(P(=O)(O)O)P(=O)(O)O,APPROVED,,nervous_system_disease
5471,10331,Diabetic Gastroparesis,Nimacimab,,PHASE2,,nervous_system_disease
5469,10274,Carotid Disease|Atherosclerosis,Menaquinone,,PHASE2,,nervous_system_disease
5468,10263,Apnea|Snoring,Polidocanol,CCCCCCCCCCCCOCCOCCOCCOCCOCCOCCOCCOCCOCCO,PHASE1|PHASE2,,nervous_system_disease
5466,10194,Endometriosis|Pelvic Pain,Raloxifene,C1CCN(CC1)CCOC2=CC=C(C=C2)C(=O)C3=C(SC4=C3C=CC(=C4)O)C5=CC=C(C=C5)O,PHASE2,,nervous_system_disease
5465,10193,"Dermatomyositis, Adult Type",Apremilast,CCOC1=C(C=CC(=C1)C(CS(=O)(=O)C)N2C(=O)C3=C(C2=O)C(=CC=C3)NC(=O)C)OC,PHASE2,,nervous_system_disease
5463,10171,"Influenza, Human|Arthralgia",Zanamivir,CC(=O)NC1C(C=C(OC1C(C(CO)O)O)C(=O)O)N=C(N)N,PHASE2,,nervous_system_disease
5462,10142,Stroke,Enecadin,CC1=NC(=CC(=N1)OCCCCCN2CCCCC2)C3=CC=C(C=C3)F,PHASE2,,nervous_system_disease
5460,10132,Diffuse Intrinsic Pontine Glioma|Progressive or Refractory High-Grade Glioma,Crenolanib,CC1(COC1)COC2=CC3=C(C=C2)N(C=N3)C4=NC5=C(C=CC=C5N6CCC(CC6)N)C=C4,PHASE1,,nervous_system_disease
5459,10078,Post Operative Analgesia,Nefopam,CN1CCOC(C2=CC=CC=C2C1)C3=CC=CC=C3,APPROVED,,nervous_system_disease
5457,10068,Post Acute Sequelae Covid-19 Hyposmia,Beclomethasone,CC1CC2C3CCC4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)CO)O)C)O)Cl)C,PHASE2,,nervous_system_disease
5456,10027,Parosmia,Ivermectin,CCC(C)C1C(CCC2(O1)CC3CC(O2)CC=C(C(C(C=CC=C4COC5C4(C(C=C(C5O)C)C(=O)O3)O)C)OC6CC(C(C(O6)C)OC7CC(C(C(O7)C)O)OC)OC)C)C,PHASE2,,nervous_system_disease
5455,10022,Parkinsons Disease,Prasinezumab,,PHASE2,,nervous_system_disease
5454,10011,Chronic Stable Angina,Capadenoson,C1=CC(=CC=C1C2=C(C(=NC(=C2C#N)SCC3=CSC(=N3)C4=CC=C(C=C4)Cl)N)C#N)OCCO,PHASE2,,nervous_system_disease
5453,9891,Breast Cancer|Chronic Pain Due to Malignancy (Finding),Sulfasalazine,C1=CC=NC(=C1)NS(=O)(=O)C2=CC=C(C=C2)N=NC3=CC(=C(C=C3)O)C(=O)O,PHASE2,,nervous_system_disease
5452,9878,Gastroparesis,Naronapride,COC1CN(CCC1NC(=O)C2=CC(=C(C=C2OC)N)Cl)CCCCCC(=O)OC3CN4CCC3CC4,PHASE2,,nervous_system_disease
5451,9827,Insomnia Disorder,Cannabinol,CCCCCC1=CC(=C2C(=C1)OC(C3=C2C=C(C=C3)C)(C)C)O,PHASE1|PHASE2,,nervous_system_disease
5449,9814,Diabetic Neuropathy,Ruboxistaurin,CN(C)CC1CCN2C=C(C3=CC=CC=C32)C4=C(C5=CN(CCO1)C6=CC=CC=C65)C(=O)NC4=O,PHASE2,,nervous_system_disease
5447,9736,X-Linked Adrenoleukodystrophy|Adrenomyeloneuropathy,Sobetirome,CC1=CC(=CC(=C1CC2=CC(=C(C=C2)O)C(C)C)C)OCC(=O)O,PHASE1,,nervous_system_disease
5446,9708,"Candidiasis, Systemic|Candida Meningitis",Micafungin,CCCCCOC1=CC=C(C=C1)C2=CC(=NO2)C3=CC=C(C=C3)C(=O)NC4CC(C(NC(=O)C5C(C(CN5C(=O)C(NC(=O)C(NC(=O)C6CC(CN6C(=O)C(NC4=O)C(C)O)O)C(C(C7=CC(=C(C=C7)O)OS(=O)(=O)O)O)O)C(CC(=O)N)O)C)O)O)O,PHASE2,,nervous_system_disease
5445,9689,Multiple Sclerosis,Nerispirdine,CCCN(C1=C(C=NC=C1)F)N2C=C(C3=CC=CC=C32)C,PHASE2,,nervous_system_disease
5444,9667,Acute Ischaemic Middle Cerebral Artery Stroke,Piracetam,C1CC(=O)N(C1)CC(=O)N,APPROVED,,nervous_system_disease
5442,9625,Delirium,Zotepine,CN(C)CCOC1=CC2=CC=CC=C2SC3=C1C=C(C=C3)Cl,APPROVED,,nervous_system_disease
5441,9620,Gastroparesis,Granisetron,CN1C2CCCC1CC(C2)NC(=O)C3=NN(C4=CC=CC=C43)C,PHASE2,,nervous_system_disease
5440,9613,Type 2 Diabetic Peripheral Neuropathy (DPN),Metanx,,APPROVED,,nervous_system_disease
5439,9581,Stroke,Desmoteplase,,PHASE2,,nervous_system_disease
5438,9517,Idiopathic Hypersomnia|Narcolepsy,Xywav,,APPROVED,,nervous_system_disease
5435,9398,DYT-1|Dystonia,Ampicillin,CC1(C(N2C(S1)C(C2=O)NC(=O)C(C3=CC=CC=C3)N)C(=O)O)C,PHASE1,,nervous_system_disease
5434,9387,Secondary-progressive Multiple Sclerosis,Siponimod,CCC1=C(C=CC(=C1)C(=NOCC2=CC(=C(C=C2)C3CCCCC3)C(F)(F)F)C)CN4CC(C4)C(=O)O,PHASE2|PHASE3,,nervous_system_disease
5433,9366,Angina|Coronary Disease,Tmr,,PHASE2,,nervous_system_disease
5432,9362,Down Syndrome|Recurrent B Acute Lymphoblastic Leukemia,Thioguanine,C1=NC2=C(N1)C(=S)N=C(N2)N,PHASE2,,nervous_system_disease
5431,9361,Down Syndrome|Recurrent B Acute Lymphoblastic Leukemia,Tioguanine,C1=NC2=C(N1)C(=S)N=C(N2)N,PHASE2,,nervous_system_disease
5430,9360,Down Syndrome|Recurrent B Acute Lymphoblastic Leukemia,Pegaspargase,CC1=CC(=C(C=C1)C(=O)C(=C)CN(C)C)C,PHASE2,,nervous_system_disease
5429,9322,Parkinson Disease,Mesdopetam,CCCNCCOC1=CC(=CC(=C1)S(=O)(=O)C)F,PHASE2,,nervous_system_disease
5427,9284,Neuralgia,Carfentanil,CCC(=O)N(C1=CC=CC=C1)C2(CCN(CC2)CCC3=CC=CC=C3)C(=O)OC,PHASE2,,nervous_system_disease
5425,9245,Narcolepsy With Cataplexy|Narcolepsy|Narcolepsy Without Cataplexy,Mazindol,C1CN2C(=N1)C3=CC=CC=C3C2(C4=CC=C(C=C4)Cl)O,PHASE2,,nervous_system_disease
5423,9109,Knee Osteoarthritis|Arthroplasty Complications|Postoperative Pain,Meloxicam,CC1=CN=C(S1)NC(=O)C2=C(C3=CC=CC=C3S(=O)(=O)N2C)O,APPROVED,,nervous_system_disease
5422,9088,Mitochondrial Diseases|Mitochondrial DNA tRNALeu(UUR) m.3243A<G Mutation|MELAS|Subacute Necrotizing Encephalomyelopathy,Sonlicromanol,CC1=C(C2=C(CCC(O2)(C)C(=O)NC3CCCNC3)C(=C1O)C)C,PHASE2,,nervous_system_disease
5421,9071,Fragile X Syndrome,Arbaclofen,C1=CC(=CC=C1C(CC(=O)O)CN)Cl,PHASE2,,nervous_system_disease
5419,9060,Down Syndrome|Acute Lymphoblastic Leukemia|Childhood Cancer,Mercaptopurine,C1=NC2=C(N1)C(=S)N=CN2,PHASE2,,nervous_system_disease
5417,9056,Down Syndrome|Acute Lymphoblastic Leukemia|Childhood Cancer,Daunorubicin,CC1C(C(CC(O1)OC2CC(CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)(C(=O)C)O)N)O,PHASE2,,nervous_system_disease
5415,8995,Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP),Rozanolixizumab,,PHASE2,,nervous_system_disease
5414,8984,Amyotrophic Lateral Sclerosis,Ozanezumab,,PHASE2,,nervous_system_disease
5412,8910,Patient-Controlled Analgesia,Dezocine,CC12CCCCCC(C1N)CC3=C2C=C(C=C3)O,APPROVED,,nervous_system_disease
5411,8909,"Muscular Dystrophy, Duchenne",Oxatomide,C1CN(CCN1CCCN2C3=CC=CC=C3NC2=O)C(C4=CC=CC=C4)C5=CC=CC=C5,PHASE2,,nervous_system_disease
5410,8906,"Chronic Migraine, Headache|Overuse Headache Medication",Cannabigerol,CCCCCC1=CC(=C(C(=C1)O)CC=C(C)CCC=C(C)C)O,APPROVED,,nervous_system_disease
5409,8902,Alzheimer's Disease,Piromelatine,COC1=CC2=C(C=C1)NC=C2CCNC(=O)C3=CC(=O)C=CO3,PHASE2|PHASE3,,nervous_system_disease
5408,8869,Relapsing-remitting Multiple Sclerosis,Vatelizumab,,PHASE2,,nervous_system_disease
5405,8827,Brain Metastases,Endostar,CN(CC(=O)C1=CC=CC=C1)N=O,PHASE2,,nervous_system_disease
5404,8794,Alzheimer Disease,Medroxyprogesterone,CC1CC2C(CCC3(C2CCC3(C(=O)C)O)C)C4(C1=CC(=O)CC4)C,PHASE2|PHASE3,,nervous_system_disease
5402,8779,FAP|Familial Amyloid Polyneuropathy|TTR|Transthyretin|Amyloidosis,Inotersen,CC1=CN(C(=O)NC1=O)C2CC(C(O2)COP(=S)(O)OC3CC(OC3COP(=S)(O)OC4CC(OC4COP(=S)(O)OC5C(OC(C5OCCOC)N6C=NC7=C6N=C(NC7=O)N)COP(=S)(O)OC8C(OC(C8OCCOC)N9C=C(C(=O)NC9=O)C)COP(=S)(O)OC1C(OC(C1OCCOC)N1C=C(C(=O)NC1=O)C)COP(=O)(OC1C(OC(C1OCCOC)N1C=C(C(=NC1=O)N)C)COP(=S)(O)OC1C(OC(C1OCCOC)N1C=C(C(=O)NC1=O)C)CO)S)N1C=NC2=C1N=C(NC2=O)N)N1C=C(C(=O)NC1=O)C)OP(=S)(O)OCC1C(CC(O1)N1C=NC2=C(N=CN=C21)N)OP(=S)(O)OCC1C(CC(O1)N1C=C(C(=NC1=O)N)C)OP(=S)(O)OCC1C(CC(O1)N1C=NC2=C(N=CN=C21)N)OP(=S)(O)OCC1C(CC(O1)N1C=C(C(=O)NC1=O)C)OP(=S)(O)OCC1C(CC(O1)N1C=NC2=C1N=C(NC2=O)N)OP(=S)(O)OCC1C(CC(O1)N1C=NC2=C(N=CN=C21)N)OP(=S)(O)OCC1C(CC(O1)N1C=NC2=C(N=CN=C21)N)OP(=S)(O)OCC1C(C(C(O1)N1C=NC2=C(N=CN=C21)N)OCCOC)OP(=S)(O)OCC1C(C(C(O1)N1C=C(C(=O)NC1=O)C)OCCOC)OP(=S)(O)OCC1C(C(C(O1)N1C=C(C(=NC1=O)N)C)OCCOC)OP(=S)(O)OCC1C(C(C(O1)N1C=C(C(=NC1=O)N)C)OCCOC)OP(=S)(O)OCC1C(C(C(O1)N1C=C(C(=NC1=O)N)C)OCCOC)O,PHASE2|PHASE3,,nervous_system_disease
5401,8739,Asymptomatic Amyloid-positive,Atabecestat,CC1(C=CSC(=N1)N)C2=C(C=CC(=C2)NC(=O)C3=NC=C(C=C3)C#N)F,PHASE2|PHASE3,,nervous_system_disease
5400,8688,Migraine,Naratriptan,CNS(=O)(=O)CCC1=CC2=C(C=C1)NC=C2C3CCN(CC3)C,PHASE1|PHASE2,,nervous_system_disease
5399,8677,"Pain, Acute",Methoxyflurane,COC(C(Cl)Cl)(F)F,APPROVED,,nervous_system_disease
5397,8648,Ischemic Stroke,Reteplase,,PHASE2,,nervous_system_disease
5396,8594,Primary Ciliary Dyskinesia,Ivacaftor,CC(C)(C)C1=CC(=C(C=C1NC(=O)C2=CNC3=CC=CC=C3C2=O)O)C(C)(C)C,PHASE2,,nervous_system_disease
5394,8570,Cerebral Small Vessel Diseases,Azelnidipine,CC1=C(C(C(=C(N1)N)C(=O)OC2CN(C2)C(C3=CC=CC=C3)C4=CC=CC=C4)C5=CC(=CC=C5)[N+](=O)[O-])C(=O)OC(C)C,APPROVED,,nervous_system_disease
5392,8508,Cataract Extraction,Besifloxacin,C1CCN(CC(C1)N)C2=C(C=C3C(=C2Cl)N(C=C(C3=O)C(=O)O)C4CC4)F,APPROVED,,nervous_system_disease
5391,8506,Spinal Cord Injuries,Mecamylamine,CC1(C2CCC(C2)C1(C)NC)C,APPROVED,,nervous_system_disease
5390,8464,Synkinesis|Facial Nerve Palsy,Apraclonidine,C1CN=C(N1)NC2=C(C=C(C=C2Cl)N)Cl,APPROVED,,nervous_system_disease
5386,8389,Congenital Muscular Dystrophy,Omigapil,CN(CC#C)CC1=CC2=CC=CC=C2OC3=CC=CC=C31,PHASE1,,nervous_system_disease
5385,8369,Alzheimer's Disease,Tryptophan,C1=CC=C2C(=C1)C(=CN2)CC(C(=O)O)N,APPROVED,,nervous_system_disease
5384,8341,"Stroke, Ischemic",Lenomorelin,CCCCCCCC(=O)OCC(C(=O)NC(CO)C(=O)NC(CC1=CC=CC=C1)C(=O)NC(CC(C)C)C(=O)NC(CO)C(=O)N2CCCC2C(=O)NC(CCC(=O)O)C(=O)NC(CC3=CNC=N3)C(=O)NC(CCC(=O)N)C(=O)NC(CCCNC(=N)N)C(=O)NC(C(C)C)C(=O)NC(CCC(=O)N)C(=O)NC(CCC(=O)N)C(=O)NC(CCCNC(=N)N)C(=O)NC(CCCCN)C(=O)NC(CCC(=O)O)C(=O)NC(CO)C(=O)NC(CCCCN)C(=O)NC(CCCCN)C(=O)N4CCCC4C(=O)N5CCCC5C(=O)NC(C)C(=O)NC(CCCCN)C(=O)NC(CC(C)C)C(=O)NC(CCC(=O)N)C(=O)N6CCCC6C(=O)NC(CCCNC(=N)N)C(=O)O)NC(=O)CN,PHASE2,,nervous_system_disease
5383,8340,"Stroke, Ischemic",Ghrelin,,PHASE2,,nervous_system_disease
5381,8272,Advanced Glioblastoma|Metastatic Melanoma in the Central Nervous System|MGMT-Unmethylated Glioblastoma,Crizanlizumab,,PHASE2,,nervous_system_disease
5379,8245,"Niemann-Pick Disease, Type C",Adrabetadex,CC(COCC1C2CC(C(O1)OC3C(OC(C(C3O)OCC(C)O)OC4C(OC(C(C4O)O)OC5C(OC(C(C5O)O)OC6C(OC(C(C6O)O)OC7C(OC(C(C7O)O)OC8C(OC(O2)C(C8O)O)COCC(C)O)CO)COCC(C)O)CO)CO)CO)O)O,PHASE2|PHASE3,,nervous_system_disease
5377,8213,"Brain Cancer|Malignant Brain Tumor|Recurrent Brain Tumor|Progressive Malignant Brain Tumor|Brain Tumor, Pediatric|Brain Tumor Adult",Magrolimab,,PHASE1,,nervous_system_disease
5376,8212,"Multiple Sclerosis, Relapsing-Remitting",Clemastine,CC(C1=CC=CC=C1)(C2=CC=C(C=C2)Cl)OCCC3CCCN3C,PHASE2,,nervous_system_disease
5375,8183,ADHD|Attention Deficit Hyperactivity Disorder|Attention Deficit Disorder With Hyperactivity|Mental Disorders Diagnosed in Childhood|Attention Deficit and Disruptive Behavior Disorders,Cyproheptadine,CN1CCC(=C2C3=CC=CC=C3C=CC4=CC=CC=C42)CC1,APPROVED,,nervous_system_disease
5374,8164,Dyskinesia,Famotidine,C1=C(N=C(S1)N=C(N)N)CSCCC(=NS(=O)(=O)N)N,PHASE2,,nervous_system_disease
5373,8158,"Brain Neoplasms|Malignant Neoplasms, Brain|Brain Tumors",Cositecan,CCC1(C2=C(COC1=O)C(=O)N3CC4=C(C5=CC=CC=C5N=C4C3=C2)CC[Si](C)(C)C)O,PHASE2,,nervous_system_disease
5372,8147,Vascular Dementia,Ergoloid,CCC(C)C1C(=O)N2CCCC2C3(N1C(=O)C(O3)(C(C)C)NC(=O)C4CC5C(CC6=CNC7=CC=CC5=C67)N(C4)C)O.CC(C)CC1C(=O)N2CCCC2C3(N1C(=O)C(O3)(C(C)C)NC(=O)C4CC5C(CC6=CNC7=CC=CC5=C67)N(C4)C)O.CC(C)C1C(=O)N2CCCC2C3(N1C(=O)C(O3)(C(C)C)NC(=O)C4CC5C(CC6=CNC7=CC=CC5=C67)N(C4)C)O.CC(C)C1(C(=O)N2C(C(=O)N3CCCC3C2(O1)O)CC4=CC=CC=C4)NC(=O)C5CC6C(CC7=CNC8=CC=CC6=C78)N(C5)C,PHASE2,,nervous_system_disease
5371,8132,Cryptococcal Meningitis,Efungumab,,PHASE2,,nervous_system_disease
5370,8124,"Neuropathic Pain|Type 2 Diabetes Mellitus|Diabetic Neuropathy, Painful",Cetirizine,C1CN(CCN1CCOCC(=O)O)C(C2=CC=CC=C2)C3=CC=C(C=C3)Cl,APPROVED,,nervous_system_disease
5368,8091,Secondary Hypothyroidism|Hypopituitarism|Hyperlipidemias,Triiodothyronine,C1=CC(=C(C=C1OC2=C(C=C(C=C2I)CC(C(=O)O)N)I)I)O,APPROVED,,nervous_system_disease
5367,8089,Secondary Hypothyroidism|Hypopituitarism|Hyperlipidemias,Thyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,APPROVED,,nervous_system_disease
5366,8083,Attention Deficit Disorder With Hyperactivity,Betahistine,CNCCC1=CC=CC=N1,PHASE1,,nervous_system_disease
5365,8076,Chronic Inflammatory Demyelinating Polyneuropathy,Batoclimab,,PHASE2,,nervous_system_disease
5364,7991,Brain Tumor,Fluciclovine,C1C(CC1(C(=O)O)N)F,PHASE2,,nervous_system_disease
5363,7990,Orthostatic Intolerance,Ganirelix,CCNC(=NCCCCC(C(=O)NC(CC(C)C)C(=O)NC(CCCCN=C(NCC)NCC)C(=O)N1CCCC1C(=O)NC(C)C(=O)N)NC(=O)C(CC2=CC=C(C=C2)O)NC(=O)C(CO)NC(=O)C(CC3=CN=CC=C3)NC(=O)C(CC4=CC=C(C=C4)Cl)NC(=O)C(CC5=CC6=CC=CC=C6C=C5)NC(=O)C)NCC,PHASE2,,nervous_system_disease
5362,7986,Digestive System Diseases|Disorientation,Alfentanil,CCC(=O)N(C1=CC=CC=C1)C2(CCN(CC2)CCN3C(=O)N(N=N3)CC)COC,APPROVED,,nervous_system_disease
5361,7982,Neurocysticercosis,Oxfendazole,COC(=O)NC1=NC2=C(N1)C=C(C=C2)S(=O)C3=CC=CC=C3,PHASE1,,nervous_system_disease
5360,7980,Peripheral Nerve Injuries|Pain,Rufinamide,C1=CC(=C(C(=C1)F)CN2C=C(N=N2)C(=O)N)F,PHASE2,,nervous_system_disease
5358,7900,Traumatic Brain Injury|Computed Tomography|Procedural Sedation,Trichloroacetaldehyde,C(=O)C(Cl)(Cl)Cl,PHASE2,,nervous_system_disease
5357,7862,Down Syndrome,Epigallocatechin,C1C(C(OC2=CC(=CC(=C21)O)O)C3=CC(=C(C(=C3)O)O)O)O,PHASE2,,nervous_system_disease
5356,7853,Fibromyalgia|Pain|Sleep|Fatigue,Cyclobenzaprine,CN(C)CCC=C1C2=CC=CC=C2C=CC3=CC=CC=C31,APPROVED,,nervous_system_disease
5355,7850,CDK Gene Mutation|Metastatic Malignant Neoplasm in the Brain|Metastatic Malignant Solid Neoplasm|NTRK Family Gene Mutation|PI3K Gene Mutation|ROS1 Gene Mutation|KRAS G12C Mutation,Adagrasib,CN1CCCC1COC2=NC3=C(CCN(C3)C4=CC=CC5=C4C(=CC=C5)Cl)C(=N2)N6CCN(C(C6)CC#N)C(=O)C(=C)F,PHASE2,,nervous_system_disease
5353,7819,Hyperalgesia|Allodynia,Fenobam,CN1CC(=O)NC1=NC(=O)NC2=CC(=CC=C2)Cl,PHASE1,,nervous_system_disease
5352,7752,Adult Angiosarcoma|Adult Desmoplastic Small Round Cell Tumor|Adult Epithelioid Sarcoma|Adult Extraskeletal Myxoid Chondrosarcoma|Adult Extraskeletal Osteosarcoma|Adult Fibrosarcoma|Adult Leiomyosarcoma|Adult Liposarcoma|Adult Malignant Mesenchymoma|Adult Malignant Peripheral Nerve Sheath Tumor|Adult Rhabdomyosarcoma|Adult Synovial Sarcoma|Adult Undifferentiated High Grade Pleomorphic Sarcoma of Bone|Childhood Angiosarcoma|Childhood Desmoplastic Small Round Cell Tumor|Childhood Epithelioid Sarcoma|Childhood Fibrosarcoma|Childhood Leiomyosarcoma|Childhood Liposarcoma|Childhood Malignant Mesenchymoma|Childhood Malignant Peripheral Nerve Sheath Tumor|Childhood Pleomorphic Rhabdomyosarcoma|Childhood Rhabdomyosarcoma With Mixed Embryonal and Alveolar Features|Childhood Synovial Sarcoma|Dermatofibrosarcoma Protuberans|Malignant Adult Hemangiopericytoma|Malignant Childhood Hemangiopericytoma|Metastatic Childhood Soft Tissue Sarcoma|Previously Treated Childhood Rhabdomyosarcoma|Recurrent Adult Soft Tissue Sarcoma|Recurrent Childhood Rhabdomyosarcoma|Recurrent Childhood Soft Tissue Sarcoma|Stage III Adult Soft Tissue Sarcoma|Stage IV Adult Soft Tissue Sarcoma|Untreated Childhood Rhabdomyosarcoma,Cixutumumab,,PHASE1,,nervous_system_disease
5351,7633,Non Small Cell Lung Cancer|Brain Metastases,Cadonilimab,,PHASE2,,nervous_system_disease
5350,7590,Subarachnoid Hemorrhage,Prostacyclin,CCCCCC(C=CC1C(CC2C1CC(=CCCCC(=O)O)O2)O)O,PHASE2,,nervous_system_disease
5349,7589,Subarachnoid Hemorrhage,Epoprostenol,CCCCCC(C=CC1C(CC2C1CC(=CCCCC(=O)O)O2)O)O,PHASE2,,nervous_system_disease
5347,7556,Parkinson Disease,Benserazide,C1=CC(=C(C(=C1CNNC(=O)C(CO)N)O)O)O,APPROVED,,nervous_system_disease
5345,7531,Anisocoria,Pilocarpine,CCC1C(COC1=O)CC2=CN=CN2C,APPROVED,,nervous_system_disease
5344,7530,Anisocoria,Tropicamide,CCN(CC1=CC=NC=C1)C(=O)C(CO)C2=CC=CC=C2,APPROVED,,nervous_system_disease
5343,7497,Sleep Initiation and Maintenance Disorders,Eplivanserin,CN(C)CCON=C(C=CC1=CC=C(C=C1)O)C2=CC=CC=C2F,PHASE1,,nervous_system_disease
5342,7455,Essential Tremor,Penpulimab,,PHASE2,,nervous_system_disease
5341,7452,Multiple Sclerosis|Fatigue,Mitoquinone,CC1=C(C(=O)C(=C(C1=O)OC)OC)CCCCCCCCCC[P+](C2=CC=CC=C2)(C3=CC=CC=C3)C4=CC=CC=C4,PHASE1|PHASE2,,nervous_system_disease
5340,7442,Mild to Moderate Diabetic Sensorimotor Polyneuropathy,Ranirestat,C1C(=O)NC(=O)C12C(=O)N(C(=O)C3=CC=CN23)CC4=C(C=C(C=C4)Br)F,PHASE2|PHASE3,,nervous_system_disease
5338,7418,Diabetic Gastroparesis,Mosapride,CCOC1=CC(=C(C=C1C(=O)NCC2CN(CCO2)CC3=CC=C(C=C3)F)Cl)N,APPROVED,,nervous_system_disease
5337,7411,Vincristine Induced Neuropathy,Acetylcarnitine,CC(=O)OC(CC(=O)[O-])C[N+](C)(C)C,PHASE2,,nervous_system_disease
5336,7410,Parkinson Disease,Spheramine,,PHASE2,,nervous_system_disease
5334,7390,Metastatic Lung Neuroendocrine Neoplasm|Metastatic Lung Non-Small Cell Carcinoma|Metastatic Lung Small Cell Carcinoma|Metastatic Malignant Neoplasm in the Brain|Stage IV Lung Cancer AJCC v8|Stage IVA Lung Cancer AJCC v8|Stage IVB Lung Cancer AJCC v8,Berzosertib,CC(C)S(=O)(=O)C1=CC=C(C=C1)C2=CN=C(C(=N2)C3=CC(=NO3)C4=CC=C(C=C4)CNC)N,PHASE1,,nervous_system_disease
5331,7316,COVID-19|Olfactory Disorder|Parosmia,Fluvoxamine,COCCCCC(=NOCCN)C1=CC=C(C=C1)C(F)(F)F,PHASE2,,nervous_system_disease
5330,7302,"MPS I|MPS II|MPS IVA|MPS VI|Mps VII|Gaucher Disease, Type 2|Gaucher Disease, Type 3|Pompe Disease Infantile-Onset|Wolman Disease",Iduronidase,,PHASE1,,nervous_system_disease
5329,7238,Autism Spectrum Disorder|Language Disorders,Levoleucovorin,C1C(N(C2=C(N1)N=C(NC2=O)N)C=O)CNC3=CC=C(C=C3)C(=O)NC(CCC(=O)O)C(=O)O,PHASE2,,nervous_system_disease
5327,7161,Infantile Spasms (IS),Radiprodil,C1CN(CCC1CC2=CC=C(C=C2)F)C(=O)C(=O)NC3=CC4=C(C=C3)NC(=O)O4,PHASE2,,nervous_system_disease
5326,7152,Ischemic Stroke|Indobufen|Aspirin,Indobufen,CCC(C1=CC=C(C=C1)N2CC3=CC=CC=C3C2=O)C(=O)O,APPROVED,,nervous_system_disease
5325,7146,Depression|Acute Ischemic Stroke,Agomelatine,CC(=O)NCCC1=CC=CC2=C1C=C(C=C2)OC,APPROVED,,nervous_system_disease
5324,7144,Parkinson Disease|Healthy,Foliglurax,C1COCCN1CCCC2=CC3=C(C=C2)OC(=CC3=NO)C4=NC=C5C=CSC5=C4,PHASE1,,nervous_system_disease
5323,7141,Primary CNS Lymphoma|Refractory Primary CNS Lymphoma|Relapsed Primary CNS Lymphoma,Tisagenlecleucel,,PHASE1,,nervous_system_disease
5320,7069,Gastroparesis,Camicinal,CC1CN(CCN1)CC2=CC=C(C=C2)CC(=O)N3CCC(CC3)NC4=CC(=CC=C4)F,PHASE2,,nervous_system_disease
5319,7050,Epstein-Barr Virus (EBV)-Associated Diseases|EBV+ Lymphoproliferative Disease With Primary Immunodeficiency (EBV+ PID LPD)|EBV+ Lymphoproliferative Disease With Acquired (Non-congenital) Immunodeficiency (EBV+ AID LPD)|EBV+ Posttransplant Lymphoproliferative Disease in Central Nervous System (EBV+ CNS PTLD)|EBV+ Post-transplant Lymphoproliferative Disease (EBV+ PTLD)|Solid Organ Transplant Complications|Lymphoproliferative Disorders|Allogeneic Hematopoietic Cell Transplant|Stem Cell Transplant Complications|EBV+ Sarcomas|Leiomyosarcoma,Tabelecleucel,,PHASE2,,nervous_system_disease
5318,7040,Williams Beuren Syndrome,Minoxidil,C1CCN(CC1)C2=NC(=N)N(C(=C2)N)O,PHASE2,,nervous_system_disease
5317,7021,Partial Epilepsy,Cenobamate,C1=CC=C(C(=C1)C(CN2N=CN=N2)OC(=O)N)Cl,PHASE1,,nervous_system_disease
5316,6991,Chronic Obstructive Pulmonary Disease,Olodaterol,CC(C)(CC1=CC=C(C=C1)OC)NCC(C2=C3C(=CC(=C2)O)NC(=O)CO3)O,APPROVED,,nervous_system_disease
5315,6990,Alzheimer Disease,Pepinemab,,PHASE1|PHASE2,,nervous_system_disease
5314,6989,Facial Bones Fracture,Ramosetron,CN1C=C(C2=CC=CC=C21)C(=O)C3CCC4=C(C3)NC=N4,APPROVED,,nervous_system_disease
5313,6980,"Muscular Dystrophy, Duchenne",Edasalonexent,CCC=CCC=CCC=CCC=CCC=CCC=CCCC(=O)NCCNC(=O)C1=CC=CC=C1O,PHASE1|PHASE2,,nervous_system_disease
5312,6979,Erosive Reflux Disease,Esomeprazole,CC1=CN=C(C(=C1OC)C)CS(=O)C2=NC3=C(N2)C=C(C=C3)OC,APPROVED,,nervous_system_disease
5311,6978,Erosive Reflux Disease,Tegoprazan,CC1=NC2=C(N1)C=C(C=C2OC3CCOC4=C3C(=CC(=C4)F)F)C(=O)N(C)C,APPROVED,,nervous_system_disease
5310,6973,"Schizophrenia|Drug Induced Movement Disorder, Unspecified|Oxidative Stress",Cobalamin,CC1=CC2=C(C=C1C)N(C=N2)C3C(C(C(O3)CO)OP(=O)([O-])OC(C)CNC(=O)CCC4(C(C5C6(C(C(C(=N6)C(=C7C(C(C(=N7)C=C8C(C(C(=N8)C(=C4[N-]5)C)CCC(=O)N)(C)C)CCC(=O)N)(C)CC(=O)N)C)CCC(=O)N)(C)CC(=O)N)C)CC(=O)N)C)O.[Co+2],PHASE2|PHASE3,,nervous_system_disease
5309,6957,Primary Progressive Multiple Sclerosis|Secondary Progressive Multiple Sclerosis|Multiple Sclerosis,Foralumab,,PHASE1,,nervous_system_disease
5308,6924,Alzheimer's Disease,Idalopirdine,C1=CC(=CC(=C1)OCC(C(F)F)(F)F)CNCCC2=CNC3=C2C=CC(=C3)F,PHASE1,,nervous_system_disease
5307,6895,Cerebral Infarction,Triflusal,CC(=O)OC1=C(C=CC(=C1)C(F)(F)F)C(=O)O,APPROVED,,nervous_system_disease
5306,6876,Stroke,Basmisanil,CC1=C(C(=NO1)C2=CC=C(C=C2)F)COC3=NC=C(C=C3)C(=O)N4CCS(=O)(=O)CC4,PHASE2,,nervous_system_disease
5305,6859,Obstructive Sleep Apnea|Obesity|Hypertension,Sibutramine,CC(C)CC(C1(CCC1)C2=CC=C(C=C2)Cl)N(C)C,APPROVED,,nervous_system_disease
5300,6806,Brain and Central Nervous System Tumors,Mibefradil,CC(C)C1C2=C(CCC1(CCN(C)CCCC3=NC4=CC=CC=C4N3)OC(=O)COC)C=C(C=C2)F,PHASE1,,nervous_system_disease
5299,6791,Brain Tumors,Esmolol,CC(C)NCC(COC1=CC=C(C=C1)CCC(=O)OC)O,PHASE1,,nervous_system_disease
5298,6789,Phrenic Nerve Paralysis|Diaphragm Sellae Meningioma|Complications|Respiratory Complication|Nerve Block|Brachial Plexus Block,Prilocaine,CCCNC(C)C(=O)NC1=CC=CC=C1C,APPROVED,,nervous_system_disease
5297,6754,Acute Ischemic Stroke,Balovaptan,CN1CC2=C(C=CC(=C2)Cl)N3C(=NN=C3C4CCC(CC4)OC5=CC=CC=N5)C1,PHASE2,,nervous_system_disease
5296,6749,Recurrent High Grade Meningioma,Trabectedin,CC1=CC2=C(C3C4C5C6=C(C(=C7C(=C6C(N4C(C(C2)N3C)O)COC(=O)C8(CS5)C9=CC(=C(C=C9CCN8)O)OC)OCO7)C)OC(=O)C)C(=C1OC)O,PHASE2,,nervous_system_disease
5294,6712,"Gaucher Disease, Type 1|Cerebroside Lipidosis Syndrome|Glucocerebrosidase Deficiency Disease|Glucosylceramide Beta-Glucosidase Deficiency Disease|Gaucher Disease, Non-Neuronopathic Form",Eliglustat,CCCCCCCC(=O)NC(CN1CCCC1)C(C2=CC3=C(C=C2)OCCO3)O,PHASE2,,nervous_system_disease
5293,6707,Alzheimer's Disease,Posiphen,CC12CCN(C1N(C3=C2C=C(C=C3)OC(=O)NC4=CC=CC=C4)C)C,PHASE1|PHASE2,,nervous_system_disease
5292,6702,"Cerebral Stroke|Cerebrovascular Accident, Acute|Cerebrovascular Stroke|Stroke, Acute|Stroke",Dapsone,C1=CC(=CC=C1N)S(=O)(=O)C2=CC=C(C=C2)N,PHASE2|PHASE3,,nervous_system_disease
5290,6646,Sarcopenia|Osteopenia,Anamorelin,CC(C)(C(=O)NC(CC1=CNC2=CC=CC=C21)C(=O)N3CCCC(C3)(CC4=CC=CC=C4)C(=O)N(C)N(C)C)N,PHASE1,,nervous_system_disease
5289,6629,Alzheimer's Disease,Velusetrag,CC(C)N1C2=CC=CC=C2C=C(C1=O)C(=O)NC3CC4CCC(C3)N4CC(CN(C)S(=O)(=O)C)O,PHASE1,,nervous_system_disease
5287,6612,Multiple Sclerosis,Ponesimod,CCCN=C1N(C(=O)C(=CC2=CC(=C(C=C2)OCC(CO)O)Cl)S1)C3=CC=CC=C3C,PHASE2,,nervous_system_disease
5285,6608,"Acute Pain|Burns|Adverse Drug Event|Respiratory Depression|Nausea and Vomiting, Postoperative",Oliceridine,COC1=C(SC=C1)CNCCC2(CCOC3(C2)CCCC3)C4=CC=CC=N4,APPROVED,,nervous_system_disease
5282,6593,Hypothyroidism|Trisomy 21,Levothyroxine,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,APPROVED,,nervous_system_disease
5281,6580,Brain Cancer|Brain Stem Tumors|Pontine Tumors,Rindopepimut,,PHASE1,,nervous_system_disease
5278,6472,Neuromyelitis Optica Spectrum Disorder Relapse,Ruxolitinib,C1CCC(C1)C(CC#N)N2C=C(C=N2)C3=C4C=CNC4=NC=N3,PHASE1|PHASE2,,nervous_system_disease
5276,6450,Plexiform Neurofibroma|Neurofibromatosis Type 1 (NF1),Mirdametinib,C1=CC(=C(C=C1I)F)NC2=C(C=CC(=C2F)F)C(=O)NOCC(CO)O,PHASE2,,nervous_system_disease
5275,6404,"Coronary Disease|Angina, Unstable",Abciximab,,APPROVED,,nervous_system_disease
5274,6401,Opioid-induced Constipation,Naldemedine,CC(C)(C1=NC(=NO1)C2=CC=CC=C2)NC(=O)C3=C(C4C56CCN(C(C5(C3)O)CC7=C6C(=C(C=C7)O)O4)CC8CC8)O,PHASE2,,nervous_system_disease
5273,6394,"Epilepsy, Partial",Seletracetam,CCC(C(=O)N)N1CC(CC1=O)C=C(F)F,PHASE2,,nervous_system_disease
5272,6343,"Breast Cancer|Cholangiocarcinoma|Colorectal Cancer|Head and Neck Neoplasms|Lymphoma, Large-Cell, Anaplastic|Melanoma|Neuroendocrine Tumors|Non-Small Cell Lung Cancer|Ovarian Cancer|Pancreatic Cancer|Papillary Thyroid Cancer|Primary Brain Tumors|Renal Cell Carcinoma|Sarcomas|Salivary Gland Cancers|Adult Solid Tumor",Entrectinib,CN1CCN(CC1)C2=CC(=C(C=C2)C(=O)NC3=NNC4=C3C=C(C=C4)CC5=CC(=CC(=C5)F)F)NC6CCOCC6,PHASE2,,nervous_system_disease
5271,6321,Epilepsy Intractable,Clioquinol,C1=CC2=C(C(=C(C=C2Cl)I)O)N=C1,PHASE2,,nervous_system_disease
5270,6316,Neuromyelitis Optica Spectrum Disorder|NMOSD,Satralizumab,,APPROVED,,nervous_system_disease
5269,6310,Sporadic Inclusion Body Myositis (sIBM),Bimagrumab,,PHASE2|PHASE3,,nervous_system_disease
5268,6288,Insomnia,Zaleplon,CCN(C1=CC=CC(=C1)C2=CC=NC3=C(C=NN23)C#N)C(=O)C,PHASE2,,nervous_system_disease
5266,6257,Multiple Sclerosis,Liothyronine,C1=CC(=C(C=C1OC2=C(C=C(C=C2I)CC(C(=O)O)N)I)I)O,PHASE1,,nervous_system_disease
5265,6255,Cerebral Infarction,Ozagrel,C1=CC(=CC=C1CN2C=CN=C2)C=CC(=O)O,APPROVED,,nervous_system_disease
5264,6233,Acromegaly,Paltusotine,C1CN(CCC1N)C2=C3C=C(C=CC3=NC=C2C4=CC(=CC(=C4)F)F)C5=CC=CC(=C5O)C#N,PHASE2,,nervous_system_disease
5263,6224,Alzheimer Disease,Donanemab,,PHASE2,,nervous_system_disease
5262,6222,Arterial Ischemic Stroke,Afamelanotide,CCCCC(C(=O)NC(CCC(=O)O)C(=O)NC(CC1=CN=CN1)C(=O)NC(CC2=CC=CC=C2)C(=O)NC(CCCNC(=N)N)C(=O)NC(CC3=CNC4=CC=CC=C43)C(=O)NCC(=O)NC(CCCCN)C(=O)N5CCCC5C(=O)NC(C(C)C)C(=O)N)NC(=O)C(CO)NC(=O)C(CC6=CC=C(C=C6)O)NC(=O)C(CO)NC(=O)C,PHASE2,,nervous_system_disease
5261,6198,Encephalopathy|HIV Infections|Radiculitis,Foscarnet,C(=O)(O)P(=O)(O)O,PHASE1,,nervous_system_disease
5260,6196,Abnormal Uterine Bleeding|Dysmenorrhea,Etonogestrel,CCC12CC(=C)C3C(C1CCC2(C#C)O)CCC4=CC(=O)CCC34,PHASE2,,nervous_system_disease
5257,6132,Atrial Fibrillation|Coronary Artery Disease|Stable Angina|Stable Chronic Angina,Edoxaban,CN1CCC2=C(C1)SC(=N2)C(=O)NC3CC(CCC3NC(=O)C(=O)NC4=NC=C(C=C4)Cl)C(=O)N(C)C,APPROVED,,nervous_system_disease
5255,6080,Multiple Sclerosis,Palifermin,,PHASE1|PHASE2,,nervous_system_disease
5254,6076,Alzheimer Disease,Rofecoxib,CS(=O)(=O)C1=CC=C(C=C1)C2=C(C(=O)OC2)C3=CC=CC=C3,PHASE2|PHASE3,,nervous_system_disease
5253,6073,Intervertebral Disc Degeneration|Modic I Discopathy|Back Pain|Low Back Pain|Magnetic Resonance Imaging (MRI),Pamidronate,C(CN)C(O)(P(=O)(O)O)P(=O)(O)O,PHASE2,,nervous_system_disease
5252,6063,Leptomeningeal Neoplasm|Metastatic Lung Non-Small Cell Carcinoma|Metastatic Malignant Neoplasm in the Brain|Recurrent Lung Non-Small Cell Carcinoma|Stage IV Lung Cancer AJCC v8|Stage IVA Lung Cancer AJCC v8|Stage IVB Lung Cancer AJCC v8,Telaglenastat,C1=CC=NC(=C1)CC(=O)NC2=NN=C(S2)CCCCC3=NN=C(C=C3)NC(=O)CC4=CC(=CC=C4)OC(F)(F)F,PHASE1,,nervous_system_disease
5250,6049,Duchenne Muscular Dystrophy,Givinostat,CCN(CC)CC1=CC2=C(C=C1)C=C(C=C2)COC(=O)NC3=CC=C(C=C3)C(=O)NO,PHASE2|PHASE3,,nervous_system_disease
5249,6044,Childhood Solid Neoplasm|Recurrent Malignant Solid Neoplasm|Recurrent Primary Central Nervous System Neoplasm|Refractory Malignant Solid Neoplasm|Refractory Primary Central Nervous System Neoplasm,Prexasertib,COC1=C(C(=CC=C1)OCCCN)C2=CC(=NN2)NC3=NC=C(N=C3)C#N,PHASE1,,nervous_system_disease
5248,6025,Cerebral Infarction,Vorapaxar,CCOC(=O)NC1CCC2C(C1)CC3C(C2C=CC4=NC=C(C=C4)C5=CC(=CC=C5)F)C(OC3=O)C,PHASE2,,nervous_system_disease
5247,6017,Multiple Sclerosis,Mangafodipir,[H+].[H+].[H+].[H+].CC1=NC=C(C(=C1O)CN(CCN(CC2=C(C(=NC=C2COP(=O)([O-])[O-])C)O)CC(=O)[O-])CC(=O)[O-])COP(=O)([O-])[O-].[Mn+2],PHASE1,,nervous_system_disease
5246,5966,Coronary Disease|Angina Pectoris,Bivalirudin,CCC(C)C(C(=O)N1CCCC1C(=O)NC(CCC(=O)O)C(=O)NC(CCC(=O)O)C(=O)NC(CC2=CC=C(C=C2)O)C(=O)NC(CC(C)C)C(=O)O)NC(=O)C(CCC(=O)O)NC(=O)C(CCC(=O)O)NC(=O)C(CC3=CC=CC=C3)NC(=O)C(CC(=O)O)NC(=O)CNC(=O)C(CC(=O)N)NC(=O)CNC(=O)CNC(=O)CNC(=O)CNC(=O)C4CCCN4C(=O)C(CCCNC(=N)N)NC(=O)C5CCCN5C(=O)C(CC6=CC=CC=C6)N,APPROVED,,nervous_system_disease
5244,5925,Relapsing Remitting Multiple Sclerosis,Flupirtine,CCOC(=O)NC1=C(N=C(C=C1)NCC2=CC=C(C=C2)F)N,PHASE2,,nervous_system_disease
5243,5895,Early Alzheimer's Disease,Obicetrapib,CCC1CC(C2=C(N1C(=O)OCC)C=CC(=C2)C(F)(F)F)N(CC3=CC(=CC(=C3)C(F)(F)F)C(F)(F)F)C4=NC=C(C=N4)OCCCC(=O)O,PHASE2,,nervous_system_disease
5242,5882,Spinal Muscular Atrophy,Reldesemtiv,C1C(CC1(CNC2=NC=C(C=N2)N3C=CC(=C3)C(=O)N)C4=C(C=CC=N4)F)F,PHASE2,,nervous_system_disease
5240,5852,Gastroparesis,Tradipitant,C1=CC=C(C(=C1)C(=O)C2=C(N=CC=C2)C3=C(N(N=N3)CC4=CC(=CC(=C4)C(F)(F)F)C(F)(F)F)C5=CC=NC=C5)Cl,PHASE2,,nervous_system_disease
5239,5850,Confirmed Genetic Diagnosis of Prader-Willi Syndrome,Tesofensine,CCOCC1C2CCC(N2C)CC1C3=CC(=C(C=C3)Cl)Cl,PHASE2,,nervous_system_disease
5233,5822,Parkinson Disease,Isradipine,CC1=C(C(C(=C(N1)C)C(=O)OC(C)C)C2=CC=CC3=NON=C32)C(=O)OC,PHASE2,,nervous_system_disease
5231,5810,Alzheimer Disease,Acitretin,CC1=CC(=C(C(=C1C=CC(=CC=CC(=CC(=O)O)C)C)C)C)OC,PHASE2,,nervous_system_disease
5230,5807,Non-small Cell Lung Cancer,Lazertinib,CN(C)CC1=CN(N=C1C2=CC=CC=C2)C3=NC(=NC=C3)NC4=C(C=C(C(=C4)NC(=O)C=C)N5CCOCC5)OC,PHASE2,,nervous_system_disease
5228,5780,Persistent Developmental Stuttering,Pagoclone,CC(C)CCC(=O)CC1C2=CC=CC=C2C(=O)N1C3=NC4=C(C=C3)C=CC(=N4)Cl,PHASE2,,nervous_system_disease
5227,5748,Crohn's Disease|Abdominal Pain,Olorinab,CC(C)(C)C(CO)NC(=O)C1=NN(C2=C1CC3C2C3)C4=NC=C[N+](=C4)[O-],PHASE2,,nervous_system_disease
5226,5747,Agitation,Levosulpiride,CCN1CCCC1CNC(=O)C2=C(C=CC(=C2)S(=O)(=O)N)OC,PHASE2|PHASE3,,nervous_system_disease
5223,5733,Brain Metastases|Non-small Cell Lung Cancer,Lucanthone,CCN(CC)CCNC1=C2C(=C(C=C1)C)SC3=CC=CC=C3C2=O,PHASE2,,nervous_system_disease
5222,5728,High Blood Pressure|Migraine Headaches|Chest Pain,Nadolol,CC(C)(C)NCC(COC1=CC=CC2=C1CC(C(C2)O)O)O,PHASE1,,nervous_system_disease
5219,5668,Essential Hypertension With Stable Angina and Dyslipidemia,Azilsartan,CCOC1=NC2=CC=CC(=C2N1CC3=CC=C(C=C3)C4=CC=CC=C4C5=NOC(=O)N5)C(=O)O,APPROVED,,nervous_system_disease
5218,5656,Memory Impairment,Vilazodone,C1CN(CCN1CCCCC2=CNC3=C2C=C(C=C3)C#N)C4=CC5=C(C=C4)OC(=C5)C(=O)N,PHASE2,,nervous_system_disease
5217,5632,Gastroparesis|Diabetes,Tegaserod,CCCCCN=C(N)NN=CC1=CNC2=C1C=C(C=C2)OC,APPROVED,,nervous_system_disease
5216,5628,"Subarachnoid Hemorrhage|Intracerebral Hemorrhage|Ventriculitis, Cerebral|Hydrocephalus",Nafcillin,CCOC1=C(C2=CC=CC=C2C=C1)C(=O)NC3C4N(C3=O)C(C(S4)(C)C)C(=O)O,PHASE1,,nervous_system_disease
5215,5625,Stroke|Acute Ischemic Stroke,Repinotan,C1CC2=CC=CC=C2OC1CNCCCCN3C(=O)C4=CC=CC=C4S3(=O)=O,PHASE2,,nervous_system_disease
5214,5624,Brain Tumors With Ill-defined Margins,Indigo,C1=CC=C2C(=C1)C(=C(N2)C3=NC4=CC=CC=C4C3=O)O,PHASE1|PHASE2,,nervous_system_disease
5213,5620,Alzheimer Disease,Talsaclidine,C#CCOC1CN2CCC1CC2,PHASE2|PHASE3,,nervous_system_disease
5212,5611,Brain and Central Nervous System Tumors,Laromustine,CNC(=O)N(N(CCCl)S(=O)(=O)C)S(=O)(=O)C,PHASE1,,nervous_system_disease
5211,5608,Duchenne Muscular Dystrophy (DMD),Bocidelpar,CC1=CN=C(N1CC2=CC=CC=C2OCCCC(C)CC(=O)O)C3=CC=C(C=C3)C(F)(F)F,PHASE1,,nervous_system_disease
5210,5579,Early Manifest Huntington Disease,Branaplam,CC1(CC(CC(N1)(C)C)OC2=NN=C(C=C2)C3=C(C=C(C=C3)C4=CNN=C4)O)C,PHASE2,,nervous_system_disease
5209,5578,Stroke|Cerebral Infarction|Brain Infarction|Brain Ischemia|Nervous System Diseases|Central Nervous System Diseases|Vascular Diseases,Butylphthalide,CCCCC1C2=CC=CC=C2C(=O)O1,APPROVED,,nervous_system_disease
5208,5576,Analgesic Rebound Headache,Almotriptan,CN(C)CCC1=CNC2=C1C=C(C=C2)CS(=O)(=O)N3CCCC3,APPROVED,,nervous_system_disease
5207,5564,Relapsing Multiple Sclerosis,Ozanimod,CC(C)OC1=C(C=C(C=C1)C2=NC(=NO2)C3=C4CCC(C4=CC=C3)NCCO)C#N,PHASE2|PHASE3,,nervous_system_disease
5206,5551,Symptomatic Neurogenic Orthostatic Hypotension (NOH)|Parkinson's Disease|Multiple System Atrophy,Fipamezole,CCC1(CC2=C(C1)C=C(C=C2)F)C3=CN=CN3,PHASE2,,nervous_system_disease
5204,5506,HIV Infections|Peripheral Nervous System Disease,Benztropine,CN1C2CCC1CC(C2)OC(C3=CC=CC=C3)C4=CC=CC=C4,PHASE2,,nervous_system_disease
5203,5505,HIV Infections|Peripheral Nervous System Disease,Benzatropine,CN1C2CCC1CC(C2)OC(C3=CC=CC=C3)C4=CC=CC=C4,PHASE2,,nervous_system_disease
5201,5476,Attention Deficit Hyperactivity Disorder,Centanafadine,C1C2C1(CNC2)C3=CC4=CC=CC=C4C=C3,PHASE2,,nervous_system_disease
5200,5473,Moderate to Severe Cyclic Mastalgia,Danazol,CC12CCC3C(C1CCC2(C#C)O)CCC4=CC5=C(CC34C)C=NO5,PHASE2,,nervous_system_disease
5199,5445,"Aneurysm, Cerebral|Endovascular Procedures",Prasugrel,CC(=O)OC1=CC2=C(S1)CCN(C2)C(C3=CC=CC=C3F)C(=O)C4CC4,APPROVED,,nervous_system_disease
5195,5329,Acute Lymphoblastic Leukemia,Blinatumomab,,PHASE2,,nervous_system_disease
5194,5322,Solid Tumors|Brain Tumors|Brain Metastases,Satraplatin,CC(=O)O.CC(=O)O.C1CCC(CC1)N.N.Cl[Pt]Cl,PHASE1,,nervous_system_disease
5193,5318,Acute Myeloid Leukemia Post Cytotoxic Therapy|Down Syndrome|Myelodysplastic Syndrome Post Cytotoxic Therapy|Recurrent Acute Myeloid Leukemia|Recurrent Mixed Phenotype Acute Leukemia|Recurrent Myelodysplastic Syndrome|Refractory Acute Myeloid Leukemia|Refractory Mixed Phenotype Acute Leukemia|Refractory Myelodysplastic Syndrome,Uproleselan,CCC1CC(CC(C1OC2C(C(C(C(O2)C)O)O)O)OC3C(C(C(C(O3)CO)O)OC(CC4CCCCC4)C(=O)O)NC(=O)C)C(=O)NCCNC(=O)CCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC,PHASE1,,nervous_system_disease
5191,5304,"Muscular Atrophy, Spinal",Amifampridine,C1=CN=CC(=C1N)N,PHASE2,,nervous_system_disease
5190,5288,Fabry Disease,Migalastat,C1C(C(C(C(N1)CO)O)O)O,PHASE2,,nervous_system_disease
5189,5284,"Nontraumatic Intracerebral Hemorrhage, Multiple Localized",Urapidil,CN1C(=CC(=O)N(C1=O)C)NCCCN2CCN(CC2)C3=CC=CC=C3OC,APPROVED,,nervous_system_disease
5188,5283,"Nontraumatic Intracerebral Hemorrhage, Multiple Localized",Clevidipine,CCCC(=O)OCOC(=O)C1=C(NC(=C(C1C2=C(C(=CC=C2)Cl)Cl)C(=O)OC)C)C,APPROVED,,nervous_system_disease
5187,5278,Meningitis|Meningococcal Meningitis|Meningococcal Infections,Gardasil,,PHASE2,,nervous_system_disease
5186,5262,"Migraine, With or Without Aura",Atogepant,CC1C(CC(C(=O)N1CC(F)(F)F)NC(=O)C2=CC3=C(CC4(C3)C5=C(NC4=O)N=CC=C5)N=C2)C6=C(C=CC(=C6F)F)F,PHASE2|PHASE3,,nervous_system_disease
5185,5247,Cesarean Section|Pain Management|Neuropathic Pain,Metamizole,CC1=C(C(=O)N(N1C)C2=CC=CC=C2)N(C)CS(=O)(=O)O,APPROVED,,nervous_system_disease
5183,5217,"Neurofibroma, Plexiform|Precursor Cell Lymphoblastic Leukemia-Lymphoma|Leukemia, Promyelocytic, Acute|Sarcoma",Pexidartinib,C1=CC(=NC=C1CC2=CNC3=C2C=C(C=N3)Cl)NCC4=CN=C(C=C4)C(F)(F)F,PHASE1,,nervous_system_disease
5182,5216,Aicardi-Goutières Syndrome (AGS),Abacavir,C1CC1NC2=C3C(=NC(=N2)N)N(C=N3)C4CC(C=C4)CO,PHASE2,,nervous_system_disease
5179,5179,Epilepsy,Vinpocetine,CCC12CCCN3C1C4=C(CC3)C5=CC=CC=C5N4C(=C2)C(=O)OCC,PHASE1|PHASE2,,nervous_system_disease
5178,5168,Chest Pain|Gastrointestinal Reflux Disease,Dexlansoprazole,CC1=C(C=CN=C1CS(=O)C2=NC3=CC=CC=C3N2)OCC(F)(F)F,APPROVED,,nervous_system_disease
5177,5146,Non-Hodgkin Lymphoma,Tafasitamab,,PHASE2,,nervous_system_disease
5176,5126,"ADHD|Attention Deficit Hyperactivity Disorder|Attention Deficit Disorder|ADD|ADHD Predominantly Inattentive Type|ADHD - Combined Type|ADHD, Predominantly Hyperactive - Impulsive|Attention-Deficit Disorder in Adolescence|Attention-Deficit Hyperactivity Disorder Symptoms|Attention-Deficit Hyperactivity Disorder",Hops,,PHASE1,,nervous_system_disease
5175,5121,Migraine,Flunarizine,C1CN(CCN1CC=CC2=CC=CC=C2)C(C3=CC=C(C=C3)F)C4=CC=C(C=C4)F,APPROVED,,nervous_system_disease
5174,5114,Morton's Neuroma,Resiniferatoxin,CC1CC2(C3C4C1(C5C=C(C(=O)C5(CC(=C4)COC(=O)CC6=CC(=C(C=C6)O)OC)O)C)OC(O3)(O2)CC7=CC=CC=C7)C(=C)C,PHASE1,,nervous_system_disease
5172,5082,Depression,Mianserin,CN1CCN2C(C1)C3=CC=CC=C3CC4=CC=CC=C42,APPROVED,,nervous_system_disease
5170,5038,Psychosis|Intellectual Disability,Clozapine,CN1CCN(CC1)C2=NC3=C(C=CC(=C3)Cl)NC4=CC=CC=C42,PHASE2,,nervous_system_disease
5169,5037,"Headache, Migraine",Norgestimate,CCC12CCC3C(C1CCC2(C#C)OC(=O)C)CCC4=CC(=NO)CCC34,PHASE1,,nervous_system_disease
5168,5004,"Malignant Primary Brain Tumors|Brain Metastases, Adult",Pritumumab,,PHASE1,,nervous_system_disease
5167,4980,Fatigue|Musculoskeletal Pain|Cognitive Decline,Pregnenolone,CC(=O)C1CCC2C1(CCC3C2CC=C4C3(CCC(C4)O)C)C,PHASE2,,nervous_system_disease
5166,4978,Spasticity,Tizanidine,C1CN=C(N1)NC2=C(C=CC3=NSN=C32)Cl,PHASE2,,nervous_system_disease
5162,4876,Autonomic Failure|Orthostatic Hypotension,Oxymetazoline,CC1=CC(=C(C(=C1CC2=NCCN2)C)O)C(C)(C)C,PHASE1,,nervous_system_disease
5161,4871,Autonomic Failure|Orthostatic Hypotension,Tranylcypromine,C1C(C1N)C2=CC=CC=C2,PHASE1,,nervous_system_disease
5159,4863,Autonomic Failure|Orthostatic Hypotension,Yohimbine,COC(=O)C1C(CCC2C1CC3C4=C(CCN3C2)C5=CC=CC=C5N4)O,PHASE1,,nervous_system_disease
5158,4834,Nicotine Withdrawal|Marijuana Dependence|Cannabis Dependence|Nicotine Dependence|Cannabis Abuse,Aprepitant,CC(C1=CC(=CC(=C1)C(F)(F)F)C(F)(F)F)OC2C(N(CCO2)CC3=NNC(=O)N3)C4=CC=C(C=C4)F,PHASE1,,nervous_system_disease
5157,4831,Parkinson Disease,Bromocriptine,CC(C)CC1C(=O)N2CCCC2C3(N1C(=O)C(O3)(C(C)C)NC(=O)C4CN(C5CC6=C(NC7=CC=CC(=C67)C5=C4)Br)C)O,APPROVED,,nervous_system_disease
5156,4818,"Acute Coronary Syndrome|Angina, Unstable",Eptifibatide,C1CC2C(=O)NC(CSSCCC(=O)NC(C(=O)NCC(=O)NC(C(=O)NC(C(=O)N2C1)CC3=CNC4=CC=CC=C43)CC(=O)O)CCCCN=C(N)N)C(=O)N,PHASE2,,nervous_system_disease
5155,4773,"Multiple Sclerosis|Multiple Sclerosis, Relapsing-Remitting",Bazedoxifene,CC1=C(N(C2=C1C=C(C=C2)O)CC3=CC=C(C=C3)OCCN4CCCCCC4)C5=CC=C(C=C5)O,PHASE2,,nervous_system_disease
5153,4761,Attention Deficit Disorder With Hyperactivity Disease|Hyperkinesis|Attention Deficit and Disruptive Behavior Disorders,Tipepidine,CN1CCCC(=C(C2=CC=CS2)C3=CC=CS3)C1,PHASE1|PHASE2,,nervous_system_disease
5150,4748,Neurologic Claudication in Patients With Lumbar Spinal Stenosis,Limaprost,CCCCC(C)CC(C=CC1C(CC(=O)C1CCCCC=CC(=O)O)O)O,APPROVED,,nervous_system_disease
5147,4675,Primary Insomnia,Adipiplon,CCCC1=C(N=CN2C1=NC(=N2)C)CN3C=CN=C3C4=C(C=CC=N4)F,PHASE2,,nervous_system_disease
5146,4652,Acute Coronary Syndrome (ACS)|High On-treatment Platelet Reactivity (HTPR)|Microvascular Obstruction (MVO)|ST-segment Elevation Myocardial Infarction (STEMI)|Thrombolysis in Myocardial Infarction (TIMI)|Unstable Angina (UA),Cangrelor,CSCCNC1=C2C(=NC(=N1)SCCC(F)(F)F)N(C=N2)C3C(C(C(O3)COP(=O)(O)OP(=O)(C(P(=O)(O)O)(Cl)Cl)O)O)O,APPROVED,,nervous_system_disease
5145,4648,Agitation on Recovery From Sedation,Hydroxyzine,C1CN(CCN1CCOCCO)C(C2=CC=CC=C2)C3=CC=C(C=C3)Cl,APPROVED,,nervous_system_disease
5144,4646,Brain Tumor|Cancer,Zotiraciclib,CN1CC=CCCOC2=CC=CC(=C2)C3=NC(=NC=C3)NC4=CC=CC(=C4)C1,PHASE1|PHASE2,,nervous_system_disease
5143,4630,Low Back Pain|Neuropathic Pain,Tapentadol,CCC(C1=CC(=CC=C1)O)C(C)CN(C)C,APPROVED,,nervous_system_disease
5142,4627,Ischemic Stroke,Mepivacaine,CC1=C(C(=CC=C1)C)NC(=O)C2CCCCN2C,PHASE2,,nervous_system_disease
5140,4621,Reflux Esophagitis,Vonoprazan,CNCC1=CN(C(=C1)C2=CC=CC=C2F)S(=O)(=O)C3=CN=CC=C3,APPROVED,,nervous_system_disease
5139,4609,Neurofibromatosis Type 1|Learning Disability|Reading Disability|NF1,Lovastatin,CCC(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC3CC(CC(=O)O3)O)C,PHASE2,,nervous_system_disease
5138,4606,Alzheimer Disease,Crenezumab,,PHASE2,,nervous_system_disease
5136,4596,Amyotrophic Lateral Sclerosis,Enoxacin,CCN1C=C(C(=O)C2=CC(=C(N=C21)N3CCNCC3)F)C(=O)O,PHASE1|PHASE2,,nervous_system_disease
5135,4579,Alzheimer's Disease|Cognitive Dysfunction,Formoterol,CC(CC1=CC=C(C=C1)OC)NCC(C2=CC(=C(C=C2)O)NC=O)O,PHASE2,,nervous_system_disease
5134,4566,Advanced Non-Small Cell Lung Cancer With MET Mutations,Tepotinib,CN1CCC(CC1)COC2=CN=C(N=C2)C3=CC=CC(=C3)CN4C(=O)C=CC(=N4)C5=CC=CC(=C5)C#N,PHASE1|PHASE2,,nervous_system_disease
5133,4552,Cushing Disease,Fimepinostat,CN(CC1=CC2=C(S1)C(=NC(=N2)C3=CN=C(C=C3)OC)N4CCOCC4)C5=NC=C(C=N5)C(=O)NO,PHASE2,,nervous_system_disease
5132,4542,Neuromyelitis Optica Spectrum Disorder,Inebilizumab,,PHASE2,,nervous_system_disease
5131,4519,"Sleep Apnea, Obstructive",Desipramine,CNCCCN1C2=CC=CC=C2CCC3=CC=CC=C31,PHASE2,,nervous_system_disease
5128,4491,Advanced Solid Tumors,Budigalimab,,PHASE1,,nervous_system_disease
5127,4486,Postherpetic Neuralgia,Zucapsaicin,CC(C)C=CCCCCC(=O)NCC1=CC(=C(C=C1)O)OC,PHASE2,,nervous_system_disease
5126,4476,Alzheimer's Disease,Bapineuzumab,,PHASE2,,nervous_system_disease
5122,4416,Alzheimer's Disease|Huntington's Disease,Ketoconazole,CC(=O)N1CCN(CC1)C2=CC=C(C=C2)OCC3COC(O3)(CN4C=CN=C4)C5=C(C=C(C=C5)Cl)Cl,PHASE1,,nervous_system_disease
5120,4381,Tourette Syndrome|Tourette Syndrome in Adolescence,Sepranolone,CC(=O)C1CCC2C1(CCC3C2CCC4C3(CCC(C4)O)C)C,PHASE2,,nervous_system_disease
5119,4380,"Ischemic Stroke, Acute",Perphenazine,C1CN(CCN1CCCN2C3=CC=CC=C3SC4=C2C=C(C=C4)Cl)CCO,PHASE2,,nervous_system_disease
5118,4379,"Ischemic Stroke, Acute",Propylthiouracil,CCCC1=CC(=O)NC(=S)N1,PHASE2,,nervous_system_disease
5114,4325,Cerebral Amyloid Angiopathy,Ponezumab,,PHASE2,,nervous_system_disease
5113,4304,Restless Legs Syndrome,Aplindore,C1C(OC2=C(O1)C=CC3=C2CC(=O)N3)CNCC4=CC=CC=C4,PHASE2,,nervous_system_disease
5112,4302,ALK Fusion-positive Solid or CNS Tumors,Alectinib,CCC1=CC2=C(C=C1N3CCC(CC3)N4CCOCC4)C(C5=C(C2=O)C6=C(N5)C=C(C=C6)C#N)(C)C,PHASE1|PHASE2,,nervous_system_disease
5110,4284,Amyotrophic Lateral Sclerosis (ALS),Masitinib,CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC(=CS4)C5=CN=CC=C5,PHASE2|PHASE3,,nervous_system_disease
5108,4262,Parkinson Disease|Idiopathic Parkinson Disease,Fluorodopa,C1=C(C(=CC(=C1O)O)F)CC(C(=O)O)N,PHASE2,,nervous_system_disease
5107,4251,Alzheimer's Disease,Flutemetamol,CNC1=C(C=C(C=C1)C2=NC3=C(S2)C=C(C=C3)O)F,PHASE2,,nervous_system_disease
5106,4250,Bipolar Disorder,Cariprazine,CN(C)C(=O)NC1CCC(CC1)CCN2CCN(CC2)C3=C(C(=CC=C3)Cl)Cl,PHASE2,,nervous_system_disease
5105,4226,Subarachnoid Hemorrhage|Aneurysmal Subarachnoid Hemorrhage,Isoflurane,C(C(F)(F)F)(OC(F)F)Cl,PHASE2,,nervous_system_disease
5104,4219,Spinal Cord Injuries,Rimonabant,CC1=C(N(N=C1C(=O)NN2CCCCC2)C3=C(C=C(C=C3)Cl)Cl)C4=CC=C(C=C4)Cl,PHASE2,,nervous_system_disease
5101,4138,Progressive Multiple Sclerosis,Dexchlorpheniramine,CN(C)CCC(C1=CC=C(C=C1)Cl)C2=CC=CC=N2,PHASE1,,nervous_system_disease
5099,4120,Migraine,Dihydroergotamine,CC1(C(=O)N2C(C(=O)N3CCCC3C2(O1)O)CC4=CC=CC=C4)NC(=O)C5CC6C(CC7=CNC8=CC=CC6=C78)N(C5)C,APPROVED,,nervous_system_disease
5098,4114,Leptomeningeal Metastasis,Endostatins,,APPROVED,,nervous_system_disease
5097,4113,Leptomeningeal Metastasis,Endostatin,CN(CC(=O)C1=CC=CC=C1)N=O,APPROVED,,nervous_system_disease
5096,4109,"Resectable, Non-functioning Pituitary Adenoma",Farletuzumab,,PHASE2,,nervous_system_disease
5095,4105,Episodic Migraine,Quinidine,COC1=CC2=C(C=CN=C2C=C1)C(C3CC4CCN3CC4C=C)O,PHASE2,,nervous_system_disease
5094,4102,Epilepsy,Brivaracetam,CCCC1CC(=O)N(C1)C(CC)C(=O)N,PHASE1,,nervous_system_disease
5091,4071,Myofascial Pain Syndromes,Thiocolchicoside,CC(=O)NC1CCC2=CC(=C(C(=C2C3=CC=C(C(=O)C=C13)SC)OC)OC)OC4C(C(C(C(O4)CO)O)O)O,APPROVED,,nervous_system_disease
5089,4040,Attention Deficit/Hyperactivity Disorder,Serdexmethylphenidate,COC(=O)C(C1CCCCN1C(=O)OC[N+]2=CC=CC(=C2)C(=O)NC(CO)C(=O)[O-])C3=CC=CC=C3,APPROVED,,nervous_system_disease
5088,4037,"Toxoplasmosis, Cerebral|HIV Infections",Atovaquone,C1CC(CCC1C2=CC=C(C=C2)Cl)C3=C(C4=CC=CC=C4C(=O)C3=O)O,PHASE2,,nervous_system_disease
5087,4036,"Toxoplasmosis, Cerebral|HIV Infections",Clarithromycin,CCC1C(C(C(C(=O)C(CC(C(C(C(C(C(=O)O1)C)OC2CC(C(C(O2)C)O)(C)OC)C)OC3C(C(CC(O3)C)N(C)C)O)(C)OC)C)C)O)(C)O,PHASE2,,nervous_system_disease
5086,4030,Parkinson's Disease,Muscimol,C1=C(ONC1=O)CN,PHASE1,,nervous_system_disease
5085,4007,Gastroparesis,Itopride,CN(C)CCOC1=CC=C(C=C1)CNC(=O)C2=CC(=C(C=C2)OC)OC,PHASE1|PHASE2,,nervous_system_disease
5084,3988,Alzheimer's Disease,Equol,C1C(COC2=C1C=CC(=C2)O)C3=CC=C(C=C3)O,PHASE1,,nervous_system_disease
5080,3906,Bipolar Disorder|Schizoaffective Disorder|Manic Disorder|Mania|Manic State,Pentazocine,CC1C2CC3=C(C1(CCN2CC=C(C)C)C)C=C(C=C3)O,PHASE2,,nervous_system_disease
5078,3891,Primary Central Nervous System Lymphoma,Glucarpidase,[Zn+2].[Zn+2].[Zn+2].[Zn+2],PHASE1,,nervous_system_disease
5077,3866,Trigeminal Neuralgia,Basimglurant,CC1=C(N=C(N1C2=CC=C(C=C2)F)C)C#CC3=CC(=NC=C3)Cl,PHASE2|PHASE3,,nervous_system_disease
5076,3838,Mania|Bipolar I|Bipolar II|Bipolar Spectrum Disorder|Bipolar Disorder,Lurasidone,C1CCC(C(C1)CN2CCN(CC2)C3=NSC4=CC=CC=C43)CN5C(=O)C6C7CCC(C7)C6C5=O,APPROVED,,nervous_system_disease
5075,3830,Central Nervous System Diseases|Pediatric Disorder|Body Indication,Gadopiclenol,C1CN(CC2=NC(=CC=C2)CN(CCN1C(CCC(=O)NCC(CO)O)C(=O)[O-])C(CCC(=O)NCC(CO)O)C(=O)[O-])C(CCC(=O)NCC(CO)O)C(=O)[O-].[Gd+3],PHASE2,,nervous_system_disease
5073,3816,Painful Diabetic Neuropathy,Astaxanthin,CC1=C(C(CC(C1=O)O)(C)C)C=CC(=CC=CC(=CC=CC=C(C)C=CC=C(C)C=CC2=C(C(=O)C(CC2(C)C)O)C)C)C,PHASE2|PHASE3,,nervous_system_disease
5072,3811,Mild Cognitive Impairment|Alzheimer Disease,Senicapoc,C1=CC=C(C=C1)C(C2=CC=C(C=C2)F)(C3=CC=C(C=C3)F)C(=O)N,PHASE2,,nervous_system_disease
5071,3751,Glaucoma; Drugs|Normal Tension Glaucoma|Primary Open-angle Glaucoma,Brimonidine,C1CN=C(N1)NC2=C(C3=NC=CN=C3C=C2)Br,APPROVED,,nervous_system_disease
5070,3750,Glaucoma; Drugs|Normal Tension Glaucoma|Primary Open-angle Glaucoma,Timolol,CC(C)(C)NCC(COC1=NSN=C1N2CCOCC2)O,APPROVED,,nervous_system_disease
5069,3734,"Spasms, Infantile|Epilepsy",Pyridoxine,CC1=NC=C(C(=C1O)CO)CO,PHASE2,,nervous_system_disease
5068,3732,Epilepsy,Eslicarbazepine,C1C(C2=CC=CC=C2N(C3=CC=CC=C31)C(=O)N)O,PHASE1,,nervous_system_disease
5066,3710,Hepatic Failure|Hepatic Impairment|Chronic Hepatitis C Infection With Hepatic Coma,Promethazine,CC(CN1C2=CC=CC=C2SC3=CC=CC=C31)N(C)C,APPROVED,,nervous_system_disease
5065,3706,Medication Overuse Headache|Analgesic Overuse Headache,Frovatriptan,CNC1CCC2=C(C1)C3=C(N2)C=CC(=C3)C(=O)N,PHASE2,,nervous_system_disease
5064,3705,Leukemia|Lymphoma|Meningeal Neoplasm,Mafosfamide,C1COP(=O)(NC1SCCS(=O)(=O)O)N(CCCl)CCCl,PHASE1,,nervous_system_disease
5063,3704,ADHD|Autism|Bipolar I Disorder|Conduct Disorder|Oppositional Defiant Disorder,Brexpiprazole,C1CN(CCN1CCCCOC2=CC3=C(C=C2)C=CC(=O)N3)C4=C5C=CSC5=CC=C4,PHASE1,,nervous_system_disease
5062,3688,Non-small Cell Lung Cancer,Capmatinib,CNC(=O)C1=C(C=C(C=C1)C2=NN3C(=CN=C3N=C2)CC4=CC5=C(C=C4)N=CC=C5)F,PHASE2,,nervous_system_disease
5061,3677,Central Nervous System Lymphoma,Acalabrutinib,CC#CC(=O)N1CCCC1C2=NC(=C3N2C=CN=C3N)C4=CC=C(C=C4)C(=O)NC5=CC=CC=N5,PHASE2,,nervous_system_disease
5060,3676,"Epilepsy, Partial Seizures",Oxcarbazepine,C1C2=CC=CC=C2N(C3=CC=CC=C3C1=O)C(=O)N,APPROVED,,nervous_system_disease
5058,3664,Amyotrophic Lateral Sclerosis,Tretinoin,CC1=C(C(CCC1)(C)C)C=CC(=CC=CC(=CC(=O)O)C)C,PHASE1|PHASE2,,nervous_system_disease
5057,3651,Pompe Disease|Hypersensitivity Reaction,Miglustat,CCCCN1CC(C(C(C1CO)O)O)O,PHASE1,,nervous_system_disease
5056,3642,Malignant Supratentorial Neoplasm|Recurrent Glioblastoma|Recurrent Gliosarcoma,Lonafarnib,C1CN(CCC1CC(=O)N2CCC(CC2)C3C4=C(CCC5=C3N=CC(=C5)Br)C=C(C=C4Br)Cl)C(=O)N,PHASE1,,nervous_system_disease
5054,3630,"Cytokine Release Syndrome|ICANS|Lymphoma, Non-Hodgkin|Multiple Myeloma|Acute Lymphoblastic Leukemia",Siltuximab,,PHASE2,,nervous_system_disease
5053,3627,Endothelial Dysfunction|Vascular Diseases|Kidney Injury|Brain Disease|Vascular Inflammation,Vericiguat,COC(=O)NC1=C(N=C(N=C1N)C2=NN(C3=C2C=C(C=N3)F)CC4=CC=CC=C4F)N,APPROVED,,nervous_system_disease
5051,3597,Migraine Disorders,Rizatriptan,CN(C)CCC1=CNC2=C1C=C(C=C2)CN3C=NC=N3,PHASE1,,nervous_system_disease
5050,3591,Multiple Sclerosis,Famciclovir,CC(=O)OCC(CCN1C=NC2=CN=C(N=C21)N)COC(=O)C,PHASE2,,nervous_system_disease
5049,3586,Adrenoleukodystrophy|Metachromatic Leukodystrophy|Globoid Cell Leukodystrophy|Tay Sachs Disease|Sandhoffs Disease|Wolman Disease|I-Cell Disease|Sanfilippo Syndrome|GM1 Gangliosidosis,Clofarabine,C1=NC2=C(N=C(N=C2N1C3C(C(C(O3)CO)O)F)Cl)N,PHASE2,,nervous_system_disease
5048,3552,Chronic Pain|Diabetic Neuropathies|Diabetes Mellitus,Cebranopadol,CN(C)C1(CCC2(CC1)C3=C(CCO2)C4=C(N3)C=CC(=C4)F)C5=CC=CC=C5,PHASE2,,nervous_system_disease
5047,3547,Attention Deficit Hyperactivity Disorder,Edivoxetine,COC1=C(C=C(C=C1)F)CC(C2CCOCC2)(C3CNCCO3)O,PHASE2|PHASE3,,nervous_system_disease
5046,3533,"Lymphoma, B-Cell",Idarubicin,CC1C(C(CC(O1)OC2CC(CC3=C2C(=C4C(=C3O)C(=O)C5=CC=CC=C5C4=O)O)(C(=O)C)O)N)O,PHASE2,,nervous_system_disease
5045,3518,"Inherited Mitochondrial Disease, Including Leigh Syndrome",Cysteamine,C(CS)N,PHASE2,,nervous_system_disease
5044,3484,Melanoma,Meprednisone,CC1CC2C3CCC4=CC(=O)C=CC4(C3C(=O)CC2(C1(C(=O)CO)O)C)C,PHASE2,,nervous_system_disease
5043,3471,Migraine,Eletriptan,CN1CCCC1CC2=CNC3=C2C=C(C=C3)CCS(=O)(=O)C4=CC=CC=C4,APPROVED,,nervous_system_disease
5042,3469,Staphylococcal Infections|Osteomyelitis|CNS Infection|Septic Arthritis|Diabetic Foot Infection|Vertebral Osteomyelitis|Abscess|Coagulase Negative Staphylococcal Infection,Cefazolin,CC1=NN=C(S1)SCC2=C(N3C(C(C3=O)NC(=O)CN4C=NN=N4)SC2)C(=O)O,APPROVED,,nervous_system_disease
5041,3468,Staphylococcal Infections|Osteomyelitis|CNS Infection|Septic Arthritis|Diabetic Foot Infection|Vertebral Osteomyelitis|Abscess|Coagulase Negative Staphylococcal Infection,Cloxacillin,CC1=C(C(=NO1)C2=CC=CC=C2Cl)C(=O)NC3C4N(C3=O)C(C(S4)(C)C)C(=O)O,APPROVED,,nervous_system_disease
5040,3459,Neurocysticercosis|Epilepsy,Albendazole,CCCSC1=CC2=C(C=C1)N=C(N2)NC(=O)OC,PHASE2|PHASE3,,nervous_system_disease
5039,3458,Neurocysticercosis|Epilepsy,Praziquantel,C1CCC(CC1)C(=O)N2CC3C4=CC=CC=C4CCN3C(=O)C2,PHASE2|PHASE3,,nervous_system_disease
5036,3385,Prosthetic Cardiac Valve Thrombosis|Cerebrovascular Accident|Prosthetic Valve Malfunction,Acenocoumarol,CC(=O)CC(C1=CC=C(C=C1)[N+](=O)[O-])C2=C(C3=CC=CC=C3OC2=O)O,APPROVED,,nervous_system_disease
5034,3361,Relapsing-remitting Multiple Sclerosis|Secondary-progressive Multiple Sclerosis|Primary-progressive Multiple Sclerosis,Norethisterone,CC12CCC3C(C1CCC2(C#C)O)CCC4=CC(=O)CCC34,PHASE2,,nervous_system_disease
5033,3360,Relapsing-remitting Multiple Sclerosis|Secondary-progressive Multiple Sclerosis|Primary-progressive Multiple Sclerosis,Norethindrone,CC12CCC3C(C1CCC2(C#C)O)CCC4=CC(=O)CCC34,PHASE2,,nervous_system_disease
5032,3346,Amyotrophic Lateral Sclerosis,Rabeprazole,CC1=C(C=CN=C1CS(=O)C2=NC3=CC=CC=C3N2)OCCCOC,PHASE1,,nervous_system_disease
5029,3299,Huntington Disease,Rolipram,COC1=C(C=C(C=C1)C2CC(=O)NC2)OC3CCCC3,PHASE1,,nervous_system_disease
5028,3294,Traumatic Brain Injury (TBI),Pregnanolone,CC(=O)C1CCC2C1(CCC3C2CCC4C3(CCC(C4)O)C)C,PHASE2,,nervous_system_disease
5027,3293,Traumatic Brain Injury (TBI),Allopregnanolone,CC(=O)C1CCC2C1(CCC3C2CCC4C3(CCC(C4)O)C)C,PHASE2,,nervous_system_disease
5026,3292,Traumatic Brain Injury (TBI),Brexanolone,CC(=O)C1CCC2C1(CCC3C2CCC4C3(CCC(C4)O)C)C,PHASE2,,nervous_system_disease
5025,3291,Transthyretin Amyloidosis,Tafamidis,C1=CC2=C(C=C1C(=O)O)OC(=N2)C3=CC(=CC(=C3)Cl)Cl,APPROVED,,nervous_system_disease
5023,3281,Amyotrophic Lateral Sclerosis,Arimoclomol,C1CCN(CC1)CC(CON=C(C2=C[N+](=CC=C2)[O-])Cl)O,PHASE2|PHASE3,,nervous_system_disease
5022,3280,Endometriosis|Pelvic Pain,Nafarelin,CC(C)CC(C(=O)NC(CCCN=C(N)N)C(=O)N1CCCC1C(=O)NCC(=O)N)NC(=O)C(CC2=CC3=CC=CC=C3C=C2)NC(=O)C(CC4=CC=C(C=C4)O)NC(=O)C(CO)NC(=O)C(CC5=CNC6=CC=CC=C65)NC(=O)C(CC7=CN=CN7)NC(=O)C8CCC(=O)N8,PHASE1|PHASE2,,nervous_system_disease
5020,3264,"Alzheimer Disease, Early Onset",Efavirenz,C1CC1C#CC2(C3=C(C=CC(=C3)Cl)NC(=O)O2)C(F)(F)F,PHASE1,,nervous_system_disease
5019,3251,Fibromyalgia,Desvenlafaxine,CN(C)CC(C1=CC=C(C=C1)O)C2(CCCCC2)O,PHASE2,,nervous_system_disease
5017,3244,"Carcinoma, Non-Small-Cell Lung|Surgery--Complications|Dexamethasone|Flubiprofen Axetil|Delirium",Flurbiprofen,CC(C1=CC(=C(C=C1)C2=CC=CC=C2)F)C(=O)O,APPROVED,,nervous_system_disease
5015,3220,"Breast Cancer Female|Pain, Postoperative",Bromelains,,APPROVED,,nervous_system_disease
5014,3219,Sleep Initiation and Maintenance Disorders|Primary Insomnia,Estazolam,C1C2=NN=CN2C3=C(C=C(C=C3)Cl)C(=N1)C4=CC=CC=C4,APPROVED,,nervous_system_disease
5011,3212,Hypertension,Trimethaphan,C1CC2C3C(C[S+]2C1)N(C(=O)N3CC4=CC=CC=C4)CC5=CC=CC=C5,PHASE1,,nervous_system_disease
5006,3148,Tinnitus,Neramexane,CC1(CC(CC(C1)(C)N)(C)C)C,PHASE2,,nervous_system_disease
5005,3146,Alzheimer´s Disease,Lornoxicam,CN1C(=C(C2=C(S1(=O)=O)C=C(S2)Cl)O)C(=O)NC3=CC=CC=N3,PHASE2,,nervous_system_disease
5003,3119,Migraine,Tezampanel,C1CC2CNC(CC2CC1CCC3=NNN=N3)C(=O)O,PHASE2,,nervous_system_disease
5001,3114,"Pulmonary Disease, Chronic Obstructive",Salmeterol,C1=CC=C(C=C1)CCCCOCCCCCCNCC(C2=CC(=C(C=C2)O)CO)O,APPROVED,,nervous_system_disease
4999,3109,Constipation,Bisacodyl,CC(=O)OC1=CC=C(C=C1)C(C2=CC=C(C=C2)OC(=O)C)C3=CC=CC=N3,APPROVED,,nervous_system_disease
4998,3108,Constipation,Docusate,CCCCC(CC)COC(=O)CC(C(=O)OCC(CC)CCCC)S(=O)(=O)O,APPROVED,,nervous_system_disease
4997,3106,Dementia With Lewy Bodies|REM Sleep Behavior Disorder|Parkinson's Disease Dementia,Nelotanserin,CN1C(=C(C=N1)Br)C2=C(C=CC(=C2)NC(=O)NC3=C(C=C(C=C3)F)F)OC,PHASE2,,nervous_system_disease
4994,3089,Aneurysmal Subarachnoid Hemorrhage,Clazosentan,CC1=CN=C(C=C1)S(=O)(=O)NC2=C(C(=NC(=N2)C3=CC(=NC=C3)C4=NNN=N4)OCCO)OC5=CC=CC=C5OC,PHASE2,,nervous_system_disease
4993,3080,Ischemic Stroke,Streptokinase,,PHASE2,,nervous_system_disease
4991,3075,Pediatric ALL|Pediatric Anesthesia,Nalbuphine,C1CC(C1)CN2CCC34C5C(CCC3(C2CC6=C4C(=C(C=C6)O)O5)O)O,APPROVED,,nervous_system_disease
4990,3063,Dementia With Lewy Bodies,Ambroxol,C1CC(CCC1NCC2=C(C(=CC(=C2)Br)Br)N)O,PHASE2,,nervous_system_disease
4989,3062,Hunter Syndrome,Idursulfase,,PHASE2|PHASE3,,nervous_system_disease
4987,3049,Coronary Artery Disease|Cerebrovascular Disease|Peripheral Vascular Disease,Rifalazil,CC1C=CC=C(C(=O)NC2=C3C(=C4C(=C(C(=C5C4=C(C(O5)(OC=CC(C(C(C(C(C(C1O)C)O)C)OC(=O)C)C)OC)C)O)C)O)C2=O)N=C6C(=CC(=CC6=O)N7CCN(CC7)CC(C)C)O3)C,PHASE2,,nervous_system_disease
4983,3035,Attention Deficit Hyperactivity Disorder,Metadoxine,CC1=NC=C(C(=C1O)CO)CO.C1CC(=O)NC1C(=O)O,PHASE1,,nervous_system_disease
4982,3027,Advanced Malignant Neoplasm|Delirium|Locally Advanced Malignant Neoplasm|Metastatic Malignant Neoplasm|Recurrent Malignant Neoplasm,Chlorpromazine,CN(C)CCCN1C2=CC=CC=C2SC3=C1C=C(C=C3)Cl,PHASE2|PHASE3,,nervous_system_disease
4978,2993,Deep Endometriosis|Pelvic Pain,Gestrinone,CCC12C=CC3=C4CCC(=O)C=C4CCC3C1CCC2(C#C)O,PHASE2,,nervous_system_disease
4975,2959,"Colon Cancer|Colon Diverticulosis|Colonic Neoplasms|Colonic Diverticulitis|Pain, Postoperative|Ileus|Ileus Paralytic|Ileus; Mechanical|Constipation Drug Induced|Constipation|Rectum Cancer|Rectum Neoplasm",Orphenadrine,CC1=CC=CC=C1C(C2=CC=CC=C2)OCCN(C)C,APPROVED,,nervous_system_disease
4974,2954,Refractory Primary Central Nervous System Lymphoma|Primary CNS Lymphoma,Tirabrutinib,CC#CC(=O)N1CCC(C1)N2C3=NC=NC(=C3N(C2=O)C4=CC=C(C=C4)OC5=CC=CC=C5)N,PHASE2,,nervous_system_disease
4973,2938,Cognitive Dysfunction|Alzheimer's Disease,Aducanumab,,PHASE2,,nervous_system_disease
4972,2909,Postural Tachycardia Syndrome,Ivabradine,CN(CCCN1CCC2=CC(=C(C=C2CC1=O)OC)OC)CC3CC4=CC(=C(C=C34)OC)OC,PHASE2,,nervous_system_disease
4971,2889,Normal Tension Glaucoma,Bimatoprost,CCNC(=O)CCCC=CCC1C(CC(C1C=CC(CCC2=CC=CC=C2)O)O)O,APPROVED,,nervous_system_disease
4970,2888,Normal Tension Glaucoma,Netarsudil,CC1=CC(=C(C=C1)C(=O)OCC2=CC=C(C=C2)C(CN)C(=O)NC3=CC4=C(C=C3)C=NC=C4)C,APPROVED,,nervous_system_disease
4969,2884,Amyotrophic Lateral Sclerosis,Biotin,C1C2C(C(S1)CCCCC(=O)O)NC(=O)N2,PHASE2,,nervous_system_disease
4968,2862,Pelvic Pain,Drospirenone,CC12CCC(=O)C=C1C3CC3C4C2CCC5(C4C6CC6C57CCC(=O)O7)C,APPROVED,,nervous_system_disease
4966,2838,Musculoskeletal Pain,Ketoprofen,CC(C1=CC(=CC=C1)C(=O)C2=CC=CC=C2)C(=O)O,PHASE1,,nervous_system_disease
4964,2822,Methamphetamine Use Disorder,Methamphetamine,CC(CC1=CC=CC=C1)NC,PHASE1,,nervous_system_disease
4963,2821,Methamphetamine Use Disorder,Metamfetamine,CC(CC1=CC=CC=C1)NC,PHASE1,,nervous_system_disease
4962,2806,Tuberous Sclerosis Complex,Vigabatrin,C=CC(CCC(=O)O)N,PHASE2|PHASE3,,nervous_system_disease
4961,2790,Delirium|Cognition Disorders,Ziprasidone,C1CN(CCN1CCC2=C(C=C3C(=C2)CC(=O)N3)Cl)C4=NSC5=CC=CC=C54,PHASE2,,nervous_system_disease
4959,2778,Tourette Syndrome,Palmidrol,CCCCCCCCCCCCCCCC(=O)NCCO,PHASE2,,nervous_system_disease
4958,2764,Brain and Central Nervous System Tumors,Mechlorethamine,CN(CCCl)CCCl,PHASE2,,nervous_system_disease
4957,2753,Stroke,Urokinase,CC(C)OC(=O)NC1=CC2=C(C=C1)N=C(N2)C3=CSC=N3,PHASE2,,nervous_system_disease
4956,2746,"Diabetes Mellitus, Type 1|Hypoglycemia|Hypoglycemia Unawareness",Diazoxide,CC1=NS(=O)(=O)C2=C(N1)C=CC(=C2)Cl,APPROVED,,nervous_system_disease
4955,2743,Spinocerebellar Ataxias|Spinocerebellar Ataxia Genotype Type 1|Spinocerebellar Ataxia Genotype Type 2|Spinocerebellar Ataxia Genotype Type 3|Spinocerebellar Ataxia Genotype Type 6|Spinocerebellar Ataxia Genotype Type 7|Spinocerebellar Ataxia Genotype Type 8|Spinocerebellar Ataxia Genotype Type 10,Troriluzole,CN(CC(=O)NC1=NC2=C(S1)C=C(C=C2)OC(F)(F)F)C(=O)CNC(=O)CN,PHASE2|PHASE3,,nervous_system_disease
4954,2730,Huntington's Disease,Tetrabenazine,CC(C)CC1CN2CCC3=CC(=C(C=C3C2CC1=O)OC)OC,APPROVED,,nervous_system_disease
4953,2724,Tardive Dyskinesia,Pyridoxal,CC1=NC=C(C(=C1O)C=O)CO,PHASE2,,nervous_system_disease
4952,2720,Huntington Disease,Deutetrabenazine,CC(C)CC1CN2CCC3=CC(=C(C=C3C2CC1=O)OC)OC,PHASE2|PHASE3,,nervous_system_disease
4951,2710,"NMO Spectrum Disorder|Spasticity, Muscle",Nabiximols,CCCCCC1=CC(=C(C(=C1)O)C2C=C(CCC2C(=C)C)C)O.CCCCCC1=CC(=C2C3C=C(CCC3C(OC2=C1)(C)C)C)O,PHASE2,,nervous_system_disease
4949,2692,Progressive Supranuclear Palsy,Davunetide,CCC(C)C(C(=O)N1CCCC1C(=O)NC(CCC(=O)N)C(=O)O)NC(=O)C(CO)NC(=O)C(C(C)C)NC(=O)C2CCCN2C(=O)C(C)NC(=O)C(CC(=O)N)N,PHASE2|PHASE3,,nervous_system_disease
4948,2675,Analgesia|Sedation,Sufentanil,CCC(=O)N(C1=CC=CC=C1)C2(CCN(CC2)CCC3=CC=CS3)COC,APPROVED,,nervous_system_disease
4946,2652,Very Low Vision Secondary to Wet Age-related Macular Degeneration,Conbercept,,PHASE2,,nervous_system_disease
4943,2613,Diabetes Mellitus|Diabetes Mellitus Complications|Gastroparesis,Relamorelin,C1CC(CNC1)C(=O)NC(CC2=CSC3=CC=CC=C32)C(=O)NC(CC4=CNC5=CC=CC=C54)C(=O)NC(CC6=CC=CC=C6)C(=O)NC7(CCNCC7)C(=O)N,PHASE2,,nervous_system_disease
4940,2610,Breast Cancer|Brain Metastases,Vinorelbine,CCC1=CC2CC(C3=C(CN(C2)C1)C4=CC=CC=C4N3)(C5=C(C=C6C(=C5)C78CCN9C7C(C=CC9)(C(C(C8N6C)(C(=O)OC)O)OC(=O)C)CC)OC)C(=O)OC,PHASE2,,nervous_system_disease
4939,2602,Relapsing Remitting Multiple Sclerosis,Loperamide,CN(C)C(=O)C(CCN1CCC(CC1)(C2=CC=C(C=C2)Cl)O)(C3=CC=CC=C3)C4=CC=CC=C4,APPROVED,,nervous_system_disease
4938,2601,Relapsing Remitting Multiple Sclerosis,Simethicone,CO[Si](C)(C)O[Si](C)(C)C.O=[Si]=O,APPROVED,,nervous_system_disease
4937,2587,Erectile Dysfunction,Avanafil,COC1=C(C=C(C=C1)CNC2=NC(=NC=C2C(=O)NCC3=NC=CC=N3)N4CCCC4CO)Cl,APPROVED,,nervous_system_disease
4934,2537,Grade 1 Meningioma|Grade 2 Meningioma|Grade 3 Meningioma|Recurrent Meningioma|Unresectable Meningioma,Dotatate,CC(C1C(=O)NC(CSSCC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N1)CCCCN)CC2=CNC3=CC=CC=C32)CC4=CC=C(C=C4)O)NC(=O)C(CC5=CC=CC=C5)NC(=O)CN6CCN(CCN(CCN(CC6)CC(=O)O)CC(=O)O)CC(=O)O)C(=O)NC(C(C)O)C(=O)O)O,PHASE2,,nervous_system_disease
4933,2534,Treatment of Depression in Adults With Parkinson's Disease (PD),Pimavanserin,CC(C)COC1=CC=C(C=C1)CNC(=O)N(CC2=CC=C(C=C2)F)C3CCN(CC3)C,PHASE2,,nervous_system_disease
4932,2530,Alzheimer Disease|Cognitive Function,Tandospirone,C1CC2CC1C3C2C(=O)N(C3=O)CCCCN4CCN(CC4)C5=NC=CC=N5,APPROVED,,nervous_system_disease
4931,2495,Chronic Obstructive Pulmonary Disease (COPD),Tesamorelin,CCC=CCC(=O)NC(CC1=CC=C(C=C1)O)C(=O)NC(C)C(=O)NC(CC(=O)O)C(=O)NC(C)C(=O)NC(C(C)CC)C(=O)NC(CC2=CC=CC=C2)C(=O)NC(C(C)O)C(=O)NC(CC(=O)N)C(=O)NC(CO)C(=O)NC(CC3=CC=C(C=C3)O)C(=O)NC(CCCNC(=N)N)C(=O)NC(CCCCN)C(=O)NC(C(C)C)C(=O)NC(CC(C)C)C(=O)NCC(=O)NC(CCC(=O)N)C(=O)NC(CC(C)C)C(=O)NC(CO)C(=O)NC(C)C(=O)NC(CCCNC(=N)N)C(=O)NC(CCCCN)C(=O)NC(CC(C)C)C(=O)NC(CC(C)C)C(=O)NC(CCC(=O)N)C(=O)NC(CC(=O)O)C(=O)NC(C(C)CC)C(=O)NC(CCSC)C(=O)NC(CO)C(=O)NC(CCCNC(=N)N)C(=O)NC(CCC(=O)N)C(=O)NC(CCC(=O)N)C(=O)NCC(=O)NC(CCC(=O)O)C(=O)NC(CO)C(=O)NC(CC(=O)N)C(=O)NC(CCC(=O)N)C(=O)NC(CCC(=O)O)C(=O)NC(CCCNC(=N)N)C(=O)NCC(=O)NC(C)C(=O)NC(CCCNC(=N)N)C(=O)NC(C)C(=O)NC(CCCNC(=N)N)C(=O)NC(CC(C)C)C(=O)N,PHASE2,,nervous_system_disease
4917,2429,Glioblastoma Multiforme|Glioma|Gliosarcoma|Malignant Brain Tumor|Ependymoma|Medulloblastoma|Diffuse Intrinsic Pontine Glioma|Primary CNS Tumor,Indoximod,CN1C=C(C2=CC=CC=C21)CC(C(=O)O)N,PHASE1,,nervous_system_disease
4916,2423,Delirium,Citicoline,C[N+](C)(C)CCOP(=O)([O-])OP(=O)(O)OCC1C(C(C(O1)N2C=CC(=NC2=O)N)O)O,APPROVED,,nervous_system_disease
4915,2410,Agitation,Loxapine,CN1CCN(CC1)C2=NC3=CC=CC=C3OC4=C2C=C(C=C4)Cl,APPROVED,,nervous_system_disease
4914,2406,Insomnia|Generalized Anxiety Disorder,Eszopiclone,CN1CCN(CC1)C(=O)OC2C3=NC=CN=C3C(=O)N2C4=NC=C(C=C4)Cl,APPROVED,,nervous_system_disease
4913,2401,Insomnia Disorder,Flurazepam,CCN(CC)CCN1C(=O)CN=C(C2=C1C=CC(=C2)Cl)C3=CC=CC=C3F,PHASE1,,nervous_system_disease
4911,2394,Breast Neoplasms|Brain Neoplasms|Neoplasms by Site|Neoplasms|Breast Diseases|Central Nervous System Neoplasms|Brain Diseases|Central Nervous System Diseases,Elacestrant,CCNCCC1=CC=C(C=C1)CN(CC)C2=C(C=CC(=C2)OC)C3CCC4=C(C3)C=CC(=C4)O,PHASE1|PHASE2,,nervous_system_disease
4910,2390,Becker Muscular Dystrophy,Vamorolone,CC1CC2C3CCC4=CC(=O)C=CC4(C3=CCC2(C1(C(=O)CO)O)C)C,PHASE2,,nervous_system_disease
4909,2383,Aneurysmal Subarachnoid Hemorrhage,Nicardipine,CC1=C(C(C(=C(N1)C)C(=O)OCCN(C)CC2=CC=CC=C2)C3=CC(=CC=C3)[N+](=O)[O-])C(=O)OC,PHASE2,,nervous_system_disease
4906,2347,REM Sleep Behavior Disorder,Clonazepam,C1C(=O)NC2=C(C=C(C=C2)[N+](=O)[O-])C(=N1)C3=CC=CC=C3Cl,PHASE2,,nervous_system_disease
4905,2344,Muscle Relaxants,Succinylcholine,C[N+](C)(C)CCOC(=O)CCC(=O)OCC[N+](C)(C)C,APPROVED,,nervous_system_disease
4904,2336,Anovulatory Infertility|Abnormal Uterine Bleeding-Ovulatory Disorders|Polycystic Ovarian Syndrome|Hyperprolactinemia|Luteinized Unruptured Follicle Syndrome|Corpus Luteum Insufficiency|Ovarian Insufficiency,Clomifene,CCN(CC)CCOC1=CC=C(C=C1)C(=C(C2=CC=CC=C2)Cl)C3=CC=CC=C3,PHASE2,,nervous_system_disease
4903,2335,Anovulatory Infertility|Abnormal Uterine Bleeding-Ovulatory Disorders|Polycystic Ovarian Syndrome|Hyperprolactinemia|Luteinized Unruptured Follicle Syndrome|Corpus Luteum Insufficiency|Ovarian Insufficiency,Clomiphene,CCN(CC)CCOC1=CC=C(C=C1)C(=C(C2=CC=CC=C2)Cl)C3=CC=CC=C3,PHASE2,,nervous_system_disease
4902,2330,Diabetes,Epalrestat,CC(=CC1=CC=CC=C1)C=C2C(=O)N(C(=S)S2)CC(=O)O,APPROVED,,nervous_system_disease
4900,2299,Amyotrophic Lateral Sclerosis,Cimetidine,CC1=C(N=CN1)CSCCNC(=NC)NC#N,PHASE1,,nervous_system_disease
4897,2263,Neurofibromatosis Type 2|Vestibular Schwannoma|Non-vestibular Schwannoma|Meningioma|Ependymoma,Brigatinib,CN1CCN(CC1)C2CCN(CC2)C3=CC(=C(C=C3)NC4=NC=C(C(=N4)NC5=CC=CC=C5P(=O)(C)C)Cl)OC,PHASE2,,nervous_system_disease
4896,2261,Metastatic BRCA-Associated Breast Carcinoma|Metastatic Breast Carcinoma|Metastatic Malignant Neoplasm in the Brain|Metastatic Triple-Negative Breast Carcinoma|Recurrent Breast Carcinoma|Stage IV Breast Cancer AJCC v6 and v7,Veliparib,CC1(CCCN1)C2=NC3=C(C=CC=C3N2)C(=O)N,PHASE2,,nervous_system_disease
4895,2255,Leptomeningeal Metastasis|Lung Cancer,Nimotuzumab,,PHASE2,,nervous_system_disease
4894,2253,Parkinson Disease|Movement Disorders,Altropane,COC(=O)C1C2CCC(N2CC=CI)CC1C3=CC=C(C=C3)F,PHASE2,,nervous_system_disease
4887,2216,"Dental Pain|Anesthesia, Local",Articaine,CCCNC(C)C(=O)NC1=C(SC=C1C)C(=O)OC,APPROVED,,nervous_system_disease
4886,2212,Myotonic Dystrophy 1,Tideglusib,C1=CC=C(C=C1)CN2C(=O)N(SC2=O)C3=CC=CC4=CC=CC=C43,PHASE2,,nervous_system_disease
4885,2204,"Medulloblastoma|Astrocytoma, Grade III|Glioblastoma|Anaplastic Astrocytoma|Brain Stem Neoplasms, Malignant|Oligodendroblastoma|Anaplastic Oligodendroglioma|Malignant Glioma",Mebendazole,COC(=O)NC1=NC2=C(N1)C=C(C=C2)C(=O)C3=CC=CC=C3,PHASE1,,nervous_system_disease
4883,2180,"Hereditary Tyrosinemia, Type I",Nitisinone,C1CC(=O)C(C(=O)C1)C(=O)C2=C(C=C(C=C2)C(F)(F)F)[N+](=O)[O-],PHASE1,,nervous_system_disease
4882,2174,Non Small Cell Lung Cancer|Brain Metastases,Dacomitinib,COC1=C(C=C2C(=C1)N=CN=C2NC3=CC(=C(C=C3)F)Cl)NC(=O)C=CCN4CCCCC4,PHASE2,,nervous_system_disease
4881,2165,Attention-Deficit/Hyperactivity Disorder (ADHD),Dexmethylphenidate,COC(=O)C(C1CCCCN1)C2=CC=CC=C2,APPROVED,,nervous_system_disease
4879,2161,Sarcopenia,Nandrolone,CC12CCC3C(C1CCC2O)CCC4=CC(=O)CCC34,PHASE2,,nervous_system_disease
4878,2159,Idiopathic Parkinson's Disease,Liatermin,,PHASE1,,nervous_system_disease
4876,2144,Active Melanoma Brain Metastases,Cobimetinib,C1CCNC(C1)C2(CN(C2)C(=O)C3=C(C(=C(C=C3)F)F)NC4=C(C=C(C=C4)I)F)O,PHASE2,,nervous_system_disease
4874,2139,Gaucher Disease|HCV,Ledipasvir,CC(C)C(C(=O)N1CC2(CC2)CC1C3=NC=C(N3)C4=CC5=C(C=C4)C6=C(C5(F)F)C=C(C=C6)C7=CC8=C(C=C7)N=C(N8)C9C1CCC(C1)N9C(=O)C(C(C)C)NC(=O)OC)NC(=O)OC,APPROVED,,nervous_system_disease
4872,2128,Gastroparesis,Nizatidine,CNC(=C[N+](=O)[O-])NCCSCC1=CSC(=N1)CN(C)C,PHASE1,,nervous_system_disease
4871,2125,Gastroparesis|Opioid Use,Naloxegol,COCCOCCOCCOCCOCCOCCOCCOC1CCC2(C3CC4=C5C2(C1OC5=C(C=C4)O)CCN3CC=C)O,PHASE2,,nervous_system_disease
4869,2114,"Muscular Dystrophy, Duchenne",Rimeporide,CC1=CC(=C(C=C1C(=O)N=C(N)N)S(=O)(=O)C)S(=O)(=O)C,PHASE1,,nervous_system_disease
4867,2096,Duchenne Muscular Dystrophy,Golodirsen,,PHASE2,,nervous_system_disease
4866,2095,Duchenne Muscular Dystrophy,Eteplirsen,,PHASE2,,nervous_system_disease
4865,2094,Duchenne Muscular Dystrophy,Casimersen,,PHASE2,,nervous_system_disease
4864,2074,CNS Lymphoma,Orelabrutinib,C=CC(=O)N1CCC(CC1)C2=NC(=C(C=C2)C(=O)N)C3=CC=C(C=C3)OC4=CC=CC=C4,PHASE2,,nervous_system_disease
4863,2060,Trigeminal Neuralgia|Glossopharyngeal Neuralgia,Galcanezumab,,APPROVED,,nervous_system_disease
4861,2053,Intraocular Pressure,Rimexolone,CCC(=O)C1(C(CC2C1(CC(C3C2CCC4=CC(=O)C=CC34C)O)C)C)C,APPROVED,,nervous_system_disease
4860,2052,Intraocular Pressure,Fluorometholone,CC1CC2C3CCC(C3(CC(C2(C4(C1=CC(=O)C=C4)C)F)O)C)(C(=O)C)O,APPROVED,,nervous_system_disease
4859,2050,"Alzheimers Disease|Dementia|Alzheimers Disease, Familial",Lecanemab,,PHASE2|PHASE3,,nervous_system_disease
4857,2024,Leber's Hereditary Optic Neuropathy (LHON),Idebenone,CC1=C(C(=O)C(=C(C1=O)OC)OC)CCCCCCCCCCO,APPROVED,,nervous_system_disease
4856,2022,Epilepsy,Clobazam,CN1C(=O)CC(=O)N(C2=C1C=CC(=C2)Cl)C3=CC=CC=C3,PHASE2,,nervous_system_disease
4855,2011,Peripheral Nerve Injury,Cambiogenplasmid,,PHASE1|PHASE2,,nervous_system_disease
4854,1985,Fibromyalgia,Esreboxetine,CCOC1=CC=CC=C1OC(C2CNCCO2)C3=CC=CC=C3,PHASE2,,nervous_system_disease
4853,1984,Multiple Sclerosis,Cladribine,C1C(C(OC1N2C=NC3=C(N=C(N=C32)Cl)N)CO)O,APPROVED,,nervous_system_disease
4852,1982,Diabetic Polyneuropathy,Eptinezumab,,PHASE2,,nervous_system_disease
4851,1981,Friedreich Ataxia,Vatiquinone,CC1=C(C(=O)C(=C(C1=O)C)CCC(C)(CCC=C(C)CCC=C(C)CCC=C(C)C)O)C,PHASE2|PHASE3,,nervous_system_disease
4850,1980,Lung Cancer,Almonertinib,CN(C)CCN(C)C1=CC(=C(C=C1NC(=O)C=C)NC2=NC=CC(=N2)C3=CN(C4=CC=CC=C43)C5CC5)OC,PHASE2,,nervous_system_disease
4849,1972,Alzheimer's Disease,Tricaprylin,CCCCCCCC(=O)OCC(COC(=O)CCCCCCC)OC(=O)CCCCCCC,PHASE2,,nervous_system_disease
4848,1968,"Stroke, Acute",Ocriplasmin,,PHASE2,,nervous_system_disease
4847,1963,Fragile X Syndrome,Gaboxadol,C1CNCC2=C1C(=O)NO2,PHASE2,,nervous_system_disease
4846,1961,Fragile X Syndrome,Sulindac,CC1=C(C2=C(C1=CC3=CC=C(C=C3)S(=O)C)C=CC(=C2)F)CC(=O)O,PHASE2,,nervous_system_disease
4843,1945,Corneal Abrasions,Proparacaine,CCCOC1=C(C=C(C=C1)C(=O)OCCN(CC)CC)N,PHASE1,,nervous_system_disease
4841,1923,Renal Colic,Piroxicam,CN1C(=C(C2=CC=CC=C2S1(=O)=O)O)C(=O)NC3=CC=CC=N3,PHASE1|PHASE2,,nervous_system_disease
4839,1916,Brain and Central Nervous System Tumors,Cytochlor,C1C(C(OC1N2C=C(C(=NC2=O)N)Cl)CO)O,PHASE1,,nervous_system_disease
4836,1891,Strabismus,Thiopental,CCCC(C)C1(C(=O)NC(=S)NC1=O)CC,PHASE2,,nervous_system_disease
4833,1866,"Alcohol Abuse, Nervous System",Pitolisant,C1CCN(CC1)CCCOCCCC2=CC=C(C=C2)Cl,PHASE2,,nervous_system_disease
4830,1834,Alzheimer Disease,Huperzine A,CC=C1C2CC3=C(C1(CC(=C2)C)N)C=CC(=O)N3,PHASE2,,nervous_system_disease
4829,1832,Hypoactive Delirium,Flumazenil,CCOC(=O)C1=C2CN(C(=O)C3=C(N2C=N1)C=CC(=C3)F)C,APPROVED,,nervous_system_disease
4828,1826,Acute Stroke|Aspiration Pneumonia,Metoclopramide,CCN(CC)CCNC(=O)C1=CC(=C(C=C1OC)N)Cl,APPROVED,,nervous_system_disease
4827,1809,Brain Cancer,Dexanabinol,CCCCCCC(C)(C)C1=CC(=C2C3CC(=CCC3C(OC2=C1)(C)C)CO)O,PHASE1,,nervous_system_disease
4824,1803,Alzheimer's Disease|Huntington's Disease,Latrepirdine,CC1=CC2=C(C=C1)N(C3=C2CN(CC3)C)CCC4=CN=C(C=C4)C,PHASE1,,nervous_system_disease
4823,1801,Gastroparesis|Diabetes Mellitus,Cisapride,COC1CN(CCC1NC(=O)C2=CC(=C(C=C2OC)N)Cl)CCCOC3=CC=C(C=C3)F,APPROVED,,nervous_system_disease
4820,1770,"Hearing Loss|Deafness|Hearing Loss, Sensorineural|Hearing Disorders|Ear Diseases",Ancrod,,PHASE1|PHASE2,,nervous_system_disease
4819,1769,Vestibular Schwannoma|Neurofibromatosis Type 2,Icotinib,C#CC1=CC(=CC=C1)NC2=NC=NC3=CC4=C(C=C32)OCCOCCOCCO4,PHASE2,,nervous_system_disease
4817,1747,Alzheimer's Disease,Avagacestat,C1=CC(=CC=C1S(=O)(=O)N(CC2=C(C=C(C=C2)C3=NOC=N3)F)C(CCC(F)(F)F)C(=O)N)Cl,PHASE2,,nervous_system_disease
4814,1723,Brain Metastasis|Non-small Cell Lung Cancer,Patupilone,CC1CCCC2(C(O2)CC(OC(=O)CC(C(C(=O)C(C1O)C)(C)C)O)C(=CC3=CSC(=N3)C)C)C,PHASE2,,nervous_system_disease
4811,1710,Dental Pain|Postoperative Pain,Benzocaine,CCOC(=O)C1=CC=C(C=C1)N,APPROVED,,nervous_system_disease
4810,1701,Renal Colic,Dipyrone,CC1=C(C(=O)N(N1C)C2=CC=CC=C2)N(C)CS(=O)(=O)[O-].[Na+],APPROVED,,nervous_system_disease
4809,1696,Pompe Disease,Clenbuterol,CC(C)(C)NCC(C1=CC(=C(C(=C1)Cl)N)Cl)O,PHASE1|PHASE2,,nervous_system_disease
4807,1689,Migraine,Levonorgestrel,CCC12CCC3C(C1CCC2(C#C)O)CCC4=CC(=O)CCC34,PHASE2,,nervous_system_disease
4806,1688,Cochlear Hearing Loss,Triamcinolone,CC12CC(C3(C(C1CC(C2(C(=O)CO)O)O)CCC4=CC(=O)C=CC43C)F)O,PHASE1,,nervous_system_disease
4805,1683,"Ischemic Stroke, Acute",Plasminogen,,APPROVED,,nervous_system_disease
4801,1671,Bacterial Infection|Brain Injury,Metronidazole,CC1=NC=C(N1CCO)[N+](=O)[O-],PHASE1,,nervous_system_disease
4800,1668,Pompe Disease,Duvoglustat,C1C(C(C(C(N1)CO)O)O)O,PHASE2,,nervous_system_disease
4799,1667,Peripheral Neuropathy|Type 1 Diabetes,Salsalate,C1=CC=C(C(=C1)C(=O)OC2=CC=CC=C2C(=O)O)O,PHASE2,,nervous_system_disease
4796,1662,Pediatric Brain Tumor|Diffuse Intrinsic Pontine Glioma,Veledimex,CCCC(C(C)(C)C)N(C(=O)C1=CC(=CC(=C1)C)C)NC(=O)C2=C(C(=CC=C2)OC)CC,PHASE1|PHASE2,,nervous_system_disease
4793,1657,Chronic Obstructive Pulmonary Disease,Glycopyrronium,C[N+]1(CCC(C1)OC(=O)C(C2CCCC2)(C3=CC=CC=C3)O)C,APPROVED,,nervous_system_disease
4792,1655,Chronic Obstructive Pulmonary Disease,Indacaterol,CCC1=C(C=C2CC(CC2=C1)NCC(C3=C4C=CC(=O)NC4=C(C=C3)O)O)CC,APPROVED,,nervous_system_disease
4791,1652,Diabetic Polyneuropathy,Lidorestat,C1=CC=C2C(=C1)C(=CN2CC(=O)O)CC3=NC4=C(C(=CC(=C4S3)F)F)F,PHASE2,,nervous_system_disease
4790,1650,Moderate to Severe Pain Due to Diabetic Polyneuropathy,Naloxone,C=CCN1CCC23C4C(=O)CCC2(C1CC5=C3C(=C(C=C5)O)O4)O,PHASE2,,nervous_system_disease
4789,1645,Obesity|Diabetes|Obstructive Sleep Apnea,Orlistat,CCCCCCCCCCCC(CC1C(C(=O)O1)CCCCCC)OC(=O)C(CC(C)C)NC=O,PHASE2,,nervous_system_disease
4788,1638,Sleep Apnea,Danavorexton,COC(=O)N1CCCC(C1COC2CCC(CC2)C3=CC=CC=C3)NS(=O)(=O)C,PHASE1,,nervous_system_disease
4787,1637,Blepharospasm|Dystonia,Dipraglurant,C1=CC=NC(=C1)C#CCCC2=CN3C=C(C=CC3=N2)F,PHASE2,,nervous_system_disease
4786,1635,Attention Deficit Hyperactivity Disorder (ADHD),Lisdexamfetamine,CC(CC1=CC=CC=C1)NC(=O)C(CCCCN)N,APPROVED,,nervous_system_disease
4785,1634,Healthy|Pituitary Disease|Thyroid Disease,Thyrotropin,,PHASE2,,nervous_system_disease
4783,1613,Acute Cerebrovascular Accident|Cerebral Edema,Conivaptan,CC1=NC2=C(N1)CCN(C3=CC=CC=C32)C(=O)C4=CC=C(C=C4)NC(=O)C5=CC=CC=C5C6=CC=CC=C6,PHASE2,,nervous_system_disease
4781,1597,"Multiple Sclerosis, Relapsing-Remitting",Ocrelizumab,,APPROVED,,nervous_system_disease
4778,1588,Ischemic Stroke,Glyburide,COC1=C(C=C(C=C1)Cl)C(=O)NCCC2=CC=C(C=C2)S(=O)(=O)NC(=O)NC3CCCCC3,PHASE1|PHASE2,,nervous_system_disease
4776,1560,Clinical Stage IV Cutaneous Melanoma AJCC v8|Metastatic Melanoma|Pathologic Stage IV Cutaneous Melanoma AJCC v8,Encorafenib,CC(C)N1C=C(C(=N1)C2=C(C(=CC(=C2)Cl)NS(=O)(=O)C)F)C3=NC(=NC=C3)NCC(C)NC(=O)OC,PHASE2,,nervous_system_disease
4774,1554,Angina Pectoris,Lacidipine,CCOC(=O)C1=C(NC(=C(C1C2=CC=CC=C2C=CC(=O)OC(C)(C)C)C(=O)OCC)C)C,PHASE2,,nervous_system_disease
4773,1542,Tonic-clonic Seizure,Phenytoin,C1=CC=C(C=C1)C2(C(=O)NC(=O)N2)C3=CC=CC=C3,APPROVED,,nervous_system_disease
4772,1541,Tonic-clonic Seizure,Fosphenytoin,C1=CC=C(C=C1)C2(C(=O)N(C(=O)N2)COP(=O)(O)O)C3=CC=CC=C3,APPROVED,,nervous_system_disease
4770,1530,Alzheimer's Disease,Nefiracetam,CC1=C(C(=CC=C1)C)NC(=O)CN2CCCC2=O,PHASE2,,nervous_system_disease
4767,1502,Neurogenic Orthostatic Hypotension,Fludrocortisone,CC12CCC(=O)C=C1CCC3C2(C(CC4(C3CCC4(C(=O)CO)O)C)O)F,APPROVED,,nervous_system_disease
4766,1499,Hearing Loss Ototoxic,Azasetron,CN1C(=O)COC2=C(C=C(C=C21)Cl)C(=O)NC3CN4CCC3CC4,PHASE2,,nervous_system_disease
4765,1492,"Multiple Sclerosis, Relapsing-Remitting|Multiple Sclerosis",Guanabenz,C1=CC(=C(C(=C1)Cl)C=NN=C(N)N)Cl,PHASE1,,nervous_system_disease
4762,1475,Toxoplasmosis,Sulfadiazine,C1=CN=C(N=C1)NS(=O)(=O)C2=CC=C(C=C2)N,APPROVED,,nervous_system_disease
4761,1474,Toxoplasmosis,Spiramycin,CC1CC=CC=CC(C(CC(C(C(C(CC(=O)O1)O)OC)OC2C(C(C(C(O2)C)OC3CC(C(C(O3)C)O)(C)O)N(C)C)O)CC=O)C)OC4CCC(C(O4)C)N(C)C,APPROVED,,nervous_system_disease
4760,1471,REM Sleep Behavior Disorder|Pre-motor Parkinson's Disease|Symptomatic Parkinson Disease,Terazosin,COC1=C(C=C2C(=C1)C(=NC(=N2)N3CCN(CC3)C(=O)C4CCCO4)N)OC,PHASE2,,nervous_system_disease
4756,1448,"Dysphonia, Spastic|Dysphonia|Laryngeal Dystonia",Pyridostigmine,C[N+]1=CC=CC(=C1)OC(=O)N(C)C,APPROVED,,nervous_system_disease
4749,1424,Alzheimer Disease,Venlafaxine,CN(C)CC(C1=CC=C(C=C1)OC)C2(CCCCC2)O,PHASE1,,nervous_system_disease
4748,1410,Multiple Sclerosis,Firategrast,CCOCC1=CC(=C(C(=C1)OC)C2=CC=C(C=C2)CC(C(=O)O)NC(=O)C3=C(C=CC=C3F)F)OC,PHASE2,,nervous_system_disease
4745,1385,"Multiple Sclerosis, Relapsing-Remitting",Inosine,C1=NC2=C(C(=O)N1)N=CN2C3C(C(C(O3)CO)O)O,PHASE2,,nervous_system_disease
4744,1380,Down Syndrome,Ubiquinol,CC1=C(C(=C(C(=C1O)OC)OC)O)CC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)C,PHASE2,,nervous_system_disease
4743,1364,Postoperative Cognitive Dysfunction|Postoperative Delirium,Tropisetron,CN1C2CCC1CC(C2)OC(=O)C3=CNC4=CC=CC=C43,APPROVED,,nervous_system_disease
4742,1352,Attention Deficit Disorder With Hyperactivity,Amphetamine,CC(CC1=CC=CC=C1)N,PHASE2,,nervous_system_disease
4741,1347,Brain Cancer,Palonosetron,C1CC2CN(C(=O)C3=CC=CC(=C23)C1)C4CN5CCC4CC5,PHASE2,,nervous_system_disease
4736,1314,Complex Regional Pain Syndrome,Soticlestat,C1CN(CCC1(CC2=CC=CC=C2)O)C(=O)C3=C(N=CC=C3)C4=CC=NC=C4,PHASE2,,nervous_system_disease
4734,1311,"Multiple Myeloma|Multiple Myeloma in Relapse|Multiple Myeloma, Refractory",Marizomib,CC12C(C(=O)NC1(C(=O)O2)C(C3CCCC=C3)O)CCCl,PHASE2,,nervous_system_disease
4729,1288,Muscular Dystrophies,Drisapersen,COC1C(C(OC1N2C=CC(=O)NC2=O)COP(=S)(O)OC3C(OC(C3OC)N4C=CC(=NC4=O)N)COP(=S)(O)OC5C(OC(C5OC)N6C=CC(=O)NC6=O)COP(=S)(O)OC7C(OC(C7OC)N8C=CC(=O)NC8=O)COP(=S)(O)OC9C(OC(C9OC)N1C=CC(=O)NC1=O)COP(=S)(O)OC1C(OC(C1OC)N1C=NC2=C(N=CN=C21)N)COP(=S)(O)OC1C(OC(C1OC)N1C=CC(=NC1=O)N)COP(=S)(O)OC1C(OC(C1OC)N1C=NC2=C1N=C(NC2=O)N)COP(=S)(O)OC1C(OC(C1OC)N1C=NC2=C1N=C(NC2=O)N)COP(=S)(O)OC1C(OC(C1OC)N1C=CC(=O)NC1=O)COP(=S)(O)OC1C(OC(C1OC)N1C=NC2=C(N=CN=C21)N)COP(=S)(O)OC1C(OC(C1OC)N1C=NC2=C1N=C(NC2=O)N)COP(=S)(O)OC1C(OC(C1OC)N1C=NC2=C(N=CN=C21)N)COP(=S)(O)OC1C(OC(C1OC)N1C=NC2=C(N=CN=C21)N)COP(=S)(O)OC1C(OC(C1OC)N1C=NC2=C1N=C(NC2=O)N)COP(=S)(O)OC1C(OC(C1OC)N1C=NC2=C1N=C(NC2=O)N)COP(=S)(O)OC1C(OC(C1OC)N1C=NC2=C(N=CN=C21)N)COP(=S)(O)OC1C(OC(C1OC)N1C=NC2=C(N=CN=C21)N)COP(=O)(OC1C(OC(C1OC)N1C=CC(=NC1=O)N)COP(=S)(O)OC1C(OC(C1OC)N1C=CC(=O)NC1=O)CO)S)O,PHASE2,,nervous_system_disease
4728,1277,Fragile X Syndrome,Roflumilast,C1CC1COC2=C(C=CC(=C2)C(=O)NC3=C(C=NC=C3Cl)Cl)OC(F)F,PHASE2,,nervous_system_disease
4724,1221,Hypoxia|Altitude|Heart Failure,Nebivolol,C1CC2=C(C=CC(=C2)F)OC1C(CNCC(C3CCC4=C(O3)C=CC(=C4)F)O)O,APPROVED,,nervous_system_disease
4723,1217,Alzheimer Disease,Lecozotan,CC(CN(C1=CC=CC=N1)C(=O)C2=CC=C(C=C2)C#N)N3CCN(CC3)C4=C5C(=CC=C4)OCCO5,PHASE1,,nervous_system_disease
4719,1210,Dementia|Alzheimer Disease,Dextroamphetamine,CC(CC1=CC=CC=C1)N,APPROVED,,nervous_system_disease
4718,1203,Multiple Sclerosis,Isoxsuprine,CC(COC1=CC=CC=C1)NC(C)C(C2=CC=C(C=C2)O)O,PHASE1|PHASE2,,nervous_system_disease
4717,1192,Amyotrophic Lateral Sclerosis,Verdiperstat,CC(C)OCCN1C2=C(C(=O)NC1=S)NC=C2,PHASE2|PHASE3,,nervous_system_disease
4716,1189,Parkinson's Disease,Istradefylline,CCN1C2=C(C(=O)N(C1=O)CC)N(C(=N2)C=CC3=CC(=C(C=C3)OC)OC)C,PHASE2,,nervous_system_disease
4714,1182,Chemotherapy-induced Neuropathic Pain|Chemotherapy-induced Peripheral Neuropathy,Tetrodotoxin,C(C1(C2C3C(N=C(NC34C(C1OC(C4O)(O2)O)O)N)O)O)O,PHASE2,,nervous_system_disease
4712,1176,Tourette's Syndrome,Ecopipam,CN1CCC2=CC(=C(C=C2C3C1CCC4=CC=CC=C34)O)Cl,PHASE1|PHASE2,,nervous_system_disease
4711,1175,Transthyretin (TTR)-Mediated Amyloidosis|Familial Amyloidotic Polyneuropathy (FAP)|ATTR Amyloidosis|Familial Amyloid Neuropathies,Revusiran,,PHASE2,,nervous_system_disease
4708,1162,Primary Mitochondrial Disease,Elamipretide,CC1=CC(=CC(=C1CC(C(=O)NC(CCCCN)C(=O)NC(CC2=CC=CC=C2)C(=O)N)NC(=O)C(CCCN=C(N)N)N)C)O,PHASE2,,nervous_system_disease
4707,1161,Amyotrophic Lateral Sclerosis,Fasudil,C1CNCCN(C1)S(=O)(=O)C2=CC=CC3=C2C=CN=C3,PHASE2,,nervous_system_disease
4703,1144,"Meningitis, Cryptococcal|HIV Infections",Flucytosine,C1=NC(=O)NC(=C1F)N,PHASE2,,nervous_system_disease
4701,1142,"Meningitis, Cryptococcal|HIV Infections",Amphotericin B,CC1C=CC=CC=CC=CC=CC=CC=CC(CC2C(C(CC(O2)(CC(CC(C(CCC(CC(CC(=O)OC(C(C1O)C)C)O)O)O)O)O)O)O)C(=O)O)OC3C(C(C(C(O3)C)O)N)O,PHASE2,,nervous_system_disease
4700,1139,Rett Syndrome,Trofinetide,CC1(CCCN1C(=O)CN)C(=O)NC(CCC(=O)O)C(=O)O,PHASE2|PHASE3,,nervous_system_disease
4697,1136,"Leukoencephalopathy, Progressive Multifocal|HIV Infections",Enfuvirtide,CCC(C)C(C(=O)NC(CCC(=O)O)C(=O)NC(CCC(=O)O)C(=O)NC(CO)C(=O)NC(CCC(=O)N)C(=O)NC(CC(=O)N)C(=O)NC(CCC(=O)N)C(=O)NC(CCC(=O)N)C(=O)NC(CCC(=O)O)C(=O)NC(CCCCN)C(=O)NC(CC(=O)N)C(=O)NC(CCC(=O)O)C(=O)NC(CCC(=O)N)C(=O)NC(CCC(=O)O)C(=O)NC(CC(C)C)C(=O)NC(CC(C)C)C(=O)NC(CCC(=O)O)C(=O)NC(CC(C)C)C(=O)NC(CC(=O)O)C(=O)NC(CCCCN)C(=O)NC(CC1=CNC2=CC=CC=C21)C(=O)NC(C)C(=O)NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC3=CNC4=CC=CC=C43)C(=O)NC(CC(=O)N)C(=O)NC(CC5=CNC6=CC=CC=C65)C(=O)NC(CC7=CC=CC=C7)C(=O)N)NC(=O)C(CC(C)C)NC(=O)C(CO)NC(=O)C(CC8=CN=CN8)NC(=O)C(C(C)CC)NC(=O)C(CC(C)C)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C(CC9=CC=C(C=C9)O)NC(=O)C,PHASE2,,nervous_system_disease
4696,1131,Diabetic Neuropathies,Carisbamate,C1=CC=C(C(=C1)C(COC(=O)N)O)Cl,PHASE2,,nervous_system_disease
4695,1120,Major Depressive Disorder|Dementia,Vortioxetine,CC1=CC(=C(C=C1)SC2=CC=CC=C2N3CCNCC3)C,APPROVED,,nervous_system_disease
4694,1116,Multiple Sclerosis,Ublituximab,,PHASE2,,nervous_system_disease
4690,1094,Intracranial Non-germinomatous Germ Cell Tumor,Thiotepa,C1CN1P(=S)(N2CC2)N3CC3,PHASE2,,nervous_system_disease
4688,1086,Parkinson Disease,Talampanel,CC1CC2=CC3=C(C=C2C(=NN1C(=O)C)C4=CC=C(C=C4)N)OCO3,PHASE2,,nervous_system_disease
4687,1081,Emotional Disorder|Neurologic Disorder,Flupentixol,C1CN(CCN1CCC=C2C3=CC=CC=C3SC4=C2C=C(C=C4)C(F)(F)F)CCO,APPROVED,,nervous_system_disease
4686,1080,Emotional Disorder|Neurologic Disorder,Flupenthixol,C1CN(CCN1CCC=C2C3=CC=CC=C3SC4=C2C=C(C=C4)C(F)(F)F)CCO,APPROVED,,nervous_system_disease
4685,1070,Parkinson Disease,Apomorphine,CN1CCC2=C3C1CC4=C(C3=CC=C2)C(=C(C=C4)O)O,APPROVED,,nervous_system_disease
4682,1057,Blood Pressure|Ischemic Stroke,Atenolol,CC(C)NCC(COC1=CC=C(C=C1)CC(=O)N)O,APPROVED,,nervous_system_disease
4680,1055,Blood Pressure|Ischemic Stroke,Fimasartan,CCCCC1=NC(=C(C(=O)N1CC2=CC=C(C=C2)C3=CC=CC=C3C4=NNN=N4)CC(=S)N(C)C)C,APPROVED,,nervous_system_disease
4679,1053,Ischemic Heart Disease,Quinapril,CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N2CC3=CC=CC=C3CC2C(=O)O,APPROVED,,nervous_system_disease
4677,1046,Primary Central Nervous System Lymphoma,Isavuconazole,CC(C1=NC(=CS1)C2=CC=C(C=C2)C#N)C(CN3C=NC=N3)(C4=C(C=CC(=C4)F)F)O,PHASE1,,nervous_system_disease
4676,1045,Dementia With Lewy Bodies (DLB),Neflamapimod,C1=CC(=C(C(=C1)Cl)C2=C3C=CC(=NN3C=NC2=O)SC4=C(C=C(C=C4)F)F)Cl,PHASE2,,nervous_system_disease
4675,1041,Primary Fibromyalgia,Milnacipran,CCN(CC)C(=O)C1(CC1CN)C2=CC=CC=C2,PHASE2,,nervous_system_disease
4674,1037,"Headache, Migraine",Ubrogepant,CC1C(CC(C(=O)N1CC(F)(F)F)NC(=O)C2=CC3=C(CC4(C3)C5=C(NC4=O)N=CC=C5)N=C2)C6=CC=CC=C6,APPROVED,,nervous_system_disease
4672,1031,"Stroke, Acute",Labetalol,CC(CCC1=CC=CC=C1)NCC(C2=CC(=C(C=C2)O)C(=O)N)O,PHASE2,,nervous_system_disease
4671,1027,Parkinson's Disease,Safinamide,CC(C(=O)N)NCC1=CC=C(C=C1)OCC2=CC(=CC=C2)F,PHASE2,,nervous_system_disease
4670,1023,Estrogen Receptor Negative (ER-Negative) Breast Cancer|Progesterone Receptor Negative (PR-Negative) Breast Cancer|Human Epidermal Growth Factor Receptor 2 Negative (HER2-Negative) Breast Cancer|Brain Metastases,Iniparib,C1=CC(=C(C=C1C(=O)N)[N+](=O)[O-])I,PHASE2,,nervous_system_disease
4669,1022,Alzheimer's Disease,Resveratrol,C1=CC(=CC=C1C=CC2=CC(=CC(=C2)O)O)O,PHASE2,,nervous_system_disease
4666,1008,Non Dystrophic Myotonia,Mexiletine,CC1=C(C(=CC=C1)C)OCC(C)N,PHASE2,,nervous_system_disease
4665,1005,Eye Injuries,Anecortave,CC12CCC(=O)C=C1CCC3C2=CCC4(C3CCC4(C(=O)CO)O)C,PHASE2,,nervous_system_disease
4663,999,Acute Migraine Headache,Zolmitriptan,CN(C)CCC1=CNC2=C1C=C(C=C2)CC3COC(=O)N3,APPROVED,,nervous_system_disease
4662,996,Cancer|Peripheral Neuropathy,Ethosuximide,CCC1(CC(=O)NC1=O)C,PHASE2,,nervous_system_disease
4658,975,DLBCL|Neurotoxicity Syndromes,Defibrotide,CC(C)C1=C(C=C(C(=C1)C2=NNC(=O)N2C3=CC4=C(C=C3)N(C=C4)C)O)OP(=O)(O)O,PHASE2,,nervous_system_disease
4657,966,Parkinson's Disease,Nebicapone,C1=CC=C(C=C1)CC(=O)C2=CC(=C(C(=C2)O)O)[N+](=O)[O-],PHASE1,,nervous_system_disease
4656,963,Post-Dural Puncture Headache,Atropine,CN1C2CCC1CC(C2)OC(=O)C(CO)C3=CC=CC=C3,APPROVED,,nervous_system_disease
4652,956,Becker Muscular Dystrophy,Epicatechin,C1C(C(OC2=CC(=CC(=C21)O)O)C3=CC(=C(C=C3)O)O)O,PHASE1,,nervous_system_disease
4650,946,"Prolonged First Stage of Labor|Failure of Cervical Dilation as Antepartum Condition|Labor Pain|Mild Birth Asphyxia, APGAR 4-7",Drotaverine,CCOC1=C(C=C(C=C1)C=C2C3=CC(=C(C=C3CCN2)OCC)OCC)OCC,PHASE2|PHASE3,,nervous_system_disease
4649,944,Migraine,Prochlorperazine,CN1CCN(CC1)CCCN2C3=CC=CC=C3SC4=C2C=C(C=C4)Cl,PHASE1,,nervous_system_disease
4648,942,Duchenne Muscular Dystrophy,Ataluren,C1=CC=C(C(=C1)C2=NC(=NO2)C3=CC(=CC=C3)C(=O)O)F,PHASE2,,nervous_system_disease
4643,919,Renal Colic,Dexketoprofen,CC(C1=CC(=CC=C1)C(=O)C2=CC=CC=C2)C(=O)O,APPROVED,,nervous_system_disease
4642,915,Vertigo,Levophencynonate,CN1CC2CCCC(C1)C2OC(=O)C(C3CCCC3)(C4=CC=CC=C4)O,PHASE2,,nervous_system_disease
4641,909,Parkinson Disease,Opicapone,CC1=C(C(=[N+](C(=C1Cl)C)[O-])Cl)C2=NOC(=N2)C3=CC(=C(C(=C3)O)O)[N+](=O)[O-],PHASE1,,nervous_system_disease
4639,899,Vestibular Migraine|Chronic Subjective Dizziness,Verapamil,CC(C)C(CCCN(C)CCC1=CC(=C(C=C1)OC)OC)(C#N)C2=CC(=C(C=C2)OC)OC,PHASE1,,nervous_system_disease
4635,872,Chronic Prostatitis With Chronic Pelvic Pain Syndrome,Cycloserine,C1C(C(=O)NO1)N,APPROVED,,nervous_system_disease
4634,863,"Dyslipidemia|Atherosclerosis|Diabetes Mellitus, Type 2",Policosanol,CCCO,APPROVED,,nervous_system_disease
4633,860,Alzheimer Disease,Seltorexant,CC1=CC(=NC(=N1)N2CC3CN(CC3C2)C(=O)C4=C(C=CC=C4F)N5N=CC=N5)C,PHASE2,,nervous_system_disease
4632,844,"Diffuse Intrinsic Pontine Glioma|Diffuse Midline Glioma, H3 K27M-Mutant|Recurrent Diffuse Intrinsic Pontine Glioma|Recurrent Diffuse Midline Glioma, H3 K27M-Mutant|Recurrent WHO Grade III Glioma|WHO Grade III Glioma",Paxalisib,CC1(C2=NC3=C(N2CCO1)N=C(N=C3N4CCOCC4)C5=CN=C(N=C5)N)C,PHASE2,,nervous_system_disease
4631,841,Medication Overuse Headache,Ibudilast,CC(C)C1=NN2C=CC=CC2=C1C(=O)C(C)C,PHASE1|PHASE2,,nervous_system_disease
4629,834,"Pain, Postoperative|Back Pain|Opioid Use|Methadone|Degenerative Spondylolisthesis|Stenosis, Spinal",Methadone,CCC(=O)C(CC(C)N(C)C)(C1=CC=CC=C1)C2=CC=CC=C2,APPROVED,,nervous_system_disease
4628,831,Insomnia Disorders,Zolpidem,CC1=CC=C(C=C1)C2=C(N3C=C(C=CC3=N2)C)CC(=O)N(C)C,PHASE1,,nervous_system_disease
4627,829,Amyotrophic Lateral Sclerosis (ALS),Pimozide,C1CN(CCC1N2C3=CC=CC=C3NC2=O)CCCC(C4=CC=C(C=C4)F)C5=CC=C(C=C5)F,PHASE2,,nervous_system_disease
4622,812,"HIV Infections|Leukoencephalopathy, Progressive Multifocal",Didanosine,C1CC(OC1CO)N2C=NC3=C2N=CNC3=O,PHASE2,,nervous_system_disease
4621,811,"HIV Infections|Leukoencephalopathy, Progressive Multifocal",Zalcitabine,C1CC(OC1CO)N2C=CC(=NC2=O)N,PHASE2,,nervous_system_disease
4620,802,Parkinson's Disease|Peripheral Edema,Domperidone,C1CN(CCC1N2C3=C(C=C(C=C3)Cl)NC2=O)CCCN4C5=CC=CC=C5NC4=O,PHASE2,,nervous_system_disease
4619,791,Wilson Disease,Tetrathiomolybdate,[SH-].[SH-].S=[Mo]=S,PHASE2,,nervous_system_disease
4618,785,Becker's Muscular Dystrophy (BMD),Citrulline,C(CC(C(=O)O)N)CNC(=O)N,PHASE2,,nervous_system_disease
4616,782,"Gaucher Disease Type I|Cerebroside Lipidosis Syndrome|Clucocerebrosidase Deficiency Disease|Glucosylceramide Beta-Glucosidase Deficiency Disease|Gaucher Disease, Non-Neuronopathic Form",Imiglucerase,,APPROVED,,nervous_system_disease
4611,770,Diabetic Peripheral Neuropathy,Bicifadine,CC1=CC=C(C=C1)C23CC2CNC3,PHASE2,,nervous_system_disease
4608,754,Tinnitus,Acamprosate,CC(=O)NCCCS(=O)(=O)O,PHASE1,,nervous_system_disease
4607,749,Alzheimer's Disease|Disruptive Behavior,Prazosin,COC1=C(C=C2C(=C1)C(=NC(=N2)N3CCN(CC3)C(=O)C4=CC=CO4)N)OC,PHASE2,,nervous_system_disease
4603,742,Autonomic Failure|Pure Autonomic Failure|Parkinson Disease|Multiple System Atrophy|Dementia With Lewy Bodies,Entacapone,CCN(CC)C(=O)C(=CC1=CC(=C(C(=C1)O)O)[N+](=O)[O-])C#N,PHASE1,,nervous_system_disease
4602,721,Neonatal Seizures,Phenobarbital,CCC1(C(=O)NC(=O)NC1=O)C2=CC=CC=C2,PHASE1|PHASE2,,nervous_system_disease
4601,715,Brain Tumor,Demeclocycline,CN(C)C1C2CC3C(C4=C(C=CC(=C4C(=C3C(=O)C2(C(=C(C1=O)C(=O)N)O)O)O)O)Cl)O,PHASE1,,nervous_system_disease
4600,712,Drug-resistant Epilepsy|Focal-Onset Seizures,Padsevonil,COCC1=NN2C(=C(N=C2S1)C(F)(F)F)CN3CC(CC3=O)CC(F)(F)Cl,PHASE2,,nervous_system_disease
4598,707,Insomnia Chronic,Zopiclone,CN1CCN(CC1)C(=O)OC2C3=NC=CN=C3C(=O)N2C4=NC=C(C=C4)Cl,PHASE2,,nervous_system_disease
4597,698,Epilepsy,Alprazolam,CC1=NN=C2N1C3=C(C=C(C=C3)Cl)C(=NC2)C4=CC=CC=C4,PHASE1,,nervous_system_disease
4595,695,Alzheimer's Disease,Semorinemab,,PHASE2,,nervous_system_disease
4594,694,Familial Amyotrophic Lateral Sclerosis,Pyrimethamine,CCC1=C(C(=NC(=N1)N)N)C2=CC=C(C=C2)Cl,PHASE1|PHASE2,,nervous_system_disease
4593,693,Infantile Spasm,Fenfluramine,CCNC(C)CC1=CC(=CC=C1)C(F)(F)F,PHASE2,,nervous_system_disease
4592,691,Migraine,Telcagepant,C1CC(C(=O)N(CC1C2=C(C(=CC=C2)F)F)CC(F)(F)F)NC(=O)N3CCC(CC3)N4C5=C(NC4=O)N=CC=C5,PHASE2,,nervous_system_disease
4591,690,Chronic Stroke|Subacute Stroke,Cerebrolysin,,PHASE2,,nervous_system_disease
4589,681,Musculoskeletal Pain,Codeine,CN1CCC23C4C1CC5=C2C(=C(C=C5)OC)OC3C(C=C4)O,PHASE2,,nervous_system_disease
4588,668,Migraine Without Aura|Migraine With Aura,Tonabersat,CC(=O)C1=CC2=C(C=C1)OC(C(C2NC(=O)C3=CC(=C(C=C3)F)Cl)O)(C)C,PHASE2,,nervous_system_disease
4587,662,Multiple Sclerosis|Clinically Isolated Syndrome of Demyelination,Natalizumab,,PHASE2,,nervous_system_disease
4586,661,Insomnia,Ramelteon,CCC(=O)NCCC1CCC2=C1C3=C(C=C2)OCC3,PHASE1,,nervous_system_disease
4583,646,Fibromyalgia Syndrome,Paroxetine,C1CNCC(C1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4,APPROVED,,nervous_system_disease
4580,636,Painful Myelopathy|Painful Neuropathy,Ziconotide,CC1C(=O)NC(C(=O)NC2CSSCC3C(=O)NC(C(=O)NC(C(=O)NCC(=O)NC(C(=O)NC(CSSCC(C(=O)NC(CSSCC(C(=O)NC(C(=O)NCC(=O)NC(C(=O)NCC(=O)N1)CCCCN)CCCCN)N)C(=O)NC(C(=O)NCC(=O)NC(C(=O)N3)CO)C(C)O)NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC2=O)CO)CCCNC(=N)N)CC(C)C)CCSC)CC4=CC=C(C=C4)O)CC(=O)O)C(=O)N)CCCCN)CO)CCCNC(=N)N)CCCCN,APPROVED,,nervous_system_disease
4573,607,"Muscular Atrophy, Spinal",Risdiplam,CC1=CC(=NN2C1=NC(=C2)C)C3=CC(=O)N4C=C(C=CC4=N3)N5CCNC6(C5)CC6,PHASE1,,nervous_system_disease
4568,591,Breast Cancer,Pyrotinib,CCOC1=C(C=C2C(=C1)N=CC(=C2NC3=CC(=C(C=C3)OCC4=CC=CC=N4)Cl)C#N)NC(=O)C=CC5CCCN5C,PHASE2,,nervous_system_disease
4566,589,Dravet Syndrome,Clemizole,C1CCN(C1)CC2=NC3=CC=CC=C3N2CC4=CC=C(C=C4)Cl,PHASE1,,nervous_system_disease
4564,587,Friedreich Ataxia,Etravirine,CC1=CC(=CC(=C1OC2=NC(=NC(=C2Br)N)NC3=CC=C(C=C3)C#N)C)C#N,PHASE2,,nervous_system_disease
4560,576,"Alzheimers Disease|Dementia|Alzheimers Disease, Familial",Solanezumab,,PHASE2|PHASE3,,nervous_system_disease
4559,575,"Alzheimers Disease|Dementia|Alzheimers Disease, Familial",Gantenerumab,,PHASE2|PHASE3,,nervous_system_disease
4558,573,Attention Deficit Hyperactivity Disorder,Dasotraline,C1CC(C2=CC=CC=C2C1C3=CC(=C(C=C3)Cl)Cl)N,PHASE2|PHASE3,,nervous_system_disease
4557,572,Delirium|Agitation,Trazodone,C1CN(CCN1CCCN2C(=O)N3C=CC=CC3=N2)C4=CC(=CC=C4)Cl,APPROVED,,nervous_system_disease
4556,570,Myoclonus,Etomidate,CCOC(=O)C1=CN=CN1C(C)C2=CC=CC=C2,APPROVED,,nervous_system_disease
4555,567,Amyotrophic Lateral Sclerosis,Riluzole,C1=CC2=C(C=C1OC(F)(F)F)SC(=N2)N,PHASE2|PHASE3,,nervous_system_disease
4553,560,Epilepsy,Carbamazepine,C1=CC=C2C(=C1)C=CC3=CC=CC=C3N2C(=O)N,APPROVED,,nervous_system_disease
4552,555,Epilepsy,Sulthiame,C1CCS(=O)(=O)N(C1)C2=CC=C(C=C2)S(=O)(=O)N,PHASE1,,nervous_system_disease
4547,524,Headache,Sumatriptan,CNS(=O)(=O)CC1=CC2=C(C=C1)NC=C2CCN(C)C,APPROVED,,nervous_system_disease
4546,518,Breast Cancer,Tesetaxel,CC1=C2C3C(C4(CCC5C(C4C(C(C2(C)C)(CC1OC(=O)C(C(C6=C(C=CC=N6)F)NC(=O)OC(C)(C)C)O)O)OC(=O)C7=CC=CC=C7)(CO5)OC(=O)C)C)OC(O3)CN(C)C,PHASE2,,nervous_system_disease
4542,507,Spinal Muscular Atrophy,Nusinersen,CC1=CN(C(=O)NC1=O)C2C(C(C(O2)CO)OP(=S)(O)OCC3C(C(C(O3)N4C=C(C(=NC4=O)N)C)OCCOC)OP(=S)(O)OCC5C(C(C(O5)N6C=NC7=C(N=CN=C76)N)OCCOC)OP(=S)(O)OCC8C(C(C(O8)N9C=C(C(=NC9=O)N)C)OCCOC)OP(=S)(O)OCC1C(C(C(O1)N1C=C(C(=O)NC1=O)C)OCCOC)OP(=S)(O)OCC1C(C(C(O1)N1C=C(C(=O)NC1=O)C)OCCOC)OP(=S)(O)OCC1C(C(C(O1)N1C=C(C(=O)NC1=O)C)OCCOC)OP(=S)(O)OCC1C(C(C(O1)N1C=C(C(=NC1=O)N)C)OCCOC)OP(=S)(O)OCC1C(C(C(O1)N1C=NC2=C(N=CN=C21)N)OCCOC)OP(=S)(O)OCC1C(C(C(O1)N1C=C(C(=O)NC1=O)C)OCCOC)OP(=S)(O)OCC1C(C(C(O1)N1C=NC2=C(N=CN=C21)N)OCCOC)OP(=S)(O)OCC1C(C(C(O1)N1C=NC2=C(N=CN=C21)N)OCCOC)OP(=S)(O)OCC1C(C(C(O1)N1C=C(C(=O)NC1=O)C)OCCOC)OP(=S)(O)OCC1C(C(C(O1)N1C=NC2=C1N=C(NC2=O)N)OCCOC)OP(=S)(O)OCC1C(C(C(O1)N1C=C(C(=NC1=O)N)C)OCCOC)OP(=S)(O)OCC1C(C(C(O1)N1C=C(C(=O)NC1=O)C)OCCOC)OP(=S)(O)OCC1C(C(C(O1)N1C=NC2=C1N=C(NC2=O)N)OCCOC)OP(=S)(O)OCC1C(C(C(O1)N1C=NC2=C1N=C(NC2=O)N)OCCOC)O)OCCOC,PHASE1|PHASE2,,nervous_system_disease
4532,475,"Cancer|Metastasis|Metastatic Cancer|Brain Metastases|Brain Metastases, Adult",Azeliragon,CCCCC1=NC(=CN1C2=CC=C(C=C2)OC3=CC=C(C=C3)Cl)C4=CC=C(C=C4)OCCCN(CC)CC,PHASE1|PHASE2,,nervous_system_disease
4531,474,Migraine|Episodic Migraine|Phonophobia|Photophobia,Rimegepant,C1CC(C2=C(C=CC=N2)C(C1C3=C(C(=CC=C3)F)F)N)OC(=O)N4CCC(CC4)N5C6=C(NC5=O)N=CC=C6,APPROVED,,nervous_system_disease
4527,468,Parkinson's Disease,Cabergoline,CCNC(=O)N(CCCN(C)C)C(=O)C1CC2C(CC3=CNC4=CC=CC2=C34)N(C1)CC=C,APPROVED,,nervous_system_disease
4525,457,Epilepsy,Diazepam,CN1C(=O)CN=C(C2=C1C=CC(=C2)Cl)C3=CC=CC=C3,PHASE1|PHASE2,,nervous_system_disease
4524,456,Parkinson's Disease,Rivastigmine,CCN(C)C(=O)OC1=CC=CC(=C1)C(C)N(C)C,APPROVED,,nervous_system_disease
4522,438,Attention Deficit Hyperactivity Disorder,Solriamfetol,C1=CC=C(C=C1)CC(COC(=O)N)N,PHASE2|PHASE3,,nervous_system_disease
4520,436,Glioma|Glioblastoma|Glioblastoma Multiforme|GBM|Brain Cancer,Dianhydrogalactitol,C1C(O1)C(C(C2CO2)O)O,PHASE2,,nervous_system_disease
4515,429,Right Hemisphere Stroke|Hemispatial Neglect|Motor Deficit,Rotigotine,CCCN(CCC1=CC=CS1)C2CCC3=C(C2)C=CC=C3O,PHASE2,,nervous_system_disease
4514,425,"Brain Injuries|Brain Injuries, Traumatic|Brain Injury, Chronic",Tolcapone,CC1=CC=C(C=C1)C(=O)C2=CC(=C(C(=C2)O)O)[N+](=O)[O-],PHASE2,,nervous_system_disease
4510,408,Knee Osteoarthritis,Etoricoxib,CC1=NC=C(C=C1)C2=C(C=C(C=N2)Cl)C3=CC=C(C=C3)S(=O)(=O)C,PHASE2,,nervous_system_disease
4509,407,REM Sleep Behavior Disorder|Parkinson Disease|Synucleinopathies,Rasagiline,C#CCNC1CCC2=CC=CC=C12,PHASE2|PHASE3,,nervous_system_disease
4500,382,Epilepsy,Perampanel,C1=CC=C(C=C1)N2C=C(C=C(C2=O)C3=CC=CC=C3C#N)C4=CC=CC=N4,PHASE2,,nervous_system_disease
4499,381,Idiopathic Parkinson Disease,Trimethobenzamide,CN(C)CCOC1=CC=C(C=C1)CNC(=O)C2=CC(=C(C(=C2)OC)OC)OC,PHASE1,,nervous_system_disease
4497,378,Advanced Cancer|Anorexia|Weight Loss|Insomnia,Mirtazapine,CN1CCN2C(C1)C3=CC=CC=C3CC4=C2N=CC=C4,PHASE2,,nervous_system_disease
4496,373,Parkinson's Disease|Psychotic Disorders,Melperone,CC1CCN(CC1)CCCC(=O)C2=CC=C(C=C2)F,PHASE2,,nervous_system_disease
4493,370,AIDS Dementia Complex|HIV Infections,Nimodipine,CC1=C(C(C(=C(N1)C)C(=O)OC(C)C)C2=CC(=CC=C2)[N+](=O)[O-])C(=O)OCCOC,PHASE1,,nervous_system_disease
4492,369,Focal Epilepsy,Zonisamide,C1=CC=C2C(=C1)C(=NO2)CS(=O)(=O)N,APPROVED,,nervous_system_disease
4491,368,Focal Epilepsy,Topiramate,CC1(OC2COC3(C(C2O1)OC(O3)(C)C)COS(=O)(=O)N)C,APPROVED,,nervous_system_disease
4490,367,Focal Epilepsy,Tiagabine,CC1=C(SC=C1)C(=CCCN2CCCC(C2)C(=O)O)C3=C(C=CS3)C,APPROVED,,nervous_system_disease
4488,359,Subarachnoid Hemorrhage|Cerebral Vasospasm,Dantrolene,C1C(=O)NC(=O)N1N=CC2=CC=C(O2)C3=CC=C(C=C3)[N+](=O)[O-],PHASE1|PHASE2,,nervous_system_disease
4486,352,Clostridium Difficile|Spinal Cord Injury,Fidaxomicin,CCC1C=C(C(CC=CC=C(C(=O)OC(CC=C(C=C(C1OC2C(C(C(C(O2)(C)C)OC(=O)C(C)C)O)O)C)C)C(C)O)COC3C(C(C(C(O3)C)OC(=O)C4=C(C(=C(C(=C4O)Cl)O)Cl)CC)O)OC)O)C,APPROVED,,nervous_system_disease
4485,351,Alcohol-induced Brain Injury,Edaravone,CC1=NN(C(=O)C1)C2=CC=CC=C2,PHASE2,,nervous_system_disease
4484,348,Fibromyalgia,Mecobalamin,[CH3-].CC1=CC2=C(C=C1C)N(C=N2)C3C(C(C(O3)CO)OP(=O)([O-])OC(C)CNC(=O)CCC4(C(C5C6(C(C(C(=C(C7=NC(=CC8=NC(=C(C4=N5)C)C(C8(C)C)CCC(=O)N)C(C7(C)CC(=O)N)CCC(=O)N)C)[N-]6)CCC(=O)N)(C)CC(=O)N)C)CC(=O)N)C)O.[Co+3],PHASE1|PHASE2,,nervous_system_disease
4483,345,Stroke,Serotonin,C1=CC2=C(C=C1O)C(=CN2)CCN,PHASE2,,nervous_system_disease
4481,342,Alzheimer Disease|Healthy Volunteers,Donepezil,COC1=C(C=C2C(=C1)CC(C2=O)CC3CCN(CC3)CC4=CC=CC=C4)OC,PHASE1,,nervous_system_disease
4478,335,Migraine,Erenumab,,APPROVED,,nervous_system_disease
4477,334,Alzheimer's Disease,Bexarotene,CC1=CC2=C(C=C1C(=C)C3=CC=C(C=C3)C(=O)O)C(CCC2(C)C)(C)C,PHASE2,,nervous_system_disease
4474,330,"Trauma, Brain",Amantadine,C1C2CC3CC1CC(C2)(C3)N,APPROVED,,nervous_system_disease
4470,324,Craniocerebral Injury,Oxiracetam,C1C(CN(C1=O)CC(=O)N)O,PHASE2,,nervous_system_disease
4469,322,Migraine Headache,Psilocybin,CN(C)CCC1=CNC2=C1C(=CC=C2)OP(=O)(O)O,PHASE1,,nervous_system_disease
4463,312,Gastroparesis,Buspirone,C1CCC2(C1)CC(=O)N(C(=O)C2)CCCCN3CCN(CC3)C4=NC=CC=N4,PHASE2,,nervous_system_disease
4461,306,Tuberculous Meningitis,Pyrazinamide,C1=CN=C(C=N1)C(=O)N,PHASE2,,nervous_system_disease
4456,299,Irritable Bowel Syndrome,Lubiprostone,CCCCC(C1(CCC2C(O1)CC(=O)C2CCCCCCC(=O)O)O)(F)F,PHASE1,,nervous_system_disease
4453,289,Von Hippel-Lindau Syndrome,Ranibizumab,,PHASE1,,nervous_system_disease
4451,287,Peripheral Nervous System Diseases,Ricolinostat,C1=CC=C(C=C1)N(C2=CC=CC=C2)C3=NC=C(C=N3)C(=O)NCCCCCCC(=O)NO,PHASE1,,nervous_system_disease
4447,276,Peripheral Neuropathy|Antineoplastic Combined Chemotherapy Protocols,Nabilone,CCCCCCC(C)(C)C1=CC(=C2C3CC(=O)CCC3C(OC2=C1)(C)C)O,APPROVED,,nervous_system_disease
4446,274,Post-Traumatic Headache,Fremanezumab,,PHASE2,,nervous_system_disease
4445,273,Eye Pain,Loteprednol,CC12CC(C3C(C1CCC2(C(=O)OCCl)O)CCC4=CC(=O)C=CC34C)O,PHASE1,,nervous_system_disease
4440,257,Spinal Cord Injury (SCI),Elezanumab,,PHASE2,,nervous_system_disease
4437,246,"Akathisia, Drug-Induced|Antipsychotic Agents|Movement Disorders",Haloperidol,C1CN(CCC1(C2=CC=C(C=C2)Cl)O)CCCC(=O)C3=CC=C(C=C3)F,PHASE2,,nervous_system_disease
4431,234,Huntington Disease,Triheptanoin,CCCCCCC(=O)OCC(COC(=O)CCCCCC)OC(=O)CCCCCC,PHASE2,,nervous_system_disease
4428,231,Brain Tumor - Metastatic,Carmustine,C(CCl)NC(=O)N(CCCl)N=O,PHASE2,,nervous_system_disease
4422,215,Huntington's Disease,Pridopidine,CCCN1CCC(CC1)C2=CC(=CC=C2)S(=O)(=O)C,PHASE2,,nervous_system_disease
4421,212,Attention Deficit Hyperactivity Disorder,Atomoxetine,CC1=CC=CC=C1OC(CCNC)C2=CC=CC=C2,APPROVED,,nervous_system_disease
4419,206,Alzheimer's Disease|Depression,Sertraline,CNC1CCC(C2=CC=CC=C12)C3=CC(=C(C=C3)Cl)Cl,PHASE2|PHASE3,,nervous_system_disease
4418,204,Duchenne Muscular Dystrophy,Viltolarsen,CC1=CN(C(=O)NC1=O)C2CN(CC(O2)COP(=O)(N3CC(OC(C3)N4C=C(C(=O)NC4=O)C)COP(=O)(N5CC(OC(C5)N6C=NC7=C6N=C(NC7=O)N)COP(=O)(N8CC(OC(C8)N9C=C(C(=O)NC9=O)C)COP(=O)(N1CC(OC(C1)N1C=NC2=C1N=C(NC2=O)N)COP(=O)(N1CC(OC(C1)N1C=NC2=C1N=C(NC2=O)N)COP(=O)(N1CC(OC(C1)N1C=NC2=C(N=CN=C21)N)COP(=O)(N1CC(OC(C1)N1C=NC2=C(N=CN=C21)N)COP(=O)(N1CC(OC(C1)N1C=NC2=C1N=C(NC2=O)N)COP(=O)(N1CC(OC(C1)N1C=C(C(=O)NC1=O)C)COP(=O)(N1CC(OC(C1)N1C=CC(=NC1=O)N)COP(=O)(N1CC(OC(C1)N1C=C(C(=O)NC1=O)C)COP(=O)(N1CC(OC(C1)N1C=C(C(=O)NC1=O)C)COP(=O)(N1CC(OC(C1)N1C=NC2=C1N=C(NC2=O)N)COP(=O)(N1CC(OC(C1)N1C=NC2=C1N=C(NC2=O)N)COP(=O)(N1CC(OC(C1)N1C=CC(=NC1=O)N)COP(=O)(N1CC(OC(C1)N1C=CC(=NC1=O)N)COP(=O)(N1CC(OC(C1)N1C=C(C(=O)NC1=O)C)COP(=O)(N1CC(OC(C1)N1C=CC(=NC1=O)N)COP(=O)(N1CC(OC(C1)N1C=CC(=NC1=O)N)CO)N(C)C)N(C)C)N(C)C)N(C)C)N(C)C)N(C)C)N(C)C)N(C)C)N(C)C)N(C)C)N(C)C)N(C)C)N(C)C)N(C)C)N(C)C)N(C)C)N(C)C)N(C)C)N(C)C)P(=O)(N(C)C)OCC1CNCC(O1)N1C=CC(=NC1=O)N,PHASE2,,nervous_system_disease
4410,190,Hypogonadism|Diabetes|Sarcopenia|Osteoporosis|Depression,Anastrozole,CC(C)(C#N)C1=CC(=CC(=C1)CN2C=NC=N2)C(C)(C)C#N,PHASE2,,nervous_system_disease
4408,188,Parkinson's Disease,Varenicline,C1C2CNCC1C3=CC4=NC=CN=C4C=C23,PHASE2,,nervous_system_disease
4407,187,Cataract|Miosis,Cyclopentolate,CN(C)CCOC(=O)C(C1=CC=CC=C1)C2(CCCC2)O,PHASE2,,nervous_system_disease
4406,186,Cataract|Miosis,Nepafenac,C1=CC=C(C=C1)C(=O)C2=CC=CC(=C2N)CC(=O)N,PHASE2,,nervous_system_disease
4403,182,Pediatric Growth Hormone Deficiency|Growth Disorders,Somavaratan,,PHASE2|PHASE3,,nervous_system_disease
4402,181,Myofacial Pain,Amitriptyline,CN(C)CCC=C1C2=CC=CC=C2CCC3=CC=CC=C31,APPROVED,,nervous_system_disease
4400,178,Relapsing-remitting Multiple Sclerosis,Glatiramer,CC(C(=O)O)N.C1=CC(=CC=C1CC(C(=O)O)N)O.C(CCN)CC(C(=O)O)N.C(CC(=O)O)C(C(=O)O)N,APPROVED,,nervous_system_disease
4399,177,Parkinson Disease,Levodopa,C1=CC(=C(C=C1CC(C(=O)O)N)O)O,PHASE2,,nervous_system_disease
4396,173,Acute Pain,Lorazepam,C1=CC=C(C(=C1)C2=NC(C(=O)NC3=C2C=C(C=C3)Cl)O)Cl,PHASE2,,nervous_system_disease
4395,171,Parkinson Disease,Selegiline,CC(CC1=CC=CC=C1)N(C)CC#C,APPROVED,,nervous_system_disease
4394,170,Amyotrophic Lateral Sclerosis (ALS),Olanzapine,CC1=CC2=C(S1)NC3=CC=CC=C3N=C2N4CCN(CC4)C,PHASE2|PHASE3,,nervous_system_disease
4392,168,Diabetic Macular Edema,Pegaptanib,COCCOC(=O)NCCCCC(C(=O)NCCCCCCCOP(=O)(C)O)NC(=O)OCCOC,APPROVED,,nervous_system_disease
4390,165,Epilepsy,Ganaxolone,CC(=O)C1CCC2C1(CCC3C2CCC4C3(CCC(C4)(C)O)C)C,PHASE2,,nervous_system_disease
4389,143,Morbid Obesity|Postoperative Pain|Postoperative Bowel Function|Postoperative Ambulation,Levobupivacaine,CCCCN1CCCCC1C(=O)NC2=C(C=CC=C2C)C,PHASE2|PHASE3,,nervous_system_disease
4386,140,Parkinson's Disease|Dyskinesia,Sarizotan,C1CC2=CC=CC=C2OC1CNCC3=CC(=CN=C3)C4=CC=C(C=C4)F,PHASE2,,nervous_system_disease
4385,139,Duchenne Muscular Dystrophy,Ezutromid,CCS(=O)(=O)C1=CC2=C(C=C1)OC(=N2)C3=CC4=CC=CC=C4C=C3,PHASE2,,nervous_system_disease
4384,137,HIV Infections|Insomnia,Doxepin,CN(C)CCC=C1C2=CC=CC=C2COC3=CC=CC=C31,APPROVED,,nervous_system_disease
4382,135,Schizophrenia,Risperidone,CC1=C(C(=O)N2CCCCC2=N1)CCN3CCC(CC3)C4=NOC5=C4C=CC(=C5)F,PHASE2|PHASE3,,nervous_system_disease
4381,133,Memory Impairment Due to Corticosteroid Use|Hypomania Due to Corticosteroid Use|Hippocampal Atrophy Due to Corticosteroid,Lamotrigine,C1=CC(=C(C(=C1)Cl)Cl)C2=C(N=C(N=N2)N)N,APPROVED,,nervous_system_disease
4378,123,Adult Giant Cell Glioblastoma|Adult Glioblastoma|Adult Gliosarcoma|Recurrent Adult Brain Neoplasm,Cilengitide,CC(C)C1C(=O)NC(C(=O)NCC(=O)NC(C(=O)NC(C(=O)N1C)CC2=CC=CC=C2)CC(=O)O)CCCN=C(N)N,PHASE1,,nervous_system_disease
4372,112,Multiple Sclerosis,Mitoxantrone,C1=CC(=C2C(=C1NCCNCCO)C(=O)C3=C(C=CC(=C3C2=O)O)O)NCCNCCO,PHASE2,,nervous_system_disease
4371,111,Multiple Sclerosis,Dexrazoxane,CC(CN1CC(=O)NC(=O)C1)N2CC(=O)NC(=O)C2,PHASE2,,nervous_system_disease
4369,104,Alzheimer's Disease,Memantine,CC12CC3CC(C1)(CC(C3)(C2)N)C,APPROVED,,nervous_system_disease
4368,103,Alzheimer's Disease,Galantamine,CN1CCC23C=CC(CC2OC4=C(C=CC(=C34)C1)OC)O,APPROVED,,nervous_system_disease
4367,100,Attention Deficit Hyperactivity Disorder,Methylphenidate,COC(=O)C(C1CCCCN1)C2=CC=CC=C2,APPROVED,,nervous_system_disease
4365,92,"Epilepsy, Partial",Ezogabine,CCOC(=O)NC1=C(C=C(C=C1)NCC2=CC=C(C=C2)F)N,PHASE1,,nervous_system_disease
4363,90,Alzheimer Disease,Flortaucipir,C1=CC2=C(C=C1C3=CN=C(C=C3)F)NC4=C2C=NC=C4,PHASE2,,nervous_system_disease
4360,86,Tourette Syndrome,Valbenazine,CC(C)CC1CN2CCC3=CC(=C(C=C3C2CC1OC(=O)C(C(C)C)N)OC)OC,PHASE2,,nervous_system_disease
4356,76,Attention Deficit Hyperactivity Disorder,Aripiprazole,C1CC(=O)NC2=C1C=CC(=C2)OCCCCN3CCN(CC3)C4=C(C(=CC=C4)Cl)Cl,APPROVED,,nervous_system_disease
4355,71,Abdominal Pain|Inflammatory Bowel Diseases|Eosinophilic Gastroenteritis|Diarrhea|Hematochezia|Weight Loss,Ondansetron,CC1=NC=CN1CC2CCC3=C(C2=O)C4=CC=CC=C4N3C,APPROVED,,nervous_system_disease
4353,65,Myasthenia Gravis,Salbutamol,CC(C)(C)NCC(C1=CC(=C(C=C1)O)CO)O,PHASE2|PHASE3,,nervous_system_disease
4352,64,Myasthenia Gravis,Albuterol,CC(C)(C)NCC(C1=CC(=C(C=C1)O)CO)O,PHASE2|PHASE3,,nervous_system_disease
4348,57,Chemotherapeutic Agent Toxicity|Cognitive/Functional Effects|Lymphoma|Neurotoxicity|Radiation Toxicity,Procarbazine,CC(C)NC(=O)C1=CC=C(C=C1)CNNC,PHASE2,,nervous_system_disease
4346,48,Acute Ischemic Stroke,Tenecteplase,,APPROVED,,nervous_system_disease
4343,45,Prader-Willi Syndrome,Guanfacine,C1=CC(=C(C(=C1)Cl)CC(=O)N=C(N)N)Cl,APPROVED,,nervous_system_disease
4342,42,Insomnia,Temazepam,CN1C2=C(C=C(C=C2)Cl)C(=NC(C1=O)O)C3=CC=CC=C3,APPROVED,,nervous_system_disease
4340,35,Acromegaly,Pegvisomant,,APPROVED,,nervous_system_disease
4339,34,Emergence Delirium,Clonidine,C1CN=C(N1)NC2=C(C=CC=C2Cl)Cl,PHASE2|PHASE3,,nervous_system_disease
4332,23,"Lymphoma, Non-Hodgkin|HIV Infections",Bleomycin,CC1=C(N=C(N=C1N)C(CC(=O)N)NCC(C(=O)N)N)C(=O)NC(C(C2=CN=CN2)OC3C(C(C(C(O3)CO)O)O)OC4C(C(C(C(O4)CO)O)OC(=O)N)O)C(=O)NC(C)C(C(C)C(=O)NC(C(C)O)C(=O)NCCC5=NC(=CS5)C6=NC(=CS6)C(=O)NCCC[S+](C)C)O,PHASE1,,nervous_system_disease
4330,19,Back Pain|Acute Pain|Back Spasm Upper Back|Back Strain|Muscle Cramp|Muscle Spasm|Low Back Pain,Tolperisone,CC1=CC=C(C=C1)C(=O)C(C)CN2CCCCC2,PHASE2,,nervous_system_disease
4329,18,Brain and Central Nervous System Tumors|Drug/Agent Toxicity by Tissue/Organ|Lymphoma|Thrombocytopenia,Cytarabine,C1=CN(C(=O)N=C1N)C2C(C(C(O2)CO)O)O,PHASE2,,nervous_system_disease
4323,11,Prader-Willi Syndrome|Hyperphagia,Livoletide,CC(C)C1C(=O)NC(C(=O)NC(C(=O)N2CCCC2C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N1)CCCN=C(N)N)CCC(=O)N)CC3=CN=CN3)CCC(=O)O)CO)CCC(=O)N,PHASE2|PHASE3,,nervous_system_disease
4318,6,Chemotherapy-Induced Peripheral Neuropathy,Olesoxime,CC(C)CCCC(C)C1CCC2C1(CCC3C2CCC4=CC(=NO)CCC34C)C,PHASE2,,nervous_system_disease
4311,1607,Depressive Disorder|Hormone Disturbance,Metyrapone,CC(C)(C1=CN=CC=C1)C(=O)C2=CN=CC=C2,APPROVED,,mental_and_behavioural_disorder
4307,1491,"Depressive Disorder, Treatment-Resistant",Ebselen,C1=CC=C(C=C1)N2C(=O)C3=CC=CC=C3[Se]2,PHASE1,,mental_and_behavioural_disorder
4301,1398,"Depressive Disorder, Major",Rapastinel,CC(C(C(=O)N1CCCC1C(=O)N2CCCC2C(=O)NC(C(C)O)C(=O)N)N)O,PHASE2,,mental_and_behavioural_disorder
4300,1376,Bipolar Depression,Uridine,C1=CN(C(=O)NC1=O)C2C(C(C(O2)CO)O)O,PHASE2,,mental_and_behavioural_disorder
4298,1359,Major Depressive Disorder,Hypidone,,PHASE2,,mental_and_behavioural_disorder
4296,1348,Major Depression,Cimicoxib,COC1=C(C=C(C=C1)C2=C(N=CN2C3=CC=C(C=C3)S(=O)(=O)N)Cl)F,PHASE2,,mental_and_behavioural_disorder
4286,1257,Major Depressive Disorder,Pexacerfont,CCC(C)NC1=NC(=NC2=C(C(=NN21)C)C3=C(N=C(C=C3)OC)C)C,PHASE1|PHASE2,,mental_and_behavioural_disorder
4281,1186,Amphetamine-Related Disorders,Reserpine,COC1C(CC2CN3CCC4=C(C3CC2C1C(=O)OC)NC5=C4C=CC(=C5)OC)OC(=O)C6=CC(=C(C(=C6)OC)OC)OC,PHASE1,,mental_and_behavioural_disorder
4280,1177,Cocaine Abuse,Disulfiram,CCN(CC)C(=S)SSC(=S)N(CC)CC,PHASE1,,mental_and_behavioural_disorder
4277,1121,Major Depressive Disorder,Tianeptine,CN1C2=CC=CC=C2C(C3=C(S1(=O)=O)C=C(C=C3)Cl)NCCCCCCC(=O)O,APPROVED,,mental_and_behavioural_disorder
4276,1114,"Major Depressive Disorder, Recurrent",Filorexant,CC1CCC(CN1C(=O)C2=C(C=CC(=C2)C)C3=NC=CC=N3)COC4=NC=C(C=C4)F,PHASE2,,mental_and_behavioural_disorder
4270,1054,Bipolar Disorder,Felbamate,C1=CC=C(C=C1)C(COC(=O)N)COC(=O)N,PHASE2,,mental_and_behavioural_disorder
4235,668,Bipolar Depression,Cytidine,C1=CN(C(=O)N=C1N)C2C(C(C(O2)CO)O)O,PHASE2,,mental_and_behavioural_disorder
4232,642,Treatment Resistant Depression,Liafensine,CN1CC(C2=C(C1)C=C(C=C2)C3=NN=C(C=C3)N)C4=CC5=CC=CC=C5C=C4,PHASE2,,mental_and_behavioural_disorder
4218,540,Schizophrenia|Alcohol Use Disorder,Samidorphan,C1CC1CN2CCC34CC(=O)CCC3(C2CC5=C4C(=C(C=C5)C(=O)N)O)O,PHASE2,,mental_and_behavioural_disorder
4201,368,Pathological Gambling,Fluphenazine,C1CN(CCN1CCCN2C3=CC=CC=C3SC4=C2C=C(C=C4)C(F)(F)F)CCO,PHASE2,,mental_and_behavioural_disorder
4191,328,Unipolar Depression|Bipolar Depression,Methohexital,CCC#CC(C)C1(C(=O)NC(=O)N(C1=O)C)CC=C,APPROVED,,mental_and_behavioural_disorder
4167,235,Major Depressive Disorder,Levomilnacipran,CCN(CC)C(=O)C1(CC1CN)C2=CC=CC=C2,PHASE2,,mental_and_behavioural_disorder
4142,171,"Depressive Disorder, Major",Radafaxine,CC1C(OCC(N1)(C)C)(C2=CC(=CC=C2)Cl)O,PHASE2,,mental_and_behavioural_disorder
4114,74,Unipolar Depression,Enoxolone,CC1(C2CCC3(C(C2(CCC1O)C)C(=O)C=C4C3(CCC5(C4CC(CC5)(C)C(=O)O)C)C)C)C,PHASE1|PHASE2,,mental_and_behavioural_disorder
4101,44,"Depressive Disorder, Major",Sirukumab,,PHASE2,,mental_and_behavioural_disorder
4077,15019,Congestive Heart Failure,Fenoterol,CC(CC1=CC=C(C=C1)O)NCC(C2=CC(=CC(=C2)O)O)O,PHASE1,,cardiovascular_disease
4075,14976,"Abnormalities, Cardiovascular",Volanesorsen,CC1=CN(C(=O)NC1=O)C2CC(C(O2)COP(=S)(O)OC3CC(OC3COP(=S)(O)OC4CC(OC4COP(=S)(O)OC5C(OC(C5OCCOC)N6C=C(C(=O)NC6=O)C)COP(=S)(O)OC7C(OC(C7OCCOC)N8C=C(C(=O)NC8=O)C)COP(=S)(O)OC9C(OC(C9OCCOC)N1C=C(C(=NC1=O)N)C)COP(=S)(O)OC1C(OC(C1OCCOC)N1C=NC2=C1N=C(NC2=O)N)COP(=S)(O)OC1C(OC(C1OCCOC)N1C=NC2=C(N=CN=C21)N)CO)N1C=C(C(=NC1=O)N)C)N1C=C(C(=O)NC1=O)C)OP(=S)(O)OCC1C(CC(O1)N1C=NC2=C1N=C(NC2=O)N)OP(=S)(O)OCC1C(CC(O1)N1C=C(C(=O)NC1=O)C)OP(=S)(O)OCC1C(CC(O1)N1C=C(C(=NC1=O)N)C)OP(=S)(O)OCC1C(CC(O1)N1C=C(C(=NC1=O)N)C)OP(=S)(O)OCC1C(CC(O1)N1C=NC2=C(N=CN=C21)N)OP(=S)(O)OCC1C(CC(O1)N1C=NC2=C1N=C(NC2=O)N)OP(=S)(O)OCC1C(CC(O1)N1C=C(C(=NC1=O)N)C)OP(=S)(O)OCC1C(C(C(O1)N1C=C(C(=O)NC1=O)C)OCCOC)OP(=S)(O)OCC1C(C(C(O1)N1C=C(C(=O)NC1=O)C)OCCOC)OP(=S)(O)OCC1C(C(C(O1)N1C=C(C(=O)NC1=O)C)OCCOC)OP(=S)(O)OCC1C(C(C(O1)N1C=NC2=C(N=CN=C21)N)OCCOC)OP(=S)(O)OCC1C(C(C(O1)N1C=C(C(=O)NC1=O)C)OCCOC)O,PHASE1,,cardiovascular_disease
4074,14949,"Lymphoma, Non-Hodgkin|Multiple Myeloma|Advanced Solid Tumors",Futibatinib,COC1=CC(=CC(=C1)C#CC2=NN(C3=NC=NC(=C23)N)C4CCN(C4)C(=O)C=C)OC,PHASE2,,cardiovascular_disease
4069,14635,Diabetic Foot Ulcers,Becaplermin,,PHASE1|PHASE2,,cardiovascular_disease
4066,14596,Atrial Fibrillation,Tecadenoson,C1COCC1NC2=C3C(=NC=N2)N(C=N3)C4C(C(C(O4)CO)O)O,PHASE2,,cardiovascular_disease
4064,14566,Multiple Myeloma,Roneparstat,CC(=O)NC1C(C(C(OC1OC2C(C(C(OC2C(=O)O)OC3C(OC(C(C3O)NC(=O)C)OC(CO)C(C(=O)O)OC(CO)O)CO)OS(=O)(=O)O)O)CO)O)O,PHASE1,,cardiovascular_disease
4061,14447,Adult Non-Hodgkin Lymphoma|Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue|Nodal Marginal Zone Lymphoma|Recurrent Adult Diffuse Large Cell Lymphoma|Recurrent Grade 1 Follicular Lymphoma|Recurrent Grade 2 Follicular Lymphoma|Recurrent Grade 3 Follicular Lymphoma|Recurrent Mantle Cell Lymphoma|Recurrent Marginal Zone Lymphoma|Recurrent Small Lymphocytic Lymphoma|Splenic Marginal Zone Lymphoma|Waldenstrom Macroglobulinemia,Agatolimod,CC1=CN(C(=O)NC1=O)C2CC(C(O2)COP(=S)(O)OC3CC(OC3COP(=S)(O)OC4CC(OC4COP(=S)(O)OC5CC(OC5COP(=S)(O)OC6CC(OC6COP(=S)(O)OC7CC(OC7COP(=S)(O)OC8CC(OC8COP(=S)(O)OC9CC(OC9COP(=S)(O)OC1CC(OC1COP(=S)(O)OC1CC(OC1COP(=S)(O)OC1CC(OC1COP(=S)(O)OC1CC(OC1COP(=S)(O)OC1CC(OC1COP(=S)(O)OC1CC(OC1COP(=S)(O)OC1CC(OC1COP(=S)(O)OC1CC(OC1COP(=S)(O)OC1CC(OC1COP(=S)(O)OC1CC(OC1COP(=S)(O)OC1CC(OC1COP(=S)(O)OC1CC(OC1COP(=S)(O)OC1CC(OC1COP(=S)(O)OC1CC(OC1COP(=S)(O)OC1CC(OC1COP(=S)(O)OC1CC(OC1CO)N1C=C(C(=O)NC1=O)C)N1C=CC(=NC1=O)N)N1C=NC2=C1N=C(NC2=O)N)N1C=C(C(=O)NC1=O)C)N1C=CC(=NC1=O)N)N1C=NC(=C1C)C(=O)NC(=C)N)N1C=C(C(=NC1=O)N)C)N1C=C(C(=NC1=O)N)C)N1C=C(C(=O)NC1=O)C)N1C=C(C(=O)NC1=O)C)N1C=NC2=C1N=C(NC2=O)N)N1C=C(C(=O)NC1=O)C)N1C=CC(=NC1=O)N)N1C=NC2=C1N=C(NC2=O)N)N1C=C(C(=NC1=O)N)C)N1C=C(C(=NC1=O)N)C)N1C=C(C(=NC1=O)N)C)N1C=C(C(=NC1=O)N)C)N1C=NC2=C1N=C(NC2=O)N)N1C=C(C(=O)NC1=O)C)N1C=CC(=NC1=O)N)N1C=NC2=C1N=C(NC2=O)N)N1C=C(C(=O)NC1=O)C)O,PHASE1|PHASE2,,cardiovascular_disease
4060,14420,Turner Syndrome|Short Stature,Vosoritide,CCC(C)C1C(=O)NCC(=O)NC(C(=O)NC(C(=O)NC(C(=O)NCC(=O)NC(C(=O)NCC(=O)NC(CSSCC(C(=O)NC(C(=O)NCC(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N1)CCCNC(=N)N)CC(=O)O)CC(C)C)CCCCN)CC(C)C)CC2=CC=CC=C2)NC(=O)CNC(=O)C(CCCCN)NC(=O)C(CO)NC(=O)C(CC(C)C)NC(=O)CNC(=O)C(CCCCN)NC(=O)C(CCCCN)NC(=O)C(CC(=O)N)NC(=O)C(C)NC(=O)CNC(=O)C(CCCCN)NC(=O)C(CC3=CC=C(C=C3)O)NC(=O)C(CCCCN)NC(=O)C(CCCNC(=N)N)NC(=O)C(C)NC(=O)C(CC(=O)N)NC(=O)C4CCCN4C(=O)C(CC5=CN=CN5)NC(=O)C(CCC(=O)O)NC(=O)C(CCC(=O)N)NC(=O)CNC(=O)C6CCCN6)C(=O)O)CC(C)C)CO)CCSC)CO,PHASE2,,cardiovascular_disease
4044,14213,"Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive|Anatomic Stage IV Breast Cancer AJCC v8|Anemia|Ann Arbor Stage III Hodgkin Lymphoma|Ann Arbor Stage III Non-Hodgkin Lymphoma|Ann Arbor Stage IV Hodgkin Lymphoma|Ann Arbor Stage IV Non-Hodgkin Lymphoma|Atypical Chronic Myeloid Leukemia, BCR-ABL1 Negative|Blast Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive|Castration-Resistant Prostate Carcinoma|Chronic Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive|Hematopoietic and Lymphoid System Neoplasm|Locally Advanced Pancreatic Adenocarcinoma|Metastatic Breast Carcinoma|Metastatic Malignant Solid Neoplasm|Metastatic Pancreatic Adenocarcinoma|Myelodysplastic/Myeloproliferative Neoplasm With Ring Sideroblasts and Thrombocytosis|Myelodysplastic/Myeloproliferative Neoplasm, Unclassifiable|Primary Myelofibrosis|Recurrent Acute Lymphoblastic Leukemia|Recurrent Acute Myeloid Leukemia|Recurrent Chronic Lymphocytic Leukemia|Recurrent Chronic Myelogenous Leukemia, BCR-ABL1 Positive|Recurrent Hematologic Malignancy|Recurrent Hodgkin Lymphoma|Recurrent Myelodysplastic Syndrome|Recurrent Myelodysplastic/Myeloproliferative Neoplasm|Recurrent Myeloproliferative Neoplasm|Recurrent Non-Hodgkin Lymphoma|Recurrent Plasma Cell Myeloma|Recurrent Small Lymphocytic Lymphoma|Refractory Acute Lymphoblastic Leukemia|Refractory Acute Myeloid Leukemia|Refractory Chronic Lymphocytic Leukemia|Refractory Chronic Myelogenous Leukemia, BCR-ABL1 Positive|Refractory Chronic Myelomonocytic Leukemia|Refractory Hematologic Malignancy|Refractory Hodgkin Lymphoma|Refractory Malignant Solid Neoplasm|Refractory Myelodysplastic Syndrome|Refractory Myelodysplastic/Myeloproliferative Neoplasm|Refractory Non-Hodgkin Lymphoma|Refractory Plasma Cell Myeloma|Refractory Primary Myelofibrosis|Refractory Small Lymphocytic Lymphoma|Stage II Pancreatic Cancer AJCC v8|Stage III Pancreatic Cancer AJCC v8|Stage IV Pancreatic Cancer AJCC v8|Stage IV Prostate Cancer AJCC v8|Unresectable Pancreatic Adenocarcinoma",Darolutamide,CC(CN1C=CC(=N1)C2=CC(=C(C=C2)C#N)Cl)NC(=O)C3=NNC(=C3)C(C)O,PHASE1,,cardiovascular_disease
4035,13925,Wegener's Granulomatosis,Gusperimus,C(CCCN=C(N)N)CCC(=O)NC(C(=O)NCCCCNCCCN)O,PHASE2,,cardiovascular_disease
4034,13887,Refractory Multiple Myeloma,Lintuzumab,,PHASE1,,cardiovascular_disease
4029,13664,Congenital Hemangioma|Hemangioendothelioma|Angiosarcoma|Arteriovenous Malformation,Lipiodol,,APPROVED,,cardiovascular_disease
4024,13420,Brugada Syndrome|Sudden Death,Ajmaline,CCC1C2CC3C4C5(CC(C2C5O)N3C1O)C6=CC=CC=C6N4C,PHASE2,,cardiovascular_disease
4018,13225,Diabetic Foot Ulcer,Ketanserin,C1CN(CCC1C(=O)C2=CC=C(C=C2)F)CCN3C(=O)C4=CC=CC=C4NC3=O,PHASE1|PHASE2,,cardiovascular_disease
4017,13157,HIV-Associated Lipodystrophy Syndrome|Cardiovascular Disease,Tipranavir,CCCC1(CC(=C(C(=O)O1)C(CC)C2=CC(=CC=C2)NS(=O)(=O)C3=NC=C(C=C3)C(F)(F)F)O)CCC4=CC=CC=C4,APPROVED,,cardiovascular_disease
4016,13154,HIV-Associated Lipodystrophy Syndrome|Cardiovascular Disease,Amprenavir,CC(C)CN(CC(C(CC1=CC=CC=C1)NC(=O)OC2CCOC2)O)S(=O)(=O)C3=CC=C(C=C3)N,APPROVED,,cardiovascular_disease
4015,13153,HIV-Associated Lipodystrophy Syndrome|Cardiovascular Disease,Saquinavir,CC(C)(C)NC(=O)C1CC2CCCCC2CN1CC(C(CC3=CC=CC=C3)NC(=O)C(CC(=O)N)NC(=O)C4=NC5=CC=CC=C5C=C4)O,APPROVED,,cardiovascular_disease
4011,13145,HIV-Associated Lipodystrophy Syndrome|Cardiovascular Disease,Stavudine,CC1=CN(C(=O)NC1=O)C2C=CC(O2)CO,APPROVED,,cardiovascular_disease
4007,12999,Hypertrophic Cardiomyopathy,Trientine,C(CNCCNCCN)N,PHASE2,,cardiovascular_disease
4006,12998,Hypertrophic Cardiomyopathy,Triethylenetetramine,C(CNCCNCCN)N,PHASE2,,cardiovascular_disease
4003,12759,Heart Rate|Blood Pressure|Arrhythmias,Dimetindene,CC(C1=CC=CC=N1)C2=C(CC3=CC=CC=C32)CCN(C)C,PHASE1|PHASE2,,cardiovascular_disease
4002,12758,Heart Rate|Blood Pressure|Arrhythmias,Dimethindene,CC(C1=CC=CC=N1)C2=C(CC3=CC=CC=C32)CCN(C)C,PHASE1|PHASE2,,cardiovascular_disease
4001,12735,Staphylococcus Aureus Bacteremia|Staphylococcus Aureus Endocarditis,Oritavancin,CC1C(C(CC(O1)OC2C3C(=O)NC(C4=C(C(=CC(=C4)O)O)C5=C(C=CC(=C5)C(C(=O)N3)NC(=O)C6C7=CC(=C(C(=C7)OC8=C(C=C2C=C8)Cl)OC9C(C(C(C(O9)CO)O)O)OC1CC(C(C(O1)C)O)(C)NCC1=CC=C(C=C1)C1=CC=C(C=C1)Cl)OC1=C(C=C(C=C1)C(C(C(=O)NC(C(=O)N6)CC(=O)N)NC(=O)C(CC(C)C)NC)O)Cl)O)C(=O)O)(C)N)O,APPROVED,,cardiovascular_disease
4000,12640,Angioedema,Cortisone,CC12CCC(=O)C=C1CCC3C2C(=O)CC4(C3CCC4(C(=O)CO)O)C,PHASE2,,cardiovascular_disease
3995,12429,Congestive Heart Failure,Piboserod,CCCCN1CCC(CC1)CNC(=O)C2=C3N(CCCO3)C4=CC=CC=C42,PHASE2,,cardiovascular_disease
3993,12415,Multiple Myeloma,Osalmid,C1=CC=C(C(=C1)C(=O)NC2=CC=C(C=C2)O)O,PHASE1|PHASE2,,cardiovascular_disease
3991,12274,Portal Hypertension,Cobiprostone,CCC(C)CC(C1(CCC2C(O1)CC(=O)C2CCCCCCC(=O)O)O)(F)F,PHASE2,,cardiovascular_disease
3990,12132,Smoldering Multiple Myeloma,Citarinostat,C1=CC=C(C=C1)N(C2=CC=CC=C2Cl)C3=NC=C(C=N3)C(=O)NCCCCCCC(=O)NO,PHASE1,,cardiovascular_disease
3989,12131,Smoldering Multiple Myeloma,Hiltonol,C1=CN(C(=O)N=C1N)C2C(C(C(O2)COP(=O)(O)O)O)O.C1=NC2=C(C(=O)N1)N=CN2C3C(C(C(O3)COP(=O)(O)O)O)O.C(CCNC(=O)O)CN.C(C(=O)O)O,PHASE1,,cardiovascular_disease
3982,11954,"Diabetes Mellitus, Type 2",Teneligliptin,CC1=NN(C(=C1)N2CCN(CC2)C3CC(NC3)C(=O)N4CCSC4)C5=CC=CC=C5,APPROVED,,cardiovascular_disease
3978,11919,Plasmacytoma|Recurrent Multiple Myeloma|Refractory Multiple Myeloma,Navtemadlin,CC(C)C(CS(=O)(=O)C(C)C)N1C(C(CC(C1=O)(C)CC(=O)O)C2=CC(=CC=C2)Cl)C3=CC=C(C=C3)Cl,PHASE1,,cardiovascular_disease
3977,11909,Type 2 Diabetes|Coronary Artery Disease,Glipizide,CC1=CN=C(C=N1)C(=O)NCCC2=CC=C(C=C2)S(=O)(=O)NC(=O)NC3CCCCC3,APPROVED,,cardiovascular_disease
3976,11840,ST-segment Elevation Myocardial Infarction (STEMI),Ketotifen,CN1CCC(=C2C3=C(C(=O)CC4=CC=CC=C42)SC=C3)CC1,APPROVED,,cardiovascular_disease
3971,11608,"Deep Vein Thrombosis|Fibrillation, Atrial|Venous Thromboembolism|Pulmonary Embolism",Odiparcil,CC1=CC(=O)OC2=C1C=CC(=C2)OC3C(C(C(CS3)O)O)O,PHASE2,,cardiovascular_disease
3969,11498,Multiple Myeloma,Tecemotide,CCCCCCCCCCCCCCCC(=O)NCCCCC(C(=O)NCC(=O)O)NC(=O)C1CCCN1C(=O)C2CCCN2C(=O)C(C)NC(=O)C(C(C)O)NC(=O)C(CO)NC(=O)CNC(=O)C3CCCN3C(=O)C(C)NC(=O)C4CCCN4C(=O)C(CCCNC(=N)N)NC(=O)C(C(C)O)NC(=O)C(CC(=O)O)NC(=O)C5CCCN5C(=O)C(C)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C(C(C)C)NC(=O)CNC(=O)C(CC6=CN=CN6)NC(=O)C(C)NC(=O)C7CCCN7C(=O)C8CCCN8C(=O)C(C)NC(=O)C(C(C)O)NC(=O)C(CO)N,PHASE2,,cardiovascular_disease
3965,11373,"Altitude Sickness|Hypertension, Pulmonary",Methazolamide,CC(=O)N=C1N(N=C(S1)S(=O)(=O)N)C,APPROVED,,cardiovascular_disease
3963,11323,Postoperative Cardiac Complication,Celiprolol,CCN(CC)C(=O)NC1=CC(=C(C=C1)OCC(CNC(C)(C)C)O)C(=O)C,PHASE2,,cardiovascular_disease
3957,11099,Coronary Artery Disease|Dyslipidemia,Laropiprant,CS(=O)(=O)C1=CC(=CC2=C1N(C3=C2CCC3CC(=O)O)CC4=CC=C(C=C4)Cl)F,APPROVED,,cardiovascular_disease
3953,11030,Copd|Heart Failure,Umeclidinium,C1C[N+]2(CCC1(CC2)C(C3=CC=CC=C3)(C4=CC=CC=C4)O)CCOCC5=CC=CC=C5,APPROVED,,cardiovascular_disease
3952,10984,Multiple Myeloma,Etodolac,CCC1=C2C(=CC=C1)C3=C(N2)C(OCC3)(CC)CC(=O)O,PHASE2,,cardiovascular_disease
3951,10960,Macular Edema|Retinal Vein Occlusion,Fluocinolone,CC12CC(C3(C(C1CC(C2(C(=O)CO)O)O)CC(C4=CC(=O)C=CC43C)F)F)O,PHASE2,,cardiovascular_disease
3950,10947,Hypotension,Metaraminol,CC(C(C1=CC(=CC=C1)O)O)N,PHASE2,,cardiovascular_disease
3945,10824,Chagas Disease,Benznidazole,C1=CC=C(C=C1)CNC(=O)CN2C=CN=C2[N+](=O)[O-],PHASE2|PHASE3,,cardiovascular_disease
3944,10823,Chagas Disease,Nifurtimox,CC1CS(=O)(=O)CCN1N=CC2=CC=C(O2)[N+](=O)[O-],PHASE2|PHASE3,,cardiovascular_disease
3942,10764,Symptomatic Atrial Fibrillation|Atrial Flutter,Vanoxerine,C1CN(CCN1CCCC2=CC=CC=C2)CCOC(C3=CC=C(C=C3)F)C4=CC=C(C=C4)F,PHASE2,,cardiovascular_disease
3941,10744,Congenital Heart Diseases,Ulinastatin,,APPROVED,,cardiovascular_disease
3937,10542,Recurrent Plasma Cell Myeloma|Refractory Plasma Cell Myeloma,Uprosertib,CN1C(=C(C=N1)Cl)C2=C(OC(=C2)C(=O)NC(CC3=CC(=C(C=C3)F)F)CN)Cl,PHASE2,,cardiovascular_disease
3932,10515,Refractory Multiple Myeloma,Noscapine,CN1CCC2=CC3=C(C(=C2C1C4C5=C(C(=C(C=C5)OC)OC)C(=O)O4)OC)OCO3,PHASE1,,cardiovascular_disease
3929,10390,Systemic Lupus Erythematosus,Prasterone,CC12CCC3C(C1CCC2=O)CC=C4C3(CCC(C4)O)C,PHASE2|PHASE3,,cardiovascular_disease
3928,10389,Systemic Lupus Erythematosus,Dehydroepiandrosterone,CC12CCC3C(C1CCC2=O)CC=C4C3(CCC(C4)O)C,PHASE2|PHASE3,,cardiovascular_disease
3925,10237,Pulmonary Embolism,Monteplase,,APPROVED,,cardiovascular_disease
3919,10093,Aortic Stenosis,Pelacarsen,,PHASE2,,cardiovascular_disease
3914,9824,Multiple Myeloma,Mapatumumab,,PHASE2,,cardiovascular_disease
3907,9747,Asthma,Benralizumab,,PHASE2,,cardiovascular_disease
3899,9577,Essential Hypertension,Bexagliflozin,C1CC1OCCOC2=CC=C(C=C2)CC3=C(C=CC(=C3)C4C(C(C(C(O4)CO)O)O)O)Cl,PHASE2|PHASE3,,cardiovascular_disease
3896,9541,Psoriasis|Inflammation|Coronary Artery Disease|Cardiometabolic Syndrome,Orticumab,,PHASE2,,cardiovascular_disease
3895,9508,Pulmonary Hypertension,Hymecromone,CC1=CC(=O)OC2=C1C=CC(=C2)O,PHASE2,,cardiovascular_disease
3893,9392,Hemodialysis Catheter Infection|Thrombosis; Dialysis Catheter,Taurolidine,C1CS(=O)(=O)NCN1CN2CCS(=O)(=O)NC2,APPROVED,,cardiovascular_disease
3886,9214,"Diabetes, Type 1|Diabetes, Type 2|Foot Ulcer, Diabetic",Bacitracin,,APPROVED,,cardiovascular_disease
3882,9148,Cardiac Arrythmias,Carbetocin,CCC(C)C1C(=O)NC(C(=O)NC(C(=O)NC(CSCCCC(=O)NC(C(=O)N1)CC2=CC=C(C=C2)OC)C(=O)N3CCCC3C(=O)NC(CC(C)C)C(=O)NCC(=O)N)CC(=O)N)CCC(=O)N,APPROVED,,cardiovascular_disease
3881,9118,Glaucoma|Ocular Hypertension,Benzalkonium,CCCCCCCCCCCCC[N+](C)(C)CC1=CC=CC=C1,PHASE2,,cardiovascular_disease
3880,9074,Diabetic Retinopathy,Pimagedine,C(=NN)(N)N,PHASE1,,cardiovascular_disease
3876,8932,Congestive Heart Failure,Azimilide,CN1CCN(CC1)CCCCN2C(=O)CN(C2=O)N=CC3=CC=C(O3)C4=CC=C(C=C4)Cl,PHASE2,,cardiovascular_disease
3874,8893,Cardiovascular Disease Risk Factors,Puerarin,C1=CC(=CC=C1C2=COC3=C(C2=O)C=CC(=C3C4C(C(C(C(O4)CO)O)O)O)O)O,PHASE2,,cardiovascular_disease
3870,8727,Acute Myocardial Infarction|Acute Myocardial Ischemia|STEMI - ST Elevation Myocardial Infarction,Dutogliptin,B(C1CCCN1C(=O)CNC2CCNC2)(O)O,PHASE2,,cardiovascular_disease
3867,8616,Gastrointestinal Cancer|Cancer of Unknown Primary Site|Pancreatic Cancer|Bile Duct Neoplasms,Gimeracil,C1=C(C(=CNC1=O)Cl)O,PHASE2,,cardiovascular_disease
3864,8532,Acute Heart Failure,Enibarcimab,,PHASE2,,cardiovascular_disease
3863,8531,Pulmonary Arterial Hypertension,Apabetalone,CC1=CC(=CC(=C1OCCO)C)C2=NC3=C(C(=CC(=C3)OC)OC)C(=O)N2,PHASE2,,cardiovascular_disease
3862,8530,Follicular Lymphoma|Small Lymphocytic Lymphoma|Marginal Zone Lymphoma|Lymphoplasmacytic Lymphoma|Diffuse Large B Cell Lymphoma|Mantle Cell Lymphoma|Burkitt's Lymphoma,Imexon,C1C2N1C(=O)N=C2N,PHASE2,,cardiovascular_disease
3857,8352,Dipeptidyl-Peptidase 4 Inhibitors|LDL Cholesterol|Glycosylated Hemoglobin|Diabetes Mellitus|Coronary Disease,Anagliptin,CC1=NN2C=C(C=NC2=C1)C(=O)NCC(C)(C)NCC(=O)N3CCCC3C#N,APPROVED,,cardiovascular_disease
3846,8057,Multiple Myeloma,Feladilimab,,PHASE1|PHASE2,,cardiovascular_disease
3845,8056,Multiple Myeloma,Tositumomab,,PHASE2,,cardiovascular_disease
3838,7871,Macular Edema|Central Retinal Vein Occlusion,Ecallantide,CCC(C)C1C(=O)NC(C(=O)NCC(=O)NCC(=O)NC2CSSCC3C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N4CCCC4C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(CSSCC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(CSSCC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NCC(=O)N5CCCC5C(=O)N3)CC(=O)O)CC(=O)O)C)CCCCN)CC6=CC=CC=C6)C)NC(=O)C(CC7=CC=CC=C7)NC(=O)C(CO)NC(=O)C(CC8=CN=CN8)NC(=O)C(CCSC)NC(=O)C(C)NC(=O)C(CCC(=O)O)N)C(=O)NC(C(C)O)C(=O)NC(CCCNC(=N)N)C(=O)NC(CC(=O)O)C(=O)O)CCSC)CCCCN)CCCCN)NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)CNC(=O)C(NC2=O)CCC(=O)O)CC(=O)N)CCC(=O)N)CC(=O)N)CCCNC(=N)N)CC9=CC=CC=C9)CCC(=O)O)CO)CC(C)C)CCC(=O)O)CCC(=O)O)C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N1)CC1=CC=CC=C1)CCC(=O)O)CCC(=O)O)CCC(=O)N)CCCNC(=N)N)C(C)O)CC1=CC=CC=C1)C(C)CC)CC(=O)N)CC1=CC=CC=C1)CC1=CC=CC=C1)CC1=CNC2=CC=CC=C21)CCCNC(=N)N)CC1=CN=CN1)C)C)CCCNC(=N)N)CC1=CC=C(C=C1)O,PHASE1,,cardiovascular_disease
3837,7852,Vasoplegic Syndrome,Hydroxocobalamin,CC1=CC2=C(C=C1C)N(C=N2)C3C(C(C(O3)CO)OP(=O)([O-])OC(C)CNC(=O)CCC4(C(C5C6(C(C(C(=N6)C(=C7C(C(C(=N7)C=C8C(C(C(=N8)C(=C4[N-]5)C)CCC(=O)N)(C)C)CCC(=O)N)(C)CC(=O)N)C)CCC(=O)N)(C)CC(=O)N)C)CC(=O)N)C)O.O.[Co+2],PHASE2,,cardiovascular_disease
3835,7849,Coronary Artery Disease,Tetrofosmin,CCOCCP(CCOCC)CCP(CCOCC)CCOCC,APPROVED,,cardiovascular_disease
3827,7702,Varicose Veins|Cicatrix,Avotermin,,PHASE2,,cardiovascular_disease
3826,7701,Multiple Myeloma,Imetelstat,CCCCCCCCCCCCCCCC(=O)NCC(COP(=S)(O)OCC1C(CC(O1)N2C=C(C(=O)NC2=O)C)NP(=S)(O)OCC3C(CC(O3)N4C=NC5=C(N=CN=C54)N)NP(=S)(O)OCC6C(CC(O6)N7C=NC8=C7N=C(NC8=O)N)NP(=S)(O)OCC9C(CC(O9)N1C=NC2=C1N=C(NC2=O)N)NP(=S)(O)OCC1C(CC(O1)N1C=NC2=C1N=C(NC2=O)N)NP(=S)(O)OCC1C(CC(O1)N1C=C(C(=O)NC1=O)C)NP(=S)(O)OCC1C(CC(O1)N1C=C(C(=O)NC1=O)C)NP(=S)(O)OCC1C(CC(O1)N1C=NC2=C(N=CN=C21)N)NP(=S)(O)OCC1C(CC(O1)N1C=NC2=C1N=C(NC2=O)N)NP(=S)(O)OCC1C(CC(O1)N1C=NC2=C(N=CN=C21)N)NP(=S)(O)OCC1C(CC(O1)N1C=CC(=NC1=O)N)NP(=S)(O)OCC1C(CC(O1)N1C=NC2=C(N=CN=C21)N)NP(=O)(OCC1C(CC(O1)N1C=NC2=C(N=CN=C21)N)N)S)O,PHASE1,,cardiovascular_disease
3817,7553,Multiple Myeloma,Opaganib,C1C2CC3(CC1CC(C2)(C3)C(=O)NCC4=CC=NC=C4)C5=CC=C(C=C5)Cl,PHASE1|PHASE2,,cardiovascular_disease
3816,7494,HIV Infections|Cardiovascular Diseases|Hypertension,Indinavir,CC(C)(C)NC(=O)C1CN(CCN1CC(CC(CC2=CC=CC=C2)C(=O)NC3C(CC4=CC=CC=C34)O)O)CC5=CN=CC=C5,PHASE1,,cardiovascular_disease
3812,7465,Arterial Occlusive Diseases|Peripheral Vascular Diseases|Thrombosis,Alfimeprase,,PHASE2,,cardiovascular_disease
3810,7345,COPD|Chronic Obstructive Pulmonary Disease|Moderate to Very Severe COPD,Aclidinium,C1C[N+]2(CCC1C(C2)OC(=O)C(C3=CC=CS3)(C4=CC=CS4)O)CCCOC5=CC=CC=C5,APPROVED,,cardiovascular_disease
3809,7320,Solid Tumor|Multiple Myeloma,Dalotuzumab,,PHASE1,,cardiovascular_disease
3808,7254,"Cardiovascular Diseases|Cardiovascular Risk Factor|Triglycerides High|Diabetes Mellitus, Type 2",Icosapent,CCC=CCC=CCC=CCC=CCC=CCCCC(=O)O,APPROVED,,cardiovascular_disease
3807,7243,Acute Myocardial Infarction,Lenograstim,,PHASE2|PHASE3,,cardiovascular_disease
3806,7228,Pulmonary Arterial Hypertension,Zamicastat,C1C(COC2=C1C=C(C=C2F)F)N3C(=CNC3=S)CCNCC4=CC=CC=C4,PHASE2,,cardiovascular_disease
3795,7077,Velo-cardio-facial Syndrome|Psychosis,Metyrosine,CC(CC1=CC=C(C=C1)O)(C(=O)O)N,PHASE2,,cardiovascular_disease
3792,7015,Multiple Myeloma,Plitidepsin,CCC(C)C1C(CC(=O)OC(C(=O)C(C(=O)NC(C(=O)N2CCCC2C(=O)N(C(C(=O)OC(C(C(=O)N1)NC(=O)C(CC(C)C)N(C)C(=O)C3CCCN3C(=O)C(=O)C)C)CC4=CC=C(C=C4)OC)C)CC(C)C)C)C(C)C)O,PHASE2,,cardiovascular_disease
3789,6985,Relapsed Refractory Multiple Myeloma,Enasidenib,CC(C)(CNC1=NC(=NC(=N1)C2=NC(=CC=C2)C(F)(F)F)NC3=CC(=NC=C3)C(F)(F)F)O,PHASE1|PHASE2,,cardiovascular_disease
3785,6894,Waldenstrom's Macroglobulinemia,Ulocuplumab,,PHASE1|PHASE2,,cardiovascular_disease
3779,6800,Hyperemia Eye,Hypromellose,CC(COCC1C(C(C(C(O1)OC)OCC(C)O)OCC(C)O)OC2C(C(C(C(O2)COC)OC3C(C(C(C(O3)CO)OC)O)O)OC)OC)O,PHASE1,,cardiovascular_disease
3778,6799,Hyperemia Eye,Naphazoline,C1CN=C(N1)CC2=CC=CC3=CC=CC=C32,PHASE1,,cardiovascular_disease
3773,6751,Coagulopathy|Cardiovascular Complication|COVID-19,Camostat,CN(C)C(=O)COC(=O)CC1=CC=C(C=C1)OC(=O)C2=CC=C(C=C2)N=C(N)N,PHASE1|PHASE2,,cardiovascular_disease
3772,6725,Prehypertension|Hypertension,Bradykinin,C1CC(N(C1)C(=O)C2CCCN2C(=O)C(CCCN=C(N)N)N)C(=O)NCC(=O)NC(CC3=CC=CC=C3)C(=O)NC(CO)C(=O)N4CCCC4C(=O)NC(CC5=CC=CC=C5)C(=O)NC(CCCN=C(N)N)C(=O)O,APPROVED,,cardiovascular_disease
3770,6691,Loss of Chromosome 17p|Recurrent Plasma Cell Myeloma,Idasanutlin,CC(C)(C)CC1C(C(C(N1)C(=O)NC2=C(C=C(C=C2)C(=O)O)OC)C3=C(C(=CC=C3)Cl)F)(C#N)C4=C(C=C(C=C4)Cl)F,PHASE1|PHASE2,,cardiovascular_disease
3769,6686,Heart Failure,Bendroflumethiazide,C1=CC=C(C=C1)CC2NC3=C(C=C(C(=C3)C(F)(F)F)S(=O)(=O)N)S(=O)(=O)N2,PHASE1,,cardiovascular_disease
3768,6682,Drug-induced QT Prolongation|Pharmacokinetics|Pharmacodynamics,Cobicistat,CC(C)C1=NC(=CS1)CN(C)C(=O)NC(CCN2CCOCC2)C(=O)NC(CCC(CC3=CC=CC=C3)NC(=O)OCC4=CN=CS4)CC5=CC=CC=C5,PHASE1,,cardiovascular_disease
3762,6527,Chronic Lymphocytic Leukemia|Indolent Non-Hodgkin Lymphoma|Follicular Lymphoma|Small Lymphocytic Lymphoma|Lymphoplasmacytic Lymphoma (With or Without Waldenstrom Macroglobulinemia)|Marginal Zone Lymphoma,Idelalisib,CCC(C1=NC2=C(C(=CC=C2)F)C(=O)N1C3=CC=CC=C3)NC4=NC=NC5=C4NC=N5,PHASE1,,cardiovascular_disease
3760,6453,Hypertension,Levamlodipine,CCOC(=O)C1=C(NC(=C(C1C2=CC=CC=C2Cl)C(=O)OC)C)COCCN,PHASE1,,cardiovascular_disease
3757,6428,Diabetes Mellitus,Albiglutide,CCC(C)C(C(=O)NC(C)C(=O)NC(CC1=CNC2=CC=CC=C21)C(=O)NC(CC(C)C)C(=O)NC(C(C)C)C(=O)NC(CCCCN)C(=O)NCC(=O)NC(CCCNC(=N)N)C(=O)N)NC(=O)C(CC3=CC=CC=C3)NC(=O)C(CCC(=O)O)NC(=O)C(CCCCN)NC(=O)C(C)NC(=O)C(C)NC(=O)C(CCC(=O)N)NC(=O)CNC(=O)C(CCC(=O)O)NC(=O)C(CC(C)C)NC(=O)C(CC4=CC=C(C=C4)O)NC(=O)C(CO)NC(=O)C(CO)NC(=O)C(C(C)C)NC(=O)C(CC(=O)O)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C(CC5=CC=CC=C5)NC(=O)C(C(C)O)NC(=O)CNC(=O)C(CCC(=O)O)NC(=O)CNC(=O)C(CC6=CN=CN6)N,APPROVED,,cardiovascular_disease
3756,6425,Pulmonary Arterial Hypertension,Ralinepag,C1CC(CCC1COCC(=O)O)COC(=O)N(C2=CC=CC=C2)C3=CC=C(C=C3)Cl,PHASE2,,cardiovascular_disease
3755,6424,HIV Infections,Cenicriviroc,CCCCOCCOC1=CC=C(C=C1)C2=CC3=C(C=C2)N(CCCC(=C3)C(=O)NC4=CC=C(C=C4)S(=O)CC5=CN=CN5CCC)CC(C)C,PHASE2,,cardiovascular_disease
3754,6381,"Cardiac Disease|Cardiac Surgery|Cardiopulmonary Bypass|Platelet Transfusion|Arrythmia, Cardiac|Mortality",Cryoprecipitate,,APPROVED,,cardiovascular_disease
3753,6335,Asthma,Reslizumab,,PHASE2,,cardiovascular_disease
3747,6242,Heart Failure,Istaroxime,CC12CCC(=NOCCN)CC1C(=O)CC3C2CCC4(C3CCC4=O)C,PHASE1,,cardiovascular_disease
3743,6212,Portal Hypertension,Entecavir,C=C1C(CC(C1CO)O)N2C=NC3=C2N=C(NC3=O)N,APPROVED,,cardiovascular_disease
3737,6141,"Heart Failure (HF)|Ventricular Dysfunction, Left",Iobenguane,C1=CC(=CC(=C1)I)CN=C(N)N,APPROVED,,cardiovascular_disease
3735,6139,Cushing Syndrome|Endocrine Disease,Pentetreotide,CC(C1C(=O)NC(CSSCC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N1)CCCCN)CC2=CNC3=CC=CC=C32)CC4=CC=CC=C4)NC(=O)C(CC5=CC=CC=C5)NC(=O)CN(CCN(CCN(CC(=O)O)CC(=O)O)CC(=O)O)CC(=O)O)C(=O)NC(CO)C(C)O)O,PHASE2,,cardiovascular_disease
3727,5936,Long QT Syndrome,Lumacaftor,CC1=C(N=C(C=C1)NC(=O)C2(CC2)C3=CC4=C(C=C3)OC(O4)(F)F)C5=CC(=CC=C5)C(=O)O,PHASE2,,cardiovascular_disease
3725,5886,Vascular Anomalies,Marimastat,CC(C)CC(C(C(=O)NO)O)C(=O)NC(C(=O)NC)C(C)(C)C,PHASE1,,cardiovascular_disease
3724,5881,Endocarditis Infective,Tedizolid,CN1N=C(N=N1)C2=NC=C(C=C2)C3=C(C=C(C=C3)N4CC(OC4=O)CO)F,APPROVED,,cardiovascular_disease
3721,5860,Endocarditis Infective,Cefaclor,C1C(=C(N2C(S1)C(C2=O)NC(=O)C(C3=CC=CC=C3)N)C(=O)O)Cl,APPROVED,,cardiovascular_disease
3714,5699,Atrial Fibrillation|Cardiac Surgery,Landiolol,CC1(OCC(O1)COC(=O)CCC2=CC=C(C=C2)OCC(CNCCNC(=O)N3CCOCC3)O)C,APPROVED,,cardiovascular_disease
3711,5689,B-cell Chronic Lymphocytic Leukemia|Multiple Myeloma,Samalizumab,,PHASE1|PHASE2,,cardiovascular_disease
3709,5682,Coronary Artery Disease,Varespladib,CCC1=C(C2=C(N1CC3=CC=CC=C3)C=CC=C2OCC(=O)O)C(=O)C(=O)N,PHASE2,,cardiovascular_disease
3700,5476,Drug Overdose|Overdose of Beta-adrenergic Blocking Drug,Glucagon,CC(C)CC(C(=O)NC(CCSC)C(=O)NC(CC(=O)N)C(=O)NC(C(C)O)C(=O)O)NC(=O)C(CC1=CNC2=CC=CC=C21)NC(=O)C(CCC(=O)N)NC(=O)C(C(C)C)NC(=O)C(CC3=CC=CC=C3)NC(=O)C(CC(=O)O)NC(=O)C(CCC(=O)N)NC(=O)C(C)NC(=O)C(CCCNC(=N)N)NC(=O)C(CCCNC(=N)N)NC(=O)C(CO)NC(=O)C(CC(=O)O)NC(=O)C(CC(C)C)NC(=O)C(CC4=CC=C(C=C4)O)NC(=O)C(CCCCN)NC(=O)C(CO)NC(=O)C(CC5=CC=C(C=C5)O)NC(=O)C(CC(=O)O)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C(CC6=CC=CC=C6)NC(=O)C(C(C)O)NC(=O)CNC(=O)C(CCC(=O)N)NC(=O)C(CO)NC(=O)C(CC7=CN=CN7)N,APPROVED,,cardiovascular_disease
3689,5316,Polypoidal Choroidal Vasculopathy,Verteporfin,CC1=C(C2=CC3=NC(=CC4=C(C(=C(N4)C=C5C6(C(C(=CC=C6C(=N5)C=C1N2)C(=O)OC)C(=O)OC)C)C)CCC(=O)OC)C(=C3C)CCC(=O)O)C=C.CC1=C(C2=CC3=NC(=CC4=C(C(=C(N4)C=C5C6(C(C(=CC=C6C(=N5)C=C1N2)C(=O)OC)C(=O)OC)C)C)CCC(=O)O)C(=C3C)CCC(=O)OC)C=C,APPROVED,,cardiovascular_disease
3686,5252,Heart Failure With Preserved Ejection Fraction,Teprenone,CC(=CCCC(=CCCC(=CCCC(=CCCC(=O)C)C)C)C)C,PHASE2,,cardiovascular_disease
3679,5154,Coronary Artery Disease|Percutaneous Coronary Intervention|Platelet Aggregation Inhibitors,Vicagrel,CC(=O)OC1=CC2=C(S1)CCN(C2)C(C3=CC=CC=C3Cl)C(=O)OC,PHASE2,,cardiovascular_disease
3677,5147,Aortic Valve Stenosis,Ataciguat,C1COCCN1S(=O)(=O)C2=CC=C(C=C2)NC(=O)C3=C(C=CC(=C3)Cl)NS(=O)(=O)C4=CC=C(S4)Cl,PHASE2,,cardiovascular_disease
3676,5127,Multiple Myeloma|Hodgkin Lymphoma|Non-Hodgkin Lymphoma|HDT-AHCT,Romiplostim,CC1=CC(=C(N1)C=C2C3=CC=CC=C3NC2=O)C,PHASE2,,cardiovascular_disease
3675,5098,Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue|Nodal Marginal Zone Lymphoma|Recurrent Adult Diffuse Large Cell Lymphoma|Recurrent Adult Diffuse Mixed Cell Lymphoma|Recurrent Adult Diffuse Small Cleaved Cell Lymphoma|Recurrent Grade 1 Follicular Lymphoma|Recurrent Grade 2 Follicular Lymphoma|Recurrent Grade 3 Follicular Lymphoma|Recurrent Mantle Cell Lymphoma|Recurrent Marginal Zone Lymphoma|Refractory Plasma Cell Myeloma|Splenic Marginal Zone Lymphoma|Waldenstrom Macroglobulinemia,Alvocidib,CN1CCC(C(C1)O)C2=C(C=C(C3=C2OC(=CC3=O)C4=CC=CC=C4Cl)O)O,PHASE1,,cardiovascular_disease
3666,4942,"Heart Failure|Ventricular Dysfunction, Left",Trandolapril,CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N2C3CCCCC3CC2C(=O)O,APPROVED,,cardiovascular_disease
3665,4932,Coronary Heart Disease,Dalcetrapib,CCC(CC)CC1(CCCCC1)C(=O)NC2=CC=CC=C2SC(=O)C(C)C,PHASE2,,cardiovascular_disease
3664,4926,Acute Leukemia|Chronic Myeloproliferative Disease|Chronic Lymphoproliferative Disease|Multiple Myeloma|Lymphoma|Poor-risk Myelodysplasia (MDS),Darinaparsin,C[As](C)SCC(C(=O)NCC(=O)O)NC(=O)CCC(C(=O)O)N,PHASE1,,cardiovascular_disease
3663,4919,Symptomatic Neurogenic Orthostatic Hypertension|nOH,Ampreloxetine,C1CNCCC1C2=CC=CC=C2COC3=C(C=C(C=C3F)F)F,PHASE1,,cardiovascular_disease
3658,4887,Atherosclerosis,Pactimibe,CCCCCCCCN1CCC2=C(C(=C(C(=C21)NC(=O)C(C)(C)C)C)CC(=O)O)C,PHASE2,,cardiovascular_disease
3654,4805,Long QT Syndrome,Dofetilide,CN(CCC1=CC=C(C=C1)NS(=O)(=O)C)CCOC2=CC=C(C=C2)NS(=O)(=O)C,PHASE1|PHASE2,,cardiovascular_disease
3649,4773,Arterial Calcification|CD73 Deficiency,Etidronate,CC(O)(P(=O)(O)O)P(=O)(O)O,PHASE2,,cardiovascular_disease
3647,4751,Oral Cancer|Head and Neck Cancer|Free Flap|Hypotension,Dopexamine,C1=CC=C(C=C1)CCNCCCCCCNCCC2=CC(=C(C=C2)O)O,APPROVED,,cardiovascular_disease
3646,4732,"Hypertension, Pulmonary",Terbogrel,CC(C)(C)N=C(NC#N)NC1=CC=CC(=C1)C(=CCCCC(=O)O)C2=CN=CC=C2,PHASE2,,cardiovascular_disease
3644,4705,Heart Failure|Hyperuricemia,Benzbromarone,CCC1=C(C2=CC=CC=C2O1)C(=O)C3=CC(=C(C(=C3)Br)O)Br,APPROVED,,cardiovascular_disease
3632,4456,Anemia|B-Cell Prolymphocytic Leukemia|Grade 1 Follicular Lymphoma|Grade 2 Follicular Lymphoma|Grade 3a Follicular Lymphoma|Hairy Cell Leukemia|Lymphoplasmacytic Lymphoma|Mantle Cell Lymphoma|Marginal Zone Lymphoma|Recurrent Chronic Lymphocytic Leukemia|Recurrent Small Lymphocytic Lymphoma|Refractory Chronic Lymphocytic Leukemia|Refractory Small Lymphocytic Lymphoma|Richter Syndrome,Entospletinib,C1COCCN1C2=CC=C(C=C2)NC3=NC(=CN4C3=NC=C4)C5=CC6=C(C=C5)C=NN6,PHASE1|PHASE2,,cardiovascular_disease
3627,4356,Recurrent Plasma Cell Myeloma,Dinaciclib,CCC1=C2N=C(C=C(N2N=C1)NCC3=C[N+](=CC=C3)[O-])N4CCCCC4CCO,PHASE1,,cardiovascular_disease
3626,4322,Non-Proliferative Diabetic Retinopathy,Faricimab,,PHASE2,,cardiovascular_disease
3610,4139,ST Segment Elevation Myocardial Infarction,Anfibatide,,PHASE2,,cardiovascular_disease
3604,4033,Turner Syndrome,Lonapegsomatropin,,PHASE2,,cardiovascular_disease
3603,4031,Hemodialysis Complication|Hypotension of Hemodialysis,Lanadelumab,,PHASE2,,cardiovascular_disease
3602,4011,Atrial Fibrillation,Flecainide,C1CCNC(C1)CNC(=O)C2=C(C=CC(=C2)OCC(F)(F)F)OCC(F)(F)F,APPROVED,,cardiovascular_disease
3597,3971,Multiple Myeloma,Nirogacestat,CCCC(C(=O)NC1=CN(C=N1)C(C)(C)CNCC(C)(C)C)NC2CCC3=C(C2)C(=CC(=C3)F)F,PHASE2,,cardiovascular_disease
3590,3905,Congestive Heart Failure,Oxypurinol,C1=NNC2=C1C(=O)NC(=O)N2,PHASE2|PHASE3,,cardiovascular_disease
3582,3748,Hypertension|Hypertriglyceridemia,Ciprofibrate,CC(C)(C(=O)O)OC1=CC=C(C=C1)C2CC2(Cl)Cl,APPROVED,,cardiovascular_disease
3581,3691,Congenital Bleeding Disorder|Haemophilia A,Concizumab,,PHASE1,,cardiovascular_disease
3578,3636,Stable Coronary Artery Disease,Selatogrel,CCCCOC(=O)N1CCN(CC1)C(=O)C(CP(=O)(O)O)NC(=O)C2=CC(=NC(=N2)C3=CC=CC=C3)N4CCC(C4)OC,PHASE2,,cardiovascular_disease
3574,3571,"Glaucoma, Open-Angle|Ocular Hypertension",Tafluprost,CC(C)OC(=O)CCCC=CCC1C(CC(C1C=CC(COC2=CC=CC=C2)(F)F)O)O,APPROVED,,cardiovascular_disease
3568,3491,Multiple Myeloma,Vactosertib,CC1=NC(=CC=C1)C2=C(N=C(N2)CNC3=CC=CC=C3F)C4=CN5C(=NC=N5)C=C4,PHASE1,,cardiovascular_disease
3561,3380,Congenital Heart Disease,Palivizumab,,PHASE2,,cardiovascular_disease
3560,3379,Congenital Heart Disease,Motavizumab,,PHASE2,,cardiovascular_disease
3557,3315,Effects of the DPP-4 Inhibitors or SGLT2 Inhibitors on the Protective Actions for Diabetic Complications,Glimepiride,CCC1=C(CN(C1=O)C(=O)NCCC2=CC=C(C=C2)S(=O)(=O)NC(=O)NC3CCC(CC3)C)C,APPROVED,,cardiovascular_disease
3548,3230,Premature Ovarian Failure,Ethinylestradiol,CC12CCC3C(C1CCC2(C#C)O)CCC4=C3C=CC(=C4)O,APPROVED,,cardiovascular_disease
3539,3103,"Neoplasms, Haematologic",Afuresertib,CN1C(=C(C=N1)Cl)C2=C(SC(=C2)C(=O)NC(CC3=CC(=CC=C3)F)CN)Cl,PHASE1,,cardiovascular_disease
3537,3093,Prevention of Subclinical Atherosclerosis Progression|Prevention of Cognitive Decline,Nattokinase,B1(OC(=O)CC(O1)(CC(=O)O)C(=O)O)C(CC(C)C)NC(=O)CNC(=O)C2=C(C=CC(=C2)Cl)Cl,PHASE2,,cardiovascular_disease
3535,3076,"Aortic Aneurysm, Thoracic",Pimonidazole,C1CCN(CC1)CC(CN2C=CN=C2[N+](=O)[O-])O,PHASE1,,cardiovascular_disease
3532,3052,Alagille Syndrome,Maralixibat,CCCCC1(CS(=O)(=O)C2=C(C=C(C=C2)N(C)C)C(C1O)C3=CC=C(C=C3)OCC4=CC=C(C=C4)C[N+]56CCN(CC5)CC6)CCCC,PHASE2,,cardiovascular_disease
3523,2939,Arrhythmia Prophylaxis|Ventricular Arrhythmia,Celivarone,CCCCC1=C(C2=C(O1)C=CC(=C2)C(=O)OC(C)C)C(=O)C3=CC=C(C=C3)CCCN(CCCC)CCCC,PHASE2,,cardiovascular_disease
3520,2917,Ulcerative Colitis|Thromboembolism,Golimumab,,APPROVED,,cardiovascular_disease
3519,2900,Coronary Artery Disease|Acute Coronary Syndrome,Trapidil,CCN(CC)C1=CC(=NC2=NC=NN12)C,APPROVED,,cardiovascular_disease
3518,2886,Acute Myeloid Leukemia|Diffuse Large B-cell Lymphoma|Acute Lymphoblastic Leukemia|Multiple Myeloma,Birabresib,CC1=C(SC2=C1C(=NC(C3=NN=C(N32)C)CC(=O)NC4=CC=C(C=C4)O)C5=CC=C(C=C5)Cl)C,PHASE1,,cardiovascular_disease
3517,2881,Multiple Myeloma,Atiprimod,CCCC1(CCC2(CC1)CCN(C2)CCCN(CC)CC)CCC,PHASE1|PHASE2,,cardiovascular_disease
3516,2868,Coronary Heart Disease|Chlamydophila Pneumoniae Infections,Rifabutin,CC1C=CC=C(C(=O)NC2=C(C3=C(C4=C(C(=C3O)C)OC(C4=O)(OC=CC(C(C(C(C(C(C1O)C)O)C)OC(=O)C)C)OC)C)C5=NC6(CCN(CC6)CC(C)C)N=C25)O)C,PHASE2,,cardiovascular_disease
3493,2571,Mantle Cell Lymphoma|B Cell Lymphoma|Multiple Myeloma,Canfosfamide,C1=CC=C(C=C1)C(C(=O)O)NC(=O)C(CS(=O)(=O)CCOP(=O)(N(CCCl)CCCl)N(CCCl)CCCl)NC(=O)CCC(C(=O)O)N,PHASE2,,cardiovascular_disease
3487,2481,Essential Hypertension,Aprocitentan,C1=CC(=CC=C1C2=C(N=CN=C2OCCOC3=NC=C(C=N3)Br)NS(=O)(=O)N)Br,PHASE2,,cardiovascular_disease
3484,2438,"Cardiac; Dysrhythmia, Postoperative|Congenital Heart Surgery",Procainamide,CCN(CC)CCNC(=O)C1=CC=C(C=C1)N,APPROVED,,cardiovascular_disease
3483,2428,Congenital Heart Disease,Phenoxybenzamine,CC(COC1=CC=CC=C1)N(CCCl)CC2=CC=CC=C2,PHASE2,,cardiovascular_disease
3482,2427,Healthy Participants,Mavacamten,CC(C)N1C(=O)C=C(NC1=O)NC(C)C2=CC=CC=C2,PHASE1,,cardiovascular_disease
3480,2407,Hypertrophic Cardiomyopathy,Perhexiline,C1CCC(CC1)C(CC2CCCCN2)C3CCCCC3,PHASE2,,cardiovascular_disease
3477,2344,Recurrent Plasma Cell Myeloma|Refractory Plasma Cell Myeloma,Sonidegib,CC1CN(CC(O1)C)C2=NC=C(C=C2)NC(=O)C3=CC=CC(=C3C)C4=CC=C(C=C4)OC(F)(F)F,PHASE2,,cardiovascular_disease
3473,2285,Heart Failure,Chlorothiazide,C1=C2C(=CC(=C1Cl)S(=O)(=O)N)S(=O)(=O)N=CN2,PHASE1,,cardiovascular_disease
3470,2261,Multiple Myeloma,Filanesib,CN(C(=O)N1C(SC(=N1)C2=C(C=CC(=C2)F)F)(CCCN)C3=CC=CC=C3)OC,PHASE1|PHASE2,,cardiovascular_disease
3467,2237,Pulmonary Arterial Hypertension,Cicletanine,CC1=NC=C2C(OCC2=C1O)C3=CC=C(C=C3)Cl,PHASE2,,cardiovascular_disease
3466,2207,Hypertension,Zofenopril,CC(CSC(=O)C1=CC=CC=C1)C(=O)N2CC(CC2C(=O)O)SC3=CC=CC=C3,APPROVED,,cardiovascular_disease
3463,2145,"Hypertension, Portal",Perflubutane,C(C(C(F)(F)F)(F)F)(C(F)(F)F)(F)F,PHASE2,,cardiovascular_disease
3455,2094,Paroxysmal Supraventricular Tachycardia (PSVT),Etripamil,CC(C)C(CCCN(C)CCC1=CC(=CC=C1)C(=O)OC)(C#N)C2=CC(=C(C=C2)OC)OC,PHASE2,,cardiovascular_disease
3450,2014,High Blood Pressure,Bunazosin,CCCC(=O)N1CCCN(CC1)C2=NC3=CC(=C(C=C3C(=N2)N)OC)OC,APPROVED,,cardiovascular_disease
3441,1928,Hypertension,Manidipine,CC1=C(C(C(=C(N1)C)C(=O)OCCN2CCN(CC2)C(C3=CC=CC=C3)C4=CC=CC=C4)C5=CC(=CC=C5)[N+](=O)[O-])C(=O)OC,APPROVED,,cardiovascular_disease
3435,1872,Pulmonary Arterial Hypertension,Tezosentan,CC(C)C1=CN=C(C=C1)S(=O)(=O)NC2=C(C(=NC(=N2)C3=CC(=NC=C3)C4=NNN=N4)OCCO)OC5=CC=CC=C5OC,PHASE2,,cardiovascular_disease
3423,1766,"Arrhythmias, Cardiac|Atrial Fibrillation",Sotalol,CC(C)NCC(C1=CC=C(C=C1)NS(=O)(=O)C)O,APPROVED,,cardiovascular_disease
3420,1757,Recurrent B-Cell Non-Hodgkin Lymphoma|Recurrent Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue|Recurrent Follicular Lymphoma|Recurrent Grade 1 Follicular Lymphoma|Recurrent Grade 2 Follicular Lymphoma|Recurrent Grade 3a Follicular Lymphoma|Recurrent Lymphoplasmacytic Lymphoma|Recurrent Mantle Cell Lymphoma|Recurrent Marginal Zone Lymphoma|Recurrent Nodal Marginal Zone Lymphoma|Recurrent Splenic Marginal Zone Lymphoma|Recurrent Waldenstrom Macroglobulinemia|Refractory B-Cell Non-Hodgkin Lymphoma|Refractory Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue|Refractory Follicular Lymphoma|Refractory Grade 1 Follicular Lymphoma|Refractory Grade 2 Follicular Lymphoma|Refractory Grade 3a Follicular Lymphoma|Refractory Lymphoplasmacytic Lymphoma|Refractory Mantle Cell Lymphoma|Refractory Marginal Zone Lymphoma|Refractory Nodal Marginal Zone Lymphoma|Refractory Splenic Marginal Zone Lymphoma|Refractory Waldenstrom Macroglobulinemia,Umbralisib,CC(C)OC1=C(C=C(C=C1)C2=NN(C3=NC=NC(=C23)N)C(C)C4=C(C(=O)C5=C(O4)C=CC(=C5)F)C6=CC(=CC=C6)F)F,PHASE1,,cardiovascular_disease
3418,1754,Retinal Neovascularization,Squalamine,CC(C)C(CCC(C)C1CCC2C1(CCC3C2C(CC4C3(CCC(C4)NCCCNCCCCN)C)O)C)OS(=O)(=O)O,PHASE2,,cardiovascular_disease
3417,1751,Primary Open-Angle Glaucoma (POAG)|Ocular Hypertension (OHT),Trabodenoson,C1CCC(C1)NC2=C3C(=NC=N2)N(C=N3)C4C(C(C(O4)CO[N+](=O)[O-])O)O,PHASE2,,cardiovascular_disease
3411,1685,Ventricular Tachycardia|Ventricular Fibrillation,Amiodarone,CCCCC1=C(C2=CC=CC=C2O1)C(=O)C3=CC(=C(C(=C3)I)OCCN(CC)CC)I,APPROVED,,cardiovascular_disease
3410,1684,Ventricular Tachycardia|Ventricular Fibrillation,Nifekalant,CN1C(=CC(=O)N(C1=O)C)NCCN(CCCC2=CC=C(C=C2)[N+](=O)[O-])CCO,APPROVED,,cardiovascular_disease
3405,1621,Cirrhosis|Portal Hypertension|Non-alcoholic Steatohepatitis,Emricasan,CC(C(=O)NC(CC(=O)O)C(=O)COC1=C(C(=CC(=C1F)F)F)F)NC(=O)C(=O)NC2=CC=CC=C2C(C)(C)C,PHASE2,,cardiovascular_disease
3401,1577,Hypertension|Sexual Dysfunction,Felodipine,CCOC(=O)C1=C(NC(=C(C1C2=C(C(=CC=C2)Cl)Cl)C(=O)OC)C)C,APPROVED,,cardiovascular_disease
3387,1457,Heart Failure|Heart Decompensation,Cinaciguat,C1=CC=C(C=C1)CCC2=CC=C(C=C2)COC3=CC=CC=C3CCN(CCCCC(=O)O)CC4=CC=C(C=C4)C(=O)O,PHASE2,,cardiovascular_disease
3383,1444,Deep Venous Thrombosis,Desirudin,CCC(C)C1C(=O)NC(C(=O)NCC(=O)NC(C(=O)NC(C(=O)NCC(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(CSSCC2C(=O)NCC(=O)NC(C(=O)NCC(=O)NC(C(=O)NC(C(=O)NC(CSSCC(C(=O)NC(C(=O)NCC(=O)NC(C(=O)NC(C(=O)NC(C(=O)N2)C(C)C)CC(=O)N)CO)CCC(=O)O)NC(=O)C(CC(C)C)NC(=O)C3CSSCC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NCC(=O)NC(C(=O)NC(C(=O)NC(C(=O)N3)CC(C)C)CC(=O)N)CCC(=O)N)CO)CCC(=O)O)C(C)O)NC(=O)C(CC(=O)O)NC(=O)C(C(C)O)NC(=O)C(CC4=CC=C(C=C4)O)NC(=O)C(C(C)C)NC(=O)C(C(C)C)N)C(=O)N1)CCCCN)CC(=O)N)CCC(=O)N)C(=O)NC(C(C)C)C(=O)NC(C(C)O)C(=O)NCC(=O)NC(CCC(=O)O)C(=O)NCC(=O)NC(C(C)O)C(=O)N5CCCC5C(=O)NC(CCCCN)C(=O)N6CCCC6C(=O)NC(CCC(=O)N)C(=O)NC(CO)C(=O)NC(CC7=CN=CN7)C(=O)NC(CC(=O)N)C(=O)NC(CC(=O)O)C(=O)NCC(=O)NC(CC(=O)O)C(=O)NC(CC8=CC=CC=C8)C(=O)NC(CCC(=O)O)C(=O)NC(CCC(=O)O)C(=O)NC(C(C)CC)C(=O)N9CCCC9C(=O)NC(CCC(=O)O)C(=O)NC(CCC(=O)O)C(=O)NC(CC1=CC=C(C=C1)O)C(=O)NC(CC(C)C)C(=O)NC(CCC(=O)N)C(=O)O)CCC(=O)N)CC(=O)N)CCCCN)CCC(=O)O)CC(=O)O)CO)CC(C)C,PHASE2|PHASE3,,cardiovascular_disease
3347,1168,Heart Disease,Pentobarbital,CCCC(C)C1(C(=O)NC(=O)NC1=O)CC,PHASE1,,cardiovascular_disease
3346,1153,Paroxysmal Atrial Fibrillation,Dronedarone,CCCCC1=C(C2=C(O1)C=CC(=C2)NS(=O)(=O)C)C(=O)C3=CC=C(C=C3)OCCCN(CCCC)CCCC,APPROVED,,cardiovascular_disease
3343,1135,Open-Angle Glaucoma|Ocular Hypertension,Brinzolamide,CCNC1CN(S(=O)(=O)C2=C1C=C(S2)S(=O)(=O)N)CCCOC,PHASE2,,cardiovascular_disease
3340,1122,Cardiovascular Diseases|Cardiovascular Risk Factor|Vasoconstriction,Tempol,CC1(CC(CC(N1[O])(C)C)O)C,PHASE1,,cardiovascular_disease
3339,1118,Cardiovascular Diseases|Cardiovascular Risk Factor|Vasoconstriction,Apocynin,CC(=O)C1=CC(=C(C=C1)O)OC,PHASE1,,cardiovascular_disease
3331,1047,"Atrial Fibrillation, Paroxysmal",Canrenone,CC12CCC(=O)C=C1C=CC3C2CCC4(C3CCC45CCC(=O)O5)C,APPROVED,,cardiovascular_disease
3316,894,Chronic Myeloid Leukemia (CML),Ponatinib,CC1=C(C=C(C=C1)C(=O)NC2=CC(=C(C=C2)CN3CCN(CC3)C)C(F)(F)F)C#CC4=CN=C5N4N=CC=C5,PHASE2,,cardiovascular_disease
3311,869,Coronary Artery Disease,Gefarnate,CC(=CCCC(=CCCC(=CCCC(=O)OCC=C(C)CCC=C(C)C)C)C)C,PHASE2|PHASE3,,cardiovascular_disease
3307,855,Postpartum Hypertension,Methyldopa,CC(CC1=CC(=C(C=C1)O)O)(C(=O)O)N,APPROVED,,cardiovascular_disease
3301,845,Endocarditis,Oxacillin,CC1=C(C(=NO1)C2=CC=CC=C2)C(=O)NC3C4N(C3=O)C(C(S4)(C)C)C(=O)O,APPROVED,,cardiovascular_disease
3297,839,Endocarditis,Dicloxacillin,CC1=C(C(=NO1)C2=C(C=CC=C2Cl)Cl)C(=O)NC3C4N(C3=O)C(C(S4)(C)C)C(=O)O,APPROVED,,cardiovascular_disease
3294,835,Portal Hypertension,Alverine,CCN(CCCC1=CC=CC=C1)CCCC2=CC=CC=C2,PHASE2,,cardiovascular_disease
3289,810,Type 2 Diabetes|Overweight|Obesity|Masked Hypertension,Mitiglinide,C1CCC2CN(CC2C1)C(=O)CC(CC3=CC=CC=C3)C(=O)O,APPROVED,,cardiovascular_disease
3288,808,Thrombosis,Lepirudin,CCC(C)C1C(=O)NC(C(=O)NCC(=O)NC(C(=O)NC(C(=O)NCC(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(CSSCC2C(=O)NCC(=O)NC(C(=O)NCC(=O)NC(C(=O)NC(C(=O)NC(CSSCC(C(=O)NC(C(=O)NCC(=O)NC(C(=O)NC(C(=O)NC(C(=O)N2)C(C)C)CC(=O)N)CO)CCC(=O)O)NC(=O)C(CC(C)C)NC(=O)C3CSSCC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NCC(=O)NC(C(=O)NC(C(=O)NC(C(=O)N3)CC(C)C)CC(=O)N)CCC(=O)N)CO)CCC(=O)O)C(C)O)NC(=O)C(CC(=O)O)NC(=O)C(C(C)O)NC(=O)C(CC4=CC=C(C=C4)O)NC(=O)C(C(C)O)NC(=O)C(CC(C)C)N)C(=O)N1)CCCCN)CC(=O)N)CCC(=O)N)C(=O)NC(C(C)C)C(=O)NC(C(C)O)C(=O)NCC(=O)NC(CCC(=O)O)C(=O)NCC(=O)NC(C(C)O)C(=O)N5CCCC5C(=O)NC(CCCCN)C(=O)N6CCCC6C(=O)NC(CCC(=O)N)C(=O)NC(CO)C(=O)NC(CC7=CNC=N7)C(=O)NC(CC(=O)N)C(=O)NC(CC(=O)O)C(=O)NCC(=O)NC(CC(=O)O)C(=O)NC(CC8=CC=CC=C8)C(=O)NC(CCC(=O)O)C(=O)NC(CCC(=O)O)C(=O)NC(C(C)CC)C(=O)N9CCCC9C(=O)NC(CCC(=O)O)C(=O)NC(CCC(=O)O)C(=O)NC(CC1=CC=C(C=C1)O)C(=O)NC(CC(C)C)C(=O)NC(CCC(=O)N)C(=O)O)CCC(=O)N)CC(=O)N)CCCCN)CCC(=O)O)CC(=O)O)CO)CC(C)C,PHASE2,,cardiovascular_disease
3287,806,Protamine Adverse Reaction,Chlorpheniramine,CN(C)CCC(C1=CC=C(C=C1)Cl)C2=CC=CC=N2,APPROVED,,cardiovascular_disease
3286,794,Hemorrhoids,Iferanserin,CN1CCCCC1CCC2=CC=CC=C2NC(=O)C=CC3=CC=CC=C3,PHASE2,,cardiovascular_disease
3285,790,Atrial Fibrillation (AF)|Stroke,Abelacimab,,PHASE2,,cardiovascular_disease
3275,712,High-Risk de Novo Multiple Myeloma,Talquetamab,,PHASE2,,cardiovascular_disease
3273,704,"Atrial Fibrillation or Pulmonary Embolism|Need of Long Term Oral Anticoagulation Therapy (OAT)|Existent Coronary or Valvular Calcification, or Both and Agatston Score > 50 in at Least One Location",Phenprocoumon,CCC(C1=CC=CC=C1)C2=C(C3=CC=CC=C3OC2=O)O,APPROVED,,cardiovascular_disease
3250,592,Multiple Myeloma,Elotuzumab,,PHASE2,,cardiovascular_disease
3244,554,Venous Thromboembolism,Semuloparin,CC(=O)NC1C(C(C(OC1O)COS(=O)(=O)O)OC2C(C(C(C(O2)C(=O)O)OC3C(C(C(C(O3)CO)OC4C(C(C(C(O4)C(=O)O)O)O)OS(=O)(=O)O)OS(=O)(=O)O)NS(=O)(=O)O)O)OS(=O)(=O)O)O,PHASE2,,cardiovascular_disease
3238,530,Essential Hypertension,Rostafuroxin,CC12CCC(CC1CCC3C2CCC4(C3(CCC4(C5=COC=C5)O)O)C)O,PHASE2,,cardiovascular_disease
3215,401,Atrial Fibrillation,Vernakalant,COC1=C(C=C(C=C1)CCOC2CCCCC2N3CCC(C3)O)OC,APPROVED,,cardiovascular_disease
3201,357,Multiple Myeloma,Oprozomib,CC1=NC=C(S1)C(=O)NC(COC)C(=O)NC(COC)C(=O)NC(CC2=CC=CC=C2)C(=O)C3(CO3)C,PHASE1|PHASE2,,cardiovascular_disease
3195,337,Multiple Myeloma,Ibritumomab,CC(CN(CC(CC1=CC=C(C=C1)NC(=O)NC)N(CC(=O)O)CC(=O)O)CC(=O)O)N(CC(=O)O)CC(=O)O,PHASE2,,cardiovascular_disease
3192,325,Pulmonary Arterial Hypertension,Treprostinil,CCCCCC(CCC1C(CC2C1CC3=C(C2)C(=CC=C3)OCC(=O)O)O)O,APPROVED,,cardiovascular_disease
3187,308,Hypereosinophilic Syndromes|Eosinophilic Gastroenteritis|Churg-Strauss Syndrome|Eosinophilic Esophagitis,Mepolizumab,,PHASE1|PHASE2,,cardiovascular_disease
3185,304,Cardiovascular Disease,Evacetrapib,CC1=CC(=C2C(=C1)C(CCCN2CC3CCC(CC3)C(=O)O)N(CC4=CC(=CC(=C4)C(F)(F)F)C(F)(F)F)C5=NN(N=N5)C)C,PHASE1,,cardiovascular_disease
3172,269,Permanent Atrial Fibrillation|Venous Thrombosis|Pulmonary Embolism|Anticoagulation Treatment at Least > or = to 12-month,Fluindione,C1=CC=C2C(=C1)C(=O)C(C2=O)C3=CC=C(C=C3)F,APPROVED,,cardiovascular_disease
3167,246,High Altitude Pulmonary Hypertension,Bambuterol,CC(C)(C)NCC(C1=CC(=CC(=C1)OC(=O)N(C)C)OC(=O)N(C)C)O,PHASE1,,cardiovascular_disease
3133,161,Atrial Fibrillation,Propafenone,CCCNCC(COC1=CC=CC=C1C(=O)CCC2=CC=CC=C2)O,APPROVED,,cardiovascular_disease
3132,160,Atrial Fibrillation,Antazoline,C1CN=C(N1)CN(CC2=CC=CC=C2)C3=CC=CC=C3,APPROVED,,cardiovascular_disease
3101,83,"Ocular Hypertension|Glaucoma, Open-Angle",Latanoprost,CC(C)OC(=O)CCCC=CCC1C(CC(C1CCC(CCC2=CC=CC=C2)O)O)O,APPROVED,,cardiovascular_disease
3079,48,Cardiovascular Disease,Rilpivirine,CC1=CC(=CC(=C1NC2=NC(=NC=C2)NC3=CC=C(C=C3)C#N)C)C=CC#N,APPROVED,,cardiovascular_disease
3070,30,Multiple Myeloma,Tabalumab,,PHASE1,,cardiovascular_disease
3061,14,"Glaucoma, Open-Angle|Ocular Hypertension",Dorzolamide,CCNC1CC(S(=O)(=O)C2=C1C=C(S2)S(=O)(=O)N)C,APPROVED,,cardiovascular_disease
3050,0,"Long QT Syndrome|Abnormalities, Drug-Induced",Ibutilide,CCCCCCCN(CC)CCCC(C1=CC=C(C=C1)NS(=O)(=O)C)O,APPROVED,,cardiovascular_disease
3048,16313,Irritable Colon,Alosetron,CC1=C(N=CN1)CN2CCC3=C(C2=O)C4=CC=CC=C4N3C,PHASE2,,digestive_system_disease
3038,16032,Cancer Stem Cell,Fursultiamine,CC1=NC=C(C(=N1)N)CN(C=O)C(=C(CCO)SSCC2CCCO2)C,PHASE2,,digestive_system_disease
3036,15885,Moderate Hepatic Impairment,Mitapivat,C1CC1CN2CCN(CC2)C(=O)C3=CC=C(C=C3)NS(=O)(=O)C4=CC=CC5=C4N=CC=C5,PHASE1,,digestive_system_disease
3035,15834,Pancreatic Insufficiency|Cystic Fibrosis|Digestive System Diseases|Lung Diseases|Respiratory Tract Diseases,Burlulipase,,PHASE1|PHASE2,,digestive_system_disease
3031,15722,Hepatocellular Carcinoma,Sugemalimab,,PHASE1|PHASE2,,digestive_system_disease
3029,15667,Alcohol-Related Disorders,Dihydromyricetin,C1=C(C=C(C(=C1O)O)O)C2C(C(=O)C3=C(C=C(C=C3O2)O)O)O,PHASE1,,digestive_system_disease
3028,15655,Cirrhosis|Hepatitis B Infection|Hepatitis C Infection|Metastatic Malignant Solid Neoplasm|Recurrent Hepatocellular Carcinoma|Recurrent Malignant Solid Neoplasm|Refractory Malignant Neoplasm|Stage IV Hepatocellular Carcinoma AJCC v7|Unresectable Solid Neoplasm,Navitoclax,CC1(CCC(=C(C1)CN2CCN(CC2)C3=CC=C(C=C3)C(=O)NS(=O)(=O)C4=CC(=C(C=C4)NC(CCN5CCOCC5)CSC6=CC=CC=C6)S(=O)(=O)C(F)(F)F)C7=CC=C(C=C7)Cl)C,PHASE1,,digestive_system_disease
3027,15554,Neoplasms,Streptozocin,CN(C(=O)NC1C(C(C(OC1O)CO)O)O)N=O,PHASE2,,digestive_system_disease
3020,15278,Colorectal Cancer,Zalutumumab,,PHASE1|PHASE2,,digestive_system_disease
3016,15142,Chronic Liver Disease|Liver Transplantation|Tuberculosis,Tuberculin,,APPROVED,,digestive_system_disease
3015,15137,Gastroesophageal Reflux Disease,Pumosetrag,C1CN2CCC1C(C2)NC(=O)C3=CNC4=C(C3=O)SC=C4,PHASE2,,digestive_system_disease
3014,15119,Solid Tumors|Non-small Cell Lung Cancer|Castration Resistant Prostate Cancer|Microsatellite Stable Colorectal Cancer,Navarixin,CCC(C1=CC=C(O1)C)NC2=C(C(=O)C2=O)NC3=CC=CC(=C3O)C(=O)N(C)C,PHASE2,,digestive_system_disease
3010,15093,Fascioliasis,Triclabendazole,CSC1=NC2=CC(=C(C=C2N1)Cl)OC3=C(C(=CC=C3)Cl)Cl,APPROVED,,digestive_system_disease
3009,15068,Rheumatoid Arthritis|Osteoarthritis|Ankylosing Spondylitis|Other Musculoskeletal Disorder|Gastric Ulcer|Enteritis|NSAID-Associated Gastropathy|NSAID (Non-Steroidal Anti-Inflammatory Drug) Induced Enteropathy,Eupatilin,COC1=C(C=C(C=C1)C2=CC(=O)C3=C(O2)C=C(C(=C3O)OC)O)OC,APPROVED,,digestive_system_disease
3005,14958,Non-alcoholic Fatty Liver Disease,Oltipraz,CC1=C(SSC1=S)C2=NC=CN=C2,PHASE2,,digestive_system_disease
3004,14947,Herpes Simplex|HIV Infections|Hepatitis B,Fialuridine,C1=C(C(=O)NC(=O)N1C2C(C(C(O2)CO)O)F)I,PHASE2,,digestive_system_disease
3003,14933,Hepatocellular Carcinoma (HCC),Fisogatinib,COC1=CC(=C(C(=C1Cl)C2=CC3=CN=C(N=C3C=C2)NC4COCCC4NC(=O)C=C)Cl)OC,PHASE1,,digestive_system_disease
2998,14753,Irritable Bowel Syndrome,Asimadoline,CN(C(CN1CCC(C1)O)C2=CC=CC=C2)C(=O)C(C3=CC=CC=C3)C4=CC=CC=C4,PHASE2,,digestive_system_disease
2997,14737,Crohn's Disease|Complex Perianal Fistula,Darvadstrocel,,APPROVED,,digestive_system_disease
2993,14588,Hepatitis|Hepatitis C,Filibuvir,CCC1=CC(=CC(=N1)CC)CCC2(CC(=C(C(=O)O2)CC3=NN4C(=CC(=NC4=N3)C)C)O)C5CCCC5,PHASE2,,digestive_system_disease
2992,14577,Non-erosive Reflux Disease,Revaprazan,CC1C2=CC=CC=C2CCN1C3=NC(=NC(=C3C)C)NC4=CC=C(C=C4)F,PHASE2,,digestive_system_disease
2991,14576,Gastroesophageal Junction Adenocarcinoma|Stage IB Esophageal Adenocarcinoma AJCC v7|Stage II Esophageal Adenocarcinoma AJCC v7|Stage IIA Esophageal Adenocarcinoma AJCC v7|Stage IIB Esophageal Adenocarcinoma AJCC v7|Stage IIIA Esophageal Adenocarcinoma AJCC v7|Stage IIIB Esophageal Adenocarcinoma AJCC v7,Taladegib,CN1C(=CC=N1)C2=NN=C(C3=CC=CC=C32)N4CCC(CC4)N(C)C(=O)C5=C(C=C(C=C5)F)C(F)(F)F,PHASE1|PHASE2,,digestive_system_disease
2990,14566,Hepatocellular Carcinoma,Menatetrenone,CC1=C(C(=O)C2=CC=CC=C2C1=O)CC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)C,PHASE2|PHASE3,,digestive_system_disease
2989,14497,Nonalcoholic Fatty Liver Disease|Nonalcoholic Steatohepatitis,Efinopegdutide,,PHASE2,,digestive_system_disease
2988,14495,Hepatic Impairment,Remibrutinib,CC1=C(C=C(C=C1NC(=O)C2=C(C=C(C=C2)C3CC3)F)F)C4=C(C(=NC=N4)N)OCCN(C)C(=O)C=C,PHASE1,,digestive_system_disease
2987,14423,"Gastroesophageal Reflux Disease|Reflux, Gastroesophageal",Lavoltidine,CN1C(=NC(=N1)CO)NCCCOC2=CC=CC(=C2)CN3CCCCC3,PHASE1,,digestive_system_disease
2986,14369,Ulcerative Colitis,Dersalazine,CC1=NC2=C(N1CC3CCN(CC3)C(=O)C=C(C4=CC=CC=C4)C5=CC=C(C=C5)N=NC6=CC(=C(C=C6)O)C(=O)O)C=CN=C2,PHASE2,,digestive_system_disease
2984,14304,Liver Cancer,Irofulven,CC1=C(C2=C(C3(CC3)C(C(=O)C2=C1)(C)O)C)CO,PHASE1|PHASE2,,digestive_system_disease
2978,13941,"Acute Intermittent Porphyria (AIP)|Acute Hepatic Porphyria (AHP)|Porphyria, Acute Intermittent|Acute Porphyria",Givosiran,CC1CC(CN1C(=O)CCCCCCCCCCC(=O)NC(COCCC(=O)NCCCNC(=O)CCCCOC2C(C(C(C(O2)CO)O)O)NC(=O)C)(COCCC(=O)NCCCNC(=O)CCCCOC3C(C(C(C(O3)CO)O)O)NC(=O)C)COCCC(=O)NCCCNC(=O)CCCCOC4C(C(C(C(O4)CO)O)O)NC(=O)C)O,PHASE1,,digestive_system_disease
2977,13934,Healthy Volunteers|Hepatic Impairment,Fedratinib,CC1=CN=C(N=C1NC2=CC(=CC=C2)S(=O)(=O)NC(C)(C)C)NC3=CC=C(C=C3)OCCN4CCCC4,PHASE1,,digestive_system_disease
2965,13651,Advanced HCC,Ningetinib,CC1=C(C(=O)N(N1C)C2=CC=CC=C2)C(=O)NC3=CC(=C(C=C3)OC4=C5C=CC(=CC5=NC=C4)OCC(C)(C)O)F,PHASE1|PHASE2,,digestive_system_disease
2960,13511,Hepatic Impairment|Moderate Impaired Hepatic Function,Quizartinib,CC(C)(C)C1=CC(=NO1)NC(=O)NC2=CC=C(C=C2)C3=CN4C5=C(C=C(C=C5)OCCN6CCOCC6)SC4=N3,PHASE1,,digestive_system_disease
2959,13494,Prostate Cancer|Metabolic Syndrome|Hypogonadism|Fatty Liver,Triptorelin,CC(C)CC(C(=O)NC(CCCN=C(N)N)C(=O)N1CCCC1C(=O)NCC(=O)N)NC(=O)C(CC2=CNC3=CC=CC=C32)NC(=O)C(CC4=CC=C(C=C4)O)NC(=O)C(CO)NC(=O)C(CC5=CNC6=CC=CC=C65)NC(=O)C(CC7=CN=CN7)NC(=O)C8CCC(=O)N8,APPROVED,,digestive_system_disease
2956,13480,Solid Tumor|Pancreatic Cancer,Evofosfamide,CN1C(=CN=C1[N+](=O)[O-])COP(=O)(NCCBr)NCCBr,PHASE1,,digestive_system_disease
2955,13441,Colorectal Adenomatous Polyp|Colorectal Carcinoma|Familial Adenomatous Polyposis|Multiple Adenomatous Polyps,Dordaviprone,CC1=CC=CC=C1CN2C(=O)C3=C(CCN(C3)CC4=CC=CC=C4)N5C2=NCC5,PHASE1,,digestive_system_disease
2953,13407,Pancreatic Neoplasm,Antroquinonol,CC1C(C(C(=C(C1=O)OC)OC)O)CC=C(C)CCC=C(C)CCC=C(C)C,PHASE1|PHASE2,,digestive_system_disease
2951,13349,Cystic Fibrosis,Ticarcillin,CC1(C(N2C(S1)C(C2=O)NC(=O)C(C3=CSC=C3)C(=O)O)C(=O)O)C,APPROVED,,digestive_system_disease
2950,13339,Nasopharyngeal Carcinoma|EBV-Related Gastric Carcinoma|EBV-Related Leiomyosarcoma|EBV Related Carcinoma|EBV-Related Sarcoma,Nanatinostat,C1C2C(C2NCC3=NC4=C(C=C3)C=C(C=C4)F)CN1C5=NC=C(C=N5)C(=O)NO,PHASE1|PHASE2,,digestive_system_disease
2949,13338,Ulcerative Colitis,Terbinafine,CC(C)(C)C#CC=CCN(C)CC1=CC=CC2=CC=CC=C21,PHASE2,,digestive_system_disease
2947,13304,Metastatic Biliary Tract Carcinoma|Metastatic Colorectal Carcinoma|Metastatic Gastroesophageal Junction Adenocarcinoma|Metastatic Malignant Digestive System Neoplasm|Metastatic Pancreatic Adenocarcinoma|Stage IV Colorectal Cancer AJCC v7|Stage IV Pancreatic Cancer AJCC v6 and v7|Stage IVA Colorectal Cancer AJCC v7|Stage IVB Colorectal Cancer AJCC v7,Sucrosofate,C(C1C(C(C(C(O1)OC2(C(C(C(O2)COS(=O)(=O)O)OS(=O)(=O)O)OS(=O)(=O)O)COS(=O)(=O)O)OS(=O)(=O)O)OS(=O)(=O)O)OS(=O)(=O)O)OS(=O)(=O)O,PHASE1|PHASE2,,digestive_system_disease
2943,13250,Alpha 1-Antitrypsin Deficiency|Emphysema|COPD,Alvelestat,CC1=C(C=C(C(=O)N1C2=CC=CC(=C2)C(F)(F)F)C(=O)NCC3=NC=C(C=C3)S(=O)(=O)C)C4=CC=NN4C,PHASE2,,digestive_system_disease
2942,13220,Gastric Cancer,Bemarituzumab,,PHASE2,,digestive_system_disease
2940,13192,Irritable Bowel Syndrome (IBS),Ebastine,CC(C)(C)C1=CC=C(C=C1)C(=O)CCCN2CCC(CC2)OC(C3=CC=CC=C3)C4=CC=CC=C4,APPROVED,,digestive_system_disease
2930,12883,Pancreatic Cancer|Cancer of Pancreas|Cancer of the Pancreas|Pancreas Cancer,Tosedostat,CC(C)CC(C(C(=O)NO)O)C(=O)NC(C1=CC=CC=C1)C(=O)OC2CCCC2,PHASE1|PHASE2,,digestive_system_disease
2929,12882,Crohn's Disease,Olokizumab,,PHASE2,,digestive_system_disease
2928,12823,"Carcinoma, Hepatocellular",Foretinib,COC1=CC2=C(C=CN=C2C=C1OCCCN3CCOCC3)OC4=C(C=C(C=C4)NC(=O)C5(CC5)C(=O)NC6=CC=C(C=C6)F)F,PHASE1,,digestive_system_disease
2926,12741,Chronic Hepatitis C,Chlorcyclizine,CN1CCN(CC1)C(C2=CC=CC=C2)C3=CC=C(C=C3)Cl,PHASE1|PHASE2,,digestive_system_disease
2925,12734,Colorectal Cancer Metastatic,Olinvacimab,,PHASE1|PHASE2,,digestive_system_disease
2924,12679,Bladder Cancer|Breast Cancer|Colorectal Cancer|Gastrointestinal Neoplasm|Head and Neck Cancer|Lung Cancer|Ovarian Cancer|Pancreatic Cancer|Prostate Cancer,Picoplatin,CC1=CC=CC=N1.N.[Cl-].[Cl-].[Pt+2],PHASE1,,digestive_system_disease
2923,12674,Digestive System Disorders,Ulimorelin,CC1CNC(C(=O)N(C(C(=O)NC(C(=O)NCCCC2=CC=CC=C2O1)CC3=CC=C(C=C3)F)C)C)C4CC4,PHASE1,,digestive_system_disease
2915,12514,Hepatic Impairment,Imeglimin,CC1N=C(NC(=N1)N(C)C)N,PHASE1,,digestive_system_disease
2910,12266,Breast Cancer|Gastrointestinal Cancer|Non Small Cell Lung Cancer|Other Cancer,Pralsetinib,CC1=CC(=NN1)NC2=NC(=NC(=C2)C)C3CCC(CC3)(C(=O)NC(C)C4=CN=C(C=C4)N5C=C(C=N5)F)OC,PHASE2,,digestive_system_disease
2908,12216,Cancer of Pancreas,Bemcentinib,C1CCN(C1)C2CCC3=C(CC2)C=C(C=C3)NC4=NN(C(=N4)N)C5=NN=C6C(=C5)CCCC7=CC=CC=C76,PHASE1|PHASE2,,digestive_system_disease
2901,12045,Colorectal Carcinoma,Dolcanatide,CC1C(=O)NC2CSSCC(C(=O)NC(C(=O)NC(C(=O)NC(CSSCC(NC(=O)CNC(=O)C(NC2=O)C(C)O)C(=O)NC(CC(C)C)C(=O)O)C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N1)C(C)C)CC(=O)N)C(C)C)CC(C)C)CCC(=O)O)NC(=O)C(CCC(=O)O)NC(=O)C(CC(=O)O)NC(=O)C(CC(=O)N)N,PHASE1,,digestive_system_disease
2900,11985,Gastroesophageal Reflux Disease (GERD),Dexrabeprazole,CC1=C(C=CN=C1CS(=O)C2=NC3=CC=CC=C3N2)OCCCOC,APPROVED,,digestive_system_disease
2898,11940,Cystic Fibrosis,Colistimethate,CCC(C)CCCCC(=O)NC(CCNCS(=O)(=O)[O-])C(=O)NC(C(C)O)C(=O)NC(CCNCS(=O)(=O)[O-])C(=O)NC1CCNC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC1=O)CCNCS(=O)(=O)[O-])CC(C)C)CC(C)C)CCNCS(=O)(=O)[O-])CCNCS(=O)(=O)[O-])C(C)O.[Na+].[Na+].[Na+].[Na+].[Na+],APPROVED,,digestive_system_disease
2895,11857,Non Small Cell Lung Cancer (NSCLC),Alclometasone,CC1CC2C3C(CC4=CC(=O)C=CC4(C3C(CC2(C1(C(=O)CO)O)C)O)C)Cl,PHASE2,,digestive_system_disease
2893,11838,Celiac Disease,Larazotide,CC(C)CC(C(=O)NC(C(C)C)C(=O)NC(CCC(=O)N)C(=O)N1CCCC1C(=O)NCC(=O)O)NC(=O)C(C(C)C)NC(=O)CNC(=O)CN,PHASE2,,digestive_system_disease
2888,11605,Advanced Malignant Solid Neoplasm|ALK Positive|Metastatic Pancreatic Adenocarcinoma|Stage III Pancreatic Cancer|Stage IV Pancreatic Cancer,Ceritinib,CC1=CC(=C(C=C1C2CCNCC2)OC(C)C)NC3=NC=C(C(=N3)NC4=CC=CC=C4S(=O)(=O)C(C)C)Cl,PHASE1,,digestive_system_disease
2886,11548,Crohn Disease,Mecasermin,,PHASE2|PHASE3,,digestive_system_disease
2885,11498,Pancreatic Cancer,Ficlatuzumab,,PHASE1,,digestive_system_disease
2882,11338,Pancreatic Cancer|Cachexia|Weight Loss,Bermekimab,,PHASE1,,digestive_system_disease
2881,11315,Hepatocellular Carcinoma,Tefinostat,C1CCC(C1)OC(=O)C(C2=CC=CC=C2)NCC3=CC=C(C=C3)NC(=O)CCCCCCC(=O)NO,PHASE1|PHASE2,,digestive_system_disease
2878,11207,Liver Dysfunction,Mivacurium,C[N+]1(CCC2=CC(=C(C=C2C1CC3=CC(=C(C(=C3)OC)OC)OC)OC)OC)CCCOC(=O)CCC=CCCC(=O)OCCC[N+]4(CCC5=CC(=C(C=C5C4CC6=CC(=C(C(=C6)OC)OC)OC)OC)OC)C,PHASE2,,digestive_system_disease
2873,11089,Hepatic Impairment,Vorasidenib,CC(C(F)(F)F)NC1=NC(=NC(=N1)C2=NC(=CC=C2)Cl)NC(C)C(F)(F)F,PHASE1,,digestive_system_disease
2868,10970,Hepatitis B,Resiquimod,CCOCC1=NC2=C(N1CC(C)(C)O)C3=CC=CC=C3N=C2N,PHASE1|PHASE2,,digestive_system_disease
2861,10802,Healthy|Hepatic Impairment,Favipiravir,C1=C(N=C(C(=O)N1)C(=O)N)F,PHASE1,,digestive_system_disease
2860,10700,Cystic Fibrosis,Fenretinide,CC1=C(C(CCC1)(C)C)C=CC(=CC=CC(=CC(=O)NC2=CC=C(C=C2)O)C)C,PHASE1,,digestive_system_disease
2858,10669,Ileus,Ipamorelin,CC(C)(C(=O)NC(CC1=CN=CN1)C(=O)NC(CC2=CC3=CC=CC=C3C=C2)C(=O)NC(CC4=CC=CC=C4)C(=O)NC(CCCCN)C(=O)N)N,PHASE2,,digestive_system_disease
2855,10595,Advanced Colorectal Carcinoma|Advanced Lung Non-Small Cell Carcinoma|Lung Non-Small Cell Carcinoma|Mismatch Repair Deficiency|Refractory Colorectal Carcinoma|Refractory Lung Carcinoma|Refractory Pancreatic Carcinoma|Stage II Pancreatic Cancer AJCC v8|Stage III Colorectal Cancer AJCC v8|Stage III Lung Cancer AJCC v8|Stage III Pancreatic Cancer AJCC v8|Stage IIIA Colorectal Cancer AJCC v8|Stage IIIA Lung Cancer AJCC v8|Stage IIIB Colorectal Cancer AJCC v8|Stage IIIB Lung Cancer AJCC v8|Stage IIIC Colorectal Cancer AJCC v8|Stage IIIC Lung Cancer AJCC v8|Stage IV Colorectal Cancer AJCC v8|Stage IV Lung Cancer AJCC v8|Stage IV Pancreatic Cancer AJCC v8|Stage IVA Colorectal Cancer AJCC v8|Stage IVA Lung Cancer AJCC v8|Stage IVB Colorectal Cancer AJCC v8|Stage IVB Lung Cancer AJCC v8|Stage IVC Colorectal Cancer AJCC v8,Danvatirsen,,PHASE2,,digestive_system_disease
2854,10584,Adenocarcinoma of the Esophagus|Adenocarcinoma of the Gastroesophageal Junction|Squamous Cell Carcinoma of the Esophagus,Monalizumab,,PHASE1|PHASE2,,digestive_system_disease
2851,10529,Advanced Lymphoma|Advanced Malignant Solid Neoplasm|Ann Arbor Stage III B-Cell Non-Hodgkin Lymphoma|Ann Arbor Stage III T-Cell Non-Hodgkin Lymphoma|Ann Arbor Stage IV B-Cell Non-Hodgkin Lymphoma|Ann Arbor Stage IV T-Cell Non-Hodgkin Lymphoma|Refractory B-Cell Non-Hodgkin Lymphoma|Refractory Lymphoma|Refractory Malignant Solid Neoplasm|Refractory Pancreatic Carcinoma|Refractory T-Cell Non-Hodgkin Lymphoma|Stage II Pancreatic Cancer AJCC v8|Stage IIA Pancreatic Cancer AJCC v8|Stage IIB Pancreatic Cancer AJCC v8|Stage III Pancreatic Cancer AJCC v8|Stage IV Pancreatic Cancer AJCC v8|Unresectable Pancreatic Carcinoma,Molibresib,CCNC(=O)CC1C2=NN=C(N2C3=C(C=C(C=C3)OC)C(=N1)C4=CC=C(C=C4)Cl)C,PHASE1,,digestive_system_disease
2848,10471,Pancreatic Cancer,Demcizumab,,PHASE1,,digestive_system_disease
2845,10420,Pancreatic Cancer,Chlorphenesin,C1=CC(=CC=C1OCC(CO)O)Cl,PHASE1,,digestive_system_disease
2842,10317,Peritoneal Carcinomatosis|Colorectal Cancer|Carcinoma|Neoplasms|Gastrointestinal Cancer,Labetuzumab,,PHASE1|PHASE2,,digestive_system_disease
2839,10301,Cancer of Stomach|Gastroesophageal Cancer,Pegamotecan,CCC1(C2=C(COC1=O)C(=O)N3CC4=CC5=CC=CC=C5N=C4C3=C2)OC(=O)C(C)NC(=O)COCCOCC(=O)NC(C)C(=O)OC6(C7=C(COC6=O)C(=O)N8CC9=CC1=CC=CC=C1N=C9C8=C7)CC,PHASE2,,digestive_system_disease
2837,10227,Liver Metastases|Colorectal Cancer,Adecatumumab,,PHASE2,,digestive_system_disease
2836,10205,Esophageal Cancer|Gastric Cancer,Matuzumab,,PHASE2,,digestive_system_disease
2835,10158,Primary Biliary Cirrhosis,Moexipril,CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N2CC3=CC(=C(C=C3CC2C(=O)O)OC)OC,PHASE2,,digestive_system_disease
2834,10135,"Carcinoma, Hepatocellular",Refametinib,COC1=CC(=C(C(=C1NS(=O)(=O)C2(CC2)CC(CO)O)NC3=C(C=C(C=C3)I)F)F)F,PHASE2,,digestive_system_disease
2832,10098,Irritable Bowel Syndrome,Dextofisopam,CCC1C(=NN=C(C2=CC(=C(C=C12)OC)OC)C3=CC(=C(C=C3)OC)OC)C,PHASE2,,digestive_system_disease
2826,9966,Hepatocellular Carcinoma Non-resectable|Hepatocellular Carcinoma Recurrent,Aldoxorubicin,CC1C(C(CC(O1)OC2CC(CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)(C(=NNC(=O)CCCCCN6C(=O)C=CC6=O)CO)O)N)O,PHASE1|PHASE2,,digestive_system_disease
2825,9948,Primary Sclerosing Cholangitis,Vidofludimus,COC1=CC=CC(=C1)C2=CC(=C(C=C2)NC(=O)C3=C(CCC3)C(=O)O)F,PHASE2,,digestive_system_disease
2824,9939,MALT Lymphoma,Chlorambucil,C1=CC(=CC=C1CCCC(=O)O)N(CCCl)CCCl,PHASE2,,digestive_system_disease
2821,9886,Bacterial Infections and Mycoses|Liver Disease,Caspofungin,CCC(C)CC(C)CCCCCCCCC(=O)NC1CC(C(NC(=O)C2C(CCN2C(=O)C(NC(=O)C(NC(=O)C3CC(CN3C(=O)C(NC1=O)C(C)O)O)C(C(C4=CC=C(C=C4)O)O)O)C(CCN)O)O)NCCN)O,APPROVED,,digestive_system_disease
2820,9859,Metastatic Pancreatic Cancer,Seribantumab,,PHASE2,,digestive_system_disease
2817,9818,Colorectal Cancer,Vanucizumab,,PHASE2,,digestive_system_disease
2811,9730,Ulcerative Colitis,Cobitolimod,CC1=CN(C(=O)NC1=O)C2CC(C(O2)COP(=O)(O)OC3CC(OC3COP(=O)(O)OC4CC(OC4COP(=O)(O)OC5CC(OC5COP(=O)(O)OC6CC(OC6COP(=O)(O)OC7CC(OC7COP(=S)(O)OC8CC(OC8COP(=S)(O)OC9CC(OC9COP(=S)(O)OC1CC(OC1CO)N1C=NC2=C1N=C(NC2=O)N)N1C=NC2=C1N=C(NC2=O)N)N1C=NC2=C(N=CN=C21)N)N1C=NC2=C(N=CN=C21)N)N1C=CC(=NC1=O)N)N1C=NC2=C(N=CN=C21)N)N1C=NC2=C1N=C(NC2=O)N)N1C=C(C(=O)NC1=O)C)OP(=O)(O)OCC1C(CC(O1)N1C=CC(=NC1=O)N)OP(=O)(O)OCC1C(CC(O1)N1C=NC2=C1N=C(NC2=O)N)OP(=O)(O)OCC1C(CC(O1)N1C=C(C(=O)NC1=O)C)OP(=O)(O)OCC1C(CC(O1)N1C=CC(=NC1=O)N)OP(=O)(O)OCC1C(CC(O1)N1C=CC(=NC1=O)N)OP(=O)(O)OCC1C(CC(O1)N1C=NC2=C(N=CN=C21)N)OP(=O)(O)OCC1C(CC(O1)N1C=C(C(=O)NC1=O)C)OP(=S)(O)OCC1C(CC(O1)N1C=NC2=C1N=C(NC2=O)N)OP(=S)(O)OCC1C(CC(O1)N1C=NC2=C1N=C(NC2=O)N)OP(=S)(O)OCC1C(CC(O1)N1C=CC(=NC1=O)N)O,PHASE1,,digestive_system_disease
2808,9671,"Hepatitis B|HBV|Hepatitis B, Chronic",Inarigivir,COC1C(C(OC1N2C=CC(=O)NC2=O)CO)OP(=S)(O)OCC3C(CC(O3)N4C=NC5=C(N=CN=C54)N)O,PHASE2,,digestive_system_disease
2806,9624,Colon Cancer|Colorectal Cancer|Gastrointestinal Cancer|Metastatic Colorectal Cancer|Rectal Cancer,Rilotumumab,,PHASE1|PHASE2,,digestive_system_disease
2804,9620,Neoplasm Metastasis,Combretastatin,COC1=C(C=C(C=C1)CC(C2=CC(=C(C(=C2)OC)OC)OC)O)O,PHASE1,,digestive_system_disease
2803,9613,Breast Cancer|Colon Cancer,Eniluracil,C#CC1=CNC(=O)NC1=O,PHASE1,,digestive_system_disease
2802,9601,Chronic Radiation Proctitis,Sucralfate,C(C1C(C(C(C(O1)OC2(C(C(C(O2)COS(=O)(=O)O[Al])OS(=O)(=O)O[Al])OS(=O)(=O)O[Al])COS(=O)(=O)O[Al])OS(=O)(=O)O[Al])OS(=O)(=O)O[Al])OS(=O)(=O)O[Al])OS(=O)(=O)O[Al].O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.[Al],APPROVED,,digestive_system_disease
2801,9583,Locally Advanced Pancreatic Adenocarcinoma|Pancreatic Acinar Cell Carcinoma|Pancreatic Ductal Adenocarcinoma|Stage III Pancreatic Cancer AJCC v6 and v7|Stage IV Pancreatic Cancer AJCC v6 and v7,Inalimarev,,PHASE1,,digestive_system_disease
2800,9582,Locally Advanced Pancreatic Adenocarcinoma|Pancreatic Acinar Cell Carcinoma|Pancreatic Ductal Adenocarcinoma|Stage III Pancreatic Cancer AJCC v6 and v7|Stage IV Pancreatic Cancer AJCC v6 and v7,Falimarev,,PHASE1,,digestive_system_disease
2797,9513,Peptic Ulcer,Irsogladine,C1=CC(=C(C=C1Cl)C2=NC(=NC(=N2)N)N)Cl,PHASE1,,digestive_system_disease
2796,9512,Peptic Ulcer,Lafutidine,C1CCN(CC1)CC2=CC(=NC=C2)OCC=CCNC(=O)CS(=O)CC3=CC=CO3,PHASE1,,digestive_system_disease
2793,9500,Hepatic Impairment,Midostaurin,CC12C(C(CC(O1)N3C4=CC=CC=C4C5=C6C(=C7C8=CC=CC=C8N2C7=C53)CNC6=O)N(C)C(=O)C9=CC=CC=C9)OC,PHASE1,,digestive_system_disease
2785,9365,Ulcerative Colitis,Alicaforsen,CC1=CN(C(=O)NC1=O)C2CC(C(O2)COP(=S)([O-])OC3CC(OC3COP(=S)([O-])OC4CC(OC4COP(=S)([O-])OC5CC(OC5COP(=S)([O-])OC6CC(OC6COP(=S)([O-])OC7CC(OC7COP(=S)([O-])OC8CC(OC8COP(=S)([O-])OC9CC(OC9COP(=S)([O-])OC1CC(OC1CO)N1C=NC2=C1N=C(NC2=O)N)N1C=CC(=NC1=O)N)N1C=CC(=NC1=O)N)N1C=CC(=NC1=O)N)N1C=NC2=C(N=CN=C21)N)N1C=NC2=C(N=CN=C21)N)N1C=NC2=C1N=C(NC2=O)N)N1C=CC(=NC1=O)N)OP(=S)([O-])OCC1C(CC(O1)N1C=NC2=C1N=C(NC2=O)N)OP(=S)([O-])OCC1C(CC(O1)N1C=NC2=C1N=C(NC2=O)N)OP(=S)([O-])OCC1C(CC(O1)N1C=CC(=NC1=O)N)OP(=S)([O-])OCC1C(CC(O1)N1C=NC2=C(N=CN=C21)N)OP(=S)([O-])OCC1C(CC(O1)N1C=C(C(=O)NC1=O)C)OP(=S)([O-])OCC1C(CC(O1)N1C=CC(=NC1=O)N)OP(=S)([O-])OCC1C(CC(O1)N1C=CC(=NC1=O)N)OP(=S)([O-])OCC1C(CC(O1)N1C=NC2=C1N=C(NC2=O)N)OP(=S)([O-])OCC1C(CC(O1)N1C=C(C(=O)NC1=O)C)OP(=S)([O-])OCC1C(CC(O1)N1C=CC(=NC1=O)N)OP(=S)([O-])OCC1C(CC(O1)N1C=NC2=C(N=CN=C21)N)O,PHASE2,,digestive_system_disease
2784,9321,Solid Tumor|Hepatocellular Carcinoma|Gastric Cancer|Gastroesophageal Junction Adenocarcinoma,Vorolanib,CC1=C(NC(=C1C(=O)NC2CCN(C2)C(=O)N(C)C)C)C=C3C4=C(C=CC(=C4)F)NC3=O,PHASE1,,digestive_system_disease
2777,9176,Resectable Hepatocellular Carcinoma,Pegargiminase,,PHASE2,,digestive_system_disease
2774,9067,Hepatitis C|Hepatitis,Merimepodib,COC1=C(C=CC(=C1)NC(=O)NC2=CC=CC(=C2)CNC(=O)OC3CCOC3)C4=CN=CO4,PHASE2,,digestive_system_disease
2772,8994,"Carcinoma, Hepatocellular",Amivantamab,,PHASE2,,digestive_system_disease
2770,8875,Irritable Bowel Syndrome,Fenoverine,C1CN(CCN1CC2=CC3=C(C=C2)OCO3)CC(=O)N4C5=CC=CC=C5SC6=CC=CC=C64,APPROVED,,digestive_system_disease
2769,8857,Hepatic Failure,Icenticaftor,CC(CNC(=O)C1=C(C=C(C(=N1)OC)C(F)(F)F)N)(C(F)(F)F)O,PHASE1,,digestive_system_disease
2768,8849,Advanced Biliary Tract Carcinoma|Advanced Colorectal Carcinoma|Advanced Gastroesophageal Junction Adenocarcinoma|Advanced Lung Adenocarcinoma|Advanced Malignant Solid Neoplasm|Advanced Ovarian Carcinoma|Advanced Pancreatic Carcinoma|Advanced Urothelial Carcinoma|Clinical Stage III Gastroesophageal Junction Adenocarcinoma AJCC v8|Clinical Stage IV Gastroesophageal Junction Adenocarcinoma AJCC v8|Metastatic Biliary Tract Carcinoma|Metastatic Colorectal Carcinoma|Metastatic Gastroesophageal Junction Adenocarcinoma|Metastatic Lung Adenocarcinoma|Metastatic Ovarian Carcinoma|Metastatic Pancreatic Carcinoma|Metastatic Urothelial Carcinoma|Refractory Biliary Tract Carcinoma|Refractory Colorectal Carcinoma|Refractory Gastroesophageal Junction Adenocarcinoma|Refractory Lung Adenocarcinoma|Refractory Ovarian Carcinoma|Refractory Pancreatic Carcinoma|Refractory Urothelial Carcinoma|Stage II Pancreatic Cancer AJCC v8|Stage III Colorectal Cancer AJCC v8|Stage III Lung Cancer AJCC v8|Stage III Ovarian Cancer AJCC v8|Stage III Pancreatic Cancer AJCC v8|Stage IV Colorectal Cancer AJCC v8|Stage IV Lung Cancer AJCC v8|Stage IV Ovarian Cancer AJCC v8|Stage IV Pancreatic Cancer AJCC v8,Devimistat,C1=CC=C(C=C1)CSCCC(CCCCC(=O)O)SCC2=CC=CC=C2,PHASE2,,digestive_system_disease
2758,8443,Germ Cell Tumors|Hepatic Cancer|Neuroblastoma|Osteosarcoma|Rhabdomyosarcoma,Thrombopoietin,,PHASE1|PHASE2,,digestive_system_disease
2757,8428,Advanced Colorectal Carcinoma,Resminostat,CN(C)CC1=CC=C(C=C1)S(=O)(=O)N2C=CC(=C2)C=CC(=O)NO,PHASE1|PHASE2,,digestive_system_disease
2754,8322,Celiac Disease,Latiglutenase,,PHASE2,,digestive_system_disease
2751,8178,Acute Diarrhea|Acute Gastroenteritis,Racecadotril,CC(=O)SCC(CC1=CC=CC=C1)C(=O)NCC(=O)OCC2=CC=CC=C2,APPROVED,,digestive_system_disease
2749,8119,Ulcerative Colitis,Rivenprost,COCC1=CC=CC(=C1)CC(C=CC2C(CC(=O)C2CCSCCCC(=O)OC)O)O,PHASE2,,digestive_system_disease
2746,8011,Metastatic Pancreatic Cancer,Necuparanib,,PHASE1|PHASE2,,digestive_system_disease
2743,7987,Colorectal Cancer|GIST,Ripretinib,CCN1C2=CC(=NC=C2C=C(C1=O)C3=CC(=C(C=C3Br)F)NC(=O)NC4=CC=CC=C4)NC,PHASE1|PHASE2,,digestive_system_disease
2741,7937,Hepatic Impairment,Delafloxacin,C1C(CN1C2=C(C=C3C(=C2Cl)N(C=C(C3=O)C(=O)O)C4=C(C=C(C(=N4)N)F)F)F)O,PHASE1,,digestive_system_disease
2739,7847,"Ulcerative Colitis, Active Moderate|Ulcerative Colitis, Active Severe",Bertilimumab,,PHASE2,,digestive_system_disease
2738,7811,Stomach Neoplasms,Edotecarin,C1=CC2=C(C=C1O)NC3=C4C(=C5C(=C23)C(=O)N(C5=O)NC(CO)CO)C6=C(N4C7C(C(C(C(O7)CO)O)O)O)C=C(C=C6)O,PHASE2,,digestive_system_disease
2736,7793,Sphincter of Oddi Dysfunction,Pinaverium,CC1(C2CCC(C1C2)CCOCC[N+]3(CCOCC3)CC4=CC(=C(C=C4Br)OC)OC)C,APPROVED,,digestive_system_disease
2733,7700,Metastatic Colorectal Cancer,Cibisatamab,,PHASE1|PHASE2,,digestive_system_disease
2728,7551,Pancreatic Cancer|Stage IV Pancreatic Cancer,Vantictumab,,PHASE1,,digestive_system_disease
2727,7504,Irritable Bowel Syndrome With Diarrhea,Mebeverine,CCN(CCCCOC(=O)C1=CC(=C(C=C1)OC)OC)C(C)CC2=CC=C(C=C2)OC,APPROVED,,digestive_system_disease
2724,7393,Colorectal Neoplasms,Pelitrexol,CC1=C(SC(=C1)C(=O)NC(CCC(=O)O)C(=O)O)CCC2CC3=C(NC2)N=C(NC3=O)N,PHASE2,,digestive_system_disease
2717,7283,Acetaminophen|Drug Overdose|Acetaminophen Overdose|Acetaminophen Poisoning|Drug-induced Liver Injury|Liver Failure|Liver Toxicity,Fomepizole,CC1=CNN=C1,PHASE2,,digestive_system_disease
2716,7275,Hepatocellular Carcinoma|Metastatic Cancer,Thymidine,CC1=CN(C(=O)NC1=O)C2CC(C(O2)CO)O,PHASE1,,digestive_system_disease
2707,7188,Amoebic Dysentery|Giardiasis,Auranofin,CCP(CC)CC.CC(=O)OCC1C(C(C(C(O1)[S-])OC(=O)C)OC(=O)C)OC(=O)C.[Au+],PHASE2,,digestive_system_disease
2700,7084,Post Operative Ileus,Alvimopan,CC1CN(CCC1(C)C2=CC(=CC=C2)O)CC(CC3=CC=CC=C3)C(=O)NCC(=O)O,APPROVED,,digestive_system_disease
2699,7077,Erythropoietic Protoporphyria,Colestipol,C1C(O1)CCl.C(CNCCNCCNCCN)N,PHASE2|PHASE3,,digestive_system_disease
2698,7016,Non Alcoholic Steatohepatitis (NASH),Icosabutate,CCC=CCC=CCC=CCC=CCC=CCCCCOC(CC)C(=O)O,PHASE2,,digestive_system_disease
2696,6942,Pancreatic Neoplasms,Aroplatin,CC(C)(C)CCCCCC(=O)[O-].CC(C)(C)CCCCCC(=O)[O-].C1CCC(C(C1)N)N.[Pt+2],PHASE1|PHASE2,,digestive_system_disease
2687,6716,Liver Diseases,Macrogol,C(CO)O,APPROVED,,digestive_system_disease
2684,6653,Nonalcoholic Fatty Liver Disease (NAFLD)|Type 2 Diabetes (T2DM),Lanifibranor,C1=CC2=C(C=C1S(=O)(=O)N3C4=C(C=C(C=C4)Cl)C=C3CCCC(=O)O)SC=N2,PHASE2,,digestive_system_disease
2681,6538,Acquired Hyperinsulinemic Hypoglycemia,Avexitide,CCC(C)C(C(=O)NC(CCC(=O)O)C(=O)NC(CC1=CNC2=CC=CC=C21)C(=O)NC(CC(C)C)C(=O)NC(CCCCN)C(=O)NC(CC(=O)N)C(=O)NCC(=O)NCC(=O)N3CCCC3C(=O)NC(CO)C(=O)NC(CO)C(=O)NCC(=O)NC(C)C(=O)N4CCCC4C(=O)N5CCCC5C(=O)N6CCCC6C(=O)NC(CO)C(=O)N)NC(=O)C(CC7=CC=CC=C7)NC(=O)C(CC(C)C)NC(=O)C(CCCNC(=N)N)NC(=O)C(C(C)C)NC(=O)C(C)NC(=O)C(CCC(=O)O)NC(=O)C(CCC(=O)O)NC(=O)C(CCC(=O)O)NC(=O)C(CCSC)NC(=O)C(CCC(=O)N)NC(=O)C(CCCCN)NC(=O)C(CO)NC(=O)C(CC(C)C)NC(=O)C(CC(=O)O)N,PHASE2,,digestive_system_disease
2677,6488,Neoplasms|Pancreatic Neoplasms,Glufosfamide,C(CCl)NP(=O)(NCCCl)OC1C(C(C(C(O1)CO)O)O)O,PHASE1|PHASE2,,digestive_system_disease
2674,6374,Colon Cancer|Minimal Residual Disease,Piritramide,C1CCN(CC1)C2(CCN(CC2)CCC(C#N)(C3=CC=CC=C3)C4=CC=CC=C4)C(=O)N,APPROVED,,digestive_system_disease
2671,6346,Crohn Disease,Risankizumab,,APPROVED,,digestive_system_disease
2662,6212,Crohn's Disease,Methoxsalen,COC1=C2C(=CC3=C1OC=C3)C=CC(=O)O2,PHASE2,,digestive_system_disease
2656,6129,Cryptosporidiosis|HIV Infections,Paromomycin,C1C(C(C(C(C1N)OC2C(C(C(C(O2)CO)O)O)N)OC3C(C(C(O3)CO)OC4C(C(C(C(O4)CN)O)O)N)O)O)N,PHASE2,,digestive_system_disease
2655,6097,Crohn Disease,Xanthohumol,CC(=CCC1=C(C(=C(C=C1O)OC)C(=O)C=CC2=CC=C(C=C2)O)O)C,PHASE2,,digestive_system_disease
2652,6062,Healthy Volunteers,Galicaftor,C1CC1(C2=CC3=C(C=C2)OC(O3)(F)F)C(=O)NC4CC(OC5=C4C=CC(=C5)OC(F)F)C6=CC=C(C=C6)C(=O)O,PHASE1,,digestive_system_disease
2650,6030,Helminthiasis|Amoebiasis,Quinfamide,C1CC2=C(C=CC(=C2)OC(=O)C3=CC=CO3)N(C1)C(=O)C(Cl)Cl,APPROVED,,digestive_system_disease
2647,5993,Resectable Pancreatic Ductal Adenocarcinoma|Stage 0 Pancreatic Cancer AJCC v8|Stage I Pancreatic Cancer AJCC v8|Stage IA Pancreatic Cancer AJCC v8|Stage IB Pancreatic Cancer AJCC v8|Stage II Pancreatic Cancer AJCC v8|Stage IIA Pancreatic Cancer AJCC v8|Stage IIB Pancreatic Cancer AJCC v8,Pyrvinium,CC1=CC(=C(N1C2=CC=CC=C2)C)C=CC3=[N+](C4=C(C=C3)C=C(C=C4)N(C)C)C,PHASE1,,digestive_system_disease
2646,5991,"Carcinoma, Hepatocellular",Tirapazamine,C1=CC=C2C(=C1)[N+](=C(N=[N+]2[O-])N)[O-],PHASE2,,digestive_system_disease
2644,5931,Chronic Pancreatitis|Exocrine Pancreatic Insufficiency,Pancreatin,,APPROVED,,digestive_system_disease
2639,5855,Liver Failure,Lofexidine,CC(C1=NCCN1)OC2=C(C=CC=C2Cl)Cl,PHASE1,,digestive_system_disease
2635,5736,Short Bowel Syndrome|Vitamin E Deficiency,Tocofersolan,CC1=C(C(=C(C2=C1OC(CC2)(C)CCCC(C)CCCC(C)CCCC(C)C)C)OC(=O)CCC(=O)OCCO)C,PHASE2,,digestive_system_disease
2634,5723,Inflammatory Bowel Diseases,Nifuroxazide,C1=CC(=CC=C1C(=O)NN=CC2=CC=C(O2)[N+](=O)[O-])O,PHASE2|PHASE3,,digestive_system_disease
2628,5614,Gall Stone Disease,Vecuronium,CC(=O)OC1CC2CCC3C(C2(CC1N4CCCCC4)C)CCC5(C3CC(C5OC(=O)C)[N+]6(CCCCC6)C)C,APPROVED,,digestive_system_disease
2626,5592,Gastric Cancer|Stomach Cancer|Esophageal Cancer,Margetuximab,,PHASE1|PHASE2,,digestive_system_disease
2624,5566,Hyperinsulinemic Hypoglycemia|Postprandial Hypoglycemia,Dasiglucagon,CC(C)CC(C(=O)NC(CCC(=O)O)C(=O)NC(CO)C(=O)NC(C(C)O)C(=O)O)NC(=O)C(CC1=CNC2=CC=CC=C21)NC(=O)C(CCCCN)NC(=O)C(C(C)C)NC(=O)C(CC3=CC=CC=C3)NC(=O)C(CCC(=O)O)NC(=O)C(CCC(=O)O)NC(=O)C(C)NC(=O)C(CCCNC(=N)N)NC(=O)C(C)NC(=O)C(C)(C)NC(=O)C(CC(=O)O)NC(=O)C(CC(C)C)NC(=O)C(CC4=CC=C(C=C4)O)NC(=O)C(CCCCN)NC(=O)C(CO)NC(=O)C(CC5=CC=C(C=C5)O)NC(=O)C(CC(=O)O)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C(CC6=CC=CC=C6)NC(=O)C(C(C)O)NC(=O)CNC(=O)C(CCC(=O)N)NC(=O)C(CO)NC(=O)C(CC7=CNC=N7)N,PHASE2,,digestive_system_disease
2622,5488,Chronic Hepatitis B,Oxymatrine,C1CC2C3CCC[N+]4(C3C(CCC4)CN2C(=O)C1)[O-],APPROVED,,digestive_system_disease
2618,5410,Cholecystitis,Cefotetan,CN1C(=NN=N1)SCC2=C(N3C(C(C3=O)(NC(=O)C4SC(=C(C(=O)N)C(=O)O)S4)OC)SC2)C(=O)O,PHASE1,,digestive_system_disease
2617,5400,Metastatic Pancreatic Cancer,Mitazalimab,,PHASE1,,digestive_system_disease
2614,5325,Hepatic Impairment,Siremadlin,CC(C)N1C2=C(C(=O)N(C2C3=CC=C(C=C3)Cl)C4=CC(=CN(C4=O)C)Cl)N=C1C5=CN=C(N=C5OC)OC,PHASE1,,digestive_system_disease
2605,5173,Cryptosporidiosis|HIV Infections,Letrazuril,C1=CC(=CC=C1C(C#N)C2=C(C=C(C=C2Cl)N3C(=O)NC(=O)C=N3)Cl)F,PHASE1,,digestive_system_disease
2604,5154,Esophagitis,Ilaprazole,CC1=C(C=CN=C1CS(=O)C2=NC3=C(N2)C=C(C=C3)N4C=CC=C4)OC,PHASE2,,digestive_system_disease
2603,5133,Colorectal Neoplasm,Modufolin,C1C2CN(CN2C3=C(N1)N=C(NC3=O)N)C4=CC=C(C=C4)C(=O)NC(CCC(=O)O)C(=O)O,PHASE1|PHASE2,,digestive_system_disease
2602,5106,Gastric Cancer|Gastroesophageal Junction Cancer|HER2-positive Gastric Cancer,Tebotelimab,,PHASE2|PHASE3,,digestive_system_disease
2591,4966,"Hepatitis C, Chronic",Celgosivir,CCCC(=O)OC1CN2CCC(C2C(C1O)O)O,PHASE2,,digestive_system_disease
2590,4964,Stomatitis,Benzydamine,CN(C)CCCOC1=NN(C2=CC=CC=C21)CC3=CC=CC=C3,PHASE2,,digestive_system_disease
2580,4800,Non Alcoholic Steatohepatitis (NASH),Licogliflozin,CCC1=C(C=C(C=C1)C2C(C(C(C(O2)CO)O)O)O)CC3=CC4=C(C=C3)OCCO4,PHASE2,,digestive_system_disease
2579,4799,Non Alcoholic Steatohepatitis (NASH),Tropifexor,C1CC1C2=C(C(=NO2)C3=CC=CC=C3OC(F)(F)F)COC4CC5CCC(C4)N5C6=NC7=C(C=C(C=C7S6)C(=O)O)F,PHASE2,,digestive_system_disease
2572,4690,Cystic Fibrosis,Teicoplanin,CCCCCCCCCC(=O)NC1C(C(C(OC1OC2=C3C=C4C=C2OC5=C(C=C(C=C5)C(C6C(=O)NC(C7=C(C(=CC(=C7)O)OC8C(C(C(C(O8)CO)O)O)O)C9=C(C=CC(=C9)C(C(=O)N6)NC(=O)C4NC(=O)C1C2=CC(=CC(=C2)OC2=C(C=CC(=C2)C(C(=O)NC(CC2=CC(=C(O3)C=C2)Cl)C(=O)N1)N)O)O)O)C(=O)O)OC1C(C(C(C(O1)CO)O)O)NC(=O)C)Cl)CO)O)O,PHASE1,,digestive_system_disease
2571,4688,Colorectal Cancer|Metastatic Colorectal Cancer,Onvansertib,CN1CCN(CC1)C2=CC(=C(C=C2)OC(F)(F)F)NC3=NC=C4CCC5=C(C4=N3)N(N=C5C(=O)N)CCO,PHASE2,,digestive_system_disease
2568,4653,Irritable Bowel Syndrome,Tiropramide,CCCN(CCC)C(=O)C(CC1=CC=C(C=C1)OCCN(CC)CC)NC(=O)C2=CC=CC=C2,APPROVED,,digestive_system_disease
2567,4615,Hepatitis C,Ravidasvir,CC(C)C(C(=O)N1CCCC1C2=NC3=C(N2)C=C(C=C3)C4=CC5=C(C=C4)C=C(C=C5)C6=CN=C(N6)C7CCCN7C(=O)C(C(C)C)NC(=O)OC)NC(=O)OC,PHASE2|PHASE3,,digestive_system_disease
2563,4578,Pancreatitis,Aprotinin,CCC(C)C1C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NCC(=O)NC(C(=O)NC2CSSCC3C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(CSSCC(C(=O)NC(C(=O)NC(C(=O)N4CCCC4C(=O)N5CCCC5C(=O)NC(C(=O)NC(C(=O)NCC(=O)N6CCCC6C(=O)NC(CSSCC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N3)CC(=O)O)CCC(=O)O)C)CO)CCCCN)CC7=CC=CC=C7)CC(=O)N)CC(=O)N)CCCNC(=N)N)CCCCN)C)CCCNC(=N)N)NC(=O)CNC(=O)CNC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC2=O)CCC(=O)N)C(C)O)CC8=CC=CC=C8)C(C)C)CC9=CC=C(C=C9)O)C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N1)CCCNC(=N)N)C)CCCCN)C(C)O)CC1=CC=C(C=C1)O)CCC(=O)O)CC(C)C)NC(=O)C(CC1=CC=CC=C1)NC(=O)C(CC(=O)O)NC(=O)C1CCCN1C(=O)C(CCCNC(=N)N)N)C(=O)NCC(=O)NCC(=O)NC(C)C(=O)O)C(C)O)CCCNC(=N)N)CCSC)CC(C)C)C)CCCCN)C)CC(=O)N)CC1=CC=C(C=C1)O)CC1=CC=CC=C1)CC1=CC=C(C=C1)O)CCCNC(=N)N)C(C)CC,PHASE1,,digestive_system_disease
2561,4540,Metastatic Pancreatic Cancer,Proglumide,CCCN(CCC)C(=O)C(CCC(=O)O)NC(=O)C1=CC=CC=C1,PHASE1,,digestive_system_disease
2556,4484,Colon Cancer|Colorectal Cancer|Rectal Cancer|Metastatic Colorectal Cancer|Oncology,Conatumumab,,PHASE1|PHASE2,,digestive_system_disease
2554,4472,Cholecystolithiasis,Droperidol,C1CN(CC=C1N2C3=CC=CC=C3NC2=O)CCCC(=O)C4=CC=C(C=C4)F,APPROVED,,digestive_system_disease
2551,4465,Hepatic Impairment,Fevipiprant,CC1=C(C2=C(N1CC3=C(C=C(C=C3)S(=O)(=O)C)C(F)(F)F)N=CC=C2)CC(=O)O,PHASE1,,digestive_system_disease
2545,4379,Inflammatory Bowel Diseases|Clostridioides Difficile Infection,Sucralose,C(C1C(C(C(C(O1)OC2(C(C(C(O2)CCl)O)O)CCl)O)O)Cl)O,PHASE1,,digestive_system_disease
2536,4325,Nonalcoholic Steatohepatitis,Cilofexor,C1CC1C2=C(C(=NO2)C3=C(C=CC=C3Cl)Cl)COC4=CC(=C(C=C4)C5(CN(C5)C6=NC=CC(=C6)C(=O)O)O)Cl,PHASE2,,digestive_system_disease
2535,4323,Hepatic Impairment,Fosmanogepix,C1=CC=NC(=C1)OCC2=CC=C(C=C2)CC3=NOC(=C3)C4=C([N+](=CC=C4)COP(=O)(O)[O-])N,PHASE1,,digestive_system_disease
2532,4290,Irritable Bowel Syndrome,Otilonium,CCCCCCCCOC1=CC=CC=C1C(=O)NC2=CC=C(C=C2)C(=O)OCC[N+](C)(CC)CC,APPROVED,,digestive_system_disease
2530,4256,Metastatic Colorectal Carcinoma|Stage IV Colorectal Cancer AJCC v8|Stage IVA Colorectal Cancer AJCC v8|Stage IVB Colorectal Cancer AJCC v8|Stage IVC Colorectal Cancer AJCC v8,Utomilumab,,PHASE1,,digestive_system_disease
2525,4225,Liver Cancer|Metastatic Cancer,Pyrazoloacridine,CN(C)CCCN1C2=C3C(=C(C=C2)[N+](=O)[O-])NC4=C(C3=N1)C=C(C=C4)OC,PHASE2,,digestive_system_disease
2519,4144,Ulcerative Colitis,Abrilumab,,PHASE2,,digestive_system_disease
2516,4117,NASH - Nonalcoholic Steatohepatitis,Seladelpar,CCOC(COC1=CC=C(C=C1)C(F)(F)F)CSC2=CC(=C(C=C2)OCC(=O)O)C,PHASE2,,digestive_system_disease
2514,4077,"Hepatitis C, Chronic",Danoprevir,CC(C)(C)OC(=O)NC1CCCCCC=CC2CC2(NC(=O)C3CC(CN3C1=O)OC(=O)N4CC5=C(C4)C(=CC=C5)F)C(=O)NS(=O)(=O)C6CC6,PHASE2,,digestive_system_disease
2511,4006,Self Efficacy,Ginsenosides,CC(=CCCC(C)(C1CCC2(C1CCC3C2(CCC4C3(CCC(C4(C)C)O)C)C)C)O)C,PHASE2,,digestive_system_disease
2505,3925,Crohn Disease|CARD9 S12N Risk Allele,Posaconazole,CCC(C(C)O)N1C(=O)N(C=N1)C2=CC=C(C=C2)N3CCN(CC3)C4=CC=C(C=C4)OCC5CC(OC5)(CN6C=NC=N6)C7=C(C=C(C=C7)F)F,APPROVED,,digestive_system_disease
2504,3909,Gastroesophageal Reflux in Neonates,Montmorillonite,O.[O-2].[O-2].[O-2].O=[Si]=O.O=[Si]=O.O=[Si]=O.O=[Si]=O.[Al+3].[Al+3],APPROVED,,digestive_system_disease
2498,3842,Ulcerative Colitis (UC),Ravagalimab,,PHASE2,,digestive_system_disease
2497,3825,Acquired Immunodeficiency Syndrome|Healthy Volunteers|HIV/AIDS|HIV Diarrhea|Human Immunodeficiency Virus,Crofelemer,COC1=CC=CC=C1CNC(=O)C2=NOC(=C2)C3=CC=CC=C3,APPROVED,,digestive_system_disease
2494,3787,Malignant Tumors of the Digestive System|Trombocitopenia,Hetrombopag,CC1=C(C(=O)N(N1)C2=CC3=C(CCCC3)C=C2)N=NC4=CC=CC(=C4O)C5=CC=C(O5)C(=O)O,APPROVED,,digestive_system_disease
2480,3669,Refractory Reflux Esophagitis,Trimebutine,CCC(COC(=O)C1=CC(=C(C(=C1)OC)OC)OC)(C2=CC=CC=C2)N(C)C,APPROVED,,digestive_system_disease
2477,3653,Fibrostenotic Crohn´s Disease,Spesolimab,,PHASE2,,digestive_system_disease
2471,3576,Hepatocellular Carcinoma,Carotuximab,,PHASE1|PHASE2,,digestive_system_disease
2465,3499,Pancreatic Adenocarcinoma|Stage III Pancreatic Cancer AJCC v6 and v7,Triapine,C1=CC(=C(N=C1)C=NNC(=S)N)N,PHASE1,,digestive_system_disease
2451,3370,Diabetes Mellitus Type 2|Non Alcoholic Fatty Liver Disease|Obesity,Amlexanox,CC(C)C1=CC2=C(C=C1)OC3=NC(=C(C=C3C2=O)C(=O)O)N,PHASE2,,digestive_system_disease
2450,3369,Chronic Hepatitis B,Vesatolimod,CCCCOC1=NC(=C2C(=N1)N(CC(=O)N2)CC3=CC=CC(=C3)CN4CCCC4)N,PHASE2,,digestive_system_disease
2444,3284,Hepatitis B|Cholestasis,Ademetionine,C[S+](CCC(C(=O)[O-])N)CC1C(C(C(O1)N2C=NC3=C(N=CN=C32)N)O)O,APPROVED,,digestive_system_disease
2443,3245,Colorectal Cancer,Niclosamide,C1=CC(=C(C=C1[N+](=O)[O-])Cl)NC(=O)C2=C(C=CC(=C2)Cl)O,PHASE2,,digestive_system_disease
2442,3244,Non-Alcoholic Fatty Liver Disease,Gemcabene,CC(C)(CCCCOCCCCC(C)(C)C(=O)O)C(=O)O,PHASE2,,digestive_system_disease
2422,3036,Pancreas Cancer,Bethanechol,CC(C[N+](C)(C)C)OC(=O)N,PHASE2,,digestive_system_disease
2417,3021,Irritable Bowel Syndrome With Constipation,Plecanatide,CC1C(=O)NC2CSSCC(C(=O)NC(C(=O)NC(C(=O)NC(CSSCC(NC(=O)CNC(=O)C(NC2=O)C(C)O)C(=O)NC(CC(C)C)C(=O)O)C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N1)C(C)C)CC(=O)N)C(C)C)CC(C)C)CCC(=O)O)NC(=O)C(CCC(=O)O)NC(=O)C(CC(=O)O)NC(=O)C(CC(=O)N)N,PHASE2,,digestive_system_disease
2415,3004,Hepatocellular Carcinoma,Adebrelimab,,PHASE2,,digestive_system_disease
2412,2974,Colorectal Cancer Metastatic,Anisodamine,CN1C2CC(CC1C(C2)O)OC(=O)C(CO)C3=CC=CC=C3,PHASE2,,digestive_system_disease
2408,2911,Epithelial Ovarian Cancer|Primary Peritoneal Cancer|Fallopian Tube Cancer,Mirvetuximab,,PHASE1|PHASE2,,digestive_system_disease
2407,2897,Gastroesophageal Reflux Disease,Lesogaberan,C(C(C[P+](=O)O)F)N,PHASE2,,digestive_system_disease
2402,2867,Chronic Hepatitis B,Myrcludex B,,PHASE1|PHASE2,,digestive_system_disease
2394,2820,Nonalcoholic Steatohepatitis (NASH),Firsocostat,CC1=C(SC2=C1C(=O)N(C(=O)N2CC(C3=CC=CC=C3OC)OC4CCOCC4)C(C)(C)C(=O)O)C5=NC=CO5,PHASE1,,digestive_system_disease
2392,2817,Hepatitis B,Birinapant,CCC(C(=O)N1CC(CC1CC2=C(NC3=C2C=CC(=C3)F)C4=C(C5=C(N4)C=C(C=C5)F)CC6CC(CN6C(=O)C(CC)NC(=O)C(C)NC)O)O)NC(=O)C(C)NC,PHASE1,,digestive_system_disease
2391,2811,Gastroenteritis Escherichia Coli,Aspartame,COC(=O)C(CC1=CC=CC=C1)NC(=O)C(CC(=O)O)N,PHASE1,,digestive_system_disease
2387,2770,Cystic Fibrosis,Colistin,CCC(C)CCCC(=O)NC(CCN)C(=O)NC(C(C)O)C(=O)NC(CCN)C(=O)NC1CCNC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC1=O)CCN)CC(C)C)CC(C)C)CCN)CCN)C(C)O,APPROVED,,digestive_system_disease
2384,2741,Primary Sclerosing Cholangitis,Volixibat,CCCCC1(CS(=O)(=O)C2=C(C=C(C=C2)N(C)C)C(C1O)C3=CC(=CC=C3)NC(=O)NC4C(C(C(C(O4)COS(=O)(=O)O)O)OCC5=CC=CC=C5)O)CC,PHASE2,,digestive_system_disease
2379,2658,Peritonitis|Sepsis,Pentaglobin,,PHASE2,,digestive_system_disease
2375,2608,Pulmonary Alveolar Proteinosis|Bronchiectasis|Cystic Fibrosis|Acute Respiratory Distress Syndrome,Molgramostim,,PHASE1,,digestive_system_disease
2374,2602,Gastrointestinal Motility Disorder,Talinolol,CC(C)(C)NCC(COC1=CC=C(C=C1)NC(=O)NC2CCCCC2)O,PHASE1,,digestive_system_disease
2366,2552,Non-alcoholic Steatohepatitis|Type2 Diabetes,Alogliptin,CN1C(=O)C=C(N(C1=O)CC2=CC=CC=C2C#N)N3CCCC(C3)N,APPROVED,,digestive_system_disease
2364,2488,Cystic Fibrosis,Lefamulin,CC1CCC23CCC(=O)C2C1(C(CC(C(C3C)O)(C)C=C)OC(=O)CSC4CCC(CC4O)N)C,PHASE1,,digestive_system_disease
2354,2389,Infantile Colic|Infantile Functional Gastrointestinal Disorders,Nepadutant,CC(C)CC1C(=O)NC(C(=O)NC2CC(=O)NCC(C(=O)N1)NC(=O)C(NC(=O)C(NC2=O)CC3=CNC4=CC=CC=C43)CC5=CC=CC=C5)CC(=O)NC6C(C(C(C(O6)CO)O)O)NC(=O)C,PHASE1,,digestive_system_disease
2347,2351,Cystic Fibrosis,Tezacaftor,CC(C)(CO)C1=CC2=CC(=C(C=C2N1CC(CO)O)F)NC(=O)C3(CC3)C4=CC5=C(C=C4)OC(O5)(F)F,PHASE2,,digestive_system_disease
2344,2333,Irritable Bowel Syndrome,Ibodutant,CC1=CC2=C(C=C1)C=C(S2)C(=O)NC3(CCCC3)C(=O)NC(CC4=CC=CC=C4)C(=O)NCC5CCN(CC5)CC6CCOCC6,PHASE2,,digestive_system_disease
2338,2292,Lung Cancer|Esophageal Cancer|Mesothelioma|Gastrointestinal Neoplasms|Breast Cancer,Plicamycin,CC1C(C(CC(O1)OC2CC(OC(C2O)C)OC3=CC4=CC5=C(C(=O)C(C(C5)C(C(=O)C(C(C)O)O)OC)OC6CC(C(C(O6)C)O)OC7CC(C(C(O7)C)O)OC8CC(C(C(O8)C)O)(C)O)C(=C4C(=C3C)O)O)O)O,PHASE2,,digestive_system_disease
2337,2279,"Colitis, Ulcerative",Tetomilast,CCOC1=C(C=C(C=C1)C2=NC(=CS2)C3=NC(=CC=C3)C(=O)O)OCC,PHASE2,,digestive_system_disease
2336,2273,Hepatocellular Carcinoma,Orantinib,CC1=C(NC(=C1CCC(=O)O)C)C=C2C3=CC=CC=C3NC2=O,PHASE1|PHASE2,,digestive_system_disease
2335,2272,Crohn's Disease,Brodalumab,,PHASE2,,digestive_system_disease
2333,2244,Metastatic Colorectal Cancer,Geptanolimab,,PHASE1,,digestive_system_disease
2321,2148,Pancreatic Cancer,Rubitecan,CCC1(C2=C(COC1=O)C(=O)N3CC4=CC5=C(C=CC=C5[N+](=O)[O-])N=C4C3=C2)O,PHASE2|PHASE3,,digestive_system_disease
2319,2138,Hepatocellular Carcinoma,Chiauranib,COC1=CC2=NC=CC(=C2C=C1)OC3=CC4=C(C=C3)C(=CC=C4)C(=O)NC5=CC=CC=C5N,PHASE1|PHASE2,,digestive_system_disease
2314,2065,Hepatocellular Carcinoma,Bavituximab,,PHASE2,,digestive_system_disease
2310,2024,Colorectal Cancer|Chemotherapy Effect|Surgery|Metastasis|Survival,Lobaplatin,CC(C(=O)[O-])[O-].C1CC(C1CN)CN.[Pt+4],PHASE2,,digestive_system_disease
2309,2012,"Hepatitis C, Chronic|Hepacivirus",Narlaprevir,CCCCC(C(=O)C(=O)NC1CC1)NC(=O)C2C3C(C3(C)C)CN2C(=O)C(C(C)(C)C)NC(=O)NC4(CCCCC4)CS(=O)(=O)C(C)(C)C,PHASE2|PHASE3,,digestive_system_disease
2306,1995,"Hepatitis C, Chronic",Tegobuvir,C1=CC=C(C(=C1)C2=NC3=CN(C=CC3=N2)CC4=NN=C(C=C4)C5=C(C=C(C=C5)C(F)(F)F)C(F)(F)F)F,PHASE2,,digestive_system_disease
2305,1994,Gastric Cancer,Varlitinib,CC1COC(=N1)NC2=CC3=C(C=C2)N=CN=C3NC4=CC(=C(C=C4)OCC5=NC=CS5)Cl,PHASE2|PHASE3,,digestive_system_disease
2303,1960,Hepatitis C,Ruzasvir,CC(C)C(C(=O)N1CCCC1C2=NC=C(N2)C3=CC4=C(C=C3)N5C(OC6=C(C5=C4)C(=CC(=C6)C7=CN=C(N7)C8CCCN8C(=O)C(C(C)C)NC(=O)OC)F)C9=CN=C(S9)C1CC1)NC(=O)OC,PHASE2,,digestive_system_disease
2302,1958,Hepatitis C,Uprifosbuvir,CC(C)OC(=O)C(C)NP(=O)(OCC1C(C(C(O1)N2C=CC(=O)NC2=O)(C)Cl)O)OC3=CC=CC=C3,PHASE2,,digestive_system_disease
2299,1931,Chronic Hepatitis B,Clevudine,CC1=CN(C(=O)NC1=O)C2C(C(C(O2)CO)O)F,APPROVED,,digestive_system_disease
2298,1911,Colorectal Neoplasms,Vicriviroc,CC1CN(CCN1C(COC)C2=CC=C(C=C2)C(F)(F)F)C3(CCN(CC3)C(=O)C4=C(N=CN=C4C)C)C,PHASE2,,digestive_system_disease
2293,1835,Irritable Bowel Syndrome Characterized by Constipation,Linaclotide,CC1C(=O)NC2CSSCC3C(=O)NC(C(=O)NC(C(=O)NC(CSSCC(NC(=O)CNC(=O)C(NC2=O)C(C)O)C(=O)NC(CC4=CC=C(C=C4)O)C(=O)O)C(=O)NC(CSSCC(C(=O)N3)N)C(=O)NC(C(=O)N5CCCC5C(=O)N1)CC(=O)N)CC6=CC=C(C=C6)O)CCC(=O)O,APPROVED,,digestive_system_disease
2286,1789,Crohn's Disease,Mirikizumab,,PHASE2,,digestive_system_disease
2285,1784,"Melanoma|Solid Tumor|CRAF Gene Amplification|RAF1 Gene Amplification|BRAF Gene Fusion|BRAF Fusion|CRAF Gene Fusion|CRAF Fusion|RAF1 Gene Fusion|RAF1 Fusion|Thyroid Cancer, Papillary|Spitzoid Melanoma|Pilocytic Astrocytoma|Pilocytic Astrocytoma, Adult|Non Small Cell Lung Cancer|Non-Small Cell Adenocarcinoma|Colorectal Cancer|Pancreatic Acinar Carcinoma|Spitzoid Malignant Melanoma|Bladder Cancer|Bladder Urothelial Carcinoma|MAP Kinase Family Gene Mutation|RAS Mutation|RAF Mutation|MEK Mutation",Pimasertib,C1=CC(=C(C=C1I)F)NC2=C(C=CN=C2)C(=O)NCC(CO)O,PHASE1|PHASE2,,digestive_system_disease
2284,1783,"Melanoma|Solid Tumor|CRAF Gene Amplification|RAF1 Gene Amplification|BRAF Gene Fusion|BRAF Fusion|CRAF Gene Fusion|CRAF Fusion|RAF1 Gene Fusion|RAF1 Fusion|Thyroid Cancer, Papillary|Spitzoid Melanoma|Pilocytic Astrocytoma|Pilocytic Astrocytoma, Adult|Non Small Cell Lung Cancer|Non-Small Cell Adenocarcinoma|Colorectal Cancer|Pancreatic Acinar Carcinoma|Spitzoid Malignant Melanoma|Bladder Cancer|Bladder Urothelial Carcinoma|MAP Kinase Family Gene Mutation|RAS Mutation|RAF Mutation|MEK Mutation",Tovorafenib,CC(C1=NC=C(S1)C(=O)NC2=NC=C(C(=C2)C(F)(F)F)Cl)NC(=O)C3=C(C(=NC=N3)N)Cl,PHASE1|PHASE2,,digestive_system_disease
2283,1763,Ulcerative Colitis,Etrolizumab,,PHASE2,,digestive_system_disease
2279,1682,Type 2 Diabetes|Non-alcoholic Fatty Liver Disease,Lobeglitazone,CN(CCOC1=CC=C(C=C1)CC2C(=O)NC(=O)S2)C3=CC(=NC=N3)OC4=CC=C(C=C4)OC,APPROVED,,digestive_system_disease
2275,1649,Gastrointestinal Stromal Tumor (GIST),Olaratumab,,PHASE2,,digestive_system_disease
2274,1637,Nonalcoholic Fatty Liver|Nonalcoholic Steatohepatitis,Elobixibat,CCCCC1(CN(C2=CC(=C(C=C2S(=O)(=O)C1)OCC(=O)NC(C3=CC=CC=C3)C(=O)NCC(=O)O)SC)C4=CC=CC=C4)CCCC,PHASE2,,digestive_system_disease
2272,1627,ERCP|Pancreatitis,Valdecoxib,CC1=C(C(=NO1)C2=CC=CC=C2)C3=CC=C(C=C3)S(=O)(=O)N,PHASE2|PHASE3,,digestive_system_disease
2271,1616,Metastatic Colorectal Adenocarcinoma|Metastatic Pancreatic Ductal Adenocarcinoma|Stage IV Colorectal Cancer AJCC v7|Stage IV Pancreatic Cancer AJCC v6 and v7|Stage IVA Colorectal Cancer AJCC v7|Stage IVB Colorectal Cancer AJCC v7,Sotigalimab,,PHASE1,,digestive_system_disease
2267,1595,Colorectal Cancer,Selicrelumab,,PHASE1|PHASE2,,digestive_system_disease
2257,1548,Hepatitis C Virus,Dasabuvir,CC(C)(C)C1=CC(=CC(=C1OC)C2=CC3=C(C=C2)C=C(C=C3)NS(=O)(=O)C)N4C=CC(=O)NC4=O,APPROVED,,digestive_system_disease
2254,1525,Pancreatic Adenocarcinoma,Pancrelipase,,PHASE2,,digestive_system_disease
2252,1520,Oral Mucositis Due to Chemotherapy,Miconazole,C1=CC(=C(C=C1Cl)Cl)COC(CN2C=CN=C2)C3=C(C=C(C=C3)Cl)Cl,PHASE2,,digestive_system_disease
2251,1519,Esophageal Carcinoma|Neoadjuvant Immunotherapy,Nedaplatin,C(C(=O)O)O.N.N.[Pt],PHASE1|PHASE2,,digestive_system_disease
2246,1470,"Hepatitis C, Chronic",Taribavirin,C1=NC(=NN1C2C(C(C(O2)CO)O)O)C(=N)N,PHASE2,,digestive_system_disease
2244,1448,Non-alcoholic Steatohepatitis,Mebrofenin,CC1=CC(=C(C(=C1NC(=O)CN(CC(=O)O)CC(=O)O)C)Br)C,PHASE1,,digestive_system_disease
2240,1416,Hepatitis C,Samatasvir,CC(C)C(C(=O)N1CCCC1C2=NC3=C(N2)C=C(C=C3)C4=CSC5=C4SC=C5C6=CC=C(C=C6)C7=CN=C(N7)C8CCCN8C(=O)C(C9=CC=CC=C9)NC(=O)OC)NC(=O)OC,PHASE1,,digestive_system_disease
2233,1341,Gastric Cancer,Telatinib,CNC(=O)C1=NC=CC(=C1)COC2=NN=C(C3=C2OC=C3)NC4=CC=C(C=C4)Cl,PHASE2,,digestive_system_disease
2232,1337,Cryptosporidiosis,Clofazimine,CC(C)N=C1C=C2C(=NC3=CC=CC=C3N2C4=CC=C(C=C4)Cl)C=C1NC5=CC=C(C=C5)Cl,PHASE2,,digestive_system_disease
2222,1257,Clostridia Difficile Colitis|Clostridium; Sepsis,Bezlotoxumab,,APPROVED,,digestive_system_disease
2220,1227,ADVANCED HEPATOCELLULAR CARCINOMA (HCC),Galunisertib,CC1=NC(=CC=C1)C2=NN3CCCC3=C2C4=C5C=C(C=CC5=NC=C4)C(=O)N,PHASE1,,digestive_system_disease
2212,1180,Hepatic Impairment,Aramchol,CCCCCCCCCCCCCCCCCCCC(=O)NC1CCC2(C(C1)CC(C3C2CC(C4(C3CCC4C(C)CCC(=O)O)C)O)O)C,PHASE1,,digestive_system_disease
2209,1165,Ulcerative Colitis,Visilizumab,,PHASE2,,digestive_system_disease
2205,1138,Metastatic Colorectal Cancer,Napabucasin,CC(=O)C1=CC2=C(O1)C(=O)C3=CC=CC=C3C2=O,PHASE1|PHASE2,,digestive_system_disease
2201,1114,Cystic Fibrosis,Cavosonstat,C1=CC(=C(C=C1C(=O)O)Cl)C2=NC3=C(C=C2)C=C(C=C3)O,PHASE2,,digestive_system_disease
2196,1084,Crohn Disease,Neomycin,C1C(C(C(C(C1N)OC2C(C(C(C(O2)CN)O)O)N)OC3C(C(C(O3)CO)OC4C(C(C(C(O4)CN)O)O)N)O)O)N,PHASE2,,digestive_system_disease
2189,1056,Chronic Hepatitis B,Selgantolimod,CCCCC(C)(CO)NC1=NC(=NC2=C1N=CC(=C2)F)N,PHASE2,,digestive_system_disease
2178,1014,Hepatitis C|Telaprevir|HIV,Fosamprenavir,CC(C)CN(CC(C(CC1=CC=CC=C1)NC(=O)OC2CCOC2)OP(=O)(O)O)S(=O)(=O)C3=CC=C(C=C3)N,PHASE1,,digestive_system_disease
2175,991,Chronic Hepatitis C,Vaniprevir,CCC1CC1(C(=O)NS(=O)(=O)C2CC2)NC(=O)C3CC4CN3C(=O)C(NC(=O)OCC(CCCCC5=C6CN(CC6=CC=C5)C(=O)O4)(C)C)C(C)(C)C,PHASE1,,digestive_system_disease
2167,958,Gastritis|Dyspepsia|Helicobacter Pylori Infection|Gastric Cancer|Peptic Ulcer,Furazolidone,C1COC(=O)N1N=CC2=CC=C(O2)[N+](=O)[O-],APPROVED,,digestive_system_disease
2166,957,Gastritis|Dyspepsia|Helicobacter Pylori Infection|Gastric Cancer|Peptic Ulcer,Tetracycline,CC1(C2CC3C(C(=O)C(=C(C3(C(=O)C2=C(C4=C1C=CC=C4O)O)O)O)C(=O)N)N(C)C)O,APPROVED,,digestive_system_disease
2164,953,Colorectal Cancer,Tipiracil,C1CC(=N)N(C1)CC2=C(C(=O)NC(=O)N2)Cl,PHASE2,,digestive_system_disease
2163,952,Colorectal Cancer,Trifluridine,C1C(C(OC1N2C=C(C(=O)NC2=O)C(F)(F)F)CO)O,PHASE2,,digestive_system_disease
2149,887,Ulcerative Colitis,Etrasimod,C1CCC(C1)C2=C(C=C(C=C2)COC3=CC4=C(C=C3)NC5=C4CCC5CC(=O)O)C(F)(F)F,PHASE2,,digestive_system_disease
2142,850,ColoRectal Cancer,Raltitrexed,CC1=NC2=C(C=C(C=C2)CN(C)C3=CC=C(S3)C(=O)NC(CCC(=O)O)C(=O)O)C(=O)N1,PHASE2,,digestive_system_disease
2141,841,Hepatitis C,Mericitabine,CC(C)C(=O)OCC1C(C(C(O1)N2C=CC(=NC2=O)N)(C)F)OC(=O)C(C)C,PHASE2,,digestive_system_disease
2139,828,"Hepatitis C, Chronic",Sovaprevir,CC(C)(C)C(CC(=O)N1CCCCC1)C(=O)N2CC(CC2C(=O)NC3(CC3C=C)C(=O)NS(=O)(=O)C4CC4)OC5=CC(=NC6=C5C=CC(=C6)OC)C7=CC=CC=C7,PHASE2,,digestive_system_disease
2138,824,Hepatitis C Viral Infection|Chronic Hepatitis C|Hepatitis C (HCV)|Hepatitis C Genotype 4,Faldaprevir,CC(C)C(=O)NC1=NC(=CS1)C2=NC3=C(C=CC(=C3Br)OC)C(=C2)OC4CC(N(C4)C(=O)C(C(C)(C)C)NC(=O)OC5CCCC5)C(=O)NC6(CC6C=C)C(=O)O,PHASE2,,digestive_system_disease
2137,819,"Hepatitis C Virus Infection, Response to Therapy of|Human Immunodeficiency Virus",Velpatasvir,CC1CCC(N1C(=O)C(C(C)C)NC(=O)OC)C2=NC3=C(N2)C=CC4=CC5=C(C=C43)OCC6=C5C=CC(=C6)C7=CN=C(N7)C8CC(CN8C(=O)C(C9=CC=CC=C9)NC(=O)OC)COC,APPROVED,,digestive_system_disease
2132,807,"Liver Cirrhosis, Biliary",Ursodiol,CC(CCC(=O)O)C1CCC2C1(CCC3C2C(CC4C3(CCC(C4)O)C)O)C,PHASE2,,digestive_system_disease
2131,806,Crohn's Disease,Semapimod,CC(=NN=C(N)N)C1=CC(=CC(=C1)NC(=O)CCCCCCCCC(=O)NC2=CC(=CC(=C2)C(=NN=C(N)N)C)C(=NN=C(N)N)C)C(=NN=C(N)N)C,PHASE2,,digestive_system_disease
2128,797,"Hepatitis B, Chronic",Hydronidone,CC1=CN(C(=O)C=C1)C2=CC=C(C=C2)O,PHASE2,,digestive_system_disease
2126,783,NASH - Nonalcoholic Steatohepatitis,Namodenoson,CNC(=O)C1C(C(C(O1)N2C=NC3=C(N=C(N=C32)Cl)NCC4=CC(=CC=C4)I)O)O,PHASE2,,digestive_system_disease
2121,754,"Hepatitis C, Chronic",Silibinin,COC1=C(C=CC(=C1)C2C(OC3=C(O2)C=C(C=C3)C4C(C(=O)C5=C(C=C(C=C5O4)O)O)O)CO)O,PHASE2|PHASE3,,digestive_system_disease
2119,745,"Colitis, Ulcerative",Anrukinzumab,,PHASE2,,digestive_system_disease
2107,704,"Hepatitis B, Chronic",Thymalfasin,CCC(C)C(C(=O)NC(C(C)O)C(=O)NC(C(C)O)C(=O)NC(CCCCN)C(=O)NC(CC(=O)O)C(=O)NC(CC(C)C)C(=O)NC(CCCCN)C(=O)NC(CCC(=O)O)C(=O)NC(CCCCN)C(=O)NC(CCCCN)C(=O)NC(CCC(=O)O)C(=O)NC(C(C)C)C(=O)NC(C(C)C)C(=O)NC(CCC(=O)O)C(=O)NC(CCC(=O)O)C(=O)NC(C)C(=O)NC(CCC(=O)O)C(=O)NC(CC(=O)N)C(=O)O)NC(=O)C(CCC(=O)O)NC(=O)C(CO)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C(CC(=O)O)NC(=O)C(C(C)C)NC(=O)C(C)NC(=O)C(C)NC(=O)C(CC(=O)O)NC(=O)C(CO)NC(=O)C,PHASE1|PHASE2,,digestive_system_disease
2100,677,Ulcerative Colitis|Inflammatory Bowel Diseases,Psyllium,CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC(=O)O,PHASE2,,digestive_system_disease
2094,649,Solid Tumours of Epithelial Origin|Metastatic Colorectal Cancer|Metastatic Bladder Cancer,Enadenotucirev,,PHASE1|PHASE2,,digestive_system_disease
2092,639,"Carcinoma, Hepatocellular",Onartuzumab,,PHASE1,,digestive_system_disease
2088,616,Pouchitis,Vedolizumab,,APPROVED,,digestive_system_disease
2083,606,Crohn's Disease|IBD,Brazikumab,,PHASE2|PHASE3,,digestive_system_disease
2073,545,Staphylococcus Aureus,Tefibazumab,,PHASE2,,digestive_system_disease
2065,519,Achalasia,Olinciguat,C1=CC=C(C(=C1)CN2C(=CC(=N2)C3=NC=C(C(=N3)NCC(C(=O)N)(C(F)(F)F)O)F)C4=NOC=C4)F,PHASE2,,digestive_system_disease
2058,489,Pancreas Cancer,Lurbinectedin,CC1=CC2=C(C3C4C5C6=C(C(=C7C(=C6C(N4C(C(C2)N3C)O)COC(=O)C8(CS5)C9=C(CCN8)C2=C(N9)C=CC(=C2)OC)OCO7)C)OC(=O)C)C(=C1OC)O,PHASE2,,digestive_system_disease
2057,477,Pancreatic Cancer|Unresectable Pancreatic Cancer|Metastatic Pancreatic Cancer|KRAS P.G12C,Sotorasib,CC1CN(CCN1C2=NC(=O)N(C3=NC(=C(C=C32)F)C4=C(C=CC=C4F)O)C5=C(C=CN=C5C(C)C)C)C(=O)C=C,PHASE1|PHASE2,,digestive_system_disease
2051,457,Pancreatic Cancer,Vatalanib,C1=CC=C2C(=C1)C(=NN=C2NC3=CC=C(C=C3)Cl)CC4=CC=NC=C4,PHASE1|PHASE2,,digestive_system_disease
2047,443,"Hepatitis B, Chronic",Adefovir,C1=NC(=C2C(=N1)N(C=N2)CCOCP(=O)(O)O)N,APPROVED,,digestive_system_disease
2046,441,Cystic Fibrosis,Lucinactant,CC(C)CC(C(=O)NC(CC(C)C)C(=O)NC(CC(C)C)C(=O)NC(CC(C)C)C(=O)NC(CCCCN)C(=O)NC(CC(C)C)C(=O)NC(CC(C)C)C(=O)NC(CC(C)C)C(=O)NC(CC(C)C)C(=O)NC(CCCCN)C(=O)NC(CC(C)C)C(=O)NC(CC(C)C)C(=O)NC(CC(C)C)C(=O)NC(CC(C)C)C(=O)NC(CCCCN)C(=O)NC(CC(C)C)C(=O)NC(CC(C)C)C(=O)NC(CC(C)C)C(=O)NC(CC(C)C)C(=O)NC(CCCCN)C(=O)O)NC(=O)C(CCCCN)N.CC(=O)O,PHASE2,,digestive_system_disease
2039,416,Gastroesophageal Reflux Disease,Proguanil,CC(C)N=C(N)N=C(N)NC1=CC=C(C=C1)Cl,PHASE1,,digestive_system_disease
2036,408,Prolonged Postoperative Ileus,Diatrizoate,CC(=O)NC1=C(C(=C(C(=C1I)C(=O)O)I)NC(=O)C)I,PHASE2|PHASE3,,digestive_system_disease
2033,400,Stomach Neoplasms|Esophagogastric Junction Disorder|Neoadjuvant Therapy|Chemoradiotherapy|Immunotherapy|Gastrectomy|Adenocarcinoma|Adjuvant Therapy,Oteracil,C1(=NC(=O)NC(=O)N1)C(=O)O,PHASE2,,digestive_system_disease
2027,384,Active Peptic Ulcer Disease/GI Bleeding,Misoprostol,CCCCC(C)(CC=CC1C(CC(=O)C1CCCCCCC(=O)OC)O)O,APPROVED,,digestive_system_disease
2023,370,Epithelial Ovarian Cancer|Fallopian Tube Cancer|Peritoneal Cancer,Gimatecan,CCC1(C2=C(COC1=O)C(=O)N3CC4=C(C5=CC=CC=C5N=C4C3=C2)C=NOC(C)(C)C)O,PHASE2,,digestive_system_disease
2021,367,Advanced Gastrointestinal Tumors,Minnelide,CC(C)C12C(O1)C3C4(O3)C5(CCC6=C(C5CC7C4(C2OCOP(=O)([O-])[O-])O7)COC6=O)C.[Na+].[Na+],PHASE1,,digestive_system_disease
2019,359,Metastatic Pancreatic Cancer,Rintatolimod,C1=CN(C(=O)N=C1N)C2C(C(C(O2)COP(=O)(O)O)O)O.C1=CN(C(=O)NC1=O)C2C(C(C(O2)COP(=O)(O)O)O)O.C1=NC2=C(C(=O)N1)N=CN2C3C(C(C(O3)COP(=O)(O)O)O)O,PHASE1|PHASE2,,digestive_system_disease
2013,312,Colorectal Cancer Metastatic,Tocotrienol,CC(=CCCC(=CCCC(=CCCC1(CCC2=C(O1)C=CC(=C2)O)C)C)C)C,PHASE2,,digestive_system_disease
2012,307,Cholangiocarcinoma|Tumor|Klatskin Tumor,Temoporfin,C1CC2=NC1=C(C3=CC=C(N3)C(=C4C=CC(=N4)C(=C5C=CC(=C2C6=CC(=CC=C6)O)N5)C7=CC(=CC=C7)O)C8=CC(=CC=C8)O)C9=CC(=CC=C9)O,PHASE2,,digestive_system_disease
2008,301,Hepatitis C|Chronic Hepatitis C,Miravirsen,CC1=CN(C(=O)NC1=O)C2CC(C(O2)COP(=S)(O)OC3C4C(OC3(CO4)COP(=S)(O)OC5CC(OC5COP(=S)(O)OC6C7C(OC6(CO7)CO)N8C=CC(=NC8=O)N)N9C=CC(=NC9=O)N)N1C=NC2=C(N=CN=C21)N)OP(=S)(O)OCC1C(CC(O1)N1C=C(C(=O)NC1=O)C)OP(=S)(O)OCC12COC(C1OP(=S)(O)OCC13COC(C1OP(=S)(O)OCC1C(CC(O1)N1C=CC(=NC1=O)N)OP(=S)(O)OCC1C(CC(O1)N1C=NC4=C(N=CN=C41)N)OP(=S)(O)OCC14COC(C1OP(=S)(O)OCC1C(CC(O1)N1C=NC5=C(N=CN=C51)N)OP(=S)(O)OCC15COC(C1OP(=S)(O)OCC1C(CC(O1)N1C=C(C(=O)NC1=O)C)OP(=S)(O)OCC16COC(C1OP(=S)(O)OCC17COC(C1O)C(O7)N1C=CC(=NC1=O)N)C(O6)N1C=CC(=NC1=O)N)C(O5)N1C=CC(=NC1=O)N)C(O4)N1C=CC(=NC1=O)N)C(O3)N1C=C(C(=O)NC1=O)C)C(O2)N1C=NC2=C1N=C(NC2=O)N,PHASE1,,digestive_system_disease
2004,286,Nonalcoholic Steatohepatitis (NASH),Miricorilant,C1CC(CCC1C2=CC=CC=C2)C3=C(C(=O)NC(=O)N3)CC4=CC(=CC=C4)C(F)(F)F,PHASE1,,digestive_system_disease
2003,285,Oral Mucositis (Ulcerative) Due to Radiation,Dexpanthenol,CC(C)(CO)C(C(=O)NCCCO)O,PHASE2,,digestive_system_disease
1989,224,Primary Biliary Cholangitis|Liver Stiffness,Setanaxib,CN1C(=O)C=C2C(=C1C3=CC(=CC=C3)N(C)C)C(=O)N(N2)C4=CC=CC=C4Cl,PHASE2|PHASE3,,digestive_system_disease
1988,223,Liver Fibrosis|Hepatitis C|HIV|HIV/HCV Co-infection,Simtuzumab,,PHASE2,,digestive_system_disease
1981,207,Irritable Bowel Syndrome,Mesalazine,C1=CC(=C(C=C1N)C(=O)O)O,PHASE2,,digestive_system_disease
1980,206,Irritable Bowel Syndrome,Mesalamine,C1=CC(=C(C=C1N)C(=O)O)O,PHASE2,,digestive_system_disease
1974,193,Metastatic Colorectal Cancer|Colorectal Cancer Metastatic|Carcinoma,Modotuximab,,PHASE2,,digestive_system_disease
1973,192,Metastatic Colorectal Cancer|Colorectal Cancer Metastatic|Carcinoma,Futuximab,,PHASE2,,digestive_system_disease
1972,188,Hepatitis C,Telaprevir,CCCC(C(=O)C(=O)NC1CC1)NC(=O)C2C3CCCC3CN2C(=O)C(C(C)(C)C)NC(=O)C(C4CCCCC4)NC(=O)C5=NC=CN=C5,PHASE2|PHASE3,,digestive_system_disease
1941,98,Gastric Cancer|Stomach Cancer,Floxuridine,C1C(C(OC1N2C=C(C(=O)NC2=O)F)CO)O,PHASE2,,digestive_system_disease
1939,88,Pancreatic Adenocarcinoma|Resectable Pancreatic Carcinoma|Stage I Pancreatic Cancer|Stage IA Pancreatic Cancer|Stage IB Pancreatic Cancer|Stage II Pancreatic Cancer|Stage IIA Pancreatic Cancer|Stage IIB Pancreatic Cancer|Stage III Pancreatic Cancer,Oregovomab,,PHASE2,,digestive_system_disease
1935,78,Hepatocellular Carcinoma (HCC),Icaritin,CC(=CCC1=C2C(=C(C=C1O)O)C(=O)C(=C(O2)C3=CC=C(C=C3)OC)O)C,PHASE2,,digestive_system_disease
1922,53,Inoperable or Recurrent or Metastatic Esophageal Squamous Carcinoma,Poziotinib,COC1=C(C=C2C(=C1)N=CN=C2NC3=C(C(=C(C=C3)Cl)Cl)F)OC4CCN(CC4)C(=O)C=C,PHASE2,,digestive_system_disease
1920,51,Stomach Ulcer,Rebamipide,C1=CC=C2C(=C1)C(=CC(=O)N2)CC(C(=O)O)NC(=O)C3=CC=C(C=C3)Cl,APPROVED,,digestive_system_disease
1906,20,"Carcinoma, Hepatocellular",Meclizine,CC1=CC(=CC=C1)CN2CCN(CC2)C(C3=CC=CC=C3)C4=CC=C(C=C4)Cl,PHASE1,,digestive_system_disease
1903,17,Esophageal Neoplasm,Tegafur,C1CC(OC1)N2C=C(C(=O)NC2=O)F,PHASE2,,digestive_system_disease
1876,7541,"Diabetes Mellitus, Type 1",Abrocitinib,CCCS(=O)(=O)NC1CC(C1)N(C)C2=NC=NC3=C2C=CN3,PHASE2,,metabolic_disease
1872,7426,Glucose Intolerance|Overweight and Obesity|Drug Effect|Adiposity,Cyanocobalamin,CC1=CC2=C(C=C1C)N(C=N2)C3C(C(C(O3)CO)OP(=O)([O-])OC(C)CNC(=O)CCC4(C(C5C6(C(C(C(=C(C7=NC(=CC8=NC(=C(C4=N5)C)C(C8(C)C)CCC(=O)N)C(C7(C)CC(=O)N)CCC(=O)N)C)[N-]6)CCC(=O)N)(C)CC(=O)N)C)CC(=O)N)C)O.[C-]#N.[Co+3],APPROVED,,metabolic_disease
1865,7190,Type 1 Diabetes,Volagidemab,,PHASE1|PHASE2,,metabolic_disease
1863,7177,Hyperlipidemia,Tetraethylammonium,CC[N+](CC)(CC)CC,PHASE2,,metabolic_disease
1859,7136,Post-menopausal Osteoporosis,Phylloquinone,CC1=C(C(=O)C2=CC=CC=C2C1=O)CC=C(C)CCCC(C)CCCC(C)CCCC(C)C,PHASE2|PHASE3,,metabolic_disease
1852,7049,Dyslipidemia,Muraglitazar,CC1=C(N=C(O1)C2=CC=CC=C2)CCOC3=CC=C(C=C3)CN(CC(=O)O)C(=O)OC4=CC=C(C=C4)OC,PHASE2|PHASE3,,metabolic_disease
1835,6775,Fungal Disease,Ibrexafungerp,CC(C)C(C)C1(CCC2(C3CCC4C5(COCC4(C3=CCC2(C1C(=O)O)C)CC(C5OCC(C)(C(C)(C)C)N)N6C(=NC=N6)C7=CC=NC=C7)C)C)C,PHASE1,,metabolic_disease
1830,6608,Type 2 Diabetes Mellitus,Fasiglifam,CC1=CC(=CC(=C1C2=CC=CC(=C2)COC3=CC4=C(C=C3)C(CO4)CC(=O)O)C)OCCCS(=O)(=O)C,PHASE2,,metabolic_disease
1816,6089,Congenital Adrenal Hyperplasia (CAH),Flutamide,CC(C)C(=O)NC1=CC(=C(C=C1)[N+](=O)[O-])C(F)(F)F,APPROVED,,metabolic_disease
1804,5872,Primary Hypercholesterolemia,Eprotirome,CC(C)C1=C(C=CC(=C1)OC2=C(C=C(C=C2Br)NC(=O)CC(=O)O)Br)O,PHASE2,,metabolic_disease
1803,5862,"Diabetes Mellitus, Type 2",Dorzagliatin,CC(C)CC(C(=O)NC1=NN(C=C1)CC(CO)O)N2CC(=CC2=O)OC3=CC=CC=C3Cl,PHASE2,,metabolic_disease
1755,4818,"Diabetes Mellitus, Type 2|Overweight or Obesity",Beinaglutide,CCC(C)C(C(=O)NC(C)C(=O)NC(CC1=CNC2=CC=CC=C21)C(=O)NC(CC(C)C)C(=O)NC(C(C)C)C(=O)NC(CCCCN)C(=O)NCC(=O)NC(CCCNC(=N)N)C(=O)O)NC(=O)C(CC3=CC=CC=C3)NC(=O)C(CCC(=O)O)NC(=O)C(CCCCN)NC(=O)C(C)NC(=O)C(C)NC(=O)C(CCC(=O)N)NC(=O)CNC(=O)C(CCC(=O)O)NC(=O)C(CC(C)C)NC(=O)C(CC4=CC=C(C=C4)O)NC(=O)C(CO)NC(=O)C(CO)NC(=O)C(C(C)C)NC(=O)C(CC(=O)O)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C(CC5=CC=CC=C5)NC(=O)C(C(C)O)NC(=O)CNC(=O)C(CCC(=O)O)NC(=O)C(C)NC(=O)C(CC6=CNC=N6)N,APPROVED,,metabolic_disease
1741,4614,Hypercholesterolemia,Bococizumab,,PHASE2,,metabolic_disease
1730,4400,Type 2 Diabetes Mellitus,Retagliptin,COC(=O)C1=C2CN(CCN2C(=N1)C(F)(F)F)C(=O)CC(CC3=CC(=C(C=C3F)F)F)N,PHASE1,,metabolic_disease
1729,4380,Type 2 Diabetes Mellitus,Rebaudioside A,CC12CCCC(C1CCC34C2CCC(C3)(C(=C)C4)OC5C(C(C(C(O5)CO)O)OC6C(C(C(C(O6)CO)O)O)O)OC7C(C(C(C(O7)CO)O)O)O)(C)C(=O)OC8C(C(C(C(O8)CO)O)O)O,PHASE1,,metabolic_disease
1713,4066,Mucopolysaccharidosis VI|Maroteaux-Lamy Syndrome,Arylsulfatase B,,APPROVED,,metabolic_disease
1712,4054,Type 2 Diabetes Mellitus,Enalaprilat,CC(C(=O)N1CCCC1C(=O)O)NC(CCC2=CC=CC=C2)C(=O)O,APPROVED,,metabolic_disease
1711,4052,Type 2 Diabetes Mellitus,Neuropeptide Y,CCC(C)C(C(=O)NC(CC(=O)N)C(=O)NC(CC(C)C)C(=O)NC(C(C)CC)C(=O)NC(C(C)O)C(=O)NC(CCCNC(=N)N)C(=O)NC(CCC(=O)N)C(=O)NC(CCCNC(=N)N)C(=O)NC(CC1=CC=C(C=C1)O)C(=O)N)NC(=O)C(CC2=CC=C(C=C2)O)NC(=O)C(CC3=CN=CN3)NC(=O)C(CCCNC(=N)N)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CO)NC(=O)C(CC4=CC=C(C=C4)O)NC(=O)C(CC5=CC=C(C=C5)O)NC(=O)C(CCCNC(=N)N)NC(=O)C(C)NC(=O)C(CC(C)C)NC(=O)C(CC(=O)O)NC(=O)C(CCC(=O)O)NC(=O)C(C)NC(=O)C6CCCN6C(=O)C(C)NC(=O)C(CC(=O)O)NC(=O)C(CCC(=O)O)NC(=O)CNC(=O)C7CCCN7C(=O)C(CC(=O)N)NC(=O)C(CC(=O)O)NC(=O)C8CCCN8C(=O)C(CCCCN)NC(=O)C(CO)NC(=O)C9CCCN9C(=O)C(CC1=CC=C(C=C1)O)N,APPROVED,,metabolic_disease
1701,3913,Obesity,Olestra,,PHASE2,,metabolic_disease
1700,3898,"Diabetes Mellitus, Type 1",Deoxyspergualin,C(CCCN=C(N)N)CCC(=O)NC(C(=O)NCCCCNCCCN)O,PHASE2,,metabolic_disease
1698,3891,Type 1 Diabetes Mellitus,Efalizumab,,PHASE2,,metabolic_disease
1691,3827,Abdominal Obesity|Insulin Resistance|Hypertriglyceridemia,Acipimox,CC1=CN=C(C=[N+]1[O-])C(=O)O,PHASE2,,metabolic_disease
1687,3768,Homozygous Familial Hypercholesterolemia,Lomitapide,C1CN(CCC1NC(=O)C2=CC=CC=C2C3=CC=C(C=C3)C(F)(F)F)CCCCC4(C5=CC=CC=C5C6=CC=CC=C64)C(=O)NCC(F)(F)F,PHASE2,,metabolic_disease
1681,3738,"Malaria, Falciparum|G6PD Deficiency",Artenimol,CC1CCC2C(C(OC3C24C1CCC(O3)(OO4)C)O)C,APPROVED,,metabolic_disease
1677,3628,Hypercholesterolemia,Evinacumab,,PHASE2,,metabolic_disease
1663,3471,Familial Hypercholesterolemia,Implitapide,CC1=CC(=NC2=C1C3=CC=CC=C3N2CC4=CC(=CC=C4)C(C5CCCC5)C(=O)NC(CO)C6=CC=CC=C6)C,PHASE2,,metabolic_disease
1657,3422,Type1 Diabetes Mellitus|Enterovirus,Pleconaril,CC1=CC(=CC(=C1OCCCC2=CC(=NO2)C)C)C3=NOC(=N3)C(F)(F)F,PHASE2,,metabolic_disease
1650,3318,Psychosis,Lumateperone,CN1CCN2C3CCN(CC3C4=C2C1=CC=C4)CCCC(=O)C5=CC=C(C=C5)F,APPROVED,,metabolic_disease
1640,3114,Congenital Adrenal Hyperplasia,Nevanimibe,CC(C)C1=C(C(=CC=C1)C(C)C)NC(=O)NCC2(CCCC2)C3=CC=C(C=C3)N(C)C,PHASE2,,metabolic_disease
1631,2987,Stunting|Wasting,Chickpea,,PHASE2|PHASE3,,metabolic_disease
1629,2980,Type 2 Diabetes,Trelagliptin,CN1C(=O)C=C(N(C1=O)CC2=C(C=CC(=C2)F)C#N)N3CCCC(C3)N,APPROVED,,metabolic_disease
1622,2857,"Diabetes Mellitus, Type 1",Otelixizumab,,PHASE1|PHASE2,,metabolic_disease
1621,2853,Osteoporosis,Apomine,CC(C)OP(=O)(C(CC1=CC(=C(C(=C1)C(C)(C)C)O)C(C)(C)C)P(=O)(OC(C)C)OC(C)C)OC(C)C,PHASE1|PHASE2,,metabolic_disease
1617,2837,Insulin Sensitivity,Eritoran,CCCCCCCCCCCC(=O)CC(=O)NC1C(C(C(OC1OP(=O)(O)O)COC2C(C(C(C(O2)COC)OP(=O)(O)O)OCCC(CCCCCCC)OC)NC(=O)CCCCCCCCCC=CCCCCCC)O)OCCCCCCCCCC,PHASE2,,metabolic_disease
1612,2736,Osteoporosis,Ronacaleret,CC(C)(CC1CC2=CC=CC=C2C1)NCC(COC3=C(C(=CC(=C3)CCC(=O)O)F)F)O,PHASE1,,metabolic_disease
1611,2730,Type2diabetes,Henagliflozin,CCOC1=C(C=C(C=C1)CC2=C(C=CC(=C2)C34C(C(C(C(O3)(CO4)CO)O)O)O)Cl)F,APPROVED,,metabolic_disease
1607,2677,Diabetes Mellitus Type 2,Taspoglutide,CCC(C)C(C(=O)NC(C)C(=O)NC(CC1=CNC2=CC=CC=C21)C(=O)NC(CC(C)C)C(=O)NC(C(C)C)C(=O)NC(CCCCN)C(=O)NC(C)(C)C(=O)NC(CCCNC(=N)N)C(=O)N)NC(=O)C(CC3=CC=CC=C3)NC(=O)C(CCC(=O)O)NC(=O)C(CCCCN)NC(=O)C(C)NC(=O)C(C)NC(=O)C(CCC(=O)N)NC(=O)CNC(=O)C(CCC(=O)O)NC(=O)C(CC(C)C)NC(=O)C(CC4=CC=C(C=C4)O)NC(=O)C(CO)NC(=O)C(CO)NC(=O)C(C(C)C)NC(=O)C(CC(=O)O)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C(CC5=CC=CC=C5)NC(=O)C(C(C)O)NC(=O)CNC(=O)C(CCC(=O)O)NC(=O)C(C)(C)NC(=O)C(CC6=CN=CN6)N,PHASE2,,metabolic_disease
1604,2668,Insulin Resistance|Type 2 Diabetes Mellitus|Obesity|Androgen Deficiency|Metabolic Disease,Acyline,CC(C)CC(C(=O)NC(CCCCNC(C)C)C(=O)N1CCCC1C(=O)NC(C)C(=O)N)NC(=O)C(CC2=CC=C(C=C2)NC(=O)C)NC(=O)C(CC3=CC=C(C=C3)NC(=O)C)NC(=O)C(CO)NC(=O)C(CC4=CN=CC=C4)NC(=O)C(CC5=CC=C(C=C5)Cl)NC(=O)C(CC6=CC7=CC=CC=C7C=C6)NC(=O)C,PHASE1|PHASE2,,metabolic_disease
1598,2592,Anorexia|Weight Loss|Cachexia,Flurandrenolone,CC1(OC2CC3C4CC(C5=CC(=O)CCC5(C4C(CC3(C2(O1)C(=O)CO)C)O)C)F)C,PHASE2,,metabolic_disease
1576,2309,Healthy|Type 1 Diabetes,Lisofylline,CC(CCCCN1C(=O)C2=C(N=CN2C)N(C1=O)C)O,PHASE1|PHASE2,,metabolic_disease
1575,2304,"Blood Glucose, Low|Hypoglycemia",Gemifloxacin,CON=C1CN(CC1CN)C2=C(C=C3C(=O)C(=CN(C3=N2)C4CC4)C(=O)O)F,PHASE1,,metabolic_disease
1574,2296,Hypercholesterolemia,Lapaquistat,CC(C)(CN1C2=C(C=C(C=C2)Cl)C(OC(C1=O)CC(=O)N3CCC(CC3)CC(=O)O)C4=C(C(=CC=C4)OC)OC)CO,PHASE2,,metabolic_disease
1572,2280,Hyperkalemia,Levalbuterol,CC(C)(C)NCC(C1=CC(=C(C=C1)O)CO)O,APPROVED,,metabolic_disease
1571,2279,Hyperkalemia,Levosalbutamol,CC(C)(C)NCC(C1=CC(=C(C=C1)O)CO)O,APPROVED,,metabolic_disease
1542,2072,Lymphoma|Advanced Cancer,Tasisulam,C1=CC(=C(C=C1Cl)Cl)C(=O)NS(=O)(=O)C2=CC=C(S2)Br,PHASE1,,metabolic_disease
1541,2071,Lymphoma|Advanced Cancer,Tolbutamide,CCCCNC(=O)NS(=O)(=O)C1=CC=C(C=C1)C,PHASE1,,metabolic_disease
1515,1857,"Osteoporosis, Postmenopausal",Blosozumab,,PHASE1,,metabolic_disease
1495,1581,Metabolic Syndrome,Treamid,C1=CN=C(N1)CCNC(=O)CCCC(=O)NCCC2=NC=CN2,PHASE1,,metabolic_disease
1473,1434,Type 2 Diabetes,Rivoglitazone,CN1C2=C(C=CC(=C2)OC)N=C1COC3=CC=C(C=C3)CC4C(=O)NC(=O)S4,PHASE2|PHASE3,,metabolic_disease
1460,1379,Obesity|Hyperglycemia|Insulin Resistance,Polydextrose,,PHASE2,,metabolic_disease
1407,983,Cancer Cachexia,Macimorelin,CC(C)(C(=O)NC(CC1=CNC2=CC=CC=C21)C(=O)NC(CC3=CNC4=CC=CC=C43)NC=O)N,PHASE2,,metabolic_disease
1389,868,Osteoarthritis,Relacatib,CC1CCC(C(=O)CN1S(=O)(=O)C2=CC=CC=N2)NC(=O)C(CC(C)C)NC(=O)C3=CC4=CC=CC=C4O3,PHASE1,,metabolic_disease
1385,859,Gout,Arhalofenate,CC(=O)NCCOC(=O)C(C1=CC=C(C=C1)Cl)OC2=CC=CC(=C2)C(F)(F)F,PHASE2,,metabolic_disease
1382,821,G6PD Normal|G6PD Deficient|Healthy,Primaquine,CC(CCCN)NC1=C2C(=CC(=C1)OC)C=CC=N2,PHASE1,,metabolic_disease
1377,793,"Osteoporosis, Postmenopausal",Abaloparatide,CCC(C)C(C(=O)NC(CCC(=O)N)C(=O)NC(CC(=O)O)C(=O)NC(CC(C)C)C(=O)NC(CCCNC(=N)N)C(=O)NC(CCCNC(=N)N)C(=O)NC(CCCNC(=N)N)C(=O)NC(CCC(=O)O)C(=O)NC(CC(C)C)C(=O)NC(CC(C)C)C(=O)NC(CCC(=O)O)C(=O)NC(CCCCN)C(=O)NC(CC(C)C)C(=O)NC(CC(C)C)C(=O)NC(C)(C)C(=O)NC(CCCCN)C(=O)NC(CC(C)C)C(=O)NC(CC1=CN=CN1)C(=O)NC(C(C)O)C(=O)NC(C)C(=O)N)NC(=O)C(CO)NC(=O)C(CCCCN)NC(=O)CNC(=O)C(CCCCN)NC(=O)C(CC(=O)O)NC(=O)C(CC2=CN=CN2)NC(=O)C(CC(C)C)NC(=O)C(CC(C)C)NC(=O)C(CCC(=O)N)NC(=O)C(CC3=CN=CN3)NC(=O)C(CCC(=O)O)NC(=O)C(CO)NC(=O)C(C(C)C)NC(=O)C(C)N,APPROVED,,metabolic_disease
1374,785,"Ultraviolet Rays|Immunosuppression|Hypersensitivity, Delayed|Immune Tolerance/Drug Effects",Diphencyprone,C1=CC=C(C=C1)C2=C(C2=O)C3=CC=CC=C3,PHASE1,,metabolic_disease
1356,685,Lipodystrophy,Leptin,CC(C)CC(C(=NC(CCC(=N)O)C(=NCC(=NC(CO)C(=NC(CC(C)C)C(=NC(CCC(=N)O)C(=NC(CC(=O)O)C(=NC(CCSC)C(=NC(CC(C)C)C(=NC(CC1=CNC2=CC=CC=C21)C(=NC(CCC(=N)O)C(=NC(CC(C)C)C(=NC(CC(=O)O)C(=NC(CC(C)C)C(=NC(CO)C(=O)N3CCCC3C(=NCC(=NC(CS)C(=O)O)O)O)O)O)O)O)O)O)O)O)O)O)O)O)O)O)N,PHASE2,,metabolic_disease
1330,576,TTR-mediated Amyloidosis,Patisiran,,PHASE2,,metabolic_disease
1296,436,Castration-resistant Prostate Cancer,Coenzyme A,CC(C)(COP(=O)(O)OP(=O)(O)OCC1C(C(C(O1)N2C=NC3=C(N=CN=C32)N)O)OP(=O)(O)O)C(C(=O)NCCC(=O)NCCS)O,PHASE1|PHASE2,,metabolic_disease
1287,399,Osteoporosis,Ibandronate,CCCCCN(C)CCC(O)(P(=O)(O)O)P(=O)(O)O,PHASE2,,metabolic_disease
1281,390,Hermansky-Pudlak Syndrome (HPS)|Pulmonary Fibrosis|Oculocutaneous Albinism|Platelet Storage Pool Deficiency|Metabolic Disease,Zileuton,CC(C1=CC2=CC=CC=C2S1)N(C(=O)N)O,PHASE1|PHASE2,,metabolic_disease
1278,368,Genetic Sucrase-Isomaltase Deficiency,Sacrosidase,,APPROVED,,metabolic_disease
1276,364,Type 1 Diabetes Mellitus,Teplizumab,,PHASE2|PHASE3,,metabolic_disease
1262,321,Beta-Thalassemia,Deferitrin,CC1(CSC(=N1)C2=C(C=C(C=C2)O)O)C(=O)O,PHASE1|PHASE2,,metabolic_disease
1261,306,Type 1 Diabetes,Eflornithine,C(CC(C(F)F)(C(=O)O)N)CN,PHASE1,,metabolic_disease
1241,259,Renal Transplant Recipients|Posttransplant Diabetes Mellitus|Posttransplant Impaired Glucose Tolerance,Nateglinide,CC(C)C1CCC(CC1)C(=O)NC(CC2=CC=CC=C2)C(=O)O,APPROVED,,metabolic_disease
1237,242,Type 2 Diabetes Mellitus|Insulin Sensitivity/Resistance,Voglibose,C1C(C(C(C(C1(CO)O)O)O)O)NC(CO)CO,APPROVED,,metabolic_disease
1233,231,"Diabetes Mellitus, Insulin-Dependent",Ladarixin,CC(C1=CC=C(C=C1)OS(=O)(=O)C(F)(F)F)C(=O)NS(=O)(=O)C,PHASE2,,metabolic_disease
1230,223,Osteoporosis,Odanacatib,CC(C)(CC(C(=O)NC1(CC1)C#N)NC(C2=CC=C(C=C2)C3=CC=C(C=C3)S(=O)(=O)C)C(F)(F)F)F,PHASE1,,metabolic_disease
1221,196,Type 2 Diabetes,Tesaglitazar,CCOC(CC1=CC=C(C=C1)OCCC2=CC=C(C=C2)OS(=O)(=O)C)C(=O)O,PHASE2,,metabolic_disease
1200,137,Osteoporosis in Postmenopausal Women,Eldecalcitol,CC(CCCC(C)(C)O)C1CCC2C1(CCCC2=CC=C3CC(C(C(C3=C)O)OCCCO)O)C,APPROVED,,metabolic_disease
1154,42,Type 1 Diabetes,Pramlintide,CCC(C)C(C(=O)NC(CC(C)C)C(=O)N1CCCC1C(=O)N2CCCC2C(=O)NC(C(C)O)C(=O)NC(CC(=O)N)C(=O)NC(C(C)C)C(=O)NCC(=O)NC(CO)C(=O)NC(CC(=O)N)C(=O)NC(C(C)O)C(=O)NC(CC3=CC=C(C=C3)O)C(=O)N)NC(=O)C4CCCN4C(=O)CNC(=O)C(CC5=CC=CC=C5)NC(=O)C(CC(=O)N)NC(=O)C(CC(=O)N)NC(=O)C(CO)NC(=O)C(CO)NC(=O)C(CC6=CNC=N6)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC7=CC=CC=C7)NC(=O)C(CC(=O)N)NC(=O)C(C)NC(=O)C(CC(C)C)NC(=O)C(CCCNC(=N)N)NC(=O)C(CCC(=O)N)NC(=O)C(C(C)O)NC(=O)C(C)NC(=O)C8CSSCC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N8)C(C)O)C)C(C)O)CC(=O)N)NC(=O)C(CCCCN)N,APPROVED,,metabolic_disease
1146,23,Mucopolysaccharidosis I,Laronidase,,PHASE1|PHASE2,,metabolic_disease
1126,22638,Skin Alterations Associated With Atopic Dermatitis,Sertaconazole,C1=CC2=C(C(=C1)Cl)SC=C2COC(CN3C=CN=C3)C4=C(C=C(C=C4)Cl)Cl,PHASE2,,immune_system_disease
1125,22611,Seasonal Allergic Rhinitis,Xylometazoline,CC1=CC(=CC(=C1CC2=NCCN2)C)C(C)(C)C,APPROVED,,immune_system_disease
1121,22429,Immune System Diseases,Strimvelis,,APPROVED,,immune_system_disease
1115,22201,Rheumatoid Arthritis,Aceclofenac,C1=CC=C(C(=C1)CC(=O)OCC(=O)O)NC2=C(C=CC=C2Cl)Cl,APPROVED,,immune_system_disease
1108,21969,Allergic Rhinitis,Emedastine,CCOCCN1C2=CC=CC=C2N=C1N3CCCN(CC3)C,APPROVED,,immune_system_disease
1104,21800,Neoplasms,Daniquidone,C1C2=C(C=CC(=C2)N)N=C3N1C(=O)C4=CC=CC=C43,PHASE1,,immune_system_disease
1085,21094,HIV Infections|Acquired Immune Deficiency Syndrome,Carbomer,,PHASE1,,immune_system_disease
1081,20733,B-cell Non Hodgkin Lymphoma|Richter's Transformation,Cosibelimab,,PHASE1,,immune_system_disease
1080,20647,"Leukemia, Lymphocytic, Acute|Leukemia, Nonlymphocytic, Acute|Leukemia, Myeloid, Chronic|Myelodysplastic Syndromes",Vosaroxin,CNC1CN(CC1OC)C2=NC3=C(C=C2)C(=O)C(=CN3C4=NC=CS4)C(=O)O,PHASE1,,immune_system_disease
1079,20620,Rheumatoid Arthritis,Roxithromycin,CCC1C(C(C(C(=NOCOCCOC)C(CC(C(C(C(C(C(=O)O1)C)OC2CC(C(C(O2)C)O)(C)OC)C)OC3C(C(CC(O3)C)N(C)C)O)(C)O)C)C)O)(C)O,APPROVED,,immune_system_disease
1078,20612,Peripheral T Cell Lymphoma|Relapse/Recurrence,Lacutamab,,PHASE2,,immune_system_disease
1074,20157,Metastatic Castration-Resistant Prostate Cancer|Metastatic Castration-Sensitive Prostate Cancer|Non-Metastatic Castration-Resistant Prostate Cancer,Relugolix,CN(C)CC1=C(SC2=C1C(=O)N(C(=O)N2CC3=C(C=CC=C3F)F)C4=NN=C(C=C4)OC)C5=CC=C(C=C5)NC(=O)NOC,PHASE1,,immune_system_disease
1072,20012,Hematopoietic and Lymphoid Cell Neoplasm|Recurrent Acute Biphenotypic Leukemia|Recurrent Acute Myeloid Leukemia|Recurrent Myelodysplastic Syndrome|Refractory Acute Biphenotypic Leukemia|Refractory Acute Myeloid Leukemia|Refractory Myelodysplastic Syndrome,Omacetaxine,COC1=CC23CCCN2CCC4=CC5=C(C=C4C3C1O)OCO5,PHASE1|PHASE2,,immune_system_disease
1070,19952,"Lymphoma, T-Cell, Cutaneous",Quisinostat,CN1C=C(C2=CC=CC=C21)CNCC3CCN(CC3)C4=NC=C(C=N4)C(=O)NO,PHASE2,,immune_system_disease
1069,19895,Asthma,Pitrakinra,,PHASE2,,immune_system_disease
1068,19875,Chronic Spontaneous Urticaria,Lirentelimab,,PHASE2,,immune_system_disease
1067,19776,Recurrent Anaplastic Large Cell Lymphoma|Recurrent Diffuse Large B-Cell Lymphoma|Recurrent Mantle Cell Lymphoma|Recurrent Transformed Non-Hodgkin Lymphoma|Refractory Anaplastic Large Cell Lymphoma|Refractory Diffuse Large B-Cell Lymphoma|Refractory Mantle Cell Lymphoma|Refractory Transformed Non-Hodgkin Lymphoma,Onalespib,CC(C)C1=CC(=C(C=C1O)O)C(=O)N2CC3=C(C2)C=C(C=C3)CN4CCN(CC4)C,PHASE2,,immune_system_disease
1064,19590,HIV Infections,Oxazepam,C1=CC=C(C=C1)C2=NC(C(=O)NC3=C2C=C(C=C3)Cl)O,PHASE1,,immune_system_disease
1062,19384,HIV Infections|Human Immunodeficiency Virus,Dexelvucitabine,C1=CC(OC1CO)N2C=C(C(=NC2=O)N)F,PHASE2,,immune_system_disease
1061,19308,Hematologic Malignancies,Tildrakizumab,,PHASE2,,immune_system_disease
1059,19095,"Lymphoma, Non-Hodgkin",Emactuzumab,,PHASE1,,immune_system_disease
1056,18969,Philadelphia Chromosome|Acute Myeloid Leukemia|Acute Lymphoblastic Leukemia|Chronic Myeloid Leukemia|Mixed Phenotype Acute Leukemia,Flumatinib,CC1=C(C=C(C=N1)NC(=O)C2=CC(=C(C=C2)CN3CCN(CC3)C)C(F)(F)F)NC4=NC=CC(=N4)C5=CN=CC=C5,PHASE2,,immune_system_disease
1055,18930,"Arthritis, Rheumatoid",Fontolizumab,,PHASE2,,immune_system_disease
1050,18562,"Lymphoma, Non-Hodgkin|HIV Infections",Mitoguazone,CC(=NN=C(N)N)C=NN=C(N)N,PHASE2,,immune_system_disease
1049,18534,"Asthma, Exercise-Induced",Reproterol,CN1C2=C(C(=O)N(C1=O)C)N(C=N2)CCCNCC(C3=CC(=CC(=C3)O)O)O,PHASE2,,immune_system_disease
1048,18524,"Rhinitis, Allergic, Perennial and Seasonal",Levocabastine,CC1CN(CCC1(C2=CC=CC=C2)C(=O)O)C3CCC(CC3)(C#N)C4=CC=C(C=C4)F,PHASE2,,immune_system_disease
1030,17912,Stage III Diffuse Large B-Cell Lymphoma|Stage IV Diffuse Large B-Cell Lymphoma,Pidilizumab,,PHASE2,,immune_system_disease
1028,17806,Primary Immune Thrombocytopenia (ITP),Ianalumab,,PHASE2,,immune_system_disease
1026,17598,Pulmonary Lymphangioleiomyomatosis,Saracatinib,CN1CCN(CC1)CCOC2=CC3=C(C(=C2)OC4CCOCC4)C(=NC=N3)NC5=C(C=CC6=C5OCO6)Cl,PHASE1,,immune_system_disease
1024,17494,"Tuberculosis, Pulmonary|Tuberculosis, Multidrug-Resistant|Tuberculosis, MDR|Tuberculosis|Drug-Resistant Tuberculosis",Bedaquiline,CN(C)CCC(C1=CC=CC2=CC=CC=C21)(C(C3=CC=CC=C3)C4=C(N=C5C=CC(=CC5=C4)Br)OC)O,PHASE2|PHASE3,,immune_system_disease
1023,17493,"Tuberculosis, Pulmonary|Tuberculosis, Multidrug-Resistant|Tuberculosis, MDR|Tuberculosis|Drug-Resistant Tuberculosis",Pretomanid,C1C(COC2=NC(=CN21)[N+](=O)[O-])OCC3=CC=C(C=C3)OC(F)(F)F,PHASE2|PHASE3,,immune_system_disease
1022,17491,"Arthritis, Rheumatoid",Otilimab,,PHASE1,,immune_system_disease
1021,17473,Advanced Solid Tumors|Lymphoma,Quarfloxin,CN1CCCC1CCNC(=O)C2=CN3C4=CC5=CC=CC=C5C=C4OC6=C3C(=CC(=C6N7CCC(C7)C8=NC=CN=C8)F)C2=O,PHASE1,,immune_system_disease
1019,17420,Placental Malaria Infection|HIV Infections|Stillbirth|Prematurity|Neonatal Deaths,Sulfadoxine,COC1=C(N=CN=C1OC)NS(=O)(=O)C2=CC=C(C=C2)N,APPROVED,,immune_system_disease
1011,17136,Solid Tumors and Lymphomas,Exemestane,CC12CCC3C(C1CCC2=O)CC(=C)C4=CC(=O)C=CC34C,PHASE1,,immune_system_disease
1010,17135,Solid Tumors and Lymphomas,Alobresib,CC1=C(C(=NO1)C)C2=CC(=C3C(=C2)NC(=N3)C4CC4)C(C5=CC=CC=N5)(C6=CC=CC=N6)O,PHASE1,,immune_system_disease
1004,16853,Recurrent Mantle Cell Lymphoma|Refractory Mantle Cell Lymphoma,Eprenetapopt,COCC1(C(=O)C2CCN1CC2)CO,PHASE2,,immune_system_disease
998,16658,"Leukemia, Lymphocytic, Chronic, B-Cell|Lymphoma, Large B-Cell, Diffuse|Lymphoma, Follicular|Lymphoma, Mantle-Cell|Precursor Cell Lymphoblastic Leukemia-Lymphoma",Duvortuxizumab,,PHASE1,,immune_system_disease
994,16469,HIV Infections,Alovudine,CC1=CN(C(=O)NC1=O)C2CC(C(O2)CO)F,PHASE2,,immune_system_disease
980,15738,Eosinophilic Asthma,Etokimab,,PHASE2,,immune_system_disease
979,15687,HIV Infections,Fostemsavir,CC1=NN(C=N1)C2=NC=C(C3=C2N(C=C3C(=O)C(=O)N4CCN(CC4)C(=O)C5=CC=CC=C5)COP(=O)(O)O)OC,PHASE1,,immune_system_disease
974,15327,Recurrent Adult Acute Lymphoblastic Leukemia|Refractory Adult Acute Lymphoblastic Leukemia,Volasertib,CCC1C(=O)N(C2=CN=C(N=C2N1C(C)C)NC3=C(C=C(C=C3)C(=O)NC4CCC(CC4)N5CCN(CC5)CC6CC6)OC)C,PHASE1,,immune_system_disease
972,15256,"Leukemia, B-Cell, Chronic",Acadesine,C1=NC(=C(N1C2C(C(C(O2)CO)O)O)N)C(=O)N,PHASE1|PHASE2,,immune_system_disease
968,15126,Asthma,Gallopamil,CC(C)C(CCCN(C)CCC1=CC(=C(C=C1)OC)OC)(C#N)C2=CC(=C(C(=C2)OC)OC)OC,PHASE2,,immune_system_disease
966,15041,Diffuse B-Cell Lymphoma,Avadomide,CC1=NC2=CC=CC(=C2C(=O)N1C3CCC(=O)NC3=O)N,PHASE1,,immune_system_disease
964,14979,Allergic Conjunctivitis,Reproxalap,CC(C)(C1=C(C=C2C=C(C=CC2=N1)Cl)N)O,PHASE1|PHASE2,,immune_system_disease
963,14930,Chronic Lymphocytic Leukemia,Milatuzumab,,PHASE1|PHASE2,,immune_system_disease
960,14846,Leukemias|Acute Myeloid Leukemia (AML)|Acute Lymphocytic Leukemia (ALL)|Adult T Cell Leukemia (ATL)|Chronic Myeloid Leukemia (CML-BP)|Chronic Lymphocytic Leukemia (CLL)|Myelodysplastic Syndrome (MDS)|Chronic Myelomonocytic Leukemia (CMML),Terameprocol,CC(CC1=CC(=C(C=C1)OC)OC)C(C)CC2=CC(=C(C=C2)OC)OC,PHASE1,,immune_system_disease
953,14591,Relapsed/Refractory Diffuse Large B Cell Lymphoma,Poseltinib,CN1CCN(CC1)C2=CC=C(C=C2)NC3=NC4=C(C(=N3)OC5=CC=CC(=C5)NC(=O)C=C)OC=C4,PHASE2,,immune_system_disease
946,14303,Chronic Spontaneous Urticaria,Ligelizumab,,PHASE2,,immune_system_disease
942,14152,Chronic Graft-versus-host-disease,Axatilimab,,PHASE2,,immune_system_disease
939,14024,HIV Infections,Lentinan,C(C1C(C(C(C(O1)OCC2C(C(C(C(O2)O)O)OC3C(C(C(C(O3)CO)O)OC4C(C(C(C(O4)CO)O)OC5C(C(C(C(O5)COC6C(C(C(C(O6)CO)O)O)O)O)OC7C(C(C(C(O7)CO)O)O)O)O)O)O)O)O)O)O)O,PHASE2,,immune_system_disease
935,13943,Cutaneous T-Cell Lymphoma,Tazarotene,CCOC(=O)C1=CN=C(C=C1)C#CC2=CC3=C(C=C2)SCCC3(C)C,PHASE1|PHASE2,,immune_system_disease
923,13511,P Acnes Colonization,Adapalene,COC1=C(C=C(C=C1)C2=CC3=C(C=C2)C=C(C=C3)C(=O)O)C45CC6CC(C4)CC(C6)C5,APPROVED,,immune_system_disease
921,13482,Allergic Reactions,Brompheniramine,CN(C)CCC(C1=CC=C(C=C1)Br)C2=CC=CC=N2,PHASE1,,immune_system_disease
920,13467,Systemic Lupus Erythematosus,Afimetoran,CC1=C(C2=NC=NN2C=C1C3=C(C4=C(N3)C=CC(=C4)C5CCN(CC5)CC(=O)N)C(C)C)C,PHASE2,,immune_system_disease
916,13417,"Blast Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive|Recurrent Acute Biphenotypic Leukemia|Recurrent Acute Lymphoblastic Leukemia|Recurrent Acute Myeloid Leukemia|Recurrent Chronic Myelogenous Leukemia, BCR-ABL1 Positive|Recurrent T-Cell Prolymphocytic Leukemia|Refractory Acute Biphenotypic Leukemia|Refractory Acute Lymphoblastic Leukemia|Refractory Acute Myeloid Leukemia|Refractory Chronic Myelogenous Leukemia, BCR-ABL1 Positive|Refractory T-Cell Prolymphocytic Leukemia",Pegcrisantaspase,,PHASE1,,immune_system_disease
914,13321,HIV Infections,Vesnarinone,COC1=C(C=C(C=C1)C(=O)N2CCN(CC2)C3=CC4=C(C=C3)NC(=O)CC4)OC,PHASE1,,immune_system_disease
913,13294,HIV Infections,Peldesine,C1=CC(=CN=C1)CC2=CNC3=C2N=C(NC3=O)N,PHASE1,,immune_system_disease
906,13076,Urticaria,Quilizumab,,PHASE2,,immune_system_disease
901,12831,Rheumatoid Arthritis,Bimekizumab,,PHASE2,,immune_system_disease
893,12576,HIV Infections,Telinavir,CC(C)CN(CC(C(CC1=CC=CC=C1)NC(=O)C(CC(=O)N)NC(=O)C2=NC3=CC=CC=C3C=C2)O)C(=O)NC(C)(C)C,PHASE1,,immune_system_disease
892,12514,Allergic Asthma,Pemirolast,CC1=CC=CN2C1=NC=C(C2=O)C3=NNN=N3,PHASE2,,immune_system_disease
890,12454,"Dermatitis, Atopic|Eczema",Desonide,CC1(OC2CC3C4CCC5=CC(=O)C=CC5(C4C(CC3(C2(O1)C(=O)CO)C)O)C)C,APPROVED,,immune_system_disease
875,11923,HIV Infections,Glycovir,CCCCN1CC(C(C(C1COC(=O)CCC)OC(=O)CCC)OC(=O)CCC)OC(=O)CCC,PHASE2,,immune_system_disease
864,11588,Hodgkin Lymphoma,Mocetinostat,C1=CC=C(C(=C1)N)NC(=O)C2=CC=C(C=C2)CNC3=NC=CC(=N3)C4=CN=CC=C4,PHASE1|PHASE2,,immune_system_disease
863,11513,Human Immunodeficiency Virus (HIV)-1 Infection,Elvucitabine,C1=CC(OC1CO)N2C=C(C(=NC2=O)N)F,PHASE2,,immune_system_disease
851,11223,"Lymphoma, Non-Hodgkin's",Galiximab,,PHASE1,,immune_system_disease
848,11177,Relapsed/Refractory Large B-cell Lymphoma,Lenzilumab,,PHASE1,,immune_system_disease
840,10897,Mantle-Cell Lymphoma,Obatoclax,CC1=CC(=C(N1)C=C2C(=CC(=C3C=C4C=CC=CC4=N3)N2)OC)C,PHASE1|PHASE2,,immune_system_disease
823,10343,Allergic Rhinitis|Upper Respiratory Infection,Doxylamine,CC(C1=CC=CC=C1)(C2=CC=CC=N2)OCCN(C)C,PHASE1,,immune_system_disease
817,10214,HIV Infections,Bevirimat,CC(=C)C1CCC2(C1C3CCC4C5(CCC(C(C5CCC4(C3(CC2)C)C)(C)C)OC(=O)CC(C)(C)C(=O)O)C)C(=O)O,PHASE2,,immune_system_disease
811,10017,Asthma,Setipiprant,C1CN(CC2=C1N(C3=C2C=C(C=C3)F)CC(=O)O)C(=O)C4=CC=CC5=CC=CC=C54,PHASE2,,immune_system_disease
810,9994,Allergic Conjunctivitis|Rhinoconjunctivitis,Alcaftadine,CN1CCC(=C2C3=CC=CC=C3CCN4C2=NC=C4C=O)CC1,APPROVED,,immune_system_disease
809,9953,Rheumatoid Arthritis,Veltuzumab,,PHASE2,,immune_system_disease
807,9909,HIV-1-infection,Lenacapavir,CC(C)(C#CC1=NC(=C(C=C1)C2=C3C(=C(C=C2)Cl)C(=NN3CC(F)(F)F)NS(=O)(=O)C)C(CC4=CC(=CC(=C4)F)F)NC(=O)CN5C6=C(C7CC7C6(F)F)C(=N5)C(F)(F)F)S(=O)(=O)C,PHASE2|PHASE3,,immune_system_disease
806,9845,HIV Infections,Dinitrochlorobenzene,C1=CC(=C(C=C1[N+](=O)[O-])[N+](=O)[O-])Cl,PHASE1,,immune_system_disease
802,9695,HIV Infections,Emivirine,CCOCN1C(=C(C(=O)NC1=O)C(C)C)CC2=CC=CC=C2,PHASE2,,immune_system_disease
790,9379,Chronic Lymphocytic Leukemia,Cirmtuzumab,,PHASE2,,immune_system_disease
783,9169,Advanced Solid Tumors|Lymphomas,Camptothecin,CCC1(C2=C(COC1=O)C(=O)N3CC4=CC5=CC=CC=C5N=C4C3=C2)O,PHASE1,,immune_system_disease
779,9149,Pruritus|Atopic Dermatitis,Serlopitant,CC(C1=CC(=CC(=C1)C(F)(F)F)C(F)(F)F)OC2CCC3CN(CC3C2C4=CC=C(C=C4)F)C5=CC(=O)CC5,PHASE2,,immune_system_disease
776,9097,Atopic Dermatitis,Omiganan,CCC(C)C(C(=O)NC(CC(C)C)C(=O)NC(CCCNC(=N)N)C(=O)NC(CC1=CNC2=CC=CC=C21)C(=O)N3CCCC3C(=O)NC(CC4=CNC5=CC=CC=C54)C(=O)NC(CC6=CNC7=CC=CC=C76)C(=O)N8CCCC8C(=O)NC(CC9=CNC1=CC=CC=C19)C(=O)NC(CCCNC(=N)N)C(=O)NC(CCCNC(=N)N)C(=O)NC(CCCCN)C(=O)N)N,PHASE2,,immune_system_disease
769,8930,Diffuse Large B-Cell Lymphoma|Follicular Lymphoma|Chronic Lymphocytic Leukemia|Mantle Cell Lymphoma|Small Lymphocytic Lymphoma,Apolizumab,,PHASE1,,immune_system_disease
766,8835,Seasonal Allergic Rhinitis,Bepotastine,C1CN(CCC1OC(C2=CC=C(C=C2)Cl)C3=CC=CC=N3)CCCC(=O)O,PHASE2,,immune_system_disease
763,8752,"Infections, Papillomavirus",Cervarix,,PHASE2,,immune_system_disease
750,8318,Rheumatoid Arthritis,Pegsunercept,,PHASE2,,immune_system_disease
749,8248,Chronic Lymphocytic Leukemia,Oblimersen,CC1=CN(C(=O)NC1=O)C2CC(C(O2)COP(=S)([O-])OC3CC(OC3COP(=O)(OC4CC(OC4COP(=S)([O-])OC5CC(OC5COP(=S)([O-])OC6CC(OC6COP(=S)([O-])OC7CC(OC7COP(=S)([O-])OC8CC(OC8COP(=S)([O-])OC9CC(OC9COP(=S)([O-])OC1CC(OC1COP(=S)([O-])OC1CC(OC1COP(=S)([O-])OC1CC(OC1COP(=S)([O-])OC1CC(OC1COP(=S)([O-])OC1CC(OC1COP(=S)([O-])OC1CC(OC1COP(=S)([O-])OC1CC(OC1COP(=S)([O-])OC1CC(OC1COP(=S)([O-])OC1CC(OC1COP(=S)([O-])OC1CC(OC1CO)N1C=C(C(=O)NC1=O)C)N1C=CC(=NC1=O)N)N1C=C(C(=O)NC1=O)C)N1C=CC(=NC1=O)N)N1C=CC(=NC1=O)N)N1C=CC(=NC1=O)N)N1C=NC2=C(N=CN=C21)N)N1C=NC2=C1N=C(NC2=O)N)N1C=CC(=NC1=O)N)N1C=NC2=C1N=C(NC2=O)N)N1C=C(C(=O)NC1=O)C)N1C=NC2=C1N=C(NC2=O)N)N1C=CC(=NC1=O)N)N1C=NC2=C1N=C(NC2=O)N)N1C=CC(=NC1=O)N)N1C=CC(=NC1=O)N)[S-])N1C=NC2=C(N=CN=C21)N)O.[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+],PHASE1|PHASE2,,immune_system_disease
741,8185,Graft-versus-host Disease,Neihulizumab,,PHASE1,,immune_system_disease
739,8114,"Recurrent ALK Positive Large B-Cell Lymphoma|Recurrent B-Cell Lymphoma, Unclassifiable, With Features Intermediate Between Diffuse Large B-Cell Lymphoma and Classic Hodgkin Lymphoma|Recurrent B-Cell Non-Hodgkin Lymphoma|Recurrent Diffuse Large B-Cell Lymphoma Associated With Chronic Inflammation|Recurrent Diffuse Large B-Cell Lymphoma, Not Otherwise Specified|Recurrent EBV-Positive Diffuse Large B-Cell Lymphoma, Not Otherwise Specified|Recurrent Grade 3b Follicular Lymphoma|Recurrent High Grade B-Cell Lymphoma|Recurrent High Grade B-Cell Lymphoma With MYC and BCL2 or BCL6 Rearrangements|Recurrent High Grade B-Cell Lymphoma With MYC, BCL2, and BCL6 Rearrangements|Recurrent High Grade B-Cell Lymphoma, Not Otherwise Specified|Recurrent Intravascular Large B-Cell Lymphoma|Recurrent Primary Cutaneous Diffuse Large B-Cell Lymphoma, Leg Type|Recurrent Primary Mediastinal (Thymic) Large B-Cell Lymphoma|Recurrent T-Cell/Histiocyte-Rich Large B-Cell Lymphoma|Refractory ALK Positive Large B-Cell Lymphoma|Refractory B-Cell Lymphoma, Unclassifiable, With Features Intermediate Between Diffuse Large B-Cell Lymphoma and Classic Hodgkin Lymphoma|Refractory Diffuse Large B-Cell Lymphoma Associated With Chronic Inflammation|Refractory Diffuse Large B-Cell Lymphoma, Not Otherwise Specified|Refractory EBV-Positive Diffuse Large B-Cell Lymphoma, Not Otherwise Specified|Refractory Grade 3b Follicular Lymphoma|Refractory High Grade B-Cell Lymphoma|Refractory High Grade B-Cell Lymphoma With MYC and BCL2 or BCL6 Rearrangements|Refractory High Grade B-Cell Lymphoma With MYC, BCL2, and BCL6 Rearrangements|Refractory High Grade B-Cell Lymphoma, Not Otherwise Specified|Refractory Intravascular Large B-Cell Lymphoma|Refractory Primary Cutaneous Diffuse Large B-Cell Lymphoma, Leg Type|Refractory Primary Mediastinal (Thymic) Large B-Cell Lymphoma|Refractory T-Cell/Histiocyte-Rich Large B-Cell Lymphoma",Ontorpacept,,PHASE2,,immune_system_disease
738,8109,Non-GCB/ABC Diffuse Large B-Cell Lymphoma|With and Without MyD88 and/or CD79B Mutations,Mivavotinib,CN1C=C(C=N1)C2=NC(=C(C3=C2C(=O)NC3)F)NC4CCCCC4N,PHASE2,,immune_system_disease
734,8051,B-Cell Prolymphocytic Leukemia|Chronic Lymphocytic Leukemia|Peripheral T-Cell Lymphoma|Primary Cutaneous T-Cell Non-Hodgkin Lymphoma|Sezary Syndrome|T-Cell Prolymphocytic Leukemia,Letermovir,COC1=C(C=C(C=C1)C(F)(F)F)N2C(C3=C(C(=CC=C3)F)N=C2N4CCN(CC4)C5=CC(=CC=C5)OC)CC(=O)O,PHASE2,,immune_system_disease
725,7895,Bullous Pemphigoid,Avdoralimab,,PHASE2,,immune_system_disease
721,7783,Asthma|Distal Lung Inflammation,Flunisolide,CC1(OC2CC3C4CC(C5=CC(=O)C=CC5(C4C(CC3(C2(O1)C(=O)CO)C)O)C)F)C,PHASE1|PHASE2,,immune_system_disease
720,7776,Solid Tumors|Lymphoma,Eflapegrastim,,PHASE2,,immune_system_disease
710,7615,Non-Hodgkin's Lymphoma,Dulanermin,CS(=O)(=O)NC1=C(C=C(C=C1)[N+](=O)[O-])OC2=CC=CC=C2,PHASE1|PHASE2,,immune_system_disease
700,7312,Atopic Dermatitis|Psoriasis,Desoximetasone,CC1CC2C3CCC4=CC(=O)C=CC4(C3(C(CC2(C1C(=O)CO)C)O)F)C,APPROVED,,immune_system_disease
697,7269,Systemic Lupus Erythematosus,Rontalizumab,,PHASE2,,immune_system_disease
696,7264,HIV Infections,Thymopentin,CC(C)C(C(=O)NC(CC1=CC=C(C=C1)O)C(=O)O)NC(=O)C(CC(=O)O)NC(=O)C(CCCCN)NC(=O)C(CCCN=C(N)N)N,PHASE2,,immune_system_disease
695,7237,Asthma,Laninamivir,CC(=O)NC1C(C=C(OC1C(C(CO)O)OC)C(=O)O)N=C(N)N,PHASE1,,immune_system_disease
691,7152,"Lymphoma, Low-Grade|Lymphoma, Small Lymphocytic|Lymphoma, Mixed-Cell, Follicular|Lymphoma, Small Cleaved-Cell, Follicular",Pixantrone,C1=CC(=C2C(=C1NCCN)C(=O)C3=C(C2=O)C=NC=C3)NCCN,PHASE1,,immune_system_disease
689,7122,Rheumatoid Arthritis,Cetrorelix,CC(C)CC(C(=O)NC(CCCN=C(N)N)C(=O)N1CCCC1C(=O)NC(C)C(=O)N)NC(=O)C(CCCNC(=O)N)NC(=O)C(CC2=CC=C(C=C2)O)NC(=O)C(CO)NC(=O)C(CC3=CN=CC=C3)NC(=O)C(CC4=CC=C(C=C4)Cl)NC(=O)C(CC5=CC6=CC=CC=C6C=C5)NC(=O)C,PHASE2,,immune_system_disease
682,6941,Asthma,Procaterol,CCC(C(C1=C2C=CC(=O)NC2=C(C=C1)O)O)NC(C)C,PHASE2,,immune_system_disease
661,6424,COVID-19,Sotrovimab,,APPROVED,,immune_system_disease
660,6404,Sarcoidosis; Antimycobacterial Therapy,Ethambutol,CCC(CO)NCCNC(CC)CO,PHASE2,,immune_system_disease
658,6380,Graft Versus Host Disease,Opebacan,,PHASE1|PHASE2,,immune_system_disease
655,6331,Hodgkin Lymphoma,Prolgolimab,,PHASE2,,immune_system_disease
654,6283,Chronic Lymphocytic Leukemia,Lumiliximab,,PHASE2,,immune_system_disease
650,6240,Hematologic Malignancy|Acute Lymphocytic Leukemia|Chronic Lymphocytic Leukemia|Myelodysplasia|Acute Myeloid Leukemia|Chronic Myelogenous Leukemia|Hodgkin's Disease,Ciclopirox,CC1=CC(=O)N(C(=C1)C2CCCCC2)O,PHASE1,,immune_system_disease
649,6232,Lymphoblastic Leukemia,Ziftomenib,CC1=C(C=CC2=C1C=C(N2CC(C)N3CCN(CC3)S(=O)(=O)C)C#N)CN4CCC(CC4)NC5=C6C=C(SC6=NC(=N5)NC)CC(F)(F)F,PHASE1|PHASE2,,immune_system_disease
646,6195,Infectious Mononucleosis,Valomaciclovir,CC(C)C(C(=O)OCCC(CN1C=NC2=C1N=C(NC2=O)N)CO)N,PHASE1|PHASE2,,immune_system_disease
634,5963,HIV Infections,Atevirdine,CCNC1=C(N=CC=C1)N2CCN(CC2)C(=O)C3=CC4=C(N3)C=CC(=C4)OC,PHASE2,,immune_system_disease
630,5850,Thrombotic Thrombocytopenic Purpura,Caplacizumab,,PHASE2|PHASE3,,immune_system_disease
628,5769,HIV Infections,Capravirine,CC(C)C1=C(N(C(=N1)COC(=O)N)CC2=CC=NC=C2)SC3=CC(=CC(=C3)Cl)Cl,PHASE2,,immune_system_disease
617,5584,Asthma,Tralokinumab,,PHASE2,,immune_system_disease
615,5532,Allergic Conjunctivitis,Lifitegrast,CS(=O)(=O)C1=CC=CC(=C1)CC(C(=O)O)NC(=O)C2=C(C=C3CN(CCC3=C2Cl)C(=O)C4=CC5=C(C=C4)C=CO5)Cl,PHASE2,,immune_system_disease
606,5368,Recurrent Acute Biphenotypic Leukemia|Recurrent Acute Myeloid Leukemia|Refractory Acute Biphenotypic Leukemia|Refractory Acute Myeloid Leukemia,Cedazuridine,C1CN(C(=O)NC1O)C2C(C(C(O2)CO)O)(F)F,PHASE2,,immune_system_disease
597,5264,Ebola|HIV/AIDS,Remdesivir,CCC(CC)COC(=O)C(C)NP(=O)(OCC1C(C(C(O1)(C#N)C2=CC=C3N2N=CN=C3N)O)O)OC4=CC=CC=C4,PHASE2,,immune_system_disease
596,5250,HIV/AIDS,Albuvirtide,CCC(C)C(C(=O)NC(CC(=O)N)C(=O)NC(CC(=O)N)C(=O)NC(CC1=CC=C(C=C1)O)C(=O)NC(C(C)O)C(=O)NC(CCCCNC(=O)COCCOCCNC(=O)CCN2C(=O)C=CC2=O)C(=O)NC(CC(C)C)C(=O)NC(C(C)CC)C(=O)NC(CC3=CNC=N3)C(=O)NC(CCC(=O)O)C(=O)NC(CC(C)C)C(=O)NC(C(C)CC)C(=O)NC(CCC(=O)O)C(=O)NC(CCC(=O)O)C(=O)NC(CO)C(=O)NC(CCC(=O)N)C(=O)NC(CC(=O)N)C(=O)NC(CCC(=O)N)C(=O)NC(CCC(=O)N)C(=O)NC(CCC(=O)O)C(=O)NC(CCCCN)C(=O)NC(CC(=O)N)C(=O)NC(CCC(=O)O)C(=O)NC(CCC(=O)N)C(=O)NC(CCC(=O)O)C(=O)NC(CC(C)C)C(=O)NC(CC(C)C)C(=O)N)NC(=O)C(CCC(=O)O)NC(=O)C(CCCNC(=N)N)NC(=O)C(CC(=O)O)NC(=O)C(CC4=CNC5=CC=CC=C54)NC(=O)C(CCC(=O)O)NC(=O)C(CCC(=O)O)NC(=O)C(CC6=CNC7=CC=CC=C76)NC(=O)C,PHASE1,,immune_system_disease
595,5214,Atopic Dermatitis,Ulobetasol,CC1CC2C3CC(C4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)CCl)O)C)O)F)C)F,PHASE2,,immune_system_disease
594,5213,Atopic Dermatitis,Halobetasol,CC1CC2C3CC(C4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)CCl)O)C)O)F)C)F,PHASE2,,immune_system_disease
590,5143,HIV Infections,Racivir,C1C(OC(S1)CO)N2C=C(C(=NC2=O)N)F,PHASE2,,immune_system_disease
587,5116,Mantle Cell Lymphoma,Pegteograstim,,PHASE2,,immune_system_disease
575,4980,Graves Disease|Relapse|Treatment|Drug Withdrawal,Methimazole,CN1C=CNC1=S,APPROVED,,immune_system_disease
571,4854,HIV Infections,Calanolide A,CCCC1=CC(=O)OC2=C1C3=C(C=CC(O3)(C)C)C4=C2C(C(C(O4)C)C)O,PHASE1,,immune_system_disease
566,4726,Advanced Solid Tumor|Lymphoma,Milademetan,CC1(CCC2(CC1)C3(C(C(N2)C(=O)NC4CCC(OC4)C(=O)N)C5=C(C(=NC=C5)Cl)F)C6=C(C=C(C=C6)Cl)NC3=O)C,PHASE1,,immune_system_disease
561,4669,"Peripheral T-Cell Lymphoma (PTCL NOS)|Nodal Lymphomas of T Follicular Helper (TFH)|Follicular T-cell Lymphoma (FTCL)|AITL|ALCL|HSTCL|EATL I,II|MEITL, EATL Type II|Nasal Lymphoma",Cerdulatinib,CCS(=O)(=O)N1CCN(CC1)C2=CC=C(C=C2)NC3=NC=C(C(=N3)NC4CC4)C(=O)N,PHASE2|PHASE3,,immune_system_disease
551,4484,Cytomegalovirus Retinitis|HIV Infections,Sevirumab,,PHASE1,,immune_system_disease
549,4482,Follicular Lymphoma,Allicin,C=CCSS(=O)CC=C,PHASE2,,immune_system_disease
543,4409,Acute Lymphoblastic Leukemia,Teniposide,COC1=CC(=CC(=C1O)OC)C2C3C(COC3=O)C(C4=CC5=C(C=C24)OCO5)OC6C(C(C7C(O6)COC(O7)C8=CC=CS8)O)O,APPROVED,,immune_system_disease
541,4390,HIV Infections,Delavirdine,CC(C)NC1=C(N=CC=C1)N2CCN(CC2)C(=O)C3=CC4=C(N3)C=CC(=C4)NS(=O)(=O)C,PHASE2,,immune_system_disease
539,4356,Allergy to House Dust Mite|Allergic Asthma,Tregalizumab,,PHASE2,,immune_system_disease
526,4156,HIV Infection,Diflunisal,C1=CC(=C(C=C1C2=C(C=C(C=C2)F)F)C(=O)O)O,APPROVED,,immune_system_disease
517,3941,HIV Infections,Tucaresol,C1=CC(=C(C(=C1)OCC2=CC=C(C=C2)C(=O)O)C=O)O,PHASE1,,immune_system_disease
511,3810,COVID-19,Bebtelovimab,,PHASE2,,immune_system_disease
510,3809,COVID-19,Etesevimab,,PHASE2,,immune_system_disease
509,3808,COVID-19,Bamlanivimab,,PHASE2,,immune_system_disease
507,3715,Seasonal Allergic Rhinitis,Epinastine,C1C2C3=CC=CC=C3CC4=CC=CC=C4N2C(=N1)N,PHASE2,,immune_system_disease
488,3354,"High-grade B-cell Lymphoma|Burkitt Lymphoma|Lymphoma, B-Cell|Lymphoma, Large B-Cell, Diffuse|Lymphatic Diseases|Lymphoma, High-Grade|C-MYC/BCL2 Double-Hit High-Grade B-Cell Lymphoma|C-MYC/BCL6 Double-Hit High-Grade B-Cell Lymphoma|C-Myc Gene Rearrangement",Sepantronium,CC1=[N+](C2=C(N1CCOC)C(=O)C3=CC=CC=C3C2=O)CC4=NC=CN=C4,PHASE2,,immune_system_disease
484,3235,Mantle Cell Lymphoma|Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma,Elsamitrucin,CC1C(C(C(C(O1)OC2C(OC(C(C2(C)O)O)C)OC3=CC=CC4=C3C5=C6C7=C(C=CC(=C7C(=O)O5)C)OC(=O)C6=C4O)N)OC)O,PHASE2,,immune_system_disease
479,3107,Acquired Immunodeficiency Syndrome,Dimiracetam,C1CC(=O)N2C1NC(=O)C2,PHASE2,,immune_system_disease
473,3038,Asthma,Tofimilast,CCC1=NN(C2=C1CCN3C2=NN=C3C4=CC=CS4)C5CCCC5,PHASE2,,immune_system_disease
467,2979,Allergic Rhinitis,Bilastine,CCOCCN1C2=CC=CC=C2N=C1C3CCN(CC3)CCC4=CC=C(C=C4)C(C)(C)C(=O)O,APPROVED,,immune_system_disease
464,2954,Atopic Dermatitis,Crisaborole,B1(C2=C(CO1)C=C(C=C2)OC3=CC=C(C=C3)C#N)O,APPROVED,,immune_system_disease
456,2852,"Lymphocytic Leukemia, Chronic|Lymphoma, Non Hodgkin",Mosunetuzumab,,PHASE1|PHASE2,,immune_system_disease
455,2849,Rheumatoid Arthritis,Revamilast,C1=CC(=C2C(=C1C(=O)N=C3C(=CN(C=C3Cl)O)Cl)C4=C(O2)C=CN=C4)OC(F)F,PHASE2,,immune_system_disease
446,2733,Recurrent Adult Lymphoblastic Lymphoma|Recurrent B Acute Lymphoblastic Leukemia|Recurrent T Acute Lymphoblastic Leukemia|Refractory B Acute Lymphoblastic Leukemia|Refractory Lymphoblastic Lymphoma|Refractory T Acute Lymphoblastic Leukemia,Tagraxofusp,,PHASE1|PHASE2,,immune_system_disease
444,2709,Asthma,Nedocromil,CCCC1=C2C(=CC3=C1OC(=CC3=O)C(=O)O)C(=O)C=C(N2CC)C(=O)O,PHASE1,,immune_system_disease
442,2699,Exercise-Induced Asthma,Oglemilast,CS(=O)(=O)NC1=CC2=C(C=C1)OC3=C(C=CC(=C23)C(=O)NC4=C(C=NC=C4Cl)Cl)OC(F)F,PHASE2,,immune_system_disease
439,2690,"Infection, Human Immunodeficiency Virus",Cabotegravir,CC1COC2N1C(=O)C3=C(C(=O)C(=CN3C2)C(=O)NCC4=C(C=C(C=C4)F)F)O,PHASE1,,immune_system_disease
434,2607,Rheumatoid Arthritis,Mavrilimumab,,PHASE2,,immune_system_disease
420,2442,Adult Acute Lymphocytic Leukemia,Vindesine,CCC1(CC2CC(C3=C(CCN(C2)C1)C4=CC=CC=C4N3)(C5=C(C=C6C(=C5)C78CCN9C7C(C=CC9)(C(C(C8N6C)(C(=O)N)O)O)CC)OC)C(=O)OC)O,APPROVED,,immune_system_disease
413,2357,Atopic Dermatitis,Tapinarof,CC(C)C1=C(C=C(C=C1O)C=CC2=CC=CC=C2)O,PHASE2,,immune_system_disease
407,2306,"Pneumonia, Pneumocystis Carinii|HIV Infections",Sitamaquine,CCN(CC)CCCCCCNC1=CC(=CC2=C(C=CN=C12)C)OC,PHASE2,,immune_system_disease
404,2297,"Recurrent Acute Leukemia|Recurrent B Acute Lymphoblastic Leukemia|Recurrent Blastic Plasmacytoid Dendritic Cell Neoplasm|Recurrent Chronic Myelogenous Leukemia, BCR-ABL1 Positive|Recurrent Hairy Cell Leukemia|Recurrent Hematologic Malignancy|Recurrent Hodgkin Lymphoma|Recurrent T Acute Lymphoblastic Leukemia|Refractory Acute Leukemia|Refractory B Acute Lymphoblastic Leukemia|Refractory Blastic Plasmacytoid Dendritic Cell Neoplasm|Refractory Chronic Myelogenous Leukemia, BCR-ABL1 Positive|Refractory Hairy Cell Leukemia|Refractory Hematologic Malignancy|Refractory Hodgkin Lymphoma|Refractory T Acute Lymphoblastic Leukemia|Systemic Mastocytosis",Flotetuzumab,,PHASE1,,immune_system_disease
402,2288,Chronic Urticaria,Miltefosine,CCCCCCCCCCCCCCCCOP(=O)([O-])OCC[N+](C)(C)C,PHASE2,,immune_system_disease
398,2235,"Cutaneous T-cell Lymphoma (CTCL)|Mycosis Fungoides (MF)|Chronic Lymphocytic Leukemia (CLL)|Diffuse Large B-Cell Lymphoma (DLBCL), ABC Subtype|Adult T-Cell Leukemia/Lymphoma (ATLL)",Cobomarsen,CC1=CN(C(=O)NC1=O)C2C3C(C(O2)(CO3)COP(=S)(O)OC4C5C(OC4(CO5)COP(=S)(O)OC6CC(OC6COP(=S)(O)OC7CC(OC7COP(=S)(O)OC8C9C(OC8(CO9)COP(=S)(O)OC1CC(OC1COP(=S)(O)OC1C2C(OC1(CO2)CO)N1C=C(C(=NC1=O)N)C)N1C=NC2=C(N=CN=C21)N)N1C=C(C(=NC1=O)N)C)N1C=NC2=C1N=C(NC2=O)N)N1C=NC2=C(N=CN=C21)N)N1C=C(C(=O)NC1=O)C)OP(=S)(O)OCC1C(CC(O1)N1C=NC2=C(N=CN=C21)N)OP(=S)(O)OCC12COC(C1OP(=S)(O)OCC1C(CC(O1)N1C=CC(=NC1=O)N)OP(=S)(O)OCC13COC(C1OP(=S)(O)OCC14COC(C1OP(=S)(O)OCC15COC(C1OP(=S)(O)OCC16COC(C1O)C(O6)N1C=NC6=C(N=CN=C61)N)C(O5)N1C=C(C(=O)NC1=O)C)C(O4)N1C=C(C(=O)NC1=O)C)C(O3)N1C=NC3=C(N=CN=C31)N)C(O2)N1C=NC2=C1N=C(NC2=O)N,PHASE1,,immune_system_disease
397,2234,Acute Lymphocytic Leukemia,Annamycin,CC1C(C(C(C(O1)OC2CC(CC3=C2C(=C4C(=C3O)C(=O)C5=CC=CC=C5C4=O)O)(C(=O)CO)O)I)O)O,PHASE1|PHASE2,,immune_system_disease
396,2218,Allergic Conjunctivitis,Tranilast,COC1=C(C=C(C=C1)C=CC(=O)NC2=CC=CC=C2C(=O)O)OC,APPROVED,,immune_system_disease
385,2120,"Arthritis, Rheumatoid",Yisaipu,,APPROVED,,immune_system_disease
382,2103,Atopic Dermatitis,Fluocinonide,CC(=O)OCC(=O)C12C(CC3C1(CC(C4(C3CC(C5=CC(=O)C=CC54C)F)F)O)C)OC(O2)(C)C,APPROVED,,immune_system_disease
375,2056,Atopic Dermatitis,Pimecrolimus,CCC1C=C(CC(CC(C2C(CC(C(O2)(C(=O)C(=O)N3CCCCC3C(=O)OC(C(C(CC1=O)O)C)C(=CC4CCC(C(C4)OC)Cl)C)O)C)OC)OC)C)C,APPROVED,,immune_system_disease
370,2000,Autoimmune Hemolytic Anemia|Failure of Two Rounds of Treatment,Linperlisib,CC(C)(C1CCN(CC1)CC2=C3C(=CC(=C2)F)C(=NC(=N3)N4CCOCC4)C5=CC(=C(N=C5)OC)NS(=O)(=O)C)O,PHASE1,,immune_system_disease
368,1969,Cutaneous T-cell Lymphoma (CTCL),Sapacitabine,CCCCCCCCCCCCCCCC(=O)NC1=NC(=O)N(C=C1)C2C(C(C(O2)CO)O)C#N,PHASE2,,immune_system_disease
365,1943,Chronic Lymphocytic Leukemia,Talabostat,B(C1CCCN1C(=O)C(C(C)C)N)(O)O,PHASE2,,immune_system_disease
364,1941,"Sarcoidosis, Cardiac",Namilumab,,PHASE2,,immune_system_disease
354,1824,Pruritus|Atopic Dermatitis,Orvepitant,CC1=C(C=CC(=C1)F)C2CC(CCN2C(=O)N(C)C(C)C3=CC(=CC(=C3)C(F)(F)F)C(F)(F)F)N4CCN5C(C4)CCC5=O,PHASE2,,immune_system_disease
349,1753,"Lymphoma, Large B-Cell, Diffuse",Glofitamab,,PHASE2,,immune_system_disease
346,1731,Asthma,Vilanterol,C1=CC(=C(C(=C1)Cl)COCCOCCCCCCNCC(C2=CC(=C(C=C2)O)CO)O)Cl,PHASE2,,immune_system_disease
331,1618,Atopic Dermatitis,Lebrikizumab,,PHASE2,,immune_system_disease
326,1592,HIV Infections,Dapivirine,CC1=CC(=C(C(=C1)C)NC2=NC(=NC=C2)NC3=CC=C(C=C3)C#N)C,PHASE1,,immune_system_disease
323,1528,Asthma,Abediterol,C1=CC=C(C=C1)C(COCCCCCCNCC(C2=C3C=CC(=O)NC3=C(C=C2)O)O)(F)F,PHASE1,,immune_system_disease
310,1389,"Conjunctivitis, Allergic",Mapracorat,CC1=NC2=C(C=C1)C(=CC=C2)NCC(CC(C)(C)C3=CC(=CC4=C3OCC4)F)(C(F)(F)F)O,PHASE2,,immune_system_disease
303,1342,Chronic Granulomatous Disease,Emapalumab,,PHASE1|PHASE2,,immune_system_disease
301,1330,"Asthma, Bronchial",Ciclesonide,CC(C)C(=O)OCC(=O)C12C(CC3C1(CC(C4C3CCC5=CC(=O)C=CC45C)O)C)OC(O2)C6CCCCC6,APPROVED,,immune_system_disease
292,1271,Immune Thrombocytopenia (ITP),Lusutrombopag,CCCCCCOC(C)C1=CC=CC(=C1OC)C2=CSC(=N2)NC(=O)C3=CC(=C(C(=C3)Cl)C=C(C)C(=O)O)Cl,PHASE2,,immune_system_disease
265,1143,Peripheral T Cell Lymphoma,Tenalisib,CCC(C1=C(C(=O)C2=CC=CC=C2O1)C3=CC(=CC=C3)F)NC4=NC=NC5=C4NC=N5,PHASE2,,immune_system_disease
263,1119,Recurrent B Acute Lymphoblastic Leukemia|Recurrent T Acute Lymphoblastic Leukemia|Refractory B Acute Lymphoblastic Leukemia|Refractory T Acute Lymphoblastic Leukemia,Nelarabine,COC1=NC(=NC2=C1N=CN2C3C(C(C(O3)CO)O)O)N,PHASE1|PHASE2,,immune_system_disease
259,1077,Allergic Contact Dermatitis,Ethylenediamine,C(CN)N,APPROVED,,immune_system_disease
241,947,HIV Infections,Raluridine,C1C(C(OC1N2C=C(C(=O)NC2=O)Cl)CO)F,PHASE1,,immune_system_disease
201,700,Asthma,Ipratropium,CC(C)[N+]1(C2CCC1CC(C2)OC(=O)C(CO)C3=CC=CC=C3)C,APPROVED,,immune_system_disease
189,625,Allergic Rhinitis,Azelastine,CN1CCCC(CC1)N2C(=O)C3=CC=CC=C3C(=N2)CC4=CC=C(C=C4)Cl,APPROVED,,immune_system_disease
187,618,Atopic Dermatitis|Healthy Volunteers,Tezepelumab,,PHASE1,,immune_system_disease
186,609,Mycobacterium Avium-intracellulare Infection,Streptomycin,CC1C(C(C(O1)OC2C(C(C(C(C2O)O)N=C(N)N)O)N=C(N)N)OC3C(C(C(C(O3)CO)O)O)NC)(C=O)O,PHASE2,,immune_system_disease
183,597,B-cell Chronic Lymphocytic Leukemia,Forodesine,C1=C(C2=C(N1)C(=O)NC=N2)C3C(C(C(N3)CO)O)O,PHASE1,,immune_system_disease
176,580,Primary Sjögren's Syndrome,Parsaclisib,CCOC1=C(C(=C(C=C1C(C)N2C3=NC=NC(=C3C(=N2)C)N)Cl)F)C4CC(=O)NC4,PHASE2,,immune_system_disease
173,555,Relapsed Follicular Lymphoma|Refractory Follicular Lymphoma,Epcoritamab,,PHASE2,,immune_system_disease
168,542,Asthma,Methacholine,CC(C[N+](C)(C)C)OC(=O)C,PHASE2,,immune_system_disease
165,519,B-cell Lymphoma Refractory,Ozogamicin,CCN(C1COC(CC1OC)OC2C(C(C(OC2OC3C#CC=CC#CC4(CC(=O)C(=C3C4=CCSSC(C)(C)CC(=O)NN=C(C)C5=CC=C(C=C5)OCCCC(=O)N)NC(=O)OC)O)C)NOC6CC(C(C(O6)C)SC(=O)C7=C(C(=C(C(=C7OC)OC)OC8C(C(C(C(O8)C)O)OC)O)I)C)O)O)C(=O)C,PHASE1,,immune_system_disease
162,502,Allergic Conjunctivitis,Olopatadine,CN(C)CCC=C1C2=CC=CC=C2COC3=C1C=C(C=C3)CC(=O)O,APPROVED,,immune_system_disease
153,433,B-cell Non Hodgkin Lymphoma,Odronextamab,,PHASE2|PHASE3,,immune_system_disease
124,298,Recurrent Chronic Lymphocytic Leukemia|Recurrent Small Lymphocytic Lymphoma|Refractory Chronic Lymphocytic Leukemia|Refractory Small Lymphocytic Lymphoma,Duvelisib,CC(C1=CC2=C(C(=CC=C2)Cl)C(=O)N1C3=CC=CC=C3)NC4=NC=NC5=C4NC=N5,PHASE2,,immune_system_disease
123,287,"Dermatitis, Atopic",Branebrutinib,CC#CC(=O)NC1CCCN(C1)C2=C(C=C(C3=C2C(=C(N3)C)C)C(=O)N)F,PHASE2,,immune_system_disease
122,286,URTICARIA,Rupatadine,CC1=CC(=CN=C1)CN2CCC(=C3C4=C(CCC5=C3N=CC=C5)C=C(C=C4)Cl)CC2,PHASE2,,immune_system_disease
112,264,Post-nasal Drip|Seasonal Allergic Rhinitis|Rhinorrhea,Desloratadine,C1CC2=C(C=CC(=C2)Cl)C(=C3CCNCC3)C4=C1C=CC=N4,PHASE2,,immune_system_disease
108,250,Acute Myeloid Leukemia|Acute Lymphoblastic Leukemia,Aspacytarabine,C1=CN(C(=O)N=C1NC(=O)CC(C(=O)O)N)C2C(C(C(O2)CO)O)O,PHASE1|PHASE2,,immune_system_disease
65,139,Human Immunodeficiency Virus|HIV,Islatravir,C#CC1(C(CC(O1)N2C=NC3=C(N=C(N=C32)F)N)O)CO,PHASE2,,immune_system_disease
54,108,HIV Infections,Amdoxovir,C1C(OC(O1)CO)N2C=NC3=C(N=C(N=C32)N)N,PHASE2,,immune_system_disease
